chrom	start	end	ref	alts	variant	gene	sentence	pmid
chr1	964593	964594	G	A	rs7414551	PLEKHN1	Allele A is not associated with trough concentration of vancomycin as compared to allele G.	26030142
chr1	2016960	2016961	C	A,T	rs13303344		Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele C.	34160285
chr1	2017365	2017366	T	A,C	rs4481796	GABRD	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	34160285
chr1	2024922	2024923	G	A,C,T	rs2376805	GABRD	Allele A is not associated with response to methadone in people with Heroin Dependence as compared to allele G.	34160285
chr1	2025597	2025598	T	C	rs2229110	GABRD	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	34160285
chr1	3167147	3167148	T	A,C,G	rs2651899	PRDM16	Allele C is associated with increased response to Selective serotonin (5HT1) agonists in people with Migraine with Aura or Migraine without Aura as compared to allele T.	26502740
chr1	3362703	3362704	T	A	rs11807862	PRDM16	Genotype AA is associated with decreased response to atorvastatin, hmg coa reductase inhibitors or simvastatin as compared to genotype TT.	24096969
chr1	7785634	7785635	T	C	rs228729	PER3	Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	21781277
chr1	7803232	7803233	C	T	rs228642	PER3	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	21781277
chr1	7808664	7808665	T	A,C	rs228666	PER3	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	21781277
chr1	7827518	7827519	C	G	rs228697	PER3	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	21781277
chr1	7828154	7828155	A	G	rs2859388	PER3	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	21781277
chr1	7830056	7830057	T	C	rs2640909	PER3	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	21781277
chr1	11107088	11107089	G	A	rs12139042	MTOR	Genotype GG is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG.	22901187
chr1	11792242	11792243	C	G,T	rs1476413	MTHFR	Genotypes CC + CT is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype TT.	25084201
chr1	11794418	11794419	T	G	rs1801131	MTHFR	Genotypes GG + GT are associated with increased response to oxaliplatin in people with Colorectal Neoplasms as compared to genotype TT.	20385995
chr1	11796320	11796321	G	A,C	rs1801133	MTHFR	Genotype AG is associated with increased response to l-methylfolate in men with Bipolar Disorder, Depression and Obsessive-Compulsive Disorder.	27520898
chr1	11797730	11797731	G	A	rs17421511	MTHFR	Genotypes AG + GG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.	25084201
chr1	11846010	11846011	A	G	rs5065	NPPA-AS1	Genotype GG is associated with decreased response to bumetanide, furosemide and torasemide in healthy individuals as compared to genotype AA.	20877298
chr1	11847590	11847591	C	T	rs5063	NPPA-AS1	Genotype TT is associated with decreased response to bumetanide, furosemide and torasemide in healthy individuals as compared to genotype CC.	20877298
chr1	12192897	12192898	T	G	rs1061622	TNFRSF1B	Genotypes GG + GT are associated with decreased response to adalimumab, etanercept, infliximab or ustekinumab in people with Psoriasis as compared to genotype TT.	25537528
chr1	12207207	12207208	A	G,T	rs1061624	TNFRSF1B	Genotype GG is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	25850964
chr1	12207234	12207235	C	T	rs3397	TNFRSF1B	Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.	25850964
chr1	12208441	12208442	G	A	rs1061631	TNFRSF1B	Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	25850964
chr1	15524107	15524108	G	A	rs4645983	CASP9	Genotypes AA + AG is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype GG.	25712183
chr1	17307076	17307077	G	A,C,T	rs2477134	PADI4	Allele G is associated with increased concentrations of uric acid in people with Hypertension as compared to allele T.	29580174
chr1	17336143	17336144	T	A,C,G	rs2240340	PADI4	Allele T is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.	25834819
chr1	19285982	19285983	C	G,T	rs2231198	AKR7A3	Genotype CC is not associated with metabolism of bupropion in healthy individuals as compared to genotypes CT + TT.	28685396
chr1	19287569	19287570	G	A,C,T	rs2013249	AKR7A3	Genotype CC is not associated with metabolism of bupropion in healthy individuals as compared to genotypes CG + GG.	28685396
chr1	19308516	19308517	C	A,G,T	rs1043657	AKR7A2	Genotypes CT + TT are not associated with concentrations of exemestane in women with Breast Neoplasms as compared to genotype CC.	27549341
chr1	19666019	19666020	C	T	rs1805054	HTR6	Genotype CC is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.	23733030
chr1	20588678	20588679	C	A,T	rs532545	CDA	Genotype CC is associated with decreased response to capecitabine in women with Breast Neoplasms as compared to genotypes CT + TT.	38156857
chr1	20589096	20589099	CCC	C,CC	rs3215400	CDA	Genotype del/del is associated with increased resistance to azacitidine in people with Leukemia.	26556583
chr1	20589207	20589208	A	C	rs2072671	CDA	Allele C is not associated with decreased metabolism of gemcitabine in people with Neoplasms as compared to allele A.	17194903
chr1	20605334	20605335	A	G,T	rs818194	CDA	Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele T.	24361227
chr1	20616701	20616702	A	G	rs12404655	CDA	Genotypes AG + GG is associated with increased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype AA.	30088438
chr1	20618561	20618562	C	T	rs1048977	CDA	Genotype TT is associated with decreased metabolism of gemcitabine as compared to genotypes CC + CT.	24300978
chr1	20726199	20726200	G	A,T	rs10916852	SH2D5	Genotypes GT + TT are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype GG.	22838950
chr1	21549422	21549423	C	T	rs885814	ALPL	Allele T is associated with decreased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.	33124499
chr1	24601069	24601070	T	C	rs4553122	NCMAP	Allele C is associated with increased response to rivaroxaban in people with Atrial Fibrillation as compared to allele T.	37203300
chr1	27530659	27530660	A	G	rs7512595		Allele A is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele G.	19749758
chr1	28810173	28810174	A	G	rs569356	OPRD1	Genotype GG is associated with decreased dose-adjusted trough concentrations of norbuprenorphine in people with Opioid-Related Disorders as compared to genotypes AA + AG.	37146669
chr1	28812462	28812463	G	C,T	rs1042114	OPRD1	Allele G is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele T.	23612435
chr1	28814642	28814643	G	A,C	rs533123	OPRD1	Allele G is not associated with dose of opioids in people with Pain as compared to allele A.	21398039
chr1	28818611	28818612	G	C,T	rs204047	OPRD1	Genotype GG is associated with increased dose of methadone as compared to genotypes GT + TT.	31907389
chr1	28818675	28818676	C	G,T	rs678849	OPRD1	Genotype TT is not associated with concentrations of methadone as compared to genotypes CC + CT.	31907389
chr1	28822848	28822849	T	C	rs6669447	OPRD1	Allele C is not associated with response to heroin as compared to allele T.	28692418
chr1	28824670	28824671	G	A	rs797397	OPRD1	Genotype AA is associated with increased concentrations of methadone as compared to genotypes AG + GG.	31907389
chr1	28835096	28835097	T	C	rs2236857	OPRD1	Allele T is not associated with dose of opioids in people with Pain as compared to allele C.	21398039
chr1	28838069	28838070	G	A,T	rs10753331		Allele A is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele G.	23612435
chr1	28839625	28839626	T	G	rs2298896	OPRD1	Allele G is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele T.	31206155
chr1	28846111	28846112	G	A,C	rs482387	OPRD1	Genotype AA is not associated with concentrations of methadone as compared to genotypes AG + GG.	31907389
chr1	28848433	28848434	A	C,G	rs529520	OPRD1	Allele C is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.	23612435
chr1	28848860	28848861	A	C,G,T	rs581111	OPRD1	Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.	23612435
chr1	28849700	28849701	A	G	rs12749204	OPRD1	Genotype AA is not associated with dose of methadone as compared to genotypes AG + GG.	31907389
chr1	28852411	28852412	A	T	rs2298895	OPRD1	Genotype AA is not associated with concentrations of methadone as compared to genotypes AT + TT.	31907389
chr1	28855012	28855013	A	G	rs508448	OPRD1	Genotype GG is not associated with concentrations of methadone as compared to genotypes AA + AG.	31907389
chr1	28863084	28863085	C	G,T	rs2234918	OPRD1	Genotype CC is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes CT + TT.	18687376
chr1	28863625	28863626	G	A,T	rs4654327	OPRD1	Genotype AA is not associated with concentrations of methadone as compared to genotypes AG + GG.	31907389
chr1	28863877	28863878	T	A,C,G	rs204076	OPRD1	Genotype AA is not associated with concentrations of methadone as compared to genotypes AT + TT.	31907389
chr1	32290837	32290838	T	A,C	rs1741981	HDAC1	Genotype CC is associated with decreased response to corticosteroids in children with Asthma as compared to genotypes CT + TT.	24307847
chr1	33973692	33973693	C	G,T	rs506546	CSMD2	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr1	36859875	36859876	A	C,G,T	rs6691840	GRIK3	Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.	31014225
chr1	40960191	40960192	G	A	rs12067645	CTPS1	Genotypes AA + AG is associated with increased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype GG.	30088438
chr1	41003731	41003732	C	T	rs4364871	CTPS1	Genotypes CT + TT is associated with decreased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype CC.	30088438
chr1	41011771	41011772	G	A	rs11577910	CTPS1	Genotype AG is associated with increased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype GG.	30088438
chr1	42692758	42692759	C	A,G,T	rs10493112	YBX1	Genotypes AC + CC is associated with increased clinical benefit to abiraterone in men with Prostatic Neoplasms as compared to genotype AA.	32787509
chr1	42805256	42805257	G	A	rs323719	YBX1	Allele A is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele G.	24070809
chr1	42805361	42805362	T	C,G	rs323720	YBX1	Allele C is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele T.	24070809
chr1	46932823	46932824	A	G	rs1126742	CYP4A11	Genotype GG is associated with decreased response to amiloride or spironolactone in people with Hypertension as compared to genotypes AA + AG.	25064769
chr1	46933070	46933071	G	C	rs3890011	CYP4A11	Genotype CC is associated with decreased response to spironolactone in people with Hypertension as compared to genotypes CG + GG.	25064769
chr1	46942277	46942278	T	C	rs9332978	CYP4A11	Genotype CT is not associated with concentrations of exemestane in women with Breast Neoplasms as compared to genotype TT.	27549341
chr1	47331950	47331951	G	A	rs3925058	CMPK1	Genotype AA is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AG + GG.	22838950
chr1	47333966	47333967	G	A,C,T	rs7543016	CMPK1	Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CG + GG.	22838950
chr1	47335172	47335173	A	C,T	rs4492666	CMPK1	Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele C.	24361227
chr1	47367540	47367541	A	C,G	rs11211524	CMPK1	Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele C.	24361227
chr1	47368536	47368537	G	T	rs35687416	CMPK1	Genotype GG is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes GT + TT.	22838950
chr1	47375884	47375885	C	T	rs12090346	CMPK1	Genotype CC is not associated with response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.	21642870
chr1	47377104	47377105	C	A,T	rs1044457	CMPK1	Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.	22838950
chr1	48608972	48608973	C	G,T	rs191190	AGBL4	Genotypes CC + CT is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotype TT.	27977334
chr1	53909896	53909897	C	A,G,T	rs2235544	DIO1	Allele A is not associated with dose of levothyroxine in people with Thyroid Neoplasms as compared to allele C.	24910925
chr1	53910027	53910028	C	T	rs11206244	DIO1	Allele T is not associated with dose of levothyroxine in people with Thyroid Neoplasms as compared to allele C.	24910925
chr1	55053078	55053079	C	T	rs7552841	PCSK9	Genotypes CT + TT is not associated with response to atorvastatin in people with Hypercholesterolemia as compared to genotype CC.	26408409
chr1	55081022	55081023	T	C	rs17111584	USP24	Genotypes CC + CT are associated with decreased response to rosuvastatin as compared to genotype TT.	22331829
chr1	56417818	56417819	G	A,C,T	rs12749274		Allele A is associated with decreased response to naltrexone in people with Alcoholism as compared to allele G.	34302059
chr1	59926821	59926822	C	A	rs890293	CYP2J2	Genotypes AA + AC is associated with increased concentrations of trans 4-hydroxypraziquantel in children with Schistosomiasis as compared to genotype CC.	38778126
chr1	63659767	63659768	A	C	rs4643	PGM1	Genotype CC is associated with decreased concentrations of ethanol in healthy individuals as compared to genotypes AA + AC.	31002879
chr1	65104344	65104345	G	A,C	rs12729349		Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr1	65432297	65432298	G	A,T	rs1045895	LEPR	Genotypes AA + AG is associated with decreased clinical benefit to apremilast in people with Psoriasis as compared to genotype GG.	38540428
chr1	65592829	65592830	A	G,T	rs1137101	LEPR	Allele G is not associated with exposure to olanzapine in healthy individuals as compared to allele A.	33378980
chr1	65772695	65772696	G	A,T	rs12046844	PDE4B	Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele G.	24361227
chr1	66121692	66121693	C	T	rs12745871	PDE4B	Allele T is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele C.	38540428
chr1	66353939	66353940	G	A,C	rs598961	PDE4B	Genotype AA is associated with decreased clinical benefit to ritodrine in women with Premature Birth as compared to genotypes AG + GG.	31324945
chr1	67240274	67240275	G	A	rs11209026	IL23R	Genotype AG is not associated with response to adalimumab in people with Psoriasis as compared to genotype GG.	27564082
chr1	70410095	70410096	C	T	rs648743	CTH	Genotype TT is not associated with clearance of busulfan in children with Hematopoietic stem cell transplantation as compared to genotypes CC + CT.	27779248
chr1	70439116	70439117	G	A,T	rs1021737	CTH	Genotype TT is not associated with clearance of busulfan in children with Hematopoietic stem cell transplantation as compared to genotypes GG + GT.	27779248
chr1	74572543	74572544	A	C	rs11580409	ERICH3	Allele C is associated with increased response to antidepressants as compared to allele A.	33230203
chr1	74591901	74591902	T	A,C	rs696692	ERICH3	Allele T is associated with decreased concentrations of serotonin in people with Depressive Disorder as compared to allele C.	26903268
chr1	78490746	78490747	T	A,C	rs3753380	PTGFR	Genotype CC is associated with increased response to latanoprost as compared to genotypes CT + TT.	17467803
chr1	78491755	78491756	C	A,T	rs3766355	PTGFR	Genotype CC is associated with increased response to latanoprost in people with Glaucoma or Ocular Hypertension as compared to genotypes AA + AC.	27336732
chr1	88090244	88090245	C	T	rs4278350		Allele T is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele C.	27001119
chr1	89384014	89384015	G	A,C	rs928655	GBP6	Genotypes AG + GG is associated with increased response to etanercept in people with Psoriasis as compared to genotype AA.	28470127
chr1	90506612	90506613	T	A,C,G	rs815147		Allele A is not associated with exposure to olanzapine in healthy individuals as compared to allele T.	33378980
chr1	91689779	91689780	T	A,C,G	rs12082710	TGFBR3	Genotype TT is associated with increased response to antidepressants in people with Depression as compared to genotypes CC + CT.	23092981
chr1	94536310	94536311	T	C	rs3917643	F3	Genotype CT is associated with increased response to simvastatin in people with Myocardial Ischemia as compared to genotype TT.	19027114
chr1	94892670	94892671	G	A	rs3818929	SLC44A3	Allele A is not associated with response to risperidone in people with Schizophrenia as compared to allele G.	28696411
chr1	96571526	96571527	T	A,C	rs10783050		Genotype TT is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CT.	26401715
chr1	97078701	97078702	A	G	rs56160474	DPYD	Genotype AG is not associated with response to capecitabine, fluorouracil or s 1 (combination) in people with Stomach Neoplasms as compared to genotype AA.	22490566
chr1	97305363	97305364	C	T	rs1801160	DPYD	Genotype CT is not associated with response to capecitabine, fluorouracil or s 1 (combination) in people with Stomach Neoplasms as compared to genotype CC.	22490566
chr1	97450067	97450068	A	G	rs17376848	DPYD	Genotypes AG + GG is associated with increased concentrations of fluorouracil in people with Colorectal Neoplasms as compared to genotype AA.	23942539
chr1	97515838	97515839	T	C	rs1801159	DPYD	Allele C is not associated with metabolism of capecitabine in people with Breast Neoplasms as compared to allele T.	23588952
chr1	97699534	97699535	T	C	rs2297595	DPYD	Genotype CT is not associated with response to capecitabine, fluorouracil or s 1 (combination) in people with Stomach Neoplasms as compared to genotype TT.	22490566
chr1	105853439	105853440	G	A,T	rs61816456	NTNG1	Allele A is associated with increased response to allopurinol as compared to allele G.	30924126
chr1	109275683	109275684	G	A,C,T	rs629301	SORT1	Allele T is associated with decreased response to hmg coa reductase inhibitors in people with Cardiovascular Diseases and Hypercholesterolemia as compared to allele G.	27648687
chr1	109275907	109275908	C	G,T	rs646776	CELSR2	Allele C is associated with increased response to hmg coa reductase inhibitors as compared to allele T.	25350695
chr1	109737078	109737079	C	T	rs7483	GSTM3	Genotype TT is associated with decreased concentrations of tacrolimus in people with Liver transplantation as compared to genotypes CC + CT.	39465171
chr1	109737630	109737635	TCCTC	TC,TCCTCCTC	rs36120609	GSTM3	Genotype TCCTC/TCCTC is associated with decreased concentrations of olanzapine in healthy individuals as compared to genotypes TC/TC + TC/TCCTC.	23559402
chr1	109825607	109825608	C	A,T	rs521093		Allele T is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele C.	27091189
chr1	111499508	111499509	T	A,C,G	rs3394	ADORA3	Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	27217051
chr1	111499526	111499527	C	T	rs3393	ADORA3	Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	27217051
chr1	111500164	111500165	T	G	rs35511654	ADORA3	Allele G is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	27217051
chr1	111503934	111503935	C	A,T	rs1544223	ADORA3	Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	27217051
chr1	111505641	111505642	T	C,G	rs2298191	ADORA3	Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	27217051
chr1	112624913	112624914	G	A	rs12076902	CAPZA1	Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G.	23087401
chr1	112671790	112671791	C	T	rs12069113	MOV10	Allele C is not associated with response to atenolol in people with Hypertension as compared to allele T.	23087401
chr1	112673920	112673921	A	C,G,T	rs2932538	MOV10	Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G.	23087401
chr1	112912476	112912477	G	A	rs7169	SLC16A1	Genotype GG is associated with increased clinical benefit to valproic acid in children with Epilepsy as compared to genotypes AA + AG.	39711059
chr1	113834945	113834946	A	G,T	rs2476601	PTPN22	Allele A is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	25834819
chr1	114693435	114693436	G	A,T	rs17602729	AMPD1	Genotypes AA + AG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.	27992285
chr1	115134561	115134562	T	A,C,G	rs2078371		Allele C is not associated with response to Selective serotonin (5HT1) agonists in people with Migraine without Aura as compared to allele T.	30256423
chr1	115295087	115295088	A	G,T	rs2239622	NGF	Genotype AA is not associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes AG + GG.	23651024
chr1	116545156	116545157	C	A	rs12044852	CD58	Genotype CC is associated with decreased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to genotypes AA + AC.	25685741
chr1	116720515	116720516	C	G	rs11586238	GAPDHP64	Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	23007924
chr1	119514622	119514623	C	A,G,T	rs1047303	HSD3B1	Genotypes AA + AC are associated with increased resistance to glucocorticoids in people with Asthma as compared to genotype CC.	31932420
chr1	119534960	119534961	T	C,G	rs7553527	HSD3B1	Genotypes CC + CT is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype TT.	27802415
chr1	119594821	119594822	A	G	rs10494227	ZNF697	Allele A is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele G.	27001119
chr1	145709376	145709377	C	T	rs12129861	PDZK1	Allele C is associated with increased dose of allopurinol in people with Gout as compared to allele T.	37202871
chr1	147209856	147209857	C	A	rs7541245	FMO5	Allele A is associated with decreased response to metformin in people with Diabetes Mellitus as compared to allele C.	26306225
chr1	152924257	152924258	T	A,C,G	rs6661932	IVL	Genotypes CT + TT is associated with decreased response to adalimumab or infliximab in people with Psoriasis as compared to genotype CC.	29192552
chr1	153348278	153348279	C	T	rs2916205	PGLYRP4	Genotypes CC + CT are associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype TT.	27670765
chr1	153947809	153947810	G	A,T	rs8450	CRTC2	Genotypes AA + AG are associated with increased concentrations of glucose in people with Transplantation as compared to genotype GG.	26644205
chr1	153956888	153956889	G	A,C	rs12117078	CRTC2	Genotype GG is not associated with concentrations of glucose in people with Transplantation as compared to genotypes CC + CG.	26644205
chr1	154408626	154408627	A	G	rs12083537	IL6R	Genotype AA is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	30647443
chr1	154419405	154419406	G	A	rs35717427	IL6R	Genotypes AG + GG is associated with decreased clinical benefit to tocilizumab in people with Rheumatoid arthritis as compared to genotype AA.	39718059
chr1	154449590	154449591	T	A,C	rs4845625	IL6R	Genotypes CT + TT is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotype CC.	36145690
chr1	154454493	154454494	A	C,T	rs2228145	IL6R	Allele A is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.	19926672
chr1	154457615	154457616	C	T	rs11265618	IL6R	Genotype CC is associated with increased response to sarilumab in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.	38001504
chr1	154459943	154459944	T	C	rs4329505	IL6R	Genotype TT is associated with increased response to sarilumab in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.	38001504
chr1	154460400	154460401	C	A,G,T	rs6690230	IL6R	Genotypes CG + GG is associated with decreased clinical benefit to tocilizumab in people with Rheumatoid arthritis as compared to genotype CC.	39718059
chr1	154470483	154470484	G	A	rs11265621	IL6R	Genotypes AA + AG is associated with decreased clinical benefit to tocilizumab in people with Rheumatoid arthritis as compared to genotype GG.	39718059
chr1	154565728	154565729	C	A,T	rs4845652	CHRNB2	Allele T is not associated with response to nicotine in women as compared to allele C.	20231857
chr1	154567748	154567749	G	A	rs2072658	CHRNB2	Genotype AG is associated with increased response to nicotine in people with daily smoking as compared to genotype GG.	20854418
chr1	154574815	154574816	A	C	rs12072348	CHRNB2	Allele C is not associated with response to nicotine in women as compared to allele A.	20231857
chr1	154576244	154576245	T	C,G	rs2072660	CHRNB2	Genotypes CT + TT are not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype CC.	25774163
chr1	154576403	154576404	G	A	rs2072661	CHRNB2	Genotypes AA + AG are not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype GG.	25774163
chr1	155309690	155309691	T	A,G	rs2297480	FDPS	Genotype GG is associated with decreased response to Bisphosphonates in people with Osteoporosis, Postmenopausal as compared to genotypes GT + TT.	18687167
chr1	155313037	155313038	A	C,G,T	rs11264359	FDPS	Allele A is associated with increased response to Bisphosphonates in people with Osteoporosis as compared to allele G.	21151198
chr1	156321808	156321809	G	A,T	rs12138564	CCT3	Allele T is associated with increased response to bevacizumab and ranibizumab in people with Macular Degeneration as compared to allele G.	29852030
chr1	156464910	156464911	G	A,C,T	rs1050316	MEF2D	Allele T is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.	31014225
chr1	156882670	156882671	A	C,G	rs2768759	PEAR1	Genotypes AC + CC are associated with decreased response to aspirin or prasugrel as compared to genotype AA.	28820077
chr1	156899254	156899255	G	A,T	rs12566888	PEAR1	Genotype TT is associated with increased response to ticagrelor in healthy individuals as compared to genotype GT.	27937053
chr1	156899921	156899922	G	A	rs12041331	PEAR1	Genotypes AA + AG are associated with increased response to aspirin, clopidogrel or prasugrel as compared to genotype GG.	28820077
chr1	156908004	156908005	C	A,T	rs77235035	PEAR1	Genotype AA is associated with decreased concentrations of ticagrelor in healthy individuals as compared to genotypes AC + CC.	35280252
chr1	156915698	156915699	T	G	rs4661012	PEAR1	Genotypes GT + TT is associated with decreased response to ticagrelor in healthy individuals as compared to genotype GG.	27937053
chr1	158658836	158658837	A	G	rs2106089	SPTA1	Allele G is associated with response to benazepril in men with Hypertension as compared to allele A.	21449848
chr1	159282211	159282212	G	A	rs10908703	FCER1A	Allele A is not associated with response to desloratadine and mizolastine in people with Urticaria as compared to allele G.	25412950
chr1	159283881	159283882	C	A,G,T	rs2494262	FCER1A	Allele A is not associated with response to desloratadine and mizolastine in people with Urticaria as compared to allele C.	25412950
chr1	159304152	159304153	G	A	rs2298805	FCER1A	Genotype AA is associated with increased response to desloratadine and mizolastine in people with Urticaria as compared to genotypes AG + GG.	25412950
chr1	159712442	159712443	C	T	rs1205	CRP	Genotype CC is not associated with response to fenofibrate in people with Metabolic Syndrome as compared to genotypes CT + TT.	18285551
chr1	159713300	159713301	G	A	rs1130864	CRP	Genotypes AG + GG are associated with increased response to adalimumab in people with Inflammatory Bowel Diseases as compared to genotype AA.	27096233
chr1	159714395	159714396	T	A,C	rs1417938	CRP	Genotype TT is associated with increased response to fenofibrate in people with Metabolic Syndrome as compared to genotypes AA + AT.	18285551
chr1	159714874	159714875	G	A,T	rs3091244	CRP	Genotypes AG + GG are associated with increased response to fenofibrate in people with Metabolic Syndrome as compared to genotypes AA + AT.	18285551
chr1	159715345	159715346	A	C,G	rs3093059	CRP	Genotype AA is not associated with response to fenofibrate in people with Metabolic Syndrome as compared to genotypes AG + GG.	18285551
chr1	160030644	160030645	A	T	rs12409352	PIGM	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr1	160108063	160108064	C	A,T	rs6688363	ATP1A2	Allele T is associated with decreased response to olanzapine in people with Schizophrenia as compared to allele C.	23241943
chr1	160546517	160546518	A	G	rs6427528	CD84	Genotypes AA + AG are associated with increased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype GG.	23555300
chr1	161081735	161081736	A	G	rs11265549	NECTIN4	Genotype AA is associated with decreased concentrations of methadone in people with Opioid-Related Disorders as compared to genotypes AG + GG.	32555608
chr1	161230795	161230796	T	G	rs2307418	NR1I3	Allele G is not associated with concentrations of tacrolimus in people with Kidney Transplantation as compared to allele T.	28777242
chr1	161232814	161232815	G	A	rs2307424	NR1I3	Genotypes AA + AG is associated with increased response to efavirenz or nevirapine in people with HIV Infections as compared to genotype GG.	34504302
chr1	161233436	161233437	G	A	rs2502815	NR1I3	Genotype AA is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype GG.	23173844
chr1	161234426	161234427	A	G,T	rs3003596	NR1I3	Genotypes AG + GG is associated with decreased response to efavirenz or nevirapine in people with HIV Infections as compared to genotype AA.	34504302
chr1	161234747	161234748	C	T	rs2501873	NR1I3	Genotype TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.	25356900
chr1	161242662	161242663	C	T	rs11584174	NR1I3	Allele C is not associated with metabolism of tacrolimus in people with liver transplantation as compared to allele T.	24351870
chr1	161242778	161242779	G	A,C,T	rs2501870		Allele A is not associated with metabolism of tacrolimus in people with liver transplantation as compared to allele G.	24351870
chr1	161242952	161242953	C	T	rs55802895	NR1I3	Allele C is not associated with metabolism of tacrolimus in people with liver transplantation as compared to allele T.	24351870
chr1	161243272	161243273	G	T	rs11265572		Genotypes GT + TT are associated with decreased metabolism of tacrolimus in people with liver transplantation as compared to genotype GG.	24351870
chr1	161308886	161308887	A	C,T	rs12065184	MPZ	Allele C is not associated with dose of warfarin in people with heart valve replacement as compared to allele A.	25126975
chr1	161509954	161509955	A	C,G	rs1801274	FCGR2A	Genotypes AG + GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic, Crohn Disease, Psoriasis and Spondylitis, Ankylosing as compared to genotype AA.	27490376
chr1	161674007	161674008	T	A,C	rs1050501	FCGR2B	Genotypes CC + CT is associated with increased response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype TT.	25823782
chr1	162115894	162115895	G	C,T	rs10494366	NOS1AP	Allele T is associated with increased response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to allele G.	20305679
chr1	163063051	163063052	C	T	rs10917670	RGS4	Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotype CC.	18204343
chr1	163063551	163063552	A	C	rs951436	RGS4	Allele C is not associated with response to antipsychotics in people with Schizophrenia as compared to allele A.	16604300
chr1	163063900	163063901	C	G,T	rs951439	RGS4	Genotype TT is associated with increased response to quetiapine and ziprasidone in people with Schizophrenia as compared to genotype CC.	17588543
chr1	163069986	163069987	T	C	rs2661319	RGS4	Allele C is associated with decreased response to risperidone in people with Schizophrenia as compared to allele T.	18204343
chr1	163070704	163070705	G	A,T	rs2842030	RGS4	Genotype TT is associated with increased response to olanzapine and perphenazine in people with Schizophrenia as compared to genotypes GG + GT.	17588543
chr1	163143469	163143470	G	C,T	rs1056515	RGS5	Genotype TT is associated with increased response to bevacizumab, fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotypes GG + GT.	25069475
chr1	163166200	163166201	G	A,C,T	rs11580141	RGS5	Allele A is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele G.	24070809
chr1	165372611	165372612	A	G	rs12081765		Allele G is associated with increased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A.	33124499
chr1	165422713	165422714	G	C,T	rs3767344	RXRG	Allele G is not associated with metabolism of irinotecan in people with Colorectal Neoplasms as compared to allele C.	29706892
chr1	168681896	168681897	A	C	rs4437856		Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr1	168683251	168683252	C	T	rs2419128		Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr1	168689000	168689001	T	A	rs12094644		Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr1	169567200	169567201	C	G,T	rs7542281	F5	Allele C is not associated with dose of warfarin in people with heart valve replacement as compared to allele T.	25126975
chr1	169731360	169731361	T	A,C,G	rs3917412	SELE	Genotype CC is associated with decreased response to capecitabine, fluorouracil, leucovorin and oxaliplatin in people with Colonic Neoplasms as compared to allele T.	24980946
chr1	171076658	171076659	T	A,C,G	rs1920145		Allele C is not associated with response to metformin in people with Diabetes Mellitus as compared to allele T.	26306225
chr1	171107793	171107794	C	G,T	rs1800822	FMO3	Genotype CC is associated with increased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes CT + TT.	28084894
chr1	171107824	171107825	G	A	rs2266782	FMO3	Genotypes AG + GG is associated with decreased clearance of teneligliptin in men as compared to genotype AA.	34512362
chr1	171114033	171114034	C	A,T	rs909530	FMO3	Genotypes CT + TT is associated with decreased clearance of teneligliptin in men as compared to genotype CC.	34512362
chr1	171114101	171114102	A	G	rs2266780	FMO3	Genotypes AG + GG is associated with decreased clearance of teneligliptin in men as compared to genotype AA.	34512362
chr1	171182498	171182499	C	T	rs12752688		Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	26306225
chr1	171210147	171210148	C	T	rs7512785	FMO2	Allele T is associated with increased response to glibenclamide in people with as compared to allele C.	27403931
chr1	171210337	171210338	C	G,T	rs7515157	FMO2	Allele T is associated with increased response to glibenclamide in people with as compared to allele C.	27403931
chr1	171266602	171266603	A	G	rs13376631	FMO1	Allele G is not associated with response to metformin in people with Diabetes Mellitus as compared to allele A.	26306225
chr1	171322877	171322878	A	G	rs2076322		Allele G is not associated with response to metformin in people with Diabetes Mellitus as compared to allele A.	26306225
chr1	172630737	172630738	G	C	rs2213712		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr1	172644100	172644101	A	G,T	rs2859228		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr1	172645876	172645877	C	A,T	rs2859229		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr1	172646254	172646255	C	T	rs1492899		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr1	172658357	172658358	C	T	rs763110	FASLG	Genotypes CC + CT is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.	22821704
chr1	172662916	172662917	A	C,G	rs929087		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr1	172664834	172664835	G	C	rs10458360		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr1	176726342	176726343	T	C	rs77977790	PAPPA2	Genotype CT is associated with increased response to salbutamol in children with Asthma as compared to genotype TT.	23992748
chr1	178597250	178597251	C	T	rs6700741		Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr1	181490623	181490624	G	A,T	rs12060765	CACNA1E	Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype GG.	30032160
chr1	181797300	181797301	T	C	rs3845446	CACNA1E	Genotype TT is not associated with dose of fentanyl in people with Pain, Postoperative as compared to genotypes CC + CT.	25615449
chr1	186674635	186674636	A	C,G	rs5273	PTGS2	Allele G is not associated with response to celecoxib in healthy individuals as compared to allele A.	16401468
chr1	186681188	186681189	C	G,T	rs20417	PTGS2	Genotypes CG + GG are not associated with response to ibuprofen in people with Pain, Postoperative as compared to genotype CC.	33812699
chr1	186681618	186681619	T	A,C,G	rs689466	PTGS2	Genotype CC is associated with increased response to celecoxib in healthy individuals as compared to genotypes CT + TT.	29066864
chr1	189871946	189871947	G	A,T	rs950569	BRINP3	Allele T is associated with increased concentrations of uric acid in people with Hypertension as compared to allele G.	29580174
chr1	196651786	196651787	C	T	rs3753394	CFH	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.	23842101
chr1	196673102	196673103	G	A	rs800292	CFH	Genotype GG is associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype AA.	22594510
chr1	196677045	196677046	T	A,C,G	rs1329424	CFH	Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.	23842101
chr1	196690106	196690107	C	A,G,T	rs1061170	CFH	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.	23559864
chr1	196691130	196691131	A	G,T	rs10801555	CFH	Genotype AA is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype GG.	22594510
chr1	196710324	196710325	A	C,T	rs10737680	CFH	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele C.	23842101
chr1	196727802	196727803	G	A,C	rs1410996	CFH	Genotype GG is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype AA.	22594510
chr1	196733679	196733680	C	G,T	rs1329428	CFH	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.	23842101
chr1	198731312	198731313	G	A,T	rs10919563	PTPRC	Allele A is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	25834819
chr1	203139379	203139380	T	A,C	rs10920573	ADORA1	Genotype CC is associated with decreased clinical benefit to caffeine in infants with Apnea of prematurity as compared to genotypes CT + TT.	39468580
chr1	203166323	203166324	C	G,T	rs16851030	ADORA1	Genotype CC is associated with increased response to caffeine in infants with apnea of prematurity as compared to genotypes CT + TT.	22462821
chr1	204547448	204547449	A	G,T	rs1563828	MDM4	Genotype AA is associated with increased response to docetaxel and epirubicin in women with Breast Neoplasms as compared to genotypes AG + GG.	24958282
chr1	205911050	205911051	G	A	rs74546197		Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr1	205927106	205927107	G	A	rs11240594	SLC26A9	Allele A is associated with increased response to olanzapine in people with Schizophrenia as compared to allele G.	21107309
chr1	205930466	205930467	T	A,C	rs7512462	SLC26A9	Genotypes CC + CT is associated with increased response to ivacaftor in children with Cystic Fibrosis as compared to genotype TT.	28171547
chr1	206768183	206768184	T	C	rs3024498	IL10	Genotypes CC + CT is associated with decreased clinical benefit to budesonide, fluticasone/salmeterol, formoterol or omalizumab in children with Asthma as compared to genotype TT.	38232251
chr1	206773061	206773062	T	G	rs1800872	IL10	Genotype TT is associated with decreased dose of tacrolimus in people with liver transplantation as compared to genotypes GG + GT.	21359536
chr1	206773288	206773289	A	G	rs1800871	IL10	Allele A is not associated with decreased dose of tacrolimus in people with Kidney Transplantation as compared to allele G.	39069949
chr1	206773551	206773552	T	C	rs1800896	IL10	Genotype CC is associated with decreased dose of tacrolimus in people with Kidney Transplantation as compared to genotypes CT + TT.	39069949
chr1	207580275	207580276	A	G	rs2274567	CR1	Genotypes AG + GG is associated with decreased response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype AA.	24038027
chr1	207616742	207616743	C	A,G	rs3811381	CR1	Genotypes CG + GG is not associated with response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype CC.	24038027
chr1	209618583	209618584	G	T	rs2076222	LAMB3	Allele G is associated with increased dose of fentanyl in people with Pain, Postoperative as compared to allele T.	26566055
chr1	209685107	209685108	A	G	rs846908	HSD11B1	Genotype AA is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotypes AG + GG.	25587129
chr1	209697570	209697571	A	C,T	rs4844880	HSD11B1	Genotype AA is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotypes AT + TT.	25587129
chr1	209701908	209701909	A	C,G,T	rs846910	HSD11B1	Genotype AA is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotypes AG + GG.	25587129
chr1	212583050	212583051	G	A	rs11811628	ATF3	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr1	222596250	222596251	A	C,G	rs1995152		Allele C is not associated with trough concentration of vancomycin as compared to allele A.	26030142
chr1	222598796	222598797	C	A,G,T	rs3002130		Allele C is not associated with trough concentration of vancomycin as compared to allele T.	26030142
chr1	222609853	222609854	T	A,C	rs3008604		Allele T is not associated with trough concentration of vancomycin as compared to allele C.	26030142
chr1	222612349	222612350	A	G	rs3008607		Allele A is not associated with trough concentration of vancomycin as compared to allele G.	26030142
chr1	222612655	222612656	A	G	rs3008608		Allele A is not associated with trough concentration of vancomycin as compared to allele G.	26030142
chr1	222614719	222614720	C	T	rs3002142		Allele C is not associated with trough concentration of vancomycin as compared to allele T.	26030142
chr1	222615511	222615512	C	G,T	rs3002143		Allele C is not associated with trough concentration of vancomycin as compared to allele T.	26030142
chr1	222617023	222617024	G	A	rs904323	MIA3	Allele A is not associated with trough concentration of vancomycin as compared to allele G.	26030142
chr1	222617178	222617179	A	G	rs35397194	MIA3	Allele G is not associated with trough concentration of vancomycin as compared to allele A.	26030142
chr1	222617217	222617218	A	G	rs142155704	MIA3	Allele G is not associated with trough concentration of vancomycin as compared to allele A.	26030142
chr1	222618564	222618565	A	C,G,T	rs3008610	MIA3	Allele A is not associated with trough concentration of vancomycin as compared to allele G.	26030142
chr1	222620357	222620358	C	T	rs10495197	MIA3	Allele T is not associated with trough concentration of vancomycin as compared to allele C.	26030142
chr1	222621775	222621776	G	T	rs17163303	MIA3	Allele T is not associated with trough concentration of vancomycin as compared to allele G.	26030142
chr1	222622784	222622785	A	C	rs75328711	MIA3	Allele C is not associated with trough concentration of vancomycin as compared to allele A.	26030142
chr1	222633670	222633671	C	G,T	rs3002145	MIA3	Allele T is not associated with trough concentration of vancomycin.	26030142
chr1	222658029	222658030	A	G	rs2088514	MIA3	Allele G is not associated with trough concentration of vancomycin as compared to allele A.	26030142
chr1	222658667	222658668	A	G	rs35822937	MIA3	Allele G is not associated with trough concentration of vancomycin as compared to allele A.	26030142
chr1	222658952	222658953	T	C	rs2291834	MIA3	Allele T is not associated with trough concentration of vancomycin as compared to allele C.	26030142
chr1	222666495	222666496	A	C,G	rs1053316	MIA3	Allele A is not associated with trough concentration of vancomycin as compared to allele G.	26030142
chr1	222671995	222671996	A	G	rs17011686	AIDA	Allele G is not associated with trough concentration of vancomycin as compared to allele A.	26030142
chr1	222672068	222672069	T	A,C,G	rs3008634	AIDA	Allele T is not associated with trough concentration of vancomycin as compared to allele C.	26030142
chr1	222682072	222682073	T	C	rs17163429	AIDA	Allele C is not associated with trough concentration of vancomycin as compared to allele T.	26030142
chr1	222690816	222690817	T	A	rs2378597	AIDA	Allele T is not associated with trough concentration of vancomycin as compared to allele A.	26030142
chr1	222709059	222709060	A	C	rs35684750	AIDA	Allele C is not associated with trough concentration of vancomycin as compared to allele A.	26030142
chr1	222713245	222713246	G	A,T	rs3748631	AIDA	Allele A is not associated with trough concentration of vancomycin as compared to allele G.	26030142
chr1	222714564	222714565	C	A,G,T	rs35762933		Allele T is not associated with trough concentration of vancomycin as compared to allele C.	26030142
chr1	222801583	222801584	T	C	rs17162912	DISP1	Allele C is not associated with response to citalopram, clomipramine, fluoxetine, fluvoxamine, paroxetine or sertraline in people with Obsessive-Compulsive Disorder as compared to allele T.	29953682
chr1	223111185	223111186	A	G	rs5744174	TLR5	Genotype AG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease as compared to genotype AA.	28139755
chr1	225807508	225807509	G	A	rs4653436	EPHX1	Allele G is not associated with dose of warfarin.	19794411
chr1	225825653	225825654	C	T	rs1877724	EPHX1	Genotype CC is associated with decreased dose of warfarin as compared to genotypes CT + TT.	29054760
chr1	225828856	225828857	G	A,C	rs3738046	EPHX1	Genotype CG is associated with concentrations of carbamazepine in people with Epilepsy as compared to genotype GG.	25495409
chr1	225831931	225831932	T	C	rs1051740	EPHX1	Allele C is not associated with dose of warfarin.	19794411
chr1	225831951	225831952	G	A	rs1131873	EPHX1	Allele A is associated with decreased dose of warfarin.	19794411
chr1	225832072	225832073	G	A,C	rs2260863	EPHX1	Allele G is not associated with dose of warfarin.	19794411
chr1	225838704	225838705	A	G,T	rs2234922	EPHX1	Allele G is not associated with dose of warfarin.	19794411
chr1	225844527	225844528	C	T	rs1051741	EPHX1	Genotype CT is associated with decreased dose of warfarin as compared to genotype CC.	20716240
chr1	230702584	230702585	G	T	rs7079	AGT	Genotype TT is associated with increased response to benazepril in people with Hypertension as compared to genotypes GG + GT.	17261659
chr1	230710047	230710048	A	G	rs699	AGT	Allele A is not associated with increased response to losartan in people with Liver Cirrhosis as compared to allele G.	15743363
chr1	230710230	230710231	G	A	rs4762	AGT	Genotype GG is not associated with response to atenolol or irbesartan in people with Hypertension as compared to genotype AG.	11593098
chr1	230714125	230714126	C	A,G,T	rs5051	AGT	Genotype CC is associated with increased response to benazepril or imidapril in people with Hypertension as compared to genotypes CT + TT.	25143324
chr1	230714139	230714140	T	C,G	rs5050	AGT	Genotype GG is not associated with response to atenolol in people with Hypertension as compared to genotypes GT + TT.	14700505
chr1	236885199	236885200	A	G	rs1805087	MTR	Allele G is associated with increased concentrations of methotrexate in people with Lymphoma, Non-Hodgkin or Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.	38381003
chr1	239622119	239622120	A	C,G	rs2165870	CHRM3	Genotype AA is associated with increased response to dexamethasone in people with Postoperative Nausea and Vomiting as compared to genotypes AG + GG.	29935595
chr1	240549088	240549089	A	G	rs77567654	GREM2	Allele G is associated with increased response to allopurinol as compared to allele A.	30924126
chr1	240550729	240550730	A	G,T	rs10802887	GREM2	Allele G is associated with increased response to allopurinol as compared to allele A.	30924126
chr1	240558251	240558252	C	A,G,T	rs1934341	GREM2	Allele T is associated with increased response to allopurinol.	30924126
chr1	240566954	240566955	T	A,C	rs4659982	GREM2	Allele C is associated with increased response to allopurinol.	30924126
chr1	241878998	241878999	G	A,C	rs1047840	EXO1	Allele A is associated with increased response to capecitabine or fluorouracil in people with Neoplasm Metastasis as compared to allele G.	25372392
chr1	247435767	247435768	T	C	rs4612666	NLRP3	Genotype TT is associated with decreased response to etanercept or infliximab in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.	37332933
chr1	247448733	247448734	G	C,T	rs10754558	NLRP3	Genotypes CG + GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammatory Bowel Diseases as compared to genotype CC.	28139755
chr1	247451959	247451961	AA	A	rs35305980	OR2B11	Allele A is associated with concentrations of axitinib in people with Carcinoma, Renal Cell as compared to allele del.	29682213
chr1	247853075	247853076	C	T	rs72772787		Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.	25897834
chr10	4768368	4768369	A	C,G,T	rs1901633		Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.	29743634
chr10	5094458	5094459	C	G,T	rs12529	AKR1C3	Genotypes CC + CG are not associated with response to abiraterone in men with Prostatic Neoplasms as compared to genotype GG.	33649516
chr10	5099114	5099115	C	A,G,T	rs1937840	AKR1C3	Genotype GG is associated with increased response to docetaxel and doxorubicin in women with Breast Neoplasms as compared to genotypes CC + CG.	23116553
chr10	5218718	5218719	C	G,T	rs17134592	AKR1C4	Genotypes CG + GG are not associated with concentrations of exemestane in women with Breast Neoplasms as compared to genotype CC.	27549341
chr10	6057081	6057082	T	C	rs2104286	IL2RA	Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.	23007924
chr10	6351297	6351298	C	G,T	rs4750316	PRKCQ	Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	23007924
chr10	8062244	8062245	C	A,G,T	rs3824662	GATA3	Genotype AA is associated with decreased clinical benefit to prednisolone in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AC + CC.	36714653
chr10	8659255	8659256	G	A	rs10795668		Allele A is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele G.	24727911
chr10	18148095	18148096	A	G,T	rs560765906	CACNB2	Allele T is associated with decreased clearance of dexmedetomidine in children with Pain, Postoperative as compared to allele A.	37353859
chr10	18249729	18249730	T	A,C	rs12245847	CACNB2	Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CT.	30032160
chr10	18273608	18273609	C	T	rs1277733	CACNB2	Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CC.	30032160
chr10	18418366	18418367	C	A,G,T	rs982003	CACNB2	Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT.	30032160
chr10	18427215	18427216	T	C	rs10741058	CACNB2	Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CC.	30032160
chr10	18509273	18509274	T	A,C,G	rs4237348	CACNB2	Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CT.	30032160
chr10	26214872	26214873	C	T	rs2839669	GAD2	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	31866536
chr10	26215410	26215411	C	A	rs2839670	GAD2	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	31866536
chr10	26216566	26216567	A	G	rs2236418	GAD2	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	31866536
chr10	26523245	26523246	C	A	rs11015149	APBB1IP	Genotypes AA + AC is associated with increased resistance to clopidogrel in people with Coronary Disease as compared to genotype CC.	36581799
chr10	31913140	31913141	C	G,T	rs2799018	ARHGAP12	Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr10	33200123	33200124	G	A,C	rs2247383	NRP1	Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele A.	26426212
chr10	33221734	33221735	G	A	rs2229935	NRP1	Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele A.	26426212
chr10	33263766	33263767	C	G,T	rs2070296	NRP1	Allele T is associated with decreased response to ranibizumab in people with Macular Degeneration as compared to genotype CC.	26426212
chr10	33323571	33323572	G	T	rs2804495	NRP1	Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.	26426212
chr10	33785634	33785635	G	A,T	rs2777511	CHRNA2	Allele G is not associated with response to nicotine in women as compared to allele A.	20231857
chr10	35252097	35252098	C	A	rs12777960	CCNY	Genotype CC is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes AA + AC.	25712183
chr10	43114670	43114671	G	A,C,T	rs1799939	RET	Allele A is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele G.	30713339
chr10	44372808	44372809	C	T	rs1801157	CXCL12	Genotypes CT + TT are associated with decreased response to alemtuzumab, chlorambucil, cyclophosphamide, fludarabine, prednisone, rituximab or vincristine in people with Leukemia, Lymphocytic, Chronic, B-Cell as compared to genotype CC.	27173875
chr10	49616070	49616071	G	A	rs1880676	CHAT	Allele A is associated with increased response to olanzapine in people with Schizophrenia as compared to allele G.	17503482
chr10	49616572	49616573	G	A	rs3810950	CHAT	Allele A is associated with increased response to olanzapine in people with Schizophrenia as compared to allele G.	17503482
chr10	49624062	49624063	C	T	rs4838391	CHAT	Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	49626931	49626932	A	G	rs4838392	CHAT	Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.	25730470
chr10	49627217	49627218	G	A	rs12246528	CHAT	Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.	25730470
chr10	49628986	49628987	C	G,T	rs11101187	CHAT	Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	49630827	49630828	A	G	rs2177370	CHAT	Allele A is associated with increased response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele G.	25730470
chr10	49632689	49632690	G	A,C	rs3793790	CHAT	Allele G is associated with increased response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.	25730470
chr10	49633657	49633658	C	G,T	rs3793791	CHAT	Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	49635682	49635683	G	A,C	rs2177369	CHAT	Genotype AA is not associated with response to donepezil in people with Alzheimer Disease as compared to genotypes AG + GG.	18780301
chr10	49639950	49639951	C	G,T	rs12266458	CHAT	Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	49641295	49641296	T	A,G	rs1917818	CHAT	Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	49646720	49646721	G	A	rs11101192	CHAT	Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.	25730470
chr10	49647321	49647322	C	G,T	rs7094248	CHAT	Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele C.	25730470
chr10	49648091	49648092	G	T	rs11101193	CHAT	Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	49649802	49649803	C	G,T	rs3793797	CHAT	Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	49650299	49650300	T	A,C	rs10776586	CHAT	Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	49655036	49655037	A	C,T	rs12264845	CHAT	Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.	25730470
chr10	49655518	49655519	C	T	rs7076926	CHAT	Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	49655576	49655577	A	G,T	rs7094421	CHAT	Allele A is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele G.	25730470
chr10	49663419	49663420	T	A,C	rs3793798	CHAT	Allele A is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	49663669	49663670	A	G	rs3793800	CHAT	Allele A is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele G.	25730470
chr10	49664865	49664866	C	T	rs3793801	CHAT	Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr10	51930013	51930014	C	T	rs7903366		Allele T is associated with decreased response to salbutamol in children with Asthma as compared to allele C.	33851947
chr10	51930570	51930571	G	A,T	rs7081864		Allele A is associated with decreased response to salbutamol in children with Asthma as compared to allele G.	33851947
chr10	59978393	59978394	G	A,C,T	rs7902657		Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.	37098852
chr10	61950344	61950345	A	C,G	rs10994982	ARID5B	Allele A is associated with decreased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	19684603
chr10	62045857	62045858	T	A,C	rs4948496	ARID5B	Allele C is not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.	31870219
chr10	62156212	62156213	G	A	rs7912580		Genotype GG is associated with increased response to haloperidol in people with Schizophrenia as compared to genotype AG.	24751813
chr10	62805173	62805174	C	G	rs10995311	ADO	Allele C is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele G.	31327267
chr10	65919289	65919290	A	C,G,T	rs1786929		Genotypes AA + AG is associated with increased response to fluticasone propionate or montelukast in children with Asthma as compared to genotype GG.	24407380
chr10	66576536	66576537	T	C	rs10997242	CTNNA3	Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	27091189
chr10	70598898	70598899	G	A,C	rs885821	PRF1	Allele G is associated with increased response to rivaroxaban in people with Atrial Fibrillation as compared to allele A.	37203300
chr10	71777856	71777857	G	A	rs17712523	CDH23	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr10	72009748	72009749	C	T	rs4148943	CHST3	Allele C is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele T.	20038957
chr10	72009831	72009832	C	T	rs4148945	CHST3	Allele C is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele T.	20038957
chr10	72010358	72010359	T	C	rs4148947	CHST3	Allele T is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele C.	20038957
chr10	72011947	72011948	G	A	rs4148950	CHST3	Allele A is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele G.	20038957
chr10	72012255	72012256	G	A,C,T	rs1871450	CHST3	Allele A is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele G.	20038957
chr10	72013003	72013004	C	T	rs730720	CHST3	Allele C is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele T.	20038957
chr10	72013255	72013256	G	A	rs12418	CHST3	Allele A is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele G.	20038957
chr10	77018975	77018976	G	A,C	rs16934182	KCNMA1	Genotypes AA + AG is associated with decreased dose of dexmedetomidine in people with surgery as compared to genotype GG.	37693312
chr10	77423279	77423280	C	A,G	rs35793	KCNMA1	Allele G is associated with response to quetiapine in people with Schizophrenia.	22920393
chr10	77811114	77811115	G	A,C,T	rs2289310	DLG5	Allele T is associated with increased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele G.	25372392
chr10	80166945	80166946	G	A,C	rs1049550	ANXA11	Genotype AA is associated with increased response to bevacizumab in people with Colorectal Neoplasms as compared to genotypes AG + GG.	21239504
chr10	87960493	87960494	T	A,C	rs17431184	PTEN	Allele C is associated with increased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele T.	25372392
chr10	88989498	88989499	G	A,T	rs2234767	FAS	Genotypes AA + AG is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	22821704
chr10	90859403	90859404	T	A,G	rs7905446	HTR7	Genotype TT is not associated with response to escitalopram or nortriptyline in people with Depression as compared to genotypes GG + GT.	30874608
chr10	94136182	94136183	A	G,T	rs932764	PLCE1	Allele A is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele G.	31327267
chr10	94645571	94645572	C	T	rs12772169		Allele T is associated with dose of warfarin as compared to allele C.	28686080
chr10	94645744	94645745	G	A,T	rs12777823		Allele A is associated with dose of warfarin as compared to allele G.	28686080
chr10	94648220	94648221	G	A	rs1998591	CYP2C18	Genotype GG is associated with increased dose of acenocoumarol in children as compared to genotypes AA + AG.	29935043
chr10	94660581	94660582	G	C,T	rs9732195		Allele T is associated with concentrations of clopidogrel thiol metabolite H4 in healthy individuals as compared to allele G.	28207573
chr10	94687804	94687805	T	A	rs41291550	CYP2C18	Allele A is associated with decreased metabolism of warfarin in people with Atrial Fibrillation, venous thromboembolism or Heart Valve Diseases as compared to allele T.	36210801
chr10	94709141	94709142	G	A	rs11188059	CYP2C18	Allele G is not associated with increased metabolism of lansoprazole or pantoprazole in children as compared to allele A.	38629502
chr10	94733300	94733301	C	T	rs1126545	CYP2C18	Allele T is associated with decreased metabolism of clozapine in people with Schizophrenia as compared to allele C.	30922102
chr10	94735474	94735475	C	T	rs2860840	CYP2C18	Allele T is not associated with increased metabolism of lansoprazole or pantoprazole in children as compared to allele C.	38629502
chr10	94759303	94759304	C	T	rs11188072	CYP2C19	Genotype TT is associated with increased metabolism of omeprazole in people with no disease as compared to genotype CC.	16413245
chr10	94761287	94761288	C	A,G,T	rs3814637	CYP2C19	Allele T is associated with decreased clearance of warfarin as compared to allele C.	21692828
chr10	94761899	94761900	C	A,T	rs12248560	CYP2C19	Genotypes CT + TT are not associated with response to clopidogrel in people with Acute coronary syndrome.	25060201
chr10	94766107	94766108	G	A,C	rs12768009	CYP2C19	Genotype AA is associated with decreased clearance of nevirapine in people with HIV Infections as compared to genotypes AG + GG.	21860339
chr10	94774505	94774506	C	T	rs6583954	CYP2C19	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32481444
chr10	94775366	94775367	A	G	rs12769205	CYP2C19	Genotypes AG + GG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype AA.	35280252
chr10	94780652	94780653	G	A	rs4986893	CYP2C19	Genotype AG is not associated with response to clopidogrel in people with Acute coronary syndrome as compared to genotype GG.	25060201
chr10	94781858	94781859	G	A,C,T	rs4244285	CYP2C19	Genotypes AA + AG is associated with increased clinical benefit to lacosamide in children with Epilepsy as compared to genotype GG.	39314259
chr10	94782224	94782225	A	G	rs12571421	CYP2C19	Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.	29318894
chr10	94808277	94808278	A	C,G,T	rs11188082	CYP2C19	Allele T is associated with decreased metabolism of warfarin in people with Atrial Fibrillation, venous thromboembolism or Heart Valve Diseases as compared to allele A.	36210801
chr10	94838681	94838682	T	G	rs11528090	CYP2C19	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr10	94842864	94842865	C	G,T	rs3758580	CYP2C19	Genotypes CT + TT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype CC.	35280252
chr10	94932869	94932870	A	G	rs77760615	CYP2C9	Allele G is associated with increased concentrations of fluvastatin in healthy individuals as compared to allele A.	30989645
chr10	94935593	94935594	G	A,T	rs12782374	CYP2C9	Genotype AG is associated with increased metabolism of phenytoin as compared to genotype GG.	19855097
chr10	94936017	94936021	TGTG	TG	rs71486745	CYP2C9	Genotypes GT/del + del/del are associated with decreased dose of phenytoin in people with Epilepsy as compared to genotype GTGT.	19855097
chr10	94936771	94936772	T	C	rs9332092	CYP2C9	Genotype TT is associated with increased dose of warfarin as compared to genotype CT.	21326313
chr10	94937494	94937495	T	A,C,G	rs4918758	CYP2C9	Genotypes CC + CT is associated with increased exposure to valproic acid in people with Epilepsy as compared to genotype TT.	36718958
chr10	94937701	94937702	G	A	rs9332098	CYP2C9	Genotype GG is associated with increased dose of warfarin as compared to genotype AG.	21326313
chr10	94938932	94938933	T	A,C	rs9332104	CYP2C9	Genotypes CC + CT are not associated with metabolism of losartan in healthy individuals as compared to genotype TT.	22294058
chr10	94942092	94942093	T	A,C	rs9332120	CYP2C9	Allele C is associated with increased response to carbamazepine, lamotrigine, phenytoin, primidone or valproic acid in children with Epilepsy as compared to allele T.	28343093
chr10	94942289	94942290	C	T	rs1799853	CYP2C9	Genotype TT is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.	39792745
chr10	94942308	94942309	G	A,C,T	rs7900194	CYP2C9	Allele A is associated with decreased dose of warfarin as compared to allele G.	20072124
chr10	94942537	94942538	G	A	rs2860905	CYP2C9	Allele A is associated with decreased dose of warfarin as compared to allele G.	19752777
chr10	94945465	94945466	A	G,T	rs7089580	CYP2C9	Allele T is associated with decreased dose of warfarin in children as compared to allele A.	24474498
chr10	94947444	94947445	C	T	rs4086116	CYP2C9	Allele T is associated with decreased dose of acenocoumarol as compared to allele C.	19578179
chr10	94947713	94947714	G	C	rs9332127	CYP2C9	Allele C is not associated with increased dose of warfarin in people with an international normalized ratio (INR) of 2.0-3.0 as compared to allele G.	22248286
chr10	94949216	94949217	A	G	rs2256871	CYP2C9	Allele G is associated with decreased metabolism of warfarin in people with Atrial Fibrillation, venous thromboembolism or Heart Valve Diseases as compared to allele A.	36210801
chr10	94950406	94950407	C	T	rs34532201	CYP2C9	Genotype TT is associated with increased exposure to apatinib and apatinib metabolite m1-1 in people with Neoplasms as compared to genotypes CC + CT.	37775332
chr10	94963666	94963667	A	G	rs2153628	CYP2C9	Allele G is associated with increased response to indomethacin as compared to allele A.	28609430
chr10	94965777	94965778	A	C,T	rs4917639	CYP2C9	Allele C is associated with decreased dose of warfarin as compared to allele A.	18535201
chr10	94972339	94972340	A	G	rs9332174	CYP2C9	Genotypes AG + GG are not associated with metabolism of losartan in healthy individuals as compared to genotype AA.	22294058
chr10	94974581	94974582	G	A,T	rs10509680	CYP2C9	Genotype GT is associated with increased concentrations of losartan and losartan E-3174 in healthy individuals as compared to genotype GG.	38637968
chr10	94981295	94981296	A	C,G	rs1057910	CYP2C9	Allele A is associated with dose of warfarin as compared to allele C.	27121899
chr10	94982059	94982060	A	C,G	rs1934968	CYP2C9	Genotype GG is associated with increased exposure to apatinib and apatinib metabolite m1-1 in people with Neoplasms as compared to genotypes AA + AG.	37775332
chr10	94988734	94988735	G	A	rs9332238	CYP2C9	Allele G is associated with increased dose of warfarin as compared to allele A.	26265036
chr10	94988737	94988738	A	T	rs1934969	CYP2C9	Genotypes AT + TT are associated with decreased metabolism of losartan in healthy individuals as compared to genotype AA.	22294058
chr10	94988979	94988980	A	T	rs1057911	CYP2C9	Genotype AT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype AA.	35280252
chr10	94989423	94989424	T	A,C	rs9332245	CYP2C9	Genotype AT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype TT.	35280252
chr10	95038991	95038992	T	C	rs10509681	CYP2C8	Allele C is associated with decreased metabolism of paclitaxel as compared to allele T.	11668219
chr10	95044693	95044694	C	T	rs7910936	CYP2C8	Allele C is associated with increased concentrations of desethylchloroquine or hydroxychloroquine in people with Lupus Erythematosus, Systemic as compared to allele T.	37993281
chr10	95049215	95049216	A	C,G,T	rs1934980	CYP2C8	Genotypes AA + AG is not associated with resistance to clopidogrel in people with Stroke as compared to genotype GG.	26961113
chr10	95057539	95057540	G	C,T	rs10882521	CYP2C8	Allele T is associated with decreased concentrations of desethylchloroquine or hydroxychloroquine in people with Lupus Erythematosus, Systemic as compared to allele G.	37993281
chr10	95058348	95058349	T	A,G	rs11572103	CYP2C8	Allele T is not associated with metabolism of paclitaxel in people with Neoplasms as compared to allele A.	16299241
chr10	95058361	95058362	G	A,C	rs1058930	CYP2C8	Allele C is not associated with metabolism of paclitaxel in people with Neoplasms as compared to allele G.	16299241
chr10	95067272	95067273	C	A,T	rs11572080	CYP2C8	Allele T is not associated with metabolism of paclitaxel in people with Neoplasms as compared to allele C.	16299241
chr10	95069672	95069673	G	T	rs7909236	CYP2C8	Allele T is not associated with concentrations of imatinib in people with Neoplasms as compared to allele G.	28383355
chr10	95069771	95069772	A	C,T	rs17110453	CYP2C8	Allele C is not associated with concentrations of imatinib in people with Neoplasms as compared to allele A.	28383355
chr10	97152178	97152179	G	A,C	rs11189015	SLIT1	Allele C is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele G.	25695618
chr10	97169184	97169185	A	G	rs2784917	SLIT1	Genotype AA is associated with decreased inhibition of etoposide as compared to genotypes AG + GG.	17537913
chr10	98417291	98417292	G	A,C,T	rs1061115	PYROXD2	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr10	99781295	99781296	A	G	rs1885301	ABCC2	Allele A is not associated with exposure to pitavastatin in healthy individuals as compared to allele G.	23007012
chr10	99781821	99781822	G	A,T	rs7910642	ABCC2	Genotypes AA + AG is not associated with concentrations of lopinavir in people with HIV Infections as compared to genotype GG.	27142945
chr10	99781825	99781826	A	G	rs2804402	ABCC2	Allele A is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele G.	27217051
chr10	99782820	99782821	C	T	rs717620	ABCC2	Genotypes CT + TT is associated with decreased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	34575187
chr10	99788710	99788711	G	A	rs4148386	ABCC2	Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG.	23252947
chr10	99793501	99793502	C	T	rs2804400	ABCC2	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	21449672
chr10	99798876	99798877	A	T	rs2804398	ABCC2	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.	21449672
chr10	99798988	99798989	G	C,T	rs2756109	ABCC2	Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.	29791011
chr10	99804057	99804058	G	A	rs2273697	ABCC2	Allele A is not associated with exposure to pitavastatin in healthy individuals as compared to allele G.	23007012
chr10	99811770	99811771	C	T	rs3740074	ABCC2	Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.	29791011
chr10	99828173	99828174	C	T	rs2002042	ABCC2	Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr10	99832864	99832865	A	G	rs4148398	ABCC2	Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.	29791011
chr10	99836217	99836218	G	A,T	rs8187692	ABCC2	Allele A is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele G.	30100615
chr10	99836238	99836239	T	A	rs17222723	ABCC2	Allele A is not associated with clearance of methotrexate in people with Lymphoma.	23069858
chr10	99842246	99842247	T	C	rs3758395	ABCC2	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	21449672
chr10	99843764	99843765	T	C	rs17216177	ABCC2	Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T.	30100615
chr10	99844023	99844024	C	G	rs3740067	ABCC2	Genotypes CG + GG is not associated with response to carbamazepine in people with Epilepsies, Partial as compared to genotype CC.	24567120
chr10	99844349	99844350	C	T	rs17216317	ABCC2	Genotype CT is associated with increased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to genotype CC.	39752799
chr10	99844449	99844450	C	G,T	rs3740066	ABCC2	Allele T is not associated with exposure to pitavastatin in healthy individuals as compared to allele C.	23007012
chr10	99845745	99845746	C	T	rs7899457	ABCC2	Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.	30100615
chr10	99845935	99845936	A	G	rs3740065	ABCC2	Allele G is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.	24404132
chr10	99850697	99850698	G	A,C	rs8187706	ABCC2	Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.	30100615
chr10	99850965	99850966	A	C,G	rs3740063	ABCC2	Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.	29791011
chr10	99851536	99851537	G	A	rs8187710	ABCC2	Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.	30100615
chr10	100216743	100216744	G	C	rs11591741	CHUK	Allele G is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.	25896535
chr10	102837394	102837395	A	G,T	rs743572	CYP17A1	Genotypes AG + GG are not associated with response to abiraterone in men with Prostatic Neoplasms as compared to genotype AA.	33649516
chr10	102837722	102837723	T	C,G	rs2486758	CYP17A1	Genotypes CC + CT are not associated with response to abiraterone in men with Prostatic Neoplasms as compared to genotype TT.	33649516
chr10	102878965	102878966	T	A,C	rs11191439	AS3MT	Allele C is associated with increased metabolism of Arsenic compounds in healthy individuals as compared to allele T.	18334919
chr10	103040447	103040448	T	C	rs58700372	CNNM2	Genotypes CC + CT are associated with decreased metabolism of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype TT.	33124053
chr10	103118696	103118697	G	A	rs72846714	NT5C2	Genotypes AA + AG are associated with decreased metabolism of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.	33124053
chr10	103138227	103138228	T	C,G	rs11598702	NT5C2	Genotype TT is associated with decreased clearance of gemcitabine as compared to genotypes CC + CT.	24300978
chr10	103918138	103918139	A	C,G	rs4387287	STN1	Allele A is associated with decreased response to atenolol in people with Hypertension as compared to allele C.	31327267
chr10	107285112	107285113	A	G,T	rs1416406	SORCS1	Genotype GG is associated with increased response to exenatide in people with Diabetes Mellitus, Type 2 as compared to genotypes AA + AG.	28535629
chr10	111075831	111075832	T	A	rs521674	ADRA2A	Allele T is associated with increased dose of doxazosin or phenoxybenzamine in people with Pheochromocytoma or Paraganglioma as compared to allele A.	35453646
chr10	111076744	111076745	G	A,C	rs1800544	ADRA2A	Genotype GG is not associated with response to buprenorphine or methadone in people with Opioid-Related Disorders as compared to genotypes CC + CG.	29333880
chr10	111077314	111077315	G	A,C,T	rs2484516	ADRA2A	Genotype CC is not associated with dose of dexmedetomidine in men as compared to genotype CG.	33915198
chr10	111077779	111077780	G	A	rs1800545	ADRA2A	Genotype GG is associated with increased response to atenolol in people with Hypertrophy, Left Ventricular as compared to genotypes AA + AG.	15614026
chr10	111078793	111078794	C	G,T	rs1800035	ADRA2A	Genotypes CG + GG are associated with decreased response to dexmedetomidine in women with Pain, Postoperative as compared to genotype CC.	32256718
chr10	111079609	111079610	C	A	rs11195419	ADRA2A	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	21398039
chr10	111079820	111079821	A	G,T	rs553668	ADRA2A	Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele G.	23609393
chr10	111079842	111079843	C	A,G,T	rs3750625	ADRA2A	Allele A is not associated with dose of dexmedetomidine in men as compared to allele C.	33915198
chr10	112998589	112998590	C	G,T	rs7903146	TCF7L2	Genotypes CT + TT is associated with increased response to exenatide in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	30700996
chr10	113049142	113049143	G	A,T	rs12255372	TCF7L2	Genotype TT is associated with decreased response to sulfonamides, urea derivatives in people with Diabetes Mellitus, Type 2 as compared to genotype GG.	17519421
chr10	113149971	113149972	C	T	rs290487	TCF7L2	Genotype TT is associated with increased response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to genotypes CC + CT.	20054294
chr10	113678444	113678445	C	A	rs12415607	CASP7	Genotypes AA + AC are associated with increased response to docetaxel, gemcitabine, paclitaxel, Platinum compounds or vinorelbine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.	22441531
chr10	113679809	113679810	C	A,G,T	rs7921977	CASP7	Genotype CC is not associated with response to docetaxel, gemcitabine, paclitaxel, Platinum compounds or vinorelbine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.	22441531
chr10	113729392	113729393	C	G,T	rs2227310	CASP7	Genotypes CG + GG are associated with increased response to docetaxel, gemcitabine, paclitaxel, Platinum compounds or vinorelbine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.	22441531
chr10	113729829	113729830	T	A,C	rs4353229	CASP7	Genotypes CC + CT are associated with increased response to docetaxel, gemcitabine, paclitaxel, Platinum compounds or vinorelbine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.	22441531
chr10	113730349	113730350	G	A	rs1127687	CASP7	Genotypes AA + AG are associated with decreased response to paclitaxel and Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	22441531
chr10	114044276	114044277	A	G	rs1801252	ADRB1	Allele G is not associated with response to atenolol or metoprolol in people with Tachycardia as compared to allele A.	31090079
chr10	114045296	114045297	G	A,C	rs1801253	ADRB1	Allele C is associated with increased response to atenolol in healthy individuals as compared to allele G.	18794726
chr10	117226884	117226885	G	A	rs363371	SLC18A2	Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.	18797399
chr10	117244567	117244568	G	A,C	rs363390	SLC18A2	Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.	18797399
chr10	117255436	117255437	C	A	rs363343	SLC18A2	Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele C.	18797399
chr10	117259614	117259615	C	T	rs929493	SLC18A2	Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele T.	18797399
chr10	117264990	117264991	C	A,G,T	rs363225	SLC18A2	Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.	22947179
chr10	117265700	117265701	G	A,C,T	rs363226	SLC18A2	Genotype GG is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CG.	22947179
chr10	118669289	118669290	G	A	rs1247117		Allele G is associated with increased resistance to vincristine as compared to allele A.	38693155
chr10	119326584	119326585	A	T	rs2230345	GRK5	Genotype AA is not associated with response to atenolol in healthy individuals as compared to genotypes AT + TT.	19842931
chr10	119335887	119335888	A	C	rs3740563	GRK5	Allele A is associated with decreased response to Beta Blocking Agents in people with Coronary Artery Disease as compared to allele C.	25049040
chr10	119340640	119340641	T	G	rs4752292	GRK5	Allele T is associated with decreased response to Beta Blocking Agents in people with Coronary Artery Disease as compared to allele G.	25049040
chr10	119348387	119348388	G	A,C	rs11198893	GRK5	Allele A is associated with decreased response to Beta Blocking Agents in people with Coronary Artery Disease as compared to allele G.	25049040
chr10	119371800	119371801	A	C,G	rs10787959	GRK5	Allele A is associated with decreased response to Beta Blocking Agents in people with Coronary Artery Disease as compared to allele G.	25049040
chr10	122454931	122454932	G	C,T	rs10490924	ARMS2	Allele G is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.	23559864
chr10	122461027	122461028	G	A,T	rs11200638	HTRA1	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23559864
chr10	127541544	127541545	G	A	rs1931704		Allele A is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele G.	19749758
chr10	133527062	133527063	A	T	rs2070673	CYP2E1	Allele T is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele A.	29318894
chr10	133535039	133535040	T	A	rs6413432	CYP2E1	Allele A is associated with increased concentrations of isoniazid in people with Tuberculosis as compared to allele T (assigned as intermediate acetylator phenotype) .	38584604
chr10_KI270825v1_alt	49806	49807	G	A,C,T	rs2289310	DLG5	Allele T is associated with increased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele G.	25372392
chr10_KQ090021v1_fix	176282	176283	T	A,C	rs17431184	PTEN	Allele C is associated with increased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele T.	25372392
chr11	636398	636399	T	C	rs3758653	DRD4	Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.	28871191
chr11	640118	640119	C	G,T	rs762502	DRD4	Allele C is associated with increased clinical benefit to clozapine in people with Schizophrenia or Psychotic Disorder as compared to allele T.	40048458
chr11	641190	641191	C	A,G	rs11246226	DRD4	Genotype AA is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotypes AC + CC.	23856854
chr11	656844	656845	G	A,C	rs4963126	DEAF1	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25642918
chr11	1219990	1219991	G	A,T	rs35705950	MUC5B	Genotype TT is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes GG + GT.	26331942
chr11	1288725	1288726	C	A,T	rs3750920	TOLLIP	Genotype TT is associated with increased response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes CC + CT.	26331942
chr11	1303541	1303542	T	A,C	rs5743894	TOLLIP	Genotype TT is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes CC + CT.	26331942
chr11	1304598	1304599	T	C	rs5743890	TOLLIP	Genotype TT is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes CC + CT.	26331942
chr11	1310023	1310024	G	A,C,T	rs5743854	TOLLIP	Genotype CC is not associated with response to acetylcysteine in people with Pulmonary Fibrosis as compared to genotypes CG + GG.	26331942
chr11	1997622	1997623	G	A,C	rs2839698	H19	Genotypes AA + AG are associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotype GG.	26729200
chr11	1999844	1999845	C	T	rs2107425		Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.	26729200
chr11	2143102	2143103	G	A,C,T	rs4244809	IGF2	Genotype GG is associated with decreased resistance to Platinum compounds in women with Ovarian Neoplasms as compared to genotypes AA + AG.	30672383
chr11	2158121	2158122	G	A,C,T	rs3842761	INS-IGF2	Genotype GG is associated with decreased resistance to Platinum compounds in women with Ovarian Neoplasms.	30672383
chr11	2163617	2163618	G	C,T	rs3842727	TH	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	32736537
chr11	2165104	2165105	A	G,T	rs2070762	TH	Genotype GG is associated with decreased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG.	26810137
chr11	2169720	2169721	C	A,T	rs6356	TH	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32736537
chr11	2172366	2172367	C	A,G,T	rs10770140	TH	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32736537
chr11	2172609	2172610	A	C,G	rs10770141	TH	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32736537
chr11	2174750	2174751	T	A,C,G	rs10743152	TH	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.	25642918
chr11	2818520	2818521	C	T	rs2237892	KCNQ1	Allele T is associated with increased clinical benefit to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele C.	27694910
chr11	2825838	2825839	T	C,G	rs163184	KCNQ1	Genotype GG is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.	39792745
chr11	2835963	2835964	A	C,T	rs2237895	KCNQ1	Allele C is associated with increased clinical benefit to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele A.	27694910
chr11	2837315	2837316	C	T	rs2237897	KCNQ1	Allele T is not associated with response to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele C.	26866747
chr11	3668952	3668953	A	C,G,T	rs2741868	CHRNA10	Allele T is not associated with response to nicotine in women as compared to allele A.	20231857
chr11	4082829	4082830	A	C	rs2898950	RRM1	Genotypes AC + CC is associated with increased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotype AA.	24024897
chr11	4092164	4092165	G	A,C,T	rs1561876	STIM1	Genotypes AG + GG is associated with increased resistance to erythropoietin in people with Kidney Diseases and Anemia as compared to genotype AA.	39214396
chr11	4094256	4094257	T	A,C	rs11030918	RRM1	Genotype CT is associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + TT.	18483375
chr11	4094743	4094744	C	A,T	rs12806698	RRM1	Genotype AC is associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + CC.	18483375
chr11	4099618	4099619	T	C	rs2284449	RRM1	Genotype TT is associated with decreased response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung.	21642870
chr11	4107614	4107615	G	A	rs725518	RRM1	Genotype GG is not associated with response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG.	21642870
chr11	4117073	4117074	C	A,T	rs7940013	RRM1	Genotype CC is not associated with response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.	21642870
chr11	4117894	4117895	G	A	rs232043	RRM1	Genotype AA is associated with decreased response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG.	21642870
chr11	4118747	4118748	T	C	rs720106	RRM1	Genotype TT is associated with decreased response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CT.	21642870
chr11	4119901	4119902	C	A	rs183484	RRM1	Genotype CC is not associated with response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AC.	21642870
chr11	4121361	4121362	T	A,C,G	rs3817657	RRM1	Genotype TT is not associated with response to cisplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CT.	21642870
chr11	4138226	4138227	A	G,T	rs9937	RRM1	Genotype AA is not associated with response to carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	20226083
chr11	4138235	4138236	G	A,T	rs1042858	RRM1	Genotype AA is not associated with response to carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	20226083
chr11	4138533	4138534	A	C,G,T	rs1042919	RRM1	Genotype AT is associated with decreased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotype AA.	24024897
chr11	4583964	4583965	G	C	rs2566255		Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr11	5040310	5040311	A	C,G	rs2499984	OR52J3	Genotype GG is associated with increased response to lithium in people with Bipolar Disorder as compared to genotype AA.	21961650
chr11	5059613	5059614	T	C,G	rs16909440	OR52E2	Genotype TT is associated with increased response to lithium in people with Bipolar Disorder as compared to genotype CC.	21961650
chr11	5573249	5573250	A	C,G,T	rs4575304	CHRNA10	Allele G is not associated with response to nicotine in women as compared to allele A.	20231857
chr11	10303777	10303778	C	A,G	rs11042725	ADM	Genotype CC is associated with decreased response to paroxetine in people with Depressive Disorder, Major as compared to genotypes AA + AC.	19636336
chr11	11354026	11354027	G	A,C	rs7937567	GALNT18	Genotype GG is associated with increased response to cisplatin in people with Urinary Bladder Neoplasms as compared to genotypes AA + AG.	27150640
chr11	11458318	11458319	C	A,T	rs4910008	GALNT18	Genotype CC is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.	27339827
chr11	13276937	13276938	T	A,C,G	rs2279287	BMAL1	Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	21781277
chr11	13328583	13328584	A	G	rs1982350	BMAL1	Allele A is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.	21781277
chr11	13376330	13376331	C	T	rs2278749	BMAL1	Allele T is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	21781277
chr11	14972977	14972978	A	C,G	rs3781719	CALCA	Allele G is associated with decreased response to botulinum toxin type a in women with Migraine NOS as compared to allele A.	31014225
chr11	17330135	17330136	C	G	rs757081	NUCB2	Allele C is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele G.	31327267
chr11	17386477	17386478	A	C,G,T	rs2285676	KCNJ11	Genotype CC is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.	39792745
chr11	17387082	17387083	C	T	rs5215	KCNJ11	Allele C is not associated with dose of glibenclamide, gliclazide, glimepiride, glipizide and gliquidone in people with Diabetes Mellitus as compared to allele T.	24442125
chr11	17388024	17388025	T	A,C,G	rs5219	KCNJ11	Allele T is not associated with decreased response to sulfonamides, urea derivatives.	11318841
chr11	17396929	17396930	C	A,T	rs757110	ABCC8	Allele C is not associated with dose of glibenclamide, gliclazide, glimepiride, glipizide and gliquidone in people with Diabetes Mellitus as compared to allele A.	24442125
chr11	17418681	17418682	A	G	rs2237991	ABCC8	Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.	29318894
chr11	18025707	18025708	G	A,T	rs1799913	TPH1	Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder.	21047205
chr11	18026268	18026269	G	T	rs1800532	TPH1	Genotype GG is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes GT + TT.	23733030
chr11	18033756	18033757	T	G	rs211105	TPH1	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr11	18042429	18042430	A	C,G,T	rs623580	TPH1	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr11	23496858	23496859	A	C,G,T	rs1350948		Allele A is associated with increased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	33124499
chr11	26578823	26578824	C	T	rs293983	ANO3	Allele T is not associated with response to belimumab in people with Lupus erythematosus as compared to allele C.	31058715
chr11	27648560	27648561	T	C,G	rs10501087	BDNF-AS	Allele T is associated with increased resistance to antidepressants as compared to allele C.	21188787
chr11	27655493	27655494	C	G,T	rs7124442	BDNF	Genotype TT is associated with decreased response to citalopram in people with Depressive Disorder, Major as compared to genotypes CC + CT.	19236730
chr11	27658368	27658369	C	T	rs6265	BDNF	Allele C is not associated with response to modafinil in people with methamphetamine dependence as compared to allele T.	22217949
chr11	27659196	27659197	A	G,T	rs11030101	BDNF-AS	Genotype AA is not associated with response to escitalopram in people with Depressive Disorder as compared to genotypes AT + TT.	29748862
chr11	27662969	27662970	A	G	rs11030104	BDNF	Genotypes AG + GG is associated with increased resistance to antipsychotics in people with Schizophrenia as compared to genotype AA.	23433505
chr11	27674362	27674363	C	A,G	rs10835210	BDNF	Genotype CC is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes AA + AC.	23651024
chr11	27676826	27676827	T	A,C	rs16917234	BDNF	Allele C is not associated with response to heroin as compared to allele T.	28692418
chr11	27678577	27678578	C	T	rs7103411	BDNF	Genotype TT is not associated with response to escitalopram in people with Depressive Disorder as compared to genotypes CC + CT.	29748862
chr11	27693336	27693337	T	C	rs7127507	BDNF	Allele C is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele T.	18182069
chr11	27700730	27700731	G	C,T	rs61888800	BDNF	Genotype GG is associated with increased response to antidepressants, desipramine and fluoxetine in people with Depressive Disorder, Major.	19414708
chr11	27703197	27703198	C	G	rs988748	BDNF	Allele C is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele G.	18182069
chr11	27705367	27705368	A	G	rs2030324	BDNF	Allele G is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele A.	18182069
chr11	27706554	27706555	G	A,T	rs11030119	BDNF	Allele G is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to allele A.	18182069
chr11	27710435	27710436	G	A	rs7934165	BDNF	Genotype AA is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes AG + GG.	23651024
chr11	27712872	27712873	T	C,G	rs962369	BDNF	Allele C is not associated with decreased response to escitalopram in people with Major Depressive Disorder as compared to allele T (assigned as normal metabolizer phenotype) .	39407134
chr11	27728177	27728178	T	C	rs1491850		Genotype CC is not associated with response to escitalopram in people with Depressive Disorder as compared to genotypes CT + TT.	29748862
chr11	34438683	34438684	C	G,T	rs1001179	CAT	Genotype CC is not associated with response to atorvastatin in people with Dyslipidaemia as compared to genotypes CT + TT.	19274593
chr11	34633815	34633816	A	C,G,T	rs286913	EHF	Allele A is associated with increased response to ziprasidone in people with Schizophrenia as compared to allele G.	21107309
chr11	35419428	35419429	T	A,G	rs4354668	SLC1A2	Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.	31014225
chr11	46723452	46723453	C	G,T	rs5896	F2	Genotype TT is associated with decreased dose of warfarin as compared to genotypes CC + CT.	21320153
chr11	46739205	46739206	G	A	rs3136516	F2	Allele G is not associated with dose of warfarin in people with heart valve replacement as compared to allele A.	25126975
chr11	57599748	57599749	C	A,T	rs1005510	SERPING1	Genotype CC is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype TT.	22594510
chr11	57610851	57610852	C	T	rs2511989	SERPING1	Genotype TT is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype CC.	22594510
chr11	58624027	58624028	G	A	rs1800169	CNTF	Genotype GG is associated with increased response to iloperidone in people with Schizophrenia as compared to genotypes AA + AG.	18303965
chr11	61792608	61792609	G	A,T	rs174538	FEN1	Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr11	61796826	61796827	G	C,T	rs4246215	FEN1	Allele T is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr11	62916052	62916053	A	G,T	rs1942499	CHRM1	Genotype GG is associated with decreased dose of clozapine in people with Schizophrenia as compared to genotypes AA + AG.	33143542
chr11	62920796	62920797	C	G,T	rs2075748	CHRM1	Genotype CC is associated with decreased dose of clozapine in people with Schizophrenia as compared to genotypes CT + TT.	33143542
chr11	62984816	62984817	C	T	rs4149170	SLC22A6	Genotype TT is associated with increased concentrations of tenofovir in people with Hepatitis B, Chronic as compared to genotypes CC + CT.	38713940
chr11	62995791	62995792	T	A	rs11568482	SLC22A8	Genotype AT is associated with decreased clearance of cefotaxime in healthy individuals as compared to genotype TT.	23649425
chr11	64185648	64185649	G	A,C,T	rs3751122	STIP1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr11	64189597	64189598	A	G	rs2701528	STIP1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr11	64191786	64191787	A	C,T	rs4980524	STIP1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr11	64191883	64191884	A	G	rs6591838	STIP1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr11	64194679	64194680	T	C	rs2282490	STIP1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr11	64196474	64196475	T	A,G	rs11607165	STIP1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr11	64197132	64197133	C	T	rs2236647	STIP1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr11	64197184	64197185	C	A,T	rs2236648	STIP1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr11	64203152	64203153	G	A	rs2070232	STIP1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr11	64205923	64205924	G	A,T	rs1011219		Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr11	64278556	64278557	G	A,T	rs671976	BAD	Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele A.	24070809
chr11	64535477	64535478	T	A,G	rs11231809	SLC22A11	Genotypes AT + TT are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.	26086825
chr11	64563989	64563990	A	G,T	rs17300741	SLC22A11	Allele G is not associated with dose of allopurinol in people with Gout as compared to allele A.	29341237
chr11	64566641	64566642	C	A,T	rs2078267	SLC22A11	Allele T is not associated with response to furosemide in healthy individuals as compared to allele C.	28951782
chr11	64589599	64589600	T	A,C	rs505802	SLC22A12	Allele T is associated with increased dose of allopurinol in people with Gout as compared to allele C.	37202871
chr11	64591336	64591337	G	A	rs3825018	SLC22A12	Allele G is not associated with dose of allopurinol in people with Gout as compared to allele A.	29341237
chr11	64591813	64591814	C	T	rs3825016	SLC22A12	Genotypes CT + TT is associated with decreased response to losartan in people with Hypertension and Hyperuricemia as compared to genotype CC.	26086348
chr11	64598470	64598471	T	A,C	rs1529909	SLC22A12	Genotypes CC + CT is associated with decreased response to losartan in people with Hypertension and Hyperuricemia as compared to genotype TT.	26086348
chr11	64728884	64728885	G	T	rs2230414	RASGRP2	Allele T is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele G.	36581799
chr11	65297218	65297219	G	A,T	rs487989	POLA2	Genotype GG is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG.	18538445
chr11	65498697	65498698	A	G,T	rs619586	MALAT1	Genotypes AG + GG are associated with decreased response to Platinum compounds in people with Lung Neoplasms as compared to genotype AA.	26729200
chr11	67585217	67585218	A	G,T	rs1695	GSTP1	Genotype GG is associated with decreased response to dimethyl fumarate in people with Psoriasis as compared to genotypes AA + AG.	26967570
chr11	67586107	67586108	C	G,T	rs1138272	GSTP1	Allele C is not associated with response to oxaliplatin in people with Gastrointestinal Neoplasms as compared to allele T.	16707601
chr11	67647582	67647583	C	G,T	rs2514036	ACY3	Allele T is associated with increased response to bisoprolol in men with Hypertension as compared to allele C.	25622599
chr11	68433826	68433827	C	T	rs3736228	LRP5	Allele T is not associated with response to risedronate in people with Osteoporosis as compared to allele C.	19148563
chr11	68682734	68682735	C	A,G,T	rs948854	GAL	Allele C is associated with decreased response to antidepressants, benzodiazepine derivatives, mirtazapine or Selective serotonin reuptake inhibitors in women Depressive Disorder, Major as compared to allele T.	20237460
chr11	69648141	69648142	G	A	rs9344	CCND1	Genotypes CA/CA + CA/CG are associated with increased response to lapatinib in women with Breast Neoplasms as compared to genotype CG/CG.	21989330
chr11	72028376	72028377	G	A	rs10898815	NUMA1	Genotypes AA + AG is associated with increased discontinuation of Dihydropyridine derivatives as compared to genotype GG.	36134646
chr11	72139083	72139084	C	T	rs61734430	FOLR3	Genotypes CT + TT is associated with decreased response to pemetrexed in people with Carcinoma, Non-Small-Cell Lung and Mesothelioma as compared to genotype CC.	24732178
chr11	75150835	75150836	G	A,C	rs2712807	SLCO2B1	Allele A is not associated with clearance of montelukast in healthy individuals as compared to allele G.	23970434
chr11	75169324	75169325	G	A	rs35199625	SLCO2B1	Allele A is not associated with clearance of montelukast in healthy individuals as compared to allele G.	23970434
chr11	75172531	75172532	G	A,T	rs12422149	SLCO2B1	Genotypes AA + AG is associated with increased concentrations of tamoxifen in women with Breast Neoplasms as compared to genotype GG.	36373739
chr11	75190555	75190556	G	A	rs1077858	SLCO2B1	Genotypes AA + AG is associated with increased concentrations of abiraterone in healthy individuals as compared to genotype GG.	37574850
chr11	75196536	75196537	C	T	rs2306168	SLCO2B1	Genotype TT is not associated with increased exposure to atenolol in healthy individuals as compared to genotype CC.	22574741
chr11	75204975	75204976	T	C,G	rs3781727	SLCO2B1	Genotypes CC + CT are associated with decreased exposure to voriconazole in healthy individuals as compared to genotype TT.	32461666
chr11	75267687	75267688	G	A,C,T	rs140226575	ARRB1	Allele A is associated with increased clinical benefit to albiglutide, dulaglutide or Glucagon-like peptide-1 (GLP-1) analogues in people with Diabetes Mellitus, Type 2 as compared to allele G.	36528349
chr11	76590271	76590272	C	T	rs7927894	EMSY	Genotype CC is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes CT + TT.	25712183
chr11	80347434	80347435	G	C,T	rs7395555		Allele C is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.	23241943
chr11	82853251	82853252	T	A,G	rs2229437	PRCP	Genotypes GG + GT are associated with decreased response to benazepril in people with Hypertension as compared to genotype TT.	20079160
chr11	83983728	83983729	T	A,C,G	rs2449598	DLG2	Allele T is associated with decreased response to anastrozole in women with Breast Neoplasms as compared to allele G.	32701512
chr11	85980618	85980619	G	A,C,T	rs588076	PICALM	Genotype GG is associated with increased response to calcium channel blockers in people with Hypertension as compared to genotype CC.	24192120
chr11	86948170	86948171	A	G	rs10898563	FZD4	Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele A.	24070809
chr11	92969795	92969796	G	A	rs8192552	MTNR1B	Genotype AG is associated with increased exposure to vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hodgkin Disease, Rhabdomyosarcoma, Medulloblastoma or Glioma as compared to genotype GG.	35884569
chr11	93951642	93951643	A	G	rs2511398		Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr11	93958165	93958166	T	A,G	rs2456568		Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr11	94398972	94398973	A	G,T	rs3758785	GPR83	Genotype GG is associated with increased response to candesartan in people with Essential hypertension as compared to genotype AA.	22566498
chr11	100140278	100140279	G	A,C	rs1813443	CNTN5	Allele C is associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	23233654
chr11	101117302	101117303	C	T	rs537681	PGR	Genotypes CT + TT is associated with decreased steady-state concentration of etonogestrel in women as compared to genotype CC.	30870275
chr11	102845216	102845221	AAAAA	AAAA,AAAAAA,AAAAAAA	rs35068180	MMP3	Genotypes A/del + AA are associated with increased response to pravastatin in men with Coronary Artery Disease.	10190398
chr11	105027115	105027116	T	C	rs557905	CASP1	Allele T is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele C.	19749758
chr11	105033842	105033843	A	C	rs568910	CASP1	Allele A is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele C.	19749758
chr11	105041730	105041731	A	C	rs1503391	CARD16	Allele A is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele C.	19749758
chr11	105041825	105041826	C	T	rs1792774	CARD16	Allele C is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T.	19749758
chr11	105553067	105553068	T	A	rs2513265		Allele A is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele T.	26788534
chr11	108412433	108412434	C	A	rs11212617	C11orf65	Allele C is associated with increased clinical benefit to metformin in people with Diabetes Mellitus, Type 2 as compared to allele A.	21186350
chr11	112155432	112155433	G	C	rs5744247	IL18	Allele C is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.	29318894
chr11	112164264	112164265	C	A,G	rs187238	IL18	Allele C is associated with decreased response to interferon alfa-2a, recombinant, interferon alfa-2b, recombinant, interferons, peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with Hepatitis C, Chronic as compared to allele G.	19455410
chr11	112164734	112164735	T	G	rs1946518	IL18	Allele T is associated with increased response to interferon alfa-2a, recombinant, interferon alfa-2b, recombinant, interferons, peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with Hepatitis C, Chronic as compared to allele G.	19455410
chr11	112164783	112164784	A	C	rs1946519	IL18	Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele C.	29318894
chr11	113240778	113240779	T	A,C	rs2303377	NCAM1	Genotype TT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes CC + CT.	28696415
chr11	113393747	113393748	A	C,G,T	rs4938013	ANKK1	Allele C is not associated with response to clozapine in people with Schizophrenia as compared to allele A.	22722500
chr11	113396098	113396099	G	A,C	rs7118900	ANKK1	Genotypes AA + AG are associated with decreased dose of methadone in people with Heroin Dependence as compared to genotype GG.	23651024
chr11	113400105	113400106	G	A	rs1800497	DRD2	Genotype AA is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes AG + GG.	18687376
chr11	113402202	113402203	G	A	rs2587550	ANKK1	Allele G is associated with increased response to haloperidol in people with Schizophrenia as compared to allele A.	22893251
chr11	113402913	113402914	A	C,G,T	rs1003641		Allele A is associated with increased response to haloperidol in people with Schizophrenia as compared to allele G.	22893251
chr11	113407760	113407761	G	C	rs2234689	DRD2	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25642918
chr11	113408041	113408042	C	T	rs1554929	DRD2	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr11	113410350	113410351	G	C	rs6279	DRD2	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113412736	113412737	G	A	rs6277	DRD2	Allele A is not associated with exposure to olanzapine in healthy individuals as compared to allele G.	33378980
chr11	113412754	113412755	A	G	rs6275	DRD2	Genotypes AA + AG are associated with decreased response to rizatriptan in people with Migraine without Aura as compared to genotype GG.	17563839
chr11	113412761	113412762	G	C	rs1801028	DRD2	Genotypes CG + GG are not associated with response to antipsychotics in people with Schizophrenia as compared to genotype CC.	27287786
chr11	113412965	113412966	C	A,G	rs1076560	DRD2	Genotype CC is associated with increased response to rasagiline in people with Parkinson Disease as compared to genotypes AA + AC.	27190009
chr11	113414813	113414814	C	A,T	rs2283265	DRD2	Genotypes AA + AC are associated with decreased dose of methadone in people with Heroin Dependence as compared to genotype CC.	23651024
chr11	113422197	113422198	G	A	rs2734833	DRD2	Allele A is not associated with response to heroin as compared to allele G.	28692418
chr11	113424175	113424176	G	A	rs2075652	DRD2	Allele A is not associated with response to heroin as compared to allele G.	28692418
chr11	113425563	113425564	C	T	rs1079597	DRD2	Allele C is associated with increased response to amisulpride in people with Schizophrenia as compared to allele T.	25679126
chr11	113425896	113425897	C	A,T	rs1079596	DRD2	Allele T is not associated with response to heroin as compared to allele C.	28692418
chr11	113426462	113426463	T	C	rs1125394	DRD2	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr11	113429187	113429188	C	T	rs7131440	DRD2	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr11	113433734	113433735	G	A	rs7122246	DRD2	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113436042	113436043	C	G,T	rs4436578	DRD2	Allele C is not associated with response to heroin as compared to allele T.	28692418
chr11	113441416	113441417	T	G	rs11214607	DRD2	Allele G is not associated with response to heroin as compared to allele T.	28692418
chr11	113442666	113442667	T	A,C,G	rs4648318	DRD2	Allele T is not associated with response to heroin as compared to allele C.	28692418
chr11	113445513	113445514	C	G,T	rs12574471	DRD2	Allele T is not associated with response to heroin as compared to allele C.	28692418
chr11	113447022	113447023	G	C	rs17601612	DRD2	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113448729	113448730	G	A,C	rs4274224	DRD2	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113459051	113459052	A	C,G	rs7131056	DRD2	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	21398039
chr11	113459728	113459729	A	G,T	rs4936274	DRD2	Allele A is not associated with response to heroin as compared to allele G.	28692418
chr11	113460809	113460810	G	A	rs4648317	DRD2	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113475529	113475530	G	GG	rs1799732	DRD2	Genotype G/del is associated with decreased response to aripiprazole in people with schizoaffective disorder.	28673279
chr11	113475628	113475629	T	C	rs1799978	DRD2	Allele C is associated with increased resistance to haloperidol, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	37880658
chr11	113522271	113522272	C	T	rs2514218	DRD2	Allele T is associated with increased response to clozapine in people with Schizophrenia as compared to allele C.	26666695
chr11	113904172	113904173	G	A	rs11214763	HTR3B	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113904829	113904834	AGAAG	AG,AGAAGAAG	rs45460698	HTR3B	Genotype del/del is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes AAG/AAG + AAG/del.	29177570
chr11	113910258	113910259	T	C	rs11606194	HTR3B	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr11	113919376	113919377	C	T	rs7103572	HTR3B	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr11	113932305	113932306	A	C	rs1176744	HTR3B	Genotype AA is not associated with response to granisetron in healthy individuals as compared to genotypes AC + CC.	28002447
chr11	113933164	113933165	A	G	rs2276307	HTR3B	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113936884	113936885	G	A,C,T	rs3782025	HTR3B	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113942010	113942011	G	A,C,T	rs1672717	HTR3B	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113946563	113946564	G	A,C	rs7943062	HTR3B	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113974818	113974819	A	G,T	rs1150226	HTR3A	Allele G is associated with increased response to clozapine in people with Schizophrenia as compared to allele A.	20168265
chr11	113975283	113975284	T	C	rs1062613	HTR3A	Genotype CC is not associated with response to granisetron in healthy individuals as compared to genotypes CT + TT.	28002447
chr11	113979417	113979418	G	A,C,T	rs2276302	HTR3A	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113981464	113981465	G	A	rs1176719	HTR3A	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr11	113989702	113989703	A	G	rs1176713	HTR3A	Allele G is not associated with response to risperidone in people with Schizophrenia as compared to allele A.	28696411
chr11	116778200	116778201	G	C	rs964184	APOA1	Allele G is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to allele C.	23119086
chr11	116791690	116791691	G	A,C	rs3135506	APOA5	Genotypes CG + GG are associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.	17431185
chr11	116792990	116792991	G	A,C	rs662799	APOA5	Genotype AA is associated with increased response to simvastatin in people with Dyslipidaemia as compared to genotypes AG + GG.	29695967
chr11	116819995	116819996	C	T	rs1263177	APOA4	Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.	19057464
chr11	116820958	116820959	T	A,C,G	rs675	APOA4	Genotypes AA + AT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.	19057464
chr11	116821617	116821618	C	A,G,T	rs5104	APOA4	Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.	19057464
chr11	116822747	116822748	C	G,T	rs5092	APOA4	Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.	19057464
chr11	116823338	116823339	C	G	rs5090	APOA4	Genotype CG is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype GG.	19057464
chr11	116827021	116827022	C	A,G	rs2542051	APOC3	Genotypes AC + CC are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype AA.	19057464
chr11	116829267	116829268	A	C,T	rs2542052	APOC3	Genotypes AA + AC are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.	19057464
chr11	116829425	116829426	T	A,C	rs2854117	APOC3	Genotypes CT + TT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.	19057464
chr11	116829452	116829453	C	T	rs2854116	APOC3	Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.	19057464
chr11	116830818	116830819	T	A,C	rs4520	APOC3	Allele C is not associated with exposure to olanzapine in healthy individuals as compared to allele T.	33378980
chr11	116832923	116832924	G	C	rs5128	APOC3	Genotypes CC + CG are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype GG.	19057464
chr11	116837696	116837697	C	A,T	rs670	APOA1	Genotypes CT + TT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.	19057464
chr11	116840251	116840252	A	G	rs613808	APOA1	Genotypes AA + AG are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype GG.	19057464
chr11	116840424	116840425	C	G,T	rs2727784	APOA1	Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.	19057464
chr11	116840633	116840634	G	A	rs11216158	APOA1	Genotypes AA + AG are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype GG.	19057464
chr11	116870855	116870856	A	C	rs533556	SIK3	Genotype AA is associated with decreased response to hmg coa reductase inhibitors in people with Hyperlipidemias as compared to genotype CC.	20195290
chr11	120792653	120792654	T	C	rs1954787	GRIK4	Genotype CC is associated with increased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotypes CT + TT.	23394390
chr11	123522137	123522138	G	A,C,T	rs61123830	GRAMD1B	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr11	126157577	126157578	A	C,G,T	rs3133084		Allele A is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele G.	27001119
chr11	126292947	126292948	C	T	rs8177374	TIRAP	Genotypes CT + TT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype CC.	28696418
chr11	130041951	130041952	G	A,T	rs112914324		Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.	37098852
chr11	131320707	131320708	C	A,G,T	rs139945292		Allele T is associated with decreased response to Beta Blocking Agents in people with Hypertension as compared to allele C.	34231218
chr11	132623599	132623600	C	G,T	rs751655	OPCML	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr11_KI270831v1_alt	50707	50708	C	T	rs2237892	KCNQ1	Allele T is associated with increased clinical benefit to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele C.	27694910
chr11_KI270831v1_alt	58016	58017	T	C,G	rs163184	KCNQ1	Genotype GG is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.	39792745
chr11_KI270831v1_alt	68141	68142	A	C,T	rs2237895	KCNQ1	Allele C is associated with increased clinical benefit to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele A.	27694910
chr11_KI270831v1_alt	69494	69495	C	T	rs2237897	KCNQ1	Allele T is not associated with response to gliclazide in people with Diabetes Mellitus, Type 2 as compared to allele C.	26866747
chr11_KI270832v1_alt	166272	166273	T	C	rs3758653	DRD4	Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.	28871191
chr11_KI270832v1_alt	169989	169990	T	C,G	rs762502	DRD4	Allele C is associated with increased clinical benefit to clozapine in people with Schizophrenia or Psychotic Disorder as compared to allele T.	40048458
chr11_KI270832v1_alt	171059	171060	A	C,G	rs11246226	DRD4	Genotype AA is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotypes AC + CC.	23856854
chr11_KI270832v1_alt	188597	188598	A	G,C	rs4963126	DEAF1	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25642918
chr11_ML143358v1_fix	190144	190145	G	A,C	rs2839698	H19	Genotypes AA + AG are associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotype GG.	26729200
chr11_ML143358v1_fix	192366	192367	C	T	rs2107425		Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.	26729200
chr12	2052394	2052395	C	A,G,T	rs723672	CACNA1C	Allele C is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	26049408
chr12	2073131	2073132	T	A	rs2283271	CACNA1C	Allele A is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	26049408
chr12	2111238	2111239	T	A,C	rs758723	CACNA1C	Allele A is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	26049408
chr12	2113565	2113566	T	C,G	rs2238032	CACNA1C	Genotype TT is not associated with response to nimodipine in healthy individuals as compared to genotype GT.	19205682
chr12	2207028	2207029	T	A,C	rs10848635	CACNA1C	Allele A is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	26049408
chr12	2338247	2338248	G	A,C	rs2239050	CACNA1C	Genotype CG is associated with increased response to nimodipine in healthy individuals as compared to genotype CC.	19205682
chr12	2504549	2504550	C	G,T	rs2238087	CACNA1C	Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT.	30032160
chr12	2585471	2585472	C	G,T	rs215976	CACNA1C	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	26216687
chr12	2611970	2611971	C	T	rs216008	CACNA1C	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	26216687
chr12	2620465	2620466	A	G	rs216013	CACNA1C	Allele A is not associated with dose of warfarin.	18535201
chr12	2627451	2627452	A	C,T	rs12813888	CACNA1C	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	26216687
chr12	2648602	2648603	T	A,C	rs2239128	CACNA1C	Genotype CC is associated with increased response to nimodipine in healthy individuals as compared to genotype CT.	19205682
chr12	2695288	2695289	G	A,C	rs7316246	CACNA1C	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.	26216687
chr12	4052704	4052705	G	A,C	rs2532560	PARP11	Allele G is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele A.	27091189
chr12	4408973	4408974	G	A,C	rs1024905		Allele G is not associated with response to Selective serotonin (5HT1) agonists in people with Migraine without Aura as compared to allele C.	30256423
chr12	5642175	5642176	C	T	rs2110166	ANO2	Genotype TT is associated with increased clinical benefit to aflibercept or ranibizumab in people with Macular Degeneration as compared to genotypes CC + CT.	38980270
chr12	5915593	5915594	T	C	rs61908402	ANO2	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr12	5915638	5915639	G	A	rs61908403	ANO2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr12	5916104	5916105	C	T	rs61908404	ANO2	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr12	5916163	5916164	C	A	rs61908405	ANO2	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr12	5916321	5916322	C	A,T	rs17724452	ANO2	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr12	5916417	5916418	G	C	rs17724464	ANO2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr12	5916923	5916924	T	A,C	rs17786394	ANO2	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr12	5916984	5916985	A	G,T	rs17786400	ANO2	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr12	5917080	5917081	G	A,T	rs61908406	ANO2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr12	5917147	5917148	G	A,T	rs17786412	ANO2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr12	5917206	5917207	A	G	rs61908407	ANO2	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr12	5917288	5917289	A	G	rs61908408	ANO2	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr12	5917404	5917405	C	G	rs61908409	ANO2	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr12	5917411	5917412	T	A	rs61908410	ANO2	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr12	5917823	5917824	G	A,C	rs78482393	ANO2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr12	5917866	5917867	A	C	rs78615940	ANO2	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr12	5918125	5918126	C	T	rs17724494	ANO2	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr12	5918477	5918478	C	G,T	rs61908411	ANO2	Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr12	6341778	6341779	T	C	rs767455	TNFRSF1A	Genotype TT is not associated with response to adalimumab, etanercept and infliximab in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.	22480748
chr12	6342196	6342197	T	G	rs2234649	TNFRSF1A	Genotype GT is not associated with response to etanercept in people with Spondylitis, Ankylosing as compared to genotypes GG + TT.	30075559
chr12	6342423	6342424	A	C,G,T	rs4149570	TNFRSF1A	Genotype AA is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease or Inflammatory Bowel Diseases as compared to genotypes AC + CC.	24776844
chr12	6839861	6839862	A	G,T	rs5441	GNB3	Genotype GG is associated with increased response to sertraline in people with Depressive Disorder, Major as compared to genotypes AA + AG.	30324302
chr12	6844092	6844093	A	C,G,T	rs11064426	GNB3	Genotype AA is associated with increased response to atenolol in people with Essential hypertension as compared to genotype CC.	20235788
chr12	6845710	6845711	C	T	rs5443	GNB3	Genotype CC is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.	23733030
chr12	6867131	6867132	C	T	rs12302749	SPSB2	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr12	9657124	9657125	G	T	rs7316769		Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr12	9657854	9657855	A	G,T	rs7306991		Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr12	9658800	9658801	T	A,C,G	rs10771997		Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr12	9658871	9658872	A	G	rs10771998		Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr12	9658875	9658876	C	A,G	rs10771999		Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr12	9670355	9670356	A	G,T	rs1560011	CLEC2D	Genotype GG is associated with increased clinical benefit to tocilizumab in people with Rheumatoid arthritis.	39718059
chr12	9753093	9753094	A	G	rs11052877	CD69	Allele A is associated with increased response to tocilizumab in people with Arthritis, Rheumatoid as compared to allele G.	27339827
chr12	10307943	10307944	A	G,T	rs2302489	KLRD1	Genotype TT is associated with decreased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + AT.	26453102
chr12	10372765	10372766	G	C,T	rs1049174	KLRK1	Genotype GG is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes CC + CG.	28004016
chr12	10406892	10406893	G	T	rs1154831	KLRC4	Genotype GG is associated with increased clinical benefit to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylarthropathy as compared to genotypes GT + TT.	38372728
chr12	10446202	10446203	A	T	rs2734414	KLRC1	Genotype TT is not associated with response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + AT.	26453102
chr12	10449090	10449091	C	T	rs7301582	KLRC1	Genotype CC is associated with decreased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.	26453102
chr12	10449477	10449478	C	A,T	rs2734440	KLRC1	Genotype TT is not associated with response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.	26453102
chr12	13562373	13562374	A	C,G	rs890	GRIN2B	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.	21047205
chr12	13713237	13713238	C	T	rs2284411	GRIN2B	Genotype CC is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CT + TT.	27624150
chr12	13785841	13785842	G	A,C	rs1072388	GRIN2B	Genotypes AA + AG are associated with increased response to clozapine in people with Schizophrenia as compared to genotype GG.	26876050
chr12	13800183	13800184	T	A,C	rs2058878	GRIN2B	Allele A is associated with increased response to acamprosate in people with Alcoholism as compared to allele T.	25290263
chr12	13828792	13828793	A	C	rs2160733	GRIN2B	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele A.	25290263
chr12	13831414	13831415	C	A,G,T	rs2160734	GRIN2B	Allele C is not associated with response to acamprosate in people with Alcoholism as compared to allele T.	25290263
chr12	13981908	13981909	C	A	rs1019385	GRIN2B	Genotype AC is associated with decreased dose of valproic acid in people with Epilepsy as compared to genotype AA.	21806385
chr12	20020829	20020830	C	A,G,T	rs12579720	PDE3A	Allele C is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele G.	31327267
chr12	20707158	20707159	G	A,C	rs3794271	SLCO1C1	Allele G is not associated with decreased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele A.	23651021
chr12	20858545	20858546	T	C,G	rs4149117	SLCO1B3	Genotypes GG + GT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.	25056761
chr12	20858646	20858647	G	A	rs4149118	SLCO1B3	Allele G is associated with decreased clearance of docetaxel in people with Nasopharyngeal Neoplasms.	21995462
chr12	20862825	20862826	G	A	rs7311358	SLCO1B3	Allele A is associated with decreased clearance of docetaxel in people with Nasopharyngeal Neoplasms.	21995462
chr12	20875273	20875274	G	A,C	rs60140950	SLCO1B3	Allele C is associated with increased concentrations of telmisartan in healthy individuals as compared to allele G.	32498119
chr12	20892759	20892760	A	G,T	rs11045585	SLCO1B3	Allele G is associated with decreased clearance of docetaxel in people with Nasopharyngeal Neoplasms.	21995462
chr12	21053899	21053900	T	C	rs1910167	SLCO1B1	Allele C is associated with increased concentrations of bilirubin in children as compared to allele T.	38826804
chr12	21130387	21130388	G	A,C,T	rs4149015	SLCO1B1	Genotype AG is associated with decreased response to pravastatin as compared to genotype GG.	15864131
chr12	21143540	21143541	T	A	rs2417955	SLCO1B1	Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.	29791011
chr12	21162480	21162481	A	C,G	rs4149026	SLCO1B1	Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.	29791011
chr12	21164733	21164734	T	C,G	rs10444413	SLCO1B1	Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.	29791011
chr12	21164856	21164857	C	T	rs4149032	SLCO1B1	Genotypes CT + TT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype CC.	35280252
chr12	21164987	21164988	G	A,C	rs4149034	SLCO1B1	Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.	29791011
chr12	21165330	21165331	T	A,C	rs4149035	SLCO1B1	Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr12	21168435	21168436	T	A,C	rs10841753	SLCO1B1	Genotypes CT + TT are associated with decreased concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	28525903
chr12	21172879	21172880	T	C,G	rs2291073	SLCO1B1	Genotypes GT + TT are associated with increased response to lovastatin as compared to genotype GG.	16103896
chr12	21174805	21174806	C	A	rs4149036	SLCO1B1	Genotypes AC + CC are associated with increased response to atorvastatin as compared to genotype AA.	16103896
chr12	21176803	21176804	A	C,G,T	rs2306283	SLCO1B1	Genotype GG is associated with increased concentrations of rosuvastatin in healthy individuals as compared to genotype AA.	16198652
chr12	21176878	21176879	C	A,T	rs11045819	SLCO1B1	Allele A is associated with increased exposure to grazoprevir in people with Hepatitis C, Chronic as compared to allele C.	31250727
chr12	21177061	21177062	A	C,T	rs4149044	SLCO1B1	Genotypes AA + AT is not associated with concentrations of lopinavir in people with HIV Infections as compared to genotype TT.	27142945
chr12	21177085	21177086	G	A	rs4149045	SLCO1B1	Genotypes AG + GG is not associated with concentrations of lopinavir in people with HIV Infections as compared to genotype AA.	27142945
chr12	21178614	21178615	T	C	rs4149056	SLCO1B1	Genotypes CC + CT are associated with increased exposure to rosuvastatin in people with Diabetes Mellitus and Hypercholesterolemia as compared to genotype TT.	32361904
chr12	21178664	21178665	T	C	rs4149057	SLCO1B1	Genotypes CC + CT is not associated with concentrations of lopinavir in people with HIV Infections as compared to genotype TT.	27142945
chr12	21179488	21179489	G	A	rs11045821	SLCO1B1	Allele A is associated with decreased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	23233662
chr12	21182446	21182447	G	C,T	rs1463565	SLCO1B1	Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.	29791011
chr12	21183128	21183129	C	G,T	rs2900476	SLCO1B1	Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.	29791011
chr12	21197099	21197100	G	A	rs11045854	SLCO1B1	Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.	30100615
chr12	21200737	21200738	G	A	rs12305884	SLCO1B1	Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.	30100615
chr12	21204776	21204777	C	A,G,T	rs58310495	SLCO1B1	Allele T is associated with increased concentrations of fluvastatin in healthy individuals as compared to allele C.	30989645
chr12	21215787	21215788	T	A,C,G	rs4363657	SLCO1B1	Allele A is associated with increased exposure to pitavastatin and pitavastatin lactone in healthy individuals as compared to allele T.	40029062
chr12	21215862	21215863	T	A	rs2900478	SLCO1B1	Allele A is associated with decreased response to hmg coa reductase inhibitors as compared to allele T.	25350695
chr12	21219409	21219410	A	G,T	rs11045872	SLCO1B1	Allele G is associated with increased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma.	23233662
chr12	21222126	21222127	T	A	rs11045873	SLCO1B1	Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T.	30100615
chr12	21222128	21222129	G	A,C,T	rs11045874	SLCO1B1	Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.	30100615
chr12	21225086	21225087	G	A	rs4149081	SLCO1B1	Genotype AA is associated with increased concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG.	21387541
chr12	21229684	21229685	T	C	rs11045879	SLCO1B1	Allele C is not associated with response to methotrexate in children with Lymphoma, Non-Hodgkin or Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.	24386571
chr12	21239041	21239042	A	C	rs34671512	SLCO1B1	Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele A.	30100615
chr12	21250044	21250045	T	C	rs113681054	SLCO1B1	Allele C is associated with increased concentrations of ticagrelor in people with Acute coronary syndrome as compared to allele T.	25935875
chr12	21267536	21267537	C	T	rs4149009	SLCO1A2	Allele T is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	33501733
chr12	21271068	21271069	T	C	rs7967354	SLCO1A2	Genotype CC is associated with decreased dose of rocuronium in women as compared to genotypes CT + TT.	33676726
chr12	21304499	21304500	T	A,G	rs11568563	SLCO1A2	Genotypes GT + TT are not associated with clearance of rocuronium in healthy individuals as compared to genotype GG.	28409297
chr12	21334609	21334610	A	G	rs10841795	SLCO1A2	Allele A is not associated with concentrations of ceftriaxone in people with Central Nervous System Infections as compared to allele G.	29873816
chr12	21334835	21334838	TTT	TTTT	rs3834939	SLCO1A2	Genotypes T/del + TT are associated with decreased clearance of rocuronium in healthy individuals as compared to genotype del/del.	28409297
chr12	21335069	21335070	C	T	rs3764043	SLCO1A2	Genotypes CT + TT are not associated with clearance of rocuronium in healthy individuals as compared to genotype CC.	28409297
chr12	21335740	21335741	C	T	rs4148978	SLCO1A2	Genotypes CT + TT is associated with increased dose-adjusted trough concentrations of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotype CC.	35144161
chr12	21355243	21355244	T	C	rs11045995	IAPP	Genotype CC is associated with decreased dose of rocuronium in women as compared to genotypes CT + TT.	33676726
chr12	21795388	21795389	C	T	rs141294036		Genotype CC is associated with increased response to dexmedetomidine in people with surgery as compared to genotypes CT + TT.	37693312
chr12	21852068	21852069	T	A,G	rs2307024	ABCC9	Genotype TT is not associated with concentrations of efavirenz in people with HIV Infections.	26774523
chr12	21891409	21891410	C	T	rs704212	ABCC9	Allele T is associated with decreased concentrations of montelukast in healthy individuals as compared to allele C.	28940478
chr12	25207289	25207290	A	C,G	rs61764370	KRAS	Allele C is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to allele A.	27897268
chr12	25654373	25654374	C	G,T	rs6487504		Allele T is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele C.	30237584
chr12	29205633	29205634	T	A,G	rs7301408		Allele G is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	21047205
chr12	47844973	47844974	A	G,T	rs731236	VDR	Allele G is not associated with response to zoledronate in people with beta-Thalassemia.	18443790
chr12	47845053	47845054	C	A	rs7975232	VDR	Allele A is associated with increased response to amoxicillin, clarithromycin and omeprazole in people with Helicobacter Infections as compared to allele C.	37449247
chr12	47846051	47846052	C	A,G,T	rs1544410	VDR	Allele C is associated with increased clearance of midazolam as compared to allele T.	22484315
chr12	47859143	47859144	T	C	rs11574077	VDR	Genotype TT is associated with increased metabolism of irinotecan in people with Colorectal Neoplasms as compared to genotype CT.	29706892
chr12	47863542	47863543	C	T	rs1540339	VDR	Allele C is associated with decreased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele T.	15282200
chr12	47863982	47863983	T	C	rs2239179	VDR	Allele C is associated with decreased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele T.	15282200
chr12	47865342	47865343	C	T	rs12717991	VDR	Allele T is not associated with metabolism of irinotecan in people with Colorectal Neoplasms as compared to allele C.	29706892
chr12	47879111	47879112	A	C,G,T	rs2228570	VDR	Allele A is associated with increased response to amoxicillin, clarithromycin and omeprazole in people with Helicobacter Infections as compared to allele G.	37449247
chr12	47899821	47899822	C	A,G	rs11168292	VDR	Genotype GG is associated with increased dose of warfarin as compared to genotypes CC + CG.	29298995
chr12	47899932	47899933	G	A,T	rs11168293	VDR	Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.	29298995
chr12	47902702	47902703	A	G	rs4760658	VDR	Genotype GG is associated with increased dose of warfarin as compared to genotypes AA + AG.	29298995
chr12	47906042	47906043	T	C	rs4516035	VDR	Allele T is associated with increased clearance of midazolam as compared to allele C.	22484315
chr12	47908761	47908762	C	T	rs11568820	VDR	Genotypes CT + TT are associated with increased clearance of midazolam as compared to genotype CC.	22484315
chr12	48005244	48005245	G	T	rs3809324	COL2A1	Genotypes GT + TT is associated with decreased response to salbutamol in children with Asthma as compared to genotype GG.	31486735
chr12	48861424	48861425	T	C	rs2453488	RND1	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr12	49903886	49903887	T	C	rs706795	FAIM2	Allele T is associated with increased response to citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline in people with Obsessive-Compulsive Disorder as compared to allele C.	40054571
chr12	49946257	49946258	C	T	rs7314734	AQP2	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr12	49947826	49947827	T	A,C,G	rs7305534	AQP2	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr12	49949824	49949825	A	C,G,T	rs3759125	AQP2	Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr12	49950078	49950079	A	C,G	rs3759126	AQP2	Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.	24643204
chr12	49951422	49951423	G	A	rs461872	AQP2	Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.	24643204
chr12	49957169	49957170	T	A,C	rs296766	AQP2	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr12	49957291	49957292	T	A,C,G	rs10875989	AQP2	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr12	51657345	51657346	T	A,C	rs4512905	SCN8A	Genotype TT is not associated with increased response to lithium in people with Bipolar Disorder as compared to genotype CC.	21961650
chr12	53429099	53429100	G	A	rs784892	AMHR2	Allele A is not associated with exposure to metformin as compared to allele G.	29352482
chr12	53430723	53430724	G	A,C,T	rs784888	SP1	Allele C is not associated with exposure to metformin as compared to allele G.	29352482
chr12	53963767	53963768	C	A,G,T	rs7958904	HOTAIR	Genotypes CC + CG are associated with decreased response to Platinum compounds in people with Lung Neoplasms as compared to genotype GG.	26729200
chr12	53967209	53967210	C	A	rs1899663	HOTAIR	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele A.	26729200
chr12	53968050	53968051	G	A,C,T	rs4759314	HOTAIR	Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.	26729200
chr12	55629198	55629199	T	G	rs17117817	OR10P1	Allele G is associated with decreased response to atenolol or metoprolol in people with Hypertension as compared to allele T.	29478026
chr12	56093416	56093417	T	C	rs2229046	ERBB3	Allele C is associated with decreased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.	30071039
chr12	56101213	56101214	A	T	rs773123	ERBB3	Allele A is associated with decreased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.	30071039
chr12	57095925	57095926	T	C	rs1059513	STAT6	Genotypes CC + CT are associated with increased response to esomeprazole in children with eosinophilic esophagitis as compared to genotype TT.	31490856
chr12	57099212	57099213	G	A	rs841718	STAT6	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr12	57099943	57099944	T	G	rs3024971	STAT6	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr12	57109991	57109992	C	T	rs167769	STAT6	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr12	57118686	57118687	C	G	rs12368672	STAT6	Genotypes CC + CG is associated with increased response to Proton pump inhibitors in people with eosinophilic esophagitis as compared to genotype GG.	38612496
chr12	57133499	57133500	T	C,G	rs11172113	LRP1	Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.	31014225
chr12	57191360	57191361	C	G,T	rs1800139	LRP1	Genotype TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.	33094665
chr12	57195875	57195876	C	T	rs1800154	LRP1	Genotype CC is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CT + TT.	33094665
chr12	57750881	57750882	C	G,T	rs2069502	CDK4	Genotype CC is associated with decreased response to somatropin recombinant in children with Turner Syndrome as compared to genotypes CT + TT.	23567489
chr12	57751372	57751373	C	A,G,T	rs2270777	CDK4	Genotype TT is associated with increased response to somatropin recombinant in children with growth hormone deficiency as compared to genotypes CC + CT.	23567489
chr12	57764204	57764205	A	G	rs4646536	CYP27B1	Genotypes AG + GG is associated with increased concentrations of rifampin in people with Tuberculosis as compared to genotype AA.	28594304
chr12	57768301	57768302	G	C,T	rs10877012	CYP27B1	Genotypes GT + TT is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotype GG.	21145801
chr12	58920930	58920931	T	C	rs7970054	LRIG3	Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.	37098852
chr12	59710258	59710259	C	A,T	rs12231740	SLC16A7	Allele T is associated with decreased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to allele C.	29589488
chr12	59779574	59779575	A	G,T	rs3763980	SLC16A7	Allele A is associated with decreased response to methotrexate in children with Arthritis, Juvenile Rheumatoid as compared to allele T.	29589488
chr12	68158741	68158742	T	A,G	rs2430561	IFNG	Allele A is not associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele T.	22111603
chr12	68161230	68161231	G	A,C	rs2069705	IFNG	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A.	26111149
chr12	68742471	68742472	T	C	rs79419059	NUP107	Allele C is associated with increased resistance to Platinum compounds in women with Ovarian Neoplasms as compared to allele T.	28562428
chr12	68813381	68813382	G	A	rs1470383	MDM2	Allele A is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.	29662106
chr12	69643739	69643740	G	A	rs61747221	BEST3	Genotypes AA + AG is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.	30289819
chr12	71584006	71584007	T	C	rs17109924	LGR5	Genotypes CC + CT is associated with increased response to fluorouracil in people with Colonic Neoplasms as compared to genotype TT.	25665511
chr12	71938142	71938143	G	A,T	rs4570625	TPH2	Allele T is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to allele G.	23131881
chr12	71938372	71938373	T	A	rs11178997	TPH2	Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele T.	28068779
chr12	71938934	71938935	A	C,G	rs11178998	TPH2	Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.	28068779
chr12	71946292	71946293	G	C,T	rs2129575	TPH2	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	32481444
chr12	71954917	71954918	G	A,T	rs1843809	TPH2	Genotype TT is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to genotypes GG + GT.	23131881
chr12	71958054	71958055	C	T	rs10879346	TPH2	Allele C is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype TT.	18496129
chr12	71958762	71958763	T	A,C,G	rs1386494	TPH2	Allele C is not associated with response to citalopram, fluoxetine or paroxetine in people with Depressive Disorder, Major as compared to allele T.	19590397
chr12	71961398	71961399	A	G,T	rs1386493	TPH2	Genotype GG is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype AG.	32481444
chr12	71966483	71966484	A	C,G,T	rs2171363	TPH2	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	32481444
chr12	71979081	71979082	A	C,G,T	rs7305115	TPH2	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32481444
chr12	71991719	71991720	C	T	rs10506645	TPH2	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32481444
chr12	72003215	72003216	C	G	rs4760820	TPH2	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32481444
chr12	72007070	72007071	T	C	rs1487278	TPH2	Allele C is associated with increased response to mirtazapine and venlafaxine in people with Depression as compared to genotype TT.	18496129
chr12	72013696	72013697	A	G	rs9325202	TPH2	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32481444
chr12	72016511	72016512	C	A,G,T	rs1487275	TPH2	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32481444
chr12	72022454	72022455	A	T	rs4290270	TPH2	Genotypes AA + AT is associated with increased response to disulfiram in people with Cocaine-Related Disorders as compared to genotype TT (assigned as high activity phenotype) .	22925276
chr12	89645548	89645549	C	T	rs12817819	ATP2B1	Genotypes CT + TT are associated with increased resistance to Antihypertensives in people with Coronary Artery Disease or Hypertension as compared to genotype CC.	25385345
chr12	99423063	99423064	C	T	rs7968606	ANKS1B	Genotype CC is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CT + TT.	28332719
chr12	100491328	100491329	G	A,C,T	rs4764980	NR1H4	Genotype AA is not associated with increased exposure to rosuvastatin in healthy individuals as compared to genotypes AG + GG.	27557342
chr12	107001327	107001328	A	G,T	rs8192440	CRY1	Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	21781277
chr12	108883715	108883716	C	A,G	rs11114083	DAO	Genotypes AA + AC are not associated with concentrations of methadone in people with Heroin Dependence as compared to genotype CC.	34983973
chr12	108883943	108883944	G	A	rs2070586	DAO	Genotypes AG + GG are not associated with concentrations of methadone in people with Heroin Dependence as compared to genotype AA.	34983973
chr12	108883966	108883967	T	G	rs2070587	DAO	Genotypes GT + TT are not associated with dose of methadone in people with Heroin Dependence as compared to genotype GG.	34983973
chr12	108898653	108898654	C	T	rs55944529	DAO	Genotype TT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes CC + CT.	34983973
chr12	109446561	109446562	G	A,C	rs7959663	MYO1H	Allele C is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr12	109604542	109604543	A	G,T	rs10161126	MVK	Genotype GG is associated with increased response to alendronate in women with Bone Diseases as compared to genotypes AA + AG.	25223561
chr12	111446803	111446804	T	A,C,G	rs3184504	SH2B3	Allele T is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele C.	23087401
chr12	111634619	111634620	A	G	rs11065987		Genotypes AA + AG is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.	29925376
chr12	111803961	111803962	G	A	rs671	ALDH2	Genotype AG is associated with increased concentrations of ethanol in healthy individuals as compared to genotype GG.	31002879
chr12	118152056	118152057	T	A,C	rs795484	TAOK3	Genotype TT is associated with decreased response to opioids in people with Neoplasms and Pain as compared to genotypes CC + CT.	30031856
chr12	118168183	118168184	G	A,C,T	rs1277441	TAOK3	Genotypes AG + GG are associated with increased dose of opioids in people with Neoplasms and Pain as compared to genotype AA.	30031856
chr12	120978846	120978847	A	C,T	rs1169288	HNF1A	Allele A is not associated with response to metformin in women with Polycystic Ovary Syndrome as compared to allele C.	28834135
chr12	120997623	120997624	G	A,C	rs2464196	HNF1A	Allele A is not associated with response to metformin in women with Polycystic Ovary Syndrome as compared to allele G.	28834135
chr12	121088082	121088083	G	A,C	rs2708092	P2RX7	Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.	25472448
chr12	121092644	121092645	T	A,C,G	rs1180012	P2RX7	Allele T is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele C.	25472448
chr12	121155215	121155216	C	T	rs1718125	P2RX7	Genotypes CT + TT are associated with increased dose of fentanyl in people with Lung Neoplasms and Pain, Postoperative as compared to genotype CC.	30762755
chr12	121162376	121162377	C	A,G,T	rs208293	P2RX7	Allele A is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele G.	25472448
chr12	121171804	121171805	A	G	rs1718136	P2RX7	Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.	25472448
chr12	121177130	121177131	C	T	rs7132846	P2RX7	Allele T is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele C.	25472448
chr12	121177299	121177300	G	A,T	rs1718119	P2RX7	Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.	31014225
chr12	121184392	121184393	A	G	rs2230912	P2RX7	Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.	31014225
chr12	121237771	121237772	G	T	rs1653586	CAMKK2	Genotype GT is associated with decreased clinical benefit to pemetrexed in people with Lung Neoplasms as compared to genotype GG.	36606188
chr12	121624816	121624817	G	T	rs12320939	ORAI1	Genotypes GG + GT is associated with increased resistance to erythropoietin in people with Kidney Diseases and Anemia as compared to genotype TT.	39214396
chr12	124800201	124800202	A	G,T	rs5888	SCARB1	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr12	124863716	124863717	C	T	rs4238001	SCARB1	Genotypes CT + TT are associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC.	18542840
chr12	131154307	131154308	A	C,T	rs7485210		Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr12_KZ208916v1_fix	394538	394539	C	A,G,T	rs723672	CACNA1C	Allele C is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	26049408
chr12_KZ208916v1_fix	415275	415276	T	A	rs2283271	CACNA1C	Allele A is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	26049408
chr12_KZ208916v1_fix	453382	453383	T	A,C	rs758723	CACNA1C	Allele A is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	26049408
chr12_KZ208916v1_fix	455709	455710	T	C,G	rs2238032	CACNA1C	Genotype TT is not associated with response to nimodipine in healthy individuals as compared to genotype GT.	19205682
chr12_KZ208916v1_fix	549172	549173	T	A,C	rs10848635	CACNA1C	Allele A is not associated with response to olanzapine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	26049408
chr12_KZ208916v1_fix	686363	686364	G	A,C	rs2239050	CACNA1C	Genotype CG is associated with increased response to nimodipine in healthy individuals as compared to genotype CC.	19205682
chr12_KZ208916v1_fix	852665	852666	C	G,T	rs2238087	CACNA1C	Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT.	30032160
chr12_KZ208916v1_fix	933587	933588	C	G,T	rs215976	CACNA1C	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	26216687
chr12_KZ208916v1_fix	960086	960087	C	T	rs216008	CACNA1C	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	26216687
chr12_KZ208916v1_fix	968581	968582	A	G	rs216013	CACNA1C	Allele A is not associated with dose of warfarin.	18535201
chr12_KZ208916v1_fix	975567	975568	A	C,T	rs12813888	CACNA1C	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	26216687
chr12_KZ208916v1_fix	996718	996719	T	A,C	rs2239128	CACNA1C	Genotype CC is associated with increased response to nimodipine in healthy individuals as compared to genotype CT.	19205682
chr12_KZ208916v1_fix	1043404	1043405	G	A,C	rs7316246	CACNA1C	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.	26216687
chr12_KZ208917v1_fix	30592	30593	G	T	rs12320939	ORAI1	Genotypes GG + GT is associated with increased resistance to erythropoietin in people with Kidney Diseases and Anemia as compared to genotype TT.	39214396
chr13	20988808	20988809	G	A,T	rs558614	LATS2	Allele A is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to allele G.	27698403
chr13	28050156	28050157	G	A,T	rs1933437	FLT3	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele A.	30713339
chr13	28305783	28305784	T	A,C,G	rs12877323	FLT1	Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele T.	24070809
chr13	28308923	28308924	G	A	rs7993418	FLT1	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele A.	30713339
chr13	28366922	28366923	A	C	rs7995976	FLT1	Allele A is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele C.	26100253
chr13	28496863	28496864	T	A,C	rs664393	FLT1	Genotypes CT + TT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype CC.	24090479
chr13	30459094	30459095	C	T	rs1045411	HMGB1	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.	24684392
chr13	30463765	30463766	G	A,C,T	rs2249825	HMGB1	Genotype GG is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotypes CC + CG.	24684392
chr13	30467457	30467458	C	A,G,T	rs1412125	HMGB1	Genotype CC is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotypes CT + TT.	24684392
chr13	33015696	33015697	A		rs36217263	KL	Genotypes A/del + del/del are associated with decreased response to Beta Blocking Agents in people with Hypertension as compared to genotype AA.	31350855
chr13	34376389	34376390	C	T	rs17798800		Allele T is associated with decreased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C.	23374588
chr13	34777293	34777294	T	A,C,G	rs9315310	NBEA	Allele T is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele C.	27091189
chr13	35202456	35202457	T	C	rs57081354	NBEA	Allele C is associated with decreased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele T.	29650774
chr13	40126484	40126485	G	T	rs953977		Allele T is associated with increased response to montelukast in people with Asthma as compared to allele G.	26083242
chr13	40553947	40553948	A	G	rs17446593		Genotype AA is associated with increased clinical benefit to glucocorticoids in children with Thrombocytopenia as compared to genotypes AG + GG.	38683649
chr13	42068673	42068674	C	T	rs9315885	DGKH	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	19818381
chr13	42079300	42079301	C	A,G	rs1012053	DGKH	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele A.	19818381
chr13	42101356	42101357	A	G,T	rs1170191	DGKH	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	19818381
chr13	46482263	46482264	C	A,T	rs585719		Genotype CT is associated with increased response to citalopram in people with Depression as compared to genotype CC.	23158458
chr13	46834434	46834435	T	G	rs3803189	HTR2A	Genotypes GG + GT are associated with increased response to escitalopram, fluoxetine, fluvoxamine or sertraline in people with Depressive Disorder, Major as compared to genotype TT.	33548906
chr13	46834898	46834899	G	A	rs6314	HTR2A	Genotype AG is not associated with exposure to olanzapine in healthy individuals as compared to genotype GG.	33378980
chr13	46837849	46837850	A	C,G,T	rs7997012	HTR2A	Genotype GG is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes AA + AG.	23733030
chr13	46845441	46845442	A	G	rs3742278	HTR2A	Allele G is not associated with response to sertraline in people with Anxiety Disorders as compared to allele A.	24154666
chr13	46856127	46856128	C	A,G,T	rs2274639	HTR2A	Allele C is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.	28068779
chr13	46859219	46859220	C	A,G,T	rs9316233	HTR2A	Allele G is not associated with decreased response to escitalopram in people with Major Depressive Disorder as compared to allele C (assigned as normal metabolizer phenotype) .	39407134
chr13	46866424	46866425	C	G,T	rs2770296	HTR2A	Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.	22947179
chr13	46882412	46882413	A	C,G	rs9567746	HTR2A	Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele G.	28068779
chr13	46895804	46895805	G	A,C	rs6313	HTR2A	Genotypes AA + AG are not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotype GG.	23733030
chr13	46896688	46896689	C	A,G,T	rs6312	HTR2A	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr13	46897342	46897343	C	A,T	rs6311	HTR2A	Genotype CC is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.	23733030
chr13	46897582	46897583	T	C,G	rs17289304	HTR2A	Allele T is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.	27445478
chr13	48037782	48037801	GGAGTCGGAGTCGGAGTCG	GGAGTCGGAGTCG,GGAGTCGGAGTCGGAGTCGGAGTCG,GGAGTCGGAGTCGGAGTCGGAGTCGGAGTCG	rs746071566	NUDT15	Allele del is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele GGAGTC.	28659275
chr13	48045718	48045719	C	T	rs116855232	NUDT15	Genotypes CT + TT are associated with decreased dose of azathioprine in people with Colitis, Ulcerative, Crohn Disease and Hepatitis, Autoimmune as compared to genotype CC.	27416873
chr13	51950351	51950352	T	C,G	rs1061472	ATP7B	Allele T is not associated with resistance to Platinum compounds in people with Lung Neoplasms as compared to allele C.	24852429
chr13	51971358	51971359	A	C	rs7999812	ATP7B	Allele C is not associated with resistance to Platinum compounds in people with Lung Neoplasms as compared to allele A.	24852429
chr13	51991989	51991990	T	C,G	rs9535826	ATP7B	Allele G is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to allele T.	24852429
chr13	51999285	51999286	G	A,C,T	rs9535828	ATP7B	Allele A is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to allele G.	24852429
chr13	59744884	59744885	C	T	rs77876672	DIAPH3	Allele C is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele T.	25695618
chr13	87301792	87301793	G	A	rs10450811	SLITRK5	Allele A is associated with increased response to citalopram, clomipramine, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline in people with Obsessive-Compulsive Disorder as compared to allele G.	40054571
chr13	90718583	90718584	T	C	rs828199		Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.	20863575
chr13	95020202	95020203	T	A,C,G	rs9516519	ABCC4	Allele G is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.	24404132
chr13	95020695	95020696	A	C,G,T	rs1059751	ABCC4	Genotypes AA + AG is associated with decreased concentrations of tenofovir in people with Hepatitis B, Chronic as compared to genotype GG.	38713940
chr13	95021536	95021537	A	C,T	rs3742106	ABCC4	Genotypes AC + CC are associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotype AA.	33850298
chr13	95030988	95030989	G	A	rs9561765	ABCC4	Genotype AG is associated with increased response to imatinib in people with Gastrointestinal Stromal Tumors as compared to genotype AA.	23127916
chr13	95061460	95061461	G	A,C,T	rs9561778	ABCC4	Genotype GG is not associated with increased response to cyclophosphamide in people with Lupus Nephritis as compared to genotypes GT + TT.	26222310
chr13	95062721	95062722	C	G,T	rs1751034	ABCC4	Genotype TT is associated with increased concentrations of tenofovir in people with HIV Infections as compared to genotypes CC + CT.	33850298
chr13	95163160	95163161	C	A,T	rs3765534	ABCC4	Genotype CC is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CT.	29683944
chr13	95206780	95206781	C	A,G,T	rs2274407	ABCC4	Allele A is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	24404132
chr13	95209549	95209550	A	G,T	rs899494	ABCC4	Genotypes AA + AG is not associated with increased discontinuation of tenofovir in people with HIV Infections as compared to genotype GG.	21288825
chr13	95210753	95210754	C	A	rs11568658	ABCC4	Genotype AC is associated with decreased response to latanoprost in people with Glaucoma, Open-Angle as compared to genotype CC.	25339146
chr13	95271268	95271269	A	C,G	rs7317112	ABCC4	Allele G is associated with decreased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.	36764694
chr13	95273059	95273060	G	T	rs17268282	ABCC4	Allele T is associated with increased response to furosemide in people with Heart Failure as compared to allele G.	26927285
chr13	95302821	95302822	C	A,G,T	rs868853	ABCC4	Allele C is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.	24404132
chr13	95978966	95978967	T	C,G	rs9590353	UGGT2	Allele G is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele T.	25695618
chr13	98448803	98448808	ATTTT	ATTTTATTATTTT,ATTTTATTTATTTT,ATTTTATTTT	rs58896682	FARP1	Allele ATTTATTTT is not associated with clearance of tenofovir in people with HIV Infections as compared to allele ATTTT.	37098852
chr13	98704357	98704358	A	C,G,T	rs1339067	SLC15A1	Genotype TT is associated with decreased response to cannabidiol in people with Epilepsy as compared to genotypes AA + AT.	34464454
chr13	101071688	101071689	T	A,C,G	rs9585618	NALCN	Allele C is associated with response to ziprasidone in people with Schizophrenia.	22920393
chr13	102844408	102844409	C	G,T	rs2094258	ERCC5	Allele T is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.	28796378
chr13	102845847	102845848	A	G	rs751402	ERCC5	Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr13	102846024	102846025	T	C	rs2296147	ERCC5	Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele T.	28796378
chr13	102852166	102852167	T	C,G	rs1047768	ERCC5	Allele C is not associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele T.	22761669
chr13	102875651	102875652	G	C	rs17655	ERCC5	Genotype GG is associated with increased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.	28314991
chr13	102875986	102875987	G	A,C	rs873601	ERCC5	Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr13	108267191	108267192	T	A,C	rs3759467		Genotype CC is associated with decreased response to rituximab in people with Vasculitis as compared to genotypes CT + TT.	27780742
chr13	113105439	113105440	A	G,T	rs510317	F7	Genotype AA is not associated with response to phenprocoumon as compared to genotypes AG + GG.	21057703
chr13	113105440	113105441	G	A,C,T	rs510335	F7	Genotype GG is not associated with response to phenprocoumon as compared to genotypes GT + TT.	21057703
chr13	113118844	113118845	G	A,C,T	rs6046	F7	Allele A is not associated with dose of warfarin as compared to allele G.	28049362
chr14	23183978	23183979	C	A,T	rs7141505	SLC7A8	Genotype AA is not associated with clearance of busulfan in children with Transplantation as compared to genotype CC.	24192117
chr14	24369414	24369415	C	G,T	rs1955915	NFATC4	Genotypes CC + CT is associated with increased dose-adjusted trough concentrations of tacrolimus in people with lung transplantation as compared to genotype TT.	38327217
chr14	29832142	29832143	A	G	rs57803087	PRKD1	Allele G is associated with increased response to linagliptin, saxagliptin, sitagliptin or vildagliptin in people with Diabetes Mellitus, Type 2 as compared to allele A.	28160554
chr14	33098543	33098544	G	A,C,T	rs1315115	NPAS3	Allele G is associated with response to risperidone in people with Schizophrenia.	22920393
chr14	33944619	33944620	A	C,G	rs1629140	EGLN3	Allele A is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele G.	26100253
chr14	34057612	34057613	A	C,G,T	rs4982133		Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	29743634
chr14	35069924	35069925	T	A,G	rs79403677	FAM177A1	Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr14	35169913	35169914	G	A	rs12436663	PRORP	Genotype AA is associated with decreased response to zileuton in people with Asthma as compared to genotypes AG + GG.	25963335
chr14	35370029	35370030	G	A,C	rs2145623	NFKBIA	Genotype CC is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotypes CG + GG.	27977334
chr14	35401886	35401887	C	G,T	rs696	NFKBIA	Allele T is associated with response to etanercept in people with Psoriasis as compared to allele C.	27348478
chr14	35402010	35402011	G	A,C,T	rs8904	NFKBIA	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	32606912
chr14	37642664	37642665	C	T	rs177852	TTC6	Genotypes CC + CT is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype TT.	27802415
chr14	53033178	53033179	A	G	rs17126068	DDHD1	Allele G is associated with decreased dose of warfarin as compared to allele A.	27488176
chr14	54844850	54844851	C	G,T	rs752688	GCH1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr14	54853844	54853845	T	C,G	rs4411417	GCH1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr14	54893420	54893421	T	A,C	rs3783641	GCH1	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr14	60298526	60298527	A	G	rs2273623	PPM1A	Genotype AA is associated with decreased response to nortriptyline in people with Depression as compared to genotypes AG + GG.	20970119
chr14	64233097	64233098	C	T	rs4986938	ESR2	Genotype CC is not associated with increased response to leflunomide in women with Arthritis, Rheumatoid as compared to genotypes CT + TT.	21174621
chr14	64233326	64233327	T	C	rs944050	ESR2	Genotype TT is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CC + CT.	22838950
chr14	64257332	64257333	C	T	rs1256049	ESR2	Genotype CC is not associated with increased response to leflunomide in women with Arthritis, Rheumatoid as compared to genotypes CT + TT.	21174621
chr14	64442126	64442127	G	A	rs2236225	MTHFD1	Allele A is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	22074251
chr14	64909367	64909368	C	A,T	rs4902333	CHURC1	Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr14	64986344	64986345	G	C	rs11623866	FNTB	Genotype GG is associated with response to carboplatin, lonafarnib and paclitaxel in women with Ovarian Neoplasms.	26033044
chr14	67648283	67648284	A	C,G	rs3742879	ARG2	Allele G is associated with increased response to Methyldopa in women with Pregnancy and Pre-Eclampsia as compared to allele A.	35971863
chr14	69778475	69778476	G	A	rs2296651	SLC10A1	Allele A is associated with increased clearance of pravastatin in healthy individuals as compared to allele G.	26744986
chr14	71133490	71133491	T	C	rs221903		Allele T is associated with decreased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.	23753411
chr14	77326863	77326864	G	A,C,T	rs7975	GSTZ1	Allele G is associated with decreased clearance of dichloroacetic acid in children with Mitochondrial Diseases.	21642471
chr14	77326893	77326894	G	A	rs7972	GSTZ1	Allele G is associated with decreased clearance of dichloroacetic acid in children with Mitochondrial Diseases.	21642471
chr14	77327939	77327940	T	A,C	rs1046428	GSTZ1	Allele T is associated with decreased clearance of dichloroacetic acid in children Mitochondrial Diseases.	21642471
chr14	77905059	77905060	A	C,G	rs56240334	ADCK1	Allele G is associated with increased response to paliperidone in people with as compared to allele A.	27846195
chr14	80203236	80203237	T	C	rs225014	DIO2	Allele C is not associated with dose of levothyroxine in people with Thyroid Neoplasms as compared to allele A.	24910925
chr14	80211922	80211923	C	A,G,T	rs12885300	DIO2	Allele T is not associated with dose of levothyroxine in people with Thyroid Neoplasms as compared to allele C.	24910925
chr14	87161811	87161812	C	A,T	rs2776546		Allele A is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.	23753411
chr14	89989843	89989844	G	A,T	rs2401863	TDP1	Genotype GG is associated with increased response to irinotecan in people with Colorectal Neoplasms as compared to genotypes GT + TT.	18347181
chr14	90397012	90397013	C	A,G,T	rs12885713	CALM1	Allele T is associated with increased response to cyclosporine in people with Psoriasis as compared to allele C.	36229649
chr14	94587511	94587512	T	C	rs6113		Allele T is not associated with response to clomipramine in people with Obsessive-Compulsive Disorder as compared to allele C.	21625751
chr14	96204801	96204802	C	G,T	rs1799722	BDKRB2	Genotype TT is associated with decreased response to enalapril in people with Hypertension as compared to genotypes CC + CT.	22706620
chr14	96241119	96241120	A	C,G,T	rs5224	BDKRB2	Allele A is associated with increased response to glibenclamide in people with as compared to allele G.	27403931
chr14	96262415	96262416	A	G	rs12050217	BDKRB1	Genotypes AA + AG is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype GG.	27021566
chr14	100857797	100857798	G	A,C	rs116907618	MEG3	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.	26729200
chr14	103699415	103699416	G	A	rs861539	XRCC3	Allele A is not associated with response to radiotherapy in people with Nasopharyngeal Neoplasms as compared to allele G.	37266339
chr14	104772854	104772855	T	C,G	rs2494732	AKT1	Allele T is not associated with response to risperidone in people with Schizophrenia as compared to allele C.	28696411
chr14	104796030	104796031	C	G,T	rs2498786	AKT1	Genotype GG is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CG.	22901187
chr14	104796443	104796444	C	T	rs74090038	AKT1	Genotype CC is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.	22901187
chr14	104796574	104796575	G	C	rs2494750	AKT1	Genotype GG is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CG.	22901187
chr14	104797270	104797271	A	G,T	rs2494752	AKT1	Genotype AG is associated with decreased response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + GG.	22901187
chr14	104803441	104803442	T	A,C	rs3803300	AKT1	Allele C is not associated with response to risperidone in people with Schizophrenia as compared to allele T.	28696411
chr14_KZ208920v1_fix	670392	670393	C	G,T	rs1955915	NFATC4	Genotypes CC + CT is associated with increased dose-adjusted trough concentrations of tacrolimus in people with lung transplantation as compared to genotype TT.	38327217
chr15	25806437	25806438	G	A,C,T	rs12595802	ATP10A	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr15	29882172	29882173	A	C,G	rs785423	TJP1	Allele A is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.	23241943
chr15	29901112	29901113	T	A,C	rs813676	TJP1	Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.	23241943
chr15	29901264	29901265	T	A,C	rs711355	TJP1	Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.	23241943
chr15	32033472	32033473	A	G	rs883473	CHRNA7	Allele A is not associated with response to nicotine in women as compared to allele G.	20231857
chr15	32104255	32104256	C	G,T	rs6494223	CHRNA7	Allele T is associated with increased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C.	24951635
chr15	32151994	32151995	C	T	rs2337980	CHRNA7	Genotype CC is associated with increased response to nicotine in women as compared to genotypes CT + TT.	20231857
chr15	32702554	32702555	T	C,G	rs4779584		Allele T is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele C.	24727911
chr15	40003757	40003758	C	T	rs2412459	EIF2AK4	Genotype TT is associated with increased response to haloperidol in people with Schizophrenia as compared to genotype CT.	24751813
chr15	40695329	40695330	G	C	rs1801320	RAD51	Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr15	40731895	40731896	G	A,C,T	rs7180135	RAD51	Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.	28796378
chr15	45253279	45253280	C	A,G,T	rs11854484	SLC28A2	Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.	37098852
chr15	45262068	45262069	C	A	rs1060896	SLC28A2	Genotype AA is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AC + CC.	20665488
chr15	51210646	51210647	A	C	rs4646	CYP19A1	Allele A is associated with increased clinical benefit to letrozole in people with Breast Neoplasms as compared to allele C.	18245543
chr15	51210788	51210789	G	A	rs10046	CYP19A1	Genotype AA is not associated with response to exemestane in women with Breast Neoplasms as compared to genotypes AG + GG.	30967597
chr15	51215310	51215311	T	A,C,G	rs2289105	CYP19A1	Allele C is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele T.	26463708
chr15	51236914	51236915	T	C	rs700518	CYP19A1	Genotype CC is associated with response to Enzyme inhibitors in women with Breast Neoplasms as compared to genotypes CC + CT.	26049585
chr15	51237067	51237068	T	A,C	rs3759811	CYP19A1	Allele C is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele T.	26463708
chr15	51243824	51243825	C	T	rs4775936	CYP19A1	Allele C is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele T.	26463708
chr15	51255740	51255741	C	G,T	rs1062033	CYP19A1	Allele G is associated with increased concentrations of hdl cholesterol in women with Breast Neoplasms and Menopause as compared to allele C.	26463708
chr15	51257401	51257402	G	A	rs1008805	CYP19A1	Allele G is associated with decreased concentrations of hdl cholesterol in women with Breast Neoplasms and Menopause as compared to allele A.	26463708
chr15	51266533	51266534	G	A	rs749292	CYP19A1	Allele A is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele G.	26463708
chr15	55830148	55830149	T	C,G	rs2288344	NEDD4	Allele G is associated with increased dose of warfarin as compared to allele T.	27488176
chr15	58137064	58137065	G	A,C,T	rs1516400	AQP9	Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.	24643204
chr15	58137347	58137348	A	C,G	rs1554203	AQP9	Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.	24643204
chr15	58184081	58184082	A	C,G,T	rs1867380	AQP9	Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.	24643204
chr15	58186750	58186751	T	A,C	rs2077737		Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr15	58189994	58189995	T	G	rs8023369		Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.	24643204
chr15	58190873	58190874	T	A,C	rs9920375		Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr15	58341620	58341621	C	T	rs261316	ALDH1A2	Allele T is associated with decreased response to atenolol and hydrochlorothiazide in people with Hypertension as compared to allele C.	29097388
chr15	58431475	58431476	C	A,G,T	rs1800588	LIPC	Genotypes CC + CT are associated with increased response to fluvastatin as compared to genotype TT.	16103896
chr15	60323391	60323393	TT	TTATT,TTCTT	rs142693425		Allele CTT is not associated with clearance of tenofovir in people with HIV Infections as compared to allele del.	37098852
chr15	61037588	61037589	A	G	rs809736	RORA	Allele G is associated with increased response to citalopram in people with Depressive Disorder, Major as compared to allele A.	19846067
chr15	61174798	61174799	C	T	rs4774388	RORA	Genotype TT is associated with increased response to interferon beta-1a in people with Multiple Sclerosis as compared to genotypes CC + CT.	31649263
chr15	74719299	74719300	A	G,T	rs4646903	CYP1A1	Genotypes AA + AG are not associated with concentrations of deferasirox in people with beta-Thalassemia as compared to genotype GG.	27193993
chr15	74720643	74720644	T	A,C,G	rs1048943	CYP1A1	Genotypes AG + GG are associated with increased response to capecitabine and docetaxel in women with Breast Neoplasms as compared to genotype AA.	22426923
chr15	74724834	74724835	C	A	rs2606345	CYP1A1	Genotype AA is associated with decreased response to antiepileptics in women with Epilepsy as compared to genotypes AC + CC.	26951882
chr15	74726548	74726549	A	C,G	rs3826041	CYP1A1	Genotype CC is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes AA + AC.	27740732
chr15	74735538	74735539	C	A,T	rs2472297	CYP1A1	Genotype CT is associated with decreased dose-adjusted trough concentrations of clozapine in people with Tobacco Use Disorder as compared to genotype CC.	36152308
chr15	74741567	74741568	A	G,T	rs2472300	CYP1A2	Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr15	74745878	74745879	G	A	rs2069514	CYP1A2	Allele A is associated with increased clinical benefit to acetaminophen in infants with Patent Ductus Arteriosus.	38445694
chr15	74746625	74746626	G	A	rs2069521		Allele A is associated with increased metabolism of escitalopram in people with Depressive Disorder, Major as compared to allele G.	23859573
chr15	74746891	74746892	T	C	rs2069522	CYP1A2	Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr15	74747271	74747272	T		rs35694136	CYP1A2	Genotype TT is not associated with metabolism of caffeine in women as compared to genotypes T/del + del/del.	25921178
chr15	74748999	74749000	T	G	rs2069526	CYP1A2	Allele G is not associated with metabolism of leflunomide in people with Arthritis as compared to genotype TT.	19581389
chr15	74749575	74749576	C	A,G	rs762551	CYP1A2	Genotype AA is associated with increased dose of clomipramine in women with Depression.	27800629
chr15	74750939	74750940	C	T	rs4646425	CYP1A2	Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr15	74751896	74751897	G	A	rs2472304	CYP1A2	Allele A is not associated with metabolism of escitalopram in people with Depressive Disorder, Major as compared to allele G.	23859573
chr15	74752058	74752059	G	A,C	rs3743484	CYP1A2	Allele C is not associated with metabolism of escitalopram in people with Depressive Disorder, Major as compared to allele G.	23859573
chr15	74753350	74753351	T	C	rs4646427	CYP1A2	Allele C is associated with increased metabolism of escitalopram in people with Depressive Disorder, Major as compared to allele T.	23859573
chr15	74755258	74755259	A	G,T	rs11636419	CYP1A2	Allele G is not associated with increased dose of warfarin in people with an international normalized ratio (INR) of 2.0-3.0 as compared to allele A.	22248286
chr15	74756061	74756062	G		rs45564134	CYP1A2	Allele G is not associated with concentrations of efavirenz in people with HIV Infections as compared to genotypes G/del + del/del.	26779253
chr15	74764016	74764017	G	A	rs11631682		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr15	74785025	74785026	C	A,T	rs1378942	CSK	Allele C is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele A.	31327267
chr15	74837252	74837253	G	A,T	rs2290573	ULK3	Genotype GG is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotypes AA + AG.	15073101
chr15	75345054	75345055	C	G	rs7402844	NEIL1	Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr15	75355622	75355623	G	A,C,T	rs4462560	NEIL1	Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.	28796378
chr15	75390171	75390172	A	G	rs7166737	SIN3A	Genotype GG is associated with decreased response to hydroxyurea in people with Beta-thalassemia and related diseases as compared to genotypes AA + AG.	27767389
chr15	78510714	78510715	C	A,G,T	rs7164594	HYKK	Genotypes CT + TT are associated with increased response to varenicline in people with Tobacco Use Disorder as compared to genotype CC.	22048466
chr15	78540693	78540694	C	A	rs57064725	PSMA4	Allele A is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele C.	26833182
chr15	78559272	78559273	G	A	rs2036527	CHRNA5	Genotypes AA + AG are associated with increased response to bupropion, nicotine or varenicline in women with Tobacco Use Disorder as compared to genotype GG.	29621993
chr15	78565470	78565501	GGGCGGGGCCAGAGGGAAATAGGGGCGGGGC	GGGCGGGGC	rs67624739	CHRNA5	Allele del is not associated with response to bupropion, nicotine and varenicline in people with Tobacco Use Disorder as compared to allele CAGAGGGAAATAGGGGCGGGGC.	29196725
chr15	78565553	78565554	T	A	rs503464	CHRNA5	Allele A is associated with increased response to bupropion, nicotine and varenicline in people with Tobacco Use Disorder as compared to allele T.	29196725
chr15	78565596	78565597	T	G	rs55853698	CHRNA5	Allele G is not associated with response to bupropion, nicotine and varenicline in people with Tobacco Use Disorder as compared to allele T.	29196725
chr15	78565643	78565644	C	G	rs55781567	CHRNA5	Allele G is not associated with response to bupropion, nicotine and varenicline in people with Tobacco Use Disorder as compared to allele C.	29196725
chr15	78571129	78571130	T	C	rs667282	CHRNA5	Allele C is not associated with exposure to nicotine in men as compared to allele T.	29666375
chr15	78573082	78573083	T	A,C,G	rs588765	CHRNA5	Genotype TT is not associated with response to nicotine or varenicline in people with Tobacco Use Disorder as compared to genotypes CC + CT.	26010901
chr15	78573550	78573551	G	A,C,T	rs6495306	CHRNA5	Allele G is not associated with exposure to nicotine in men as compared to allele A.	29666375
chr15	78578945	78578946	T	C	rs680244	CHRNA5	Allele C is associated with increased response to Drugs used in nicotine dependence in people with Tobacco Use Disorder.	22648373
chr15	78580518	78580519	G	A	rs621849	CHRNA5	Allele G is not associated with exposure to nicotine in men as compared to allele A.	29666375
chr15	78584162	78584163	C	G,T	rs692780	CHRNA5	Allele C is not associated with exposure to nicotine in men as compared to allele G.	29666375
chr15	78586899	78586900	G	A,C	rs555018	CHRNA5	Allele G is not associated with exposure to nicotine in men as compared to allele A.	29666375
chr15	78588138	78588139	T	A,C,G	rs647041	CHRNA5	Allele T is not associated with exposure to nicotine in men as compared to allele C.	29666375
chr15	78590582	78590583	G	A	rs16969968	CHRNA3	Allele G is associated with increased response to Drugs used in nicotine dependence in people with Tobacco Use Disorder.	22648373
chr15	78591884	78591885	T	A,C,G	rs514743	CHRNA5	Allele T is not associated with exposure to nicotine in men as compared to allele A.	29666375
chr15	78593645	78593646	T	C	rs615470	CHRNA5	Allele T is not associated with exposure to nicotine in men as compared to allele C.	29666375
chr15	78595489	78595490	A	C,G,T	rs660652	CHRNA3	Allele A is not associated with exposure to nicotine in men as compared to allele G.	29666375
chr15	78596057	78596058	G	A,C	rs578776	CHRNA3	Allele A is not associated with concentrations of 3-hydroxycotinine, cotinine or nicotine in people with Tobacco Use Disorder as compared to allele G.	31796940
chr15	78597978	78597979	C	A,T	rs6495307	CHRNA3	Allele T is not associated with exposure to nicotine in men as compared to allele C.	29666375
chr15	78601996	78601997	G	A	rs1051730	CHRNA3	Allele A is not associated with response to bupropion, nicotine or varenicline in people with Tobacco Use Disorder as compared to allele G.	29621993
chr15	78602553	78602554	C	T	rs3743077	CHRNA3	Allele T is not associated with exposure to nicotine in men as compared to allele C.	29666375
chr15	78615002	78615003	C	A,G,T	rs2869546	CHRNA3	Allele C is not associated with exposure to nicotine in men as compared to allele T.	29666375
chr15	78617109	78617110	T	A,C	rs3743075	CHRNA3	Allele T is not associated with exposure to nicotine in men as compared to allele C.	29666375
chr15	78617137	78617138	G	A,T	rs3743074	CHRNA3	Allele G is not associated with exposure to nicotine in men as compared to allele A.	29666375
chr15	78620600	78620601	G	A,C	rs7170068	CHRNA3	Allele A is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele G.	26833182
chr15	78623521	78623522	G	A,C	rs10851907	CHRNB4	Allele A is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele G.	26833182
chr15	78625056	78625057	A	G,T	rs1948	CHRNB4	Allele A is not associated with exposure to nicotine in men as compared to allele G.	29666375
chr15	78628734	78628735	C	A,G,T	rs7178270	CHRNB4	Allele G is not associated with exposure to nicotine in men as compared to allele C.	29666375
chr15	78633675	78633676	T	A,C	rs950776	CHRNB4	Allele C is not associated with exposure to nicotine in men as compared to allele T.	29666375
chr15	81296653	81296654	T	C	rs4778889	IL16	Genotype TT is associated with increased clinical benefit to morphine in people with Neoplasms and Pain as compared to genotypes CC + CT.	39720462
chr15	84137307	84137308	G	A	rs66486766		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr15	84895080	84895081	T	TGT,TTAT,TTGT	rs17215836	SLC28A1	Genotype TGT/TGT is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes TGT/del + del/del.	18538445
chr15	84904199	84904200	G	A,C	rs2290272	SLC28A1	Allele A is not associated with metabolism of capecitabine in people with Breast Neoplasms as compared to allele G.	23588952
chr15	84905643	84905644	C	A	rs8187758	SLC28A1	Genotype CC is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AA + AC.	20665488
chr15	84913114	84913115	T	A,C,G	rs11853372	SLC28A1	Genotype TT is not associated with metabolism of gemcitabine as compared to genotypes GG + GT.	24300978
chr15	84935178	84935179	A	G,T	rs2242048	SLC28A1	Genotype GG is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG.	18538445
chr15	84935464	84935465	C	T	rs2242047	SLC28A1	Genotype CC is associated with increased response to gemcitabine in people with Colorectal Neoplasms as compared to genotype TT.	22838950
chr15	84935497	84935498	G	A,T	rs2242046	SLC28A1	Genotype GG is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AG.	18538445
chr15	88610512	88610513	C	A,T	rs1470108	MIR7-2	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr15	91526974	91526975	C	T	rs7170769		Allele T is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele C.	21635146
chr15	91528727	91528728	G	A,C	rs4932551		Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele G.	21635146
chr15	91941606	91941607	G	T	rs8027174	SLCO3A1	Genotypes GT + TT is associated with decreased clearance of darunavir in people with HIV Infections as compared to genotypes GG + TT.	23494984
chr15	92104414	92104415	G	A,C	rs1517618	SLCO3A1	Allele G is not associated with increased resistance to efavirenz, lamivudine, nevirapine and zidovudine in people with HIV Infections as compared to allele C.	23996099
chr15	95072556	95072557	C	T	rs291028		Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr15	99069943	99069944	T	A,C	rs1703794		Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	29743634
chr15_KI270905v1_alt	2166311	2166312	G	A,C	rs785423	TJP1	Allele A is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.	23241943
chr15_KI270905v1_alt	2185255	2185256	C	T,A	rs813676	TJP1	Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.	23241943
chr15_KI270905v1_alt	2185407	2185408	C	T,A	rs711355	TJP1	Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.	23241943
chr15_KI270905v1_alt	4318592	4318593	G	A	rs883473	CHRNA7	Allele A is not associated with response to nicotine in women as compared to allele G.	20231857
chr15_KI270905v1_alt	4389396	4389397	C	G,T	rs6494223	CHRNA7	Allele T is associated with increased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C.	24951635
chr15_KI270905v1_alt	4437145	4437146	T	C	rs2337980	CHRNA7	Genotype CC is associated with increased response to nicotine in women as compared to genotypes CT + TT.	20231857
chr15_KI270905v1_alt	4917146	4917147	C	T,G	rs4779584		Allele T is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele C.	24727911
chr15_KN538374v1_fix	2053827	2053828	G	A,C	rs785423	TJP1	Allele A is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.	23241943
chr15_KN538374v1_fix	2072771	2072772	C	T,A	rs813676	TJP1	Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.	23241943
chr15_KN538374v1_fix	2072923	2072924	C	T,A	rs711355	TJP1	Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele C.	23241943
chr15_KN538374v1_fix	4206140	4206141	G	A	rs883473	CHRNA7	Allele A is not associated with response to nicotine in women as compared to allele G.	20231857
chr15_KN538374v1_fix	4276944	4276945	C	G,T	rs6494223	CHRNA7	Allele T is associated with increased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C.	24951635
chr15_KN538374v1_fix	4324693	4324694	T	C	rs2337980	CHRNA7	Genotype CC is associated with increased response to nicotine in women as compared to genotypes CT + TT.	20231857
chr15_KN538374v1_fix	4754694	4754695	C	T,G	rs4779584		Allele T is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele C.	24727911
chr15_KQ031389v1_alt	376267	376268	G	A	rs2337980	CHRNA7	Genotype CC is associated with increased response to nicotine in women as compared to genotypes CT + TT.	20231857
chr15_KQ031389v1_alt	424094	424095	G	C,A	rs6494223	CHRNA7	Allele T is associated with increased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C.	24951635
chr15_KQ031389v1_alt	494817	494818	T	C	rs883473	CHRNA7	Allele A is not associated with response to nicotine in women as compared to allele G.	20231857
chr15_KQ031389v1_alt	2220968	2220969	C	T,G	rs4779584		Allele T is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele C.	24727911
chr16	286915	286916	C	A,T	rs1048786	PDIA2	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr16	1175627	1175628	A	G	rs11640796	CACNA1H	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.	26216687
chr16	1197481	1197482	T	C	rs3794619	CACNA1H	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	26216687
chr16	1202368	1202369	C	A,T	rs61734410	CACNA1H	Allele T is associated with decreased clinical benefit to ethosuximide in children with Epilepsy as compared to allele C.	28165634
chr16	1202736	1202737	G	C	rs7191246	CACNA1H	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.	26216687
chr16	1204368	1204369	C	A,T	rs3751664	CACNA1H	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	26216687
chr16	1211218	1211219	A	G	rs2753326	CACNA1H	Allele A is associated with increased clinical benefit to lamotrigine in children with Epilepsy as compared to allele G.	28165634
chr16	1211221	1211222	A	C,G	rs2753325	CACNA1H	Allele A is associated with increased clinical benefit to lamotrigine in children with Epilepsy as compared to allele G.	28165634
chr16	1220161	1220162	G	A,C	rs1054645	CACNA1H	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.	26216687
chr16	1324949	1324950	C	G,T	rs9597	UBE2I	Genotype CG is associated with increased response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.	19859084
chr16	2278648	2278649	G	A,C,T	rs150929	ABCA3	Genotypes GG + GT is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.	25056761
chr16	3983434	3983435	T	A,C,G	rs2230739	ADCY9	Genotype CC is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.	22480177
chr16	4015581	4015582	A	G,T	rs1967309	ADCY9	Genotype AA is associated with increased response to dalcetrapib in people with as compared to genotype GG.	27418594
chr16	4382027	4382028	A	C,G,T	rs3810818	CORO7	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr16	8746096	8746097	A	G,T	rs1731017	ABAT	Genotypes AA + AG is associated with increased resistance to valproic acid in people with Epilepsy as compared to genotype GG.	27918244
chr16	9849808	9849809	C	T	rs2229193	GRIN2A	Genotype CC is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CT.	27624150
chr16	11155471	11155472	G	A	rs6498169	CLEC16A	Allele A is associated with increased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.	29095108
chr16	11680344	11680345	G	A,T	rs3784921	TXNDC11	Allele G is not associated with dose of hydrochlorothiazide in people with Hypertension as compared to allele T.	29650764
chr16	12826708	12826709	T	C	rs111860321	CPPED1	Allele C is associated with decreased clearance of fentanyl in children with Pain, Postoperative as compared to allele T.	37353859
chr16	13656001	13656002	T	A,C,G	rs7405404		Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr16	13919808	13919809	A	C,T	rs6498486	ERCC4	Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.	28796378
chr16	13948100	13948101	T	C	rs1799801	ERCC4	Genotype TT is associated with decreased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CT.	25069034
chr16	13949072	13949073	G	A,C	rs2276464	ERCC4	Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr16	13949317	13949318	C	A,G	rs2276466	ERCC4	Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.	28796378
chr16	15938948	15938949	A	C,G,T	rs6498588	ABCC1	Genotypes AT + TT are associated with increased exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.	27845419
chr16	15966536	15966537	G	A,C	rs215095	ABCC1	Genotypes AG + GG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.	27845419
chr16	16004617	16004618	G	A,T	rs11075291	ABCC1	Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.	29791011
chr16	16008017	16008018	G	A,C,T	rs8187843	ABCC1	Genotypes AA + AG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype GG.	27845419
chr16	16017033	16017034	G	A,C	rs3784862	ABCC1	Allele A is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	33501733
chr16	16025166	16025167	A	G,T	rs246240	ABCC1	Genotypes AG + GG are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.	26086825
chr16	16031467	16031468	G	A	rs3784864	ABCC1	Genotypes AG + GG are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.	26086825
chr16	16044464	16044465	T	C,G	rs246221	ABCC1	Genotype CC is not associated with increased response to cyclophosphamide in people with Lupus Nephritis as compared to genotype CT.	26222310
chr16	16047965	16047966	T	C	rs35592	ABCC1	Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	29743634
chr16	16052430	16052443	AAAAAAAAAAAAA	AAAAAAAAA,AAAAAAAAAAAA,AAAAAAAAAAAAAA,AAAAAAAAAAAAAAA,AAAAAAAAAAAAAAAA	rs58572178	ABCC1	Allele (A)14 is associated with increased clearance of fentanyl in children with Pain and Premature Birth as compared to allele (A)13.	39025933
chr16	16074750	16074751	C	G,T	rs35621	ABCC1	Genotypes CT + TT are associated with increased exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype CC.	27845419
chr16	16076619	16076620	G	T	rs4148350	ABCC1	Genotype GG is not associated with increased response to cyclophosphamide in people with Lupus Nephritis as compared to genotype GT.	26222310
chr16	16090374	16090375	C	A,G	rs2074087	ABCC1	Allele G is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	33501733
chr16	16120014	16120015	G	A	rs2238476	ABCC1	Genotype GG is associated with increased response to methotrexate in people with Psoriasis as compared to allele A.	18256692
chr16	16133289	16133290	A	G	rs212082	ABCC1	Genotypes AG + GG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.	27845419
chr16	16134384	16134385	G	A,C	rs2230671	ABCC1	Allele A is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	33501733
chr16	16141823	16141824	C	T	rs3743527	ABCC1	Allele T is not associated with increased resistance to lamivudine, lopinavir, ritonavir and zidovudine in people with HIV Infections as compared to allele C.	23996099
chr16	16142792	16142793	T	A,C	rs212091	ABCC1	Genotypes CC + CT are associated with increased resistance to lamivudine, lopinavir, ritonavir and zidovudine in people with HIV Infections as compared to genotype TT.	23996099
chr16	20356367	20356368	G	A,T	rs12917707	UMOD	Genotypes GT + TT is associated with increased response to cyclosporine in people with Kidney Transplantation as compared to genotype GG.	28418009
chr16	24324350	24324351	T	C	rs1859204	CACNG3	Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CC.	30032160
chr16	25946918	25946919	G	A	rs9933692	HS3ST4	Allele A is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.	23753411
chr16	25948028	25948029	T	G	rs4074471	HS3ST4	Allele T is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.	23753411
chr16	27325105	27325106	G	A	rs1110470	IL4R	Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AG + GG.	22541248
chr16	27339365	27339366	A	G	rs3024530	IL4R	Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AG + GG.	22541248
chr16	27344881	27344882	A	C,G,T	rs1805010	IL4R	Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AG + GG.	22541248
chr16	27347699	27347700	A	C	rs2239347	IL4R	Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AC + CC.	22541248
chr16	27362858	27362859	T	C	rs1805015	IL4R	Allele C is associated with increased response to Hepatitis vaccines as compared to allele T.	21111021
chr16	27364465	27364466	A	G	rs8832	IL4R	Genotype GG is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AA + AG.	22541248
chr16	27364895	27364896	A	G	rs1029489	IL4R	Genotype GG is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AA + AG.	22541248
chr16	27452126	27452127	C	T	rs3093390	IL21R	Allele C is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T.	19749758
chr16	28592333	28592334	T	G	rs1059491	SULT1A2	Genotype TT are associated with decreased concentrations of 4-hydroxytamoxifen or endoxifen in women with Breast Neoplasms as compared to genotypes GG + GT.	23922954
chr16	28595910	28595911	A	C,G,T	rs1136703	SULT1A2	Genotype AA are associated with decreased concentrations of 4-hydroxytamoxifen or endoxifen in women with Breast Neoplasms as compared to genotypes AG + GG.	23922954
chr16	28826193	28826194	T	A,C,G	rs8049439	IL27	Genotypes CT + TT is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype CC.	25712183
chr16	28878164	28878165	C	A,G,T	rs3888190	SH2B1	Genotype CC is associated with increased concentrations of low density lipoprotein in people with Bipolar Disorder, Depressive Disorder, Psychotic Disorders or schizoaffective disorder as compared to genotypes AA + AC.	28694205
chr16	29819104	29819105	T	A,C,G	rs4788184	LRP1	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr16	29822166	29822167	G	T	rs1057451	LRP1	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.	24643204
chr16	29829903	29829904	A	G	rs4788186	LRP1	Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele G.	24643204
chr16	29852847	29852848	C	T	rs7204252	LRP1	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr16	30506719	30506720	G	C	rs2230433	ITGAL	Allele C is associated with increased clinical benefit to verapamil in people with Migraine NOS as compared to allele G.	33829662
chr16	30999861	30999862	A	G	rs4889606	STX1B	Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.	28135054
chr16	31011317	31011318	G	A	rs72800847	STX1B	Genotypes AA + AG is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype GG.	27740732
chr16	31036757	31036758	C	T	rs10871454	STX4	Allele T is associated with decreased dose of warfarin.	18535201
chr16	31077025	31077026	G	A,C,T	rs749671	VKORC1	Allele G is associated with increased dose of warfarin as compared to allele A.	26265036
chr16	31087689	31087690	T	A,C	rs11150606	VKORC1	Allele C is associated with decreased dose of warfarin as compared to allele T.	15883587
chr16	31090999	31091000	C	T	rs7294	VKORC1	Allele T is associated with increased dose of warfarin as compared to allele C.	16270629
chr16	31091267	31091268	G	A	rs7200749	VKORC1	Genotypes AA + AG is associated with increased dose of acenocoumarol as compared to genotype GG.	23691226
chr16	31092474	31092475	A	G	rs2359612	VKORC1	Genotype AA is associated with decreased dose of warfarin as compared to genotype GG.	18322281
chr16	31093125	31093126	A	G	rs17886199	PRSS53	Allele A is associated with decreased dose of warfarin as compared to allele G.	20716240
chr16	31093187	31093188	C	A,G,T	rs8050894	VKORC1	Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC.	31869433
chr16	31093556	31093557	G	A,C	rs9934438	VKORC1	Allele A is associated with dose of acenocoumarol in people with a stable maintenance dose.	22920394
chr16	31094031	31094032	G	A	rs17708472	VKORC1	Allele A is associated with increased dose of warfarin as compared to allele G.	22676192
chr16	31094232	31094233	A	C	rs2884737	VKORC1	Genotypes AC + CC are associated with decreased dose of warfarin as compared to genotype AA.	31869433
chr16	31096367	31096368	C	A,G,T	rs9923231	VKORC1	Genotype TT is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.	28429387
chr16	31096605	31096606	T	C	rs17878544	VKORC1	Genotype TT is associated with decreased dose of acenocoumarol as compared to genotypes CC + CT.	23691226
chr16	31099179	31099180	G	T	rs17880887	VKORC1	Allele T is not associated with decreased dose of warfarin as compared to allele G.	20072124
chr16	31099659	31099660	G	A,C	rs7196161	VKORC1	Allele A is not associated with increased dose of acenocoumarol as compared to allele G.	25519826
chr16	31102912	31102913	A	C,G,T	rs61162043	VKORC1	Allele G is associated with increased dose of warfarin.	21270790
chr16	31484255	31484256	A	G,T	rs9924771	SLC5A2	Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.	28134748
chr16	31484349	31484350	G	A,C,T	rs11646054	SLC5A2	Allele C is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.	28134748
chr16	31484404	31484405	G	A	rs3116149	SLC5A2	Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.	28134748
chr16	31486559	31486560	G	A,C	rs3813008	SLC5A2	Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.	28134748
chr16	31486699	31486700	G	A	rs3116150	SLC5A2	Allele A is not associated with response to empagliflozin in people with Diabetes Mellitus, Type 2 as compared to allele G.	28134748
chr16	52885653	52885654	G	A	rs7184292		Allele A is associated with increased response to atenolol in people with Hypertension as compared to allele G.	29650764
chr16	53779454	53779455	T	A,G	rs17817449	FTO	Genotype GG is not associated with dose of ethanol as compared to genotypes GT + TT.	31055022
chr16	53786614	53786615	T	A	rs9939609	FTO	Genotypes AA + AT is associated with decreased response to interferon alfa-2a, recombinant, interferon alfa-2b, recombinant and ribavirin in people with Hepatitis C, Chronic and HIV Infections as compared to genotype TT.	25367448
chr16	53821378	53821379	A	C,G,T	rs11075995	FTO	Genotypes AT + TT is associated with increased clinical benefit to PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors in people with Neoplasms as compared to genotype AA.	38669948
chr16	55477893	55477894	C	T	rs243865	MMP2	Allele T is associated with decreased response to ulinastatin in people with Pancreatitis as compared to allele C.	31192912
chr16	55652905	55652906	T	A,C,G	rs28386840	SLC6A2	Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.	28871191
chr16	55654571	55654572	G	A	rs1362621	SLC6A2	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25642918
chr16	55655631	55655632	A	G	rs168924	SLC6A2	Allele G is not associated with response to 3,4-methylenedioxymethamphetamine as compared to allele A.	29198060
chr16	55656512	55656513	C	A,G,T	rs2242446	SLC6A2	Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.	20863575
chr16	55661193	55661194	C	T	rs3785143	SLC6A2	Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.	29374517
chr16	55662843	55662844	A	G	rs36029	SLC6A2	Genotype AA is associated with increased response to 3,4-methylenedioxymethamphetamine as compared to genotypes AG + GG.	29198060
chr16	55692062	55692063	A	G,T	rs5564	SLC6A2	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25642918
chr16	55692549	55692550	C	A	rs47958	SLC6A2	Allele C is not associated with response to 3,4-methylenedioxymethamphetamine as compared to allele A.	29198060
chr16	55694493	55694494	G	A,C,T	rs1861647	SLC6A2	Genotype GG is associated with increased response to 3,4-methylenedioxymethamphetamine as compared to genotypes AA + AG.	29198060
chr16	55695923	55695924	C	T	rs3785157	SLC6A2	Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.	29374517
chr16	55696211	55696212	A	C,G	rs5568	SLC6A2	Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.	20863575
chr16	55697686	55697687	C	A	rs12708954	SLC6A2	Allele A is associated with increased response to atomoxetine in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.	19387424
chr16	55697922	55697923	G	A,C	rs5569	SLC6A2	Genotype GG is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes AA + AG.	23733030
chr16	55698033	55698034	G	A,C,T	rs998424	SLC6A2	Allele A is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele G.	20863575
chr16	55703778	55703779	C	G,T	rs7194256	SLC6A2	Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.	29374517
chr16	55759782	55759783	A	C	rs3785161	CES1P1	Allele C is not associated with response to trandolapril in people with Hypertension as compared to allele A.	26915813
chr16	55810696	55810697	G	A,C,T	rs2244613	CES1	Genotype GT is associated with decreased half-life time of fesoterodine in healthy individuals as compared to genotype TT.	39338398
chr16	55810890	55810891	G	A,C	rs74019272	CES1	Genotypes AA + AG is associated with decreased dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype GG.	36741090
chr16	55815589	55815590	G	A,C,T	rs2002577	CES1	Genotype CC is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CG + GG.	24350812
chr16	55819533	55819534	C	A	rs4513095	CES1	Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.	35107877
chr16	55819632	55819633	C	A,G	rs115629050	CES1	Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.	35107877
chr16	55822804	55822805	A	C,G,T	rs4122238	CES1	Genotypes AG + GG is associated with decreased dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype AA.	36741090
chr16	55823539	55823540	G	A,C	rs147055479	CES1	Genotype GG is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG.	24350812
chr16	55827881	55827882	A	G	rs8192935	CES1	Allele G is not associated with clearance of Dabigatran in healthy individuals as compared to allele A.	32564268
chr16	55828799	55828800	C	T	rs2307240	CES1	Genotype CT is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CC.	24350812
chr16	55832424	55832425	T	A,C	rs12443580	CES1	Genotype TT is not associated with dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CC + CT.	24350812
chr16	56955677	56955678	C	T	rs247616		Allele T is associated with increased response to hmg coa reductase inhibitors as compared to allele C.	27587472
chr16	56960981	56960982	G	A	rs4783961	CETP	Genotype GG is associated with increased response to fluvastatin in people with Hypercholesterolemia as compared to genotypes AA + AG.	16002074
chr16	56961323	56961324	C	A,G	rs1800775	CETP	Genotype AA is not associated with response to atorvastatin as compared to genotype CC.	16103896
chr16	56962375	56962376	G	A,C	rs708272	CETP	Allele A is associated with decreased response to rosuvastatin as compared to allele G.	31806882
chr16	56971566	56971567	C	A	rs1532624	CETP	Genotype AA is associated with decreased response to hmg coa reductase inhibitors in people with Hyperlipidemias as compared to genotype CC.	20195290
chr16	56982179	56982180	G	A,C	rs5882	CETP	Genotype GG is associated with decreased response to fluvastatin in people with Hypercholesterolemia as compared to genotype AG.	16002074
chr16	58662801	58662802	A	G	rs11648166		Allele G is associated with increased concentrations of anastrozole in women with Breast Neoplasms as compared to allele A.	30648747
chr16	64410684	64410685	G	A,T	rs1437153		Allele T is associated with decreased response to anastrozole in women with Breast Neoplasms as compared to allele G.	32701512
chr16	66124832	66124833	A	C,T	rs8050896		Allele T is associated with increased response to risperidone in people with Schizophrenia as compared to allele A.	23241943
chr16	66521841	66521842	T	C	rs3826160	TK2	Genotypes CC + CT is associated with increased concentrations of telbivudine in people with Hepatitis B, Chronic as compared to genotype TT.	38502357
chr16	66935272	66935273	C	G	rs11075646	CES2	Allele C is not associated with metabolism of capecitabine in people with Breast Neoplasms as compared to allele G.	23588952
chr16	69709856	69709857	A	C,G,T	rs10517	NQO1	Genotype GG is associated with decreased dose of warfarin as compared to genotypes AA + AG.	26257249
chr16	69711241	69711242	G	A	rs1800566	NQO1	Genotypes AA + AG is associated with increased dose of warfarin as compared to genotype GG.	37273173
chr16	69716945	69716946	C	T	rs2917677	NQO1	Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT.	26257249
chr16	69725059	69725060	T	C	rs2917670	NQO1	Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT.	26257249
chr16	72008782	72008783	A	C,G,T	rs3213422	DHODH	Genotype CC is associated with increased clinical benefit to leflunomide in people with Arthritis, Rheumatoid as compared to genotypes AA + AC.	34747629
chr16	75213346	75213347	T	C,G	rs7202877	CTRB1	Genotypes GG + GT is associated with decreased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus, Type 2 as compared to genotype TT.	23674605
chr16	78134008	78134009	A	G,T	rs13338697	WWOX	Genotypes AA + GG are not associated with response to cisplatin and fluorouracil in people with Liver Neoplasms as compared to genotype AG.	31611591
chr16	79957794	79957795	G	A	rs10514475		Allele A is associated with increased response to Selective serotonin reuptake inhibitors in people with Depression as compared to allele G.	25649181
chr16	81123747	81123748	G	A	rs16954698	PKD1L2	Allele A is associated with decreased clearance of methotrexate in children with Acute lymphoblastic leukemia as compared to allele G.	39611166
chr16	82632533	82632534	G	A	rs2116971	CDH13	Allele G is associated with response to perphenazine in people with Schizophrenia.	22920393
chr16	83678829	83678830	A	C,G	rs3784943	CDH13	Genotypes AG + GG is associated with increased response to amphetamine as compared to genotype AA.	27771748
chr16	84814216	84814217	C	T	rs7205113		Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.	34488071
chr16	84975856	84975857	T	C,G	rs3210967	ZDHHC7	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr16	87855596	87855597	G	A,C,T	rs4240803	SLC7A5	Genotype AG is associated with increased dose of gabapentin in people with neuropathic pain as compared to genotype GG.	33190395
chr16	88468932	88468933	G	A,C	rs56292801	MIR5189	Genotypes AA + AG are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.	27649261
chr16_GL383556v1_alt	34573	34574	G	A,C,T	rs2244613	CES1	Genotype GT is associated with decreased half-life time of fesoterodine in healthy individuals as compared to genotype TT.	39338398
chr16_GL383556v1_alt	34767	34768	G	A,C	rs74019272	CES1	Genotypes AA + AG is associated with decreased dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype GG.	36741090
chr16_GL383556v1_alt	39467	39468	G	A,C,T	rs2002577	CES1	Genotype CC is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CG + GG.	24350812
chr16_GL383556v1_alt	43411	43412	C	A	rs4513095	CES1	Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.	35107877
chr16_GL383556v1_alt	43510	43511	C	A,G	rs115629050	CES1	Allele A is associated with decreased response to sofosbuvir in people with Hepatitis C, Chronic as compared to allele C.	35107877
chr16_GL383556v1_alt	46682	46683	G	A,C,T	rs4122238	CES1	Genotypes AG + GG is associated with decreased dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype AA.	36741090
chr16_GL383556v1_alt	47417	47418	G	A,C	rs147055479	CES1	Genotype GG is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AA + AG.	24350812
chr16_GL383556v1_alt	51762	51763	A	G	rs8192935	CES1	Allele G is not associated with clearance of Dabigatran in healthy individuals as compared to allele A.	32564268
chr16_GL383556v1_alt	52680	52681	C	T	rs2307240	CES1	Genotype CT is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype CC.	24350812
chr16_GL383556v1_alt	56328	56329	T	A,C	rs12443580	CES1	Genotype TT is not associated with dose of methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes CC + CT.	24350812
chr16_KI270853v1_alt	1596909	1596910	A	C,G,T	rs6498588	ABCC1	Genotypes AT + TT are associated with increased exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.	27845419
chr16_KI270853v1_alt	1624514	1624515	G	A,C	rs215095	ABCC1	Genotypes AG + GG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.	27845419
chr16_KI270853v1_alt	1662495	1662496	G	A,T	rs11075291	ABCC1	Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.	29791011
chr16_KI270853v1_alt	1665891	1665892	G	A,C,T	rs8187843	ABCC1	Genotypes AA + AG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype GG.	27845419
chr16_KI270853v1_alt	1674908	1674909	A	G,C	rs3784862	ABCC1	Allele A is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	33501733
chr16_KI270853v1_alt	1683047	1683048	A	G,T	rs246240	ABCC1	Genotypes AG + GG are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.	26086825
chr16_KI270853v1_alt	1689345	1689346	A	G	rs3784864	ABCC1	Genotypes AG + GG are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA.	26086825
chr16_KI270853v1_alt	1702361	1702362	C	T,G	rs246221	ABCC1	Genotype CC is not associated with increased response to cyclophosphamide in people with Lupus Nephritis as compared to genotype CT.	26222310
chr16_KI270853v1_alt	1705862	1705863	T	C	rs35592	ABCC1	Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	29743634
chr16_KI270853v1_alt	1710327	1710341	AAAAAAAAAAAAAA	AAAAAAAAAA,AAAAAAAAAAAAA,AAAAAAAAAAAAAAA,AAAAAAAAAAAAAAAA,AAAAAAAAAAAAAAAAA	rs58572178	ABCC1	Allele (A)14 is associated with increased clearance of fentanyl in children with Pain and Premature Birth as compared to allele (A)13.	39025933
chr16_KI270853v1_alt	1732641	1732642	C	G,T	rs35621	ABCC1	Genotypes CT + TT are associated with increased exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype CC.	27845419
chr16_KI270853v1_alt	1734471	1734472	G	T	rs4148350	ABCC1	Genotype GG is not associated with increased response to cyclophosphamide in people with Lupus Nephritis as compared to genotype GT.	26222310
chr16_KI270853v1_alt	1748232	1748233	G	C,A	rs2074087	ABCC1	Allele G is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	33501733
chr16_KI270853v1_alt	1777879	1777880	G	A	rs2238476	ABCC1	Genotype GG is associated with increased response to methotrexate in people with Psoriasis as compared to allele A.	18256692
chr16_KI270853v1_alt	1791174	1791175	A	G	rs212082	ABCC1	Genotypes AG + GG are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.	27845419
chr16_KI270853v1_alt	1792275	1792276	A	G,C	rs2230671	ABCC1	Allele A is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele G.	33501733
chr16_KI270853v1_alt	1799714	1799715	C	T	rs3743527	ABCC1	Allele T is not associated with increased resistance to lamivudine, lopinavir, ritonavir and zidovudine in people with HIV Infections as compared to allele C.	23996099
chr16_KI270853v1_alt	1800684	1800685	T	A,C	rs212091	ABCC1	Genotypes CC + CT are associated with increased resistance to lamivudine, lopinavir, ritonavir and zidovudine in people with HIV Infections as compared to genotype TT.	23996099
chr16_KI270855v1_alt	84350	84351	A	C,G,T	rs3810818	CORO7	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr16_KZ208921v1_alt	45801	45802	A	G,C	rs7202877	CTRB1	Genotypes GG + GT is associated with decreased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus, Type 2 as compared to genotype TT.	23674605
chr17	1769981	1769982	C	T	rs1136287	SERPINF1	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.	23842101
chr17	2312963	2312964	T	C	rs391300	SRR	Genotypes CC + CT are associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to genotype TT.	21933224
chr17	3518180	3518181	A	C,G,T	rs7217270	TRPV3	Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.	31014225
chr17	3577152	3577153	T	C	rs8065080	TRPV1	Genotype CC is associated with increased clinical benefit to cannabinoids in people with Pain as compared to genotypes CT + TT.	36292717
chr17	3583407	3583408	G	A,C	rs224534	TRPV1	Genotypes AA + AG is associated with increased response to acetaminophen in healthy individuals as compared to genotype GG.	30908574
chr17	3589905	3589906	C	A,G,T	rs222747	TRPV1	Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.	31014225
chr17	3592079	3592080	G	A	rs222749	TRPV1	Allele A is associated with decreased response to botulinum toxin type a in women with Migraine NOS as compared to allele G.	31014225
chr17	3605585	3605586	G	A,C,T	rs222741	TRPV1	Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.	31014225
chr17	4711301	4711302	C	A,G,T	rs4790693	ARRB2	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr17	4711802	4711803	A	C,G,T	rs3786047	ARRB2	Allele A is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele G.	17978999
chr17	4717201	4717202	C	A,G,T	rs7208257	ARRB2	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr17	4719342	4719343	C	T	rs1045280	ARRB2	Allele C is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele T.	17978999
chr17	4719584	4719585	A	C,G,T	rs2271167	ARRB2	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr17	4721863	4721864	G	A,C	rs2036657	ARRB2	Allele A is not associated with response to nicotine in people with Tobacco Use Disorder as compared to allele G.	17978999
chr17	4932599	4932600	T	C	rs2243093	GP1BA	Genotypes CC + CT are not associated with response to aspirin in men as compared to genotype TT.	18417193
chr17	4933085	4933086	C	G,T	rs6065	GP1BA	Genotypes CT + TT are associated with increased response to aspirin in men as compared to genotype CC.	18417193
chr17	5379956	5379957	A	C,G,T	rs1000940	RABEP1	Genotypes AG + GG is associated with decreased concentrations of glucose in people with Bipolar Disorder, Depressive Disorder, Psychotic Disorders and schizoaffective disorder as compared to genotype AA.	28694205
chr17	7260419	7260420	A	G,T	rs4562	ELP5	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr17	7559237	7559238	G	A,C	rs11552708	SENP3	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr17	7580782	7580783	C	A,G,T	rs9901673	SENP3	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr17	7581493	7581494	G	A	rs9901675	FXR2	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr17	7676153	7676154	G	A,C,T	rs1042522	TP53	Genotypes CG + GG is associated with decreased response to oxaliplatin in people with Colorectal Neoplasms as compared to genotype CC.	29925895
chr17	17836850	17836853	CCC	C,CC,CCCC	rs60282872	SREBF1	Genotype del/del is not associated with response to simvastatin in people with Hypercholesterolemia as compared to genotype CC.	16158080
chr17	18264082	18264083	G	A,T	rs3889402	MIEF2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr17	18264369	18264370	G	A	rs12603700	MIEF2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr17	18265929	18265930	G	A,C,T	rs56355515	MIEF2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr17	18266632	18266633	A	G,T	rs58042962		Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr17	18328781	18328782	G	A,T	rs1979277	SHMT1	Allele A is not associated with response to folic acid, hydroxychloroquine, methotrexate and sulfasalazine in people with Arthritis, Rheumatoid.	18322994
chr17	19533873	19533874	T	C	rs2252281	SLC47A1	Allele C is not associated with exposure to metformin as compared to allele T.	29352482
chr17	19560029	19560030	G	A	rs2289669	SLC47A1	Allele A is not associated with response to tipiracil hydrochloride and trifluridine in people with Colorectal Neoplasms as compared to allele G.	28992563
chr17	19561877	19561878	C	T	rs8065082	SLC47A1	Genotypes CT + TT is associated with increased response to metformin in people with Glucose Intolerance as compared to genotype CC.	20682687
chr17	19614454	19614455	A	G,T	rs2120274	SLC47A1	Allele A is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele G.	25991289
chr17	19646956	19646957	T	A,C,G	rs4621031	ALDH3A2	Allele T is not associated with decreased clinical benefit to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.	39612420
chr17	19716684	19716685	G	A	rs12943590	SLC47A2	Genotype GG is not associated with increased clearance of metformin in healthy individuals as compared to genotypes AA + AG.	23417334
chr17	22180453	22180454	A	G	rs1975974		Genotypes AG + GG is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype AA.	27977334
chr17	30196707	30196708	G	A,C,T	rs7224199	SLC6A4	Allele T is not associated with dose of morphine in people with Lung Neoplasms and Pain as compared to allele G.	32432768
chr17	30197992	30197993	A	C	rs1042173	SLC6A4	Genotype CC is associated with decreased dose of morphine in people with Lung Neoplasms and Pain as compared to genotypes AA + AC.	32432768
chr17	30237327	30237328	T	C,G	rs25531	SLC6A4	Allele C is not associated with response to nortriptyline in people with Tobacco Use Disorder as compared to allele T.	21658141
chr17	34011851	34011852	G	A,C,T	rs11869731	ASIC2	Genotype CC is associated with increased response to lithium in people with Bipolar Disorder as compared to genotypes CG + GG.	21961650
chr17	34247428	34247429	G	A	rs4795893	CCL2	Allele G is associated with decreased response to antipsychotics in people with Schizophrenia as compared to allele A.	26788534
chr17	34256112	34256113	G	C,T	rs2857657	CCL2	Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.	24495780
chr17	34256249	34256250	T	A,C	rs4586	CCL2	Allele T is associated with decreased response to antipsychotics in people with Schizophrenia as compared to allele C.	26788534
chr17	34285424	34285425	A	C,G,T	rs17809012	CCL11	Genotype AA is associated with decreased clinical benefit to morphine in people with Neoplasms and Pain as compared to genotypes AG + GG.	39720462
chr17	37692681	37692682	G	A	rs11868513	HNF1B	Genotypes AA + AG are associated with increased response to metformin as compared to genotype GG.	28453780
chr17	39723334	39723335	A	G,T	rs1136201	ERBB2	Allele G is associated with decreased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.	30071039
chr17	39884509	39884510	G	A,T	rs2872507	ORMDL3	Genotypes AA + AG are associated with increased response to fluticasone propionate in children with Asthma as compared to genotype GG.	22986918
chr17	40094528	40094529	C	T	rs4794826	NR1D1	Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.	20348464
chr17	40096958	40096959	C	A,G,T	rs2314339	NR1D1	Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	20348464
chr17	40098238	40098239	C	A,G,T	rs2071427	NR1D1	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	21781277
chr17	40098435	40098436	T	C	rs2269457	NR1D1	Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.	20348464
chr17	40099340	40099341	G	A,C	rs12941497	NR1D1	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	19818381
chr17	40100439	40100440	G	A,C	rs939347	NR1D1	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	19818381
chr17	40100836	40100837	C	A,G	rs2071570	NR1D1	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele C.	20348464
chr17	42390191	42390192	G	A,C	rs4796793	STAT3	Genotype GG is associated with increased response to interferons in people with Carcinoma, Renal Cell as compared to genotypes CC + CG.	17602083
chr17	44260983	44260984	T	A,C	rs45545233	SLC4A1	Genotypes CC + CT are associated with decreased response to atenolol or metoprolol in people with Hypertension as compared to genotype TT.	31033190
chr17	44977670	44977671	A	G	rs894685		Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17	45290286	45290287	T	A,C	rs7222094	MAP3K14	Allele C is not associated with response to adalimumab or infliximab in people with Crohn Disease as compared to allele T.	35852914
chr17	45793324	45793325	A	G	rs9892359	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17	45799465	45799466	G	A	rs4792886	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17	45799653	45799654	C	T	rs4792887	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17	45802680	45802681	G	A,C	rs110402	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17	45807884	45807885	A	G	rs12103667	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17	45814821	45814822	G	A	rs3785877	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17	45815153	45815154	A	C,T	rs242941	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17	45816120	45816121	G	A,C,T	rs171440	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17	45817623	45817624	T	A,G	rs739645	CRHR1	Allele G is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.	22370858
chr17	45818212	45818213	C	A,G,T	rs242939	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17	45818861	45818862	T	C	rs12150390	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17	45821842	45821843	A	G,T	rs242936	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17	45825577	45825578	C	T	rs1912151	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17	45825630	45825631	G	A	rs1396862	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17	45828114	45828115	T	G	rs17763086	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17	45830378	45830379	C	G,T	rs1876831	CRHR1	Allele T is associated with increased response to fluticasone propionate in people with Asthma as compared to allele C.	22370858
chr17	45830529	45830530	T	C	rs16940665	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17	45833088	45833089	G	A,C	rs17689966	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17	45833140	45833141	C	T	rs16940674	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17	45834076	45834077	T	C	rs1876829	CRHR1	Allele C is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.	22370858
chr17	45834158	45834159	C	T	rs1876828	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17	45834975	45834976	G	A,T	rs28364032	CRHR1	Genotypes AA + AG is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype GG.	24422887
chr17	45835123	45835124	C	G,T	rs878886	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17	45835215	45835216	C	T	rs878887	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17	45835268	45835269	A	G	rs878888	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17	45835356	45835357	T	C	rs4525537	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17	45835419	45835420	G	A,C	rs4640231	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17	45835663	45835664	G	T	rs16940686	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17	45974479	45974480	A	G	rs1800547	MAPT	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17	46024196	46024197	T	C	rs9468	MAPT	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17	46025237	46025238	T	C	rs1052587	MAPT	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17	46159358	46159359	C	A	rs1528072	KANSL1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17	46159701	46159702	A	T	rs2532292	KANSL1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17	46939874	46939875	G	A,T	rs758391		Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17	47257955	47257956	G	A,C,T	rs58847127	ITGB3	Allele C is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele G.	36581799
chr17	47283363	47283364	T	C	rs5918	ITGB3	Allele C is not associated with resistance to aspirin or clopidogrel as compared to allele T.	23834376
chr17	47301871	47301872	G	A,T	rs3785873	ITGB3	Allele A is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele G.	36581799
chr17	47731940	47731941	T	C	rs17250932	TBX21	Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype TT.	28139755
chr17	47733552	47733553	C	G	rs2240017	TBX21	Genotype CG is associated with increased response to corticosteroids in children with Asthma as compared to genotype CC.	15604153
chr17	50200387	50200388	C	A	rs1800012	COL1A1	Genotype AA is associated with decreased dose of somatropin recombinant in people with growth hormone deficiency as compared to genotype CC.	22026923
chr17	50634725	50634726	C	A,G,T	rs4793665	ABCC3	Allele T is associated with decreased clearance of morphine in children as compared to allele C.	32090339
chr17	50656453	50656454	T	A,C,G	rs4148412	ABCC3	Genotype TT is associated with increased concentrations of morphine-3-glucuronide in children with tonsillectomy as compared to genotypes CC + CT.	26810133
chr17	50675017	50675018	T	C,G	rs11079921	ABCC3	Allele C is associated with increased clearance of fentanyl in children with Pain and Premature Birth as compared to allele T.	39025933
chr17	50676061	50676062	C	T	rs4148416	ABCC3	Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr17	50676160	50676161	C	T	rs8077268	ABCC3	Allele T is associated with increased clearance of fentanyl in children with Pain and Premature Birth as compared to allele C.	39025933
chr17	51153129	51153130	A	T	rs3760468	NME1	Genotype AA is not associated with increased clinical benefit to daclatasvir null sofosbuvir in people with Hepatitis C, Chronic as compared to genotypes AT + TT.	34843922
chr17	51882948	51882949	T	C,G	rs967676	CA10	Genotypes CC + CT is associated with increased response to fluticasone propionate or montelukast in children with Asthma as compared to genotype TT.	24407380
chr17	56355849	56355850	A	G	rs9915451	ANKFN1	Allele G is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele A.	25695618
chr17	61406404	61406405	C	G,T	rs8068318	TBX2	Allele C is associated with decreased response to atenolol in people with Hypertension as compared to allele T.	31327267
chr17	63316454	63316455	G	A	rs2429427	TANC2	Genotype GG is associated with increased response to calcium channel blockers in people with Hypertension as compared to genotype AA.	24192120
chr17	63476832	63476833	T	A,C	rs4291	ACE	Genotype TT is not associated with response to sertraline in people with Depressive Disorder.	27262302
chr17	63486690	63486691	A	C,G,T	rs4331	ACE	Genotype AA is not associated with response to fluvastatin as compared to genotype GG.	16103896
chr17	63488628	63488629	G	A,C,T	rs4341	ACE	Genotypes CG + GG are associated with increased response to pravastatin as compared to genotype CC.	16103896
chr17	63488669	63488670	G	A	rs4343	ACE	Genotype GG is not associated with response to sertraline in people with Depressive Disorder.	27262302
chr17	63489362	63489363	G	A,C	rs4344	ACE	Genotypes AA + GG are associated with increased response to ramipril in people with Hypertension as compared to genotype AG.	17885551
chr17	63494981	63494982	T	A,C	rs4359	ACE	Genotypes CC + TT are associated with increased response to ramipril in people with Hypertension as compared to genotype CT.	17885551
chr17	63497130	63497131	G	A,C	rs4363	ACE	Genotypes AA + AG are not associated with increased response to ramipril in people with Hypertension as compared to genotype GG.	17885551
chr17	63505530	63505531	C	T	rs8075924	ACE	Genotype TT is associated with decreased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CT.	22947179
chr17	66212166	66212167	C	G	rs1801690	APOH	Allele C is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele G.	26670100
chr17	66214461	66214462	A	C,G	rs1801689	APOH	Allele A is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele C.	26670100
chr17	66220735	66220736	A	C,G	rs52797880	APOH	Allele A is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele G.	26670100
chr17	66229410	66229411	G	A,T	rs8178822	APOH	Allele G is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele T.	26670100
chr17	66235597	66235598	T	A,C,G	rs12944940		Allele T is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele C.	26670100
chr17	66240199	66240200	T	A,C,G	rs10048158		Allele C is not associated with increased response to boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to allele T.	26670100
chr17	66310014	66310015	C	G,T	rs9909004	PRKCA	Allele C is not associated with response to Ace Inhibitors, Plain, Angiotensin II Antagonists or Beta Blocking Agents in people with Heart Failure as compared to allele T.	31728800
chr17	66319247	66319248	G	C	rs9303504	PRKCA	Allele G is not associated with response to Ace Inhibitors, Plain, Angiotensin II Antagonists or Beta Blocking Agents in people with Heart Failure as compared to allele C.	31728800
chr17	66791454	66791455	T	C	rs4791040	PRKCA	Allele T is associated with decreased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.	23753411
chr17	66792708	66792709	G	A	rs16960228	PRKCA	Allele A is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.	23753411
chr17	78214285	78214286	G	A,C,T	rs9904341	BIRC5	Genotype CG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.	26651826
chr17_GL000258v2_alt	627285	627286	A	T	rs2532292	KANSL1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_GL000258v2_alt	627628	627629	T	G	rs1528072	KANSL1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_GL000258v2_alt	763376	763377	G	A	rs1052587	MAPT	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_GL000258v2_alt	764421	764422	G	A	rs9468	MAPT	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_GL000258v2_alt	813970	813971	C	T	rs1800547	MAPT	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_GL000258v2_alt	952485	952486	C	A	rs16940686	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_GL000258v2_alt	952729	952730	G	C,T	rs4640231	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_GL000258v2_alt	952792	952793	G	A	rs4525537	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_GL000258v2_alt	952880	952881	C	T	rs878888	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_GL000258v2_alt	952933	952934	A	G	rs878887	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_GL000258v2_alt	953025	953026	C	G,A	rs878886	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_GL000258v2_alt	953173	953174	C	T,A	rs28364032	CRHR1	Genotypes AA + AG is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype GG.	24422887
chr17_GL000258v2_alt	953991	953992	A	G	rs1876828	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_GL000258v2_alt	954073	954074	G	A	rs1876829	CRHR1	Allele C is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.	22370858
chr17_GL000258v2_alt	955009	955010	A	G	rs16940674	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_GL000258v2_alt	955061	955062	C	T,G	rs17689966	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_GL000258v2_alt	957651	957652	G	A	rs16940665	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_GL000258v2_alt	957802	957803	A	G,C	rs1876831	CRHR1	Allele T is associated with increased response to fluticasone propionate in people with Asthma as compared to allele C.	22370858
chr17_GL000258v2_alt	960072	960073	C	A	rs17763086	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_GL000258v2_alt	962556	962557	T	C	rs1396862	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_GL000258v2_alt	962609	962610	A	G	rs1912151	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_GL000258v2_alt	966346	966347	C	T,A	rs242936	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_GL000258v2_alt	969319	969320	G	A	rs12150390	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_GL000258v2_alt	969968	969969	A	G,T,C	rs242939	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_GL000258v2_alt	970558	970559	C	A,T	rs739645	CRHR1	Allele G is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.	22370858
chr17_GL000258v2_alt	972056	972057	C	T,G,A	rs171440	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_GL000258v2_alt	973009	973010	G	T,A	rs242941	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_GL000258v2_alt	973341	973342	C	T	rs3785877	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_GL000258v2_alt	980278	980279	T	C	rs12103667	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_GL000258v2_alt	985487	985488	C	T,G	rs110402	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_GL000258v2_alt	988514	988515	G	A	rs4792887	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_GL000258v2_alt	988702	988703	C	T	rs4792886	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_GL000258v2_alt	994844	994845	T	C	rs9892359	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_KI270857v1_alt	1931756	1931757	G	A	rs11868513	HNF1B	Genotypes AA + AG are associated with increased response to metformin as compared to genotype GG.	28453780
chr17_KI270908v1_alt	495434	495435	G	A	rs9892359	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_KI270908v1_alt	501582	501583	A	G	rs4792886	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_KI270908v1_alt	501770	501771	T	C	rs4792887	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_KI270908v1_alt	504797	504798	G	A,C	rs110402	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_KI270908v1_alt	510006	510007	A	G	rs12103667	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_KI270908v1_alt	516943	516944	G	A	rs3785877	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_KI270908v1_alt	517275	517276	C	A,T	rs242941	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_KI270908v1_alt	518242	518243	A	G,C,T	rs171440	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_KI270908v1_alt	519745	519746	T	A,G	rs739645	CRHR1	Allele G is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.	22370858
chr17_KI270908v1_alt	520334	520335	T	C,A,G	rs242939	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_KI270908v1_alt	520983	520984	T	C	rs12150390	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_KI270908v1_alt	523964	523965	G	A,T	rs242936	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_KI270908v1_alt	527699	527700	C	T	rs1912151	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_KI270908v1_alt	527752	527753	G	A	rs1396862	CRHR1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_KI270908v1_alt	530236	530237	T	G	rs17763086	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_KI270908v1_alt	532500	532501	C	G,T	rs1876831	CRHR1	Allele T is associated with increased response to fluticasone propionate in people with Asthma as compared to allele C.	22370858
chr17_KI270908v1_alt	532651	532652	T	C	rs16940665	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_KI270908v1_alt	535210	535211	A	G,C	rs17689966	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_KI270908v1_alt	535262	535263	C	T	rs16940674	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_KI270908v1_alt	536198	536199	T	C	rs1876829	CRHR1	Allele C is associated with increased response to fluticasone propionate in people with Asthma as compared to allele T.	22370858
chr17_KI270908v1_alt	536280	536281	C	T	rs1876828	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_KI270908v1_alt	537097	537098	G	A,T	rs28364032	CRHR1	Genotypes AA + AG is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype GG.	24422887
chr17_KI270908v1_alt	537245	537246	C	G,T	rs878886	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_KI270908v1_alt	537337	537338	C	T	rs878887	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_KI270908v1_alt	537390	537391	A	G	rs878888	CRHR1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_KI270908v1_alt	537478	537479	T	C	rs4525537	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_KI270908v1_alt	537541	537542	G	A,C	rs4640231	CRHR1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_KI270908v1_alt	537785	537786	G	T	rs16940686	CRHR1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr17_KI270908v1_alt	676597	676598	A	G	rs1800547	MAPT	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_KI270908v1_alt	726308	726309	T	C	rs9468	MAPT	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_KI270908v1_alt	727349	727350	T	C	rs1052587	MAPT	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr17_KI270908v1_alt	861463	861464	C	A	rs1528072	KANSL1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr17_KI270908v1_alt	861806	861807	A	T	rs2532292	KANSL1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr17_KV766198v1_alt	24456	24457	G	A,T	rs3889402	MIEF2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr17_KV766198v1_alt	24743	24744	G	A	rs12603700	MIEF2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr17_KV766198v1_alt	26303	26304	G	A,C,T	rs56355515	MIEF2	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr17_KV766198v1_alt	27006	27007	A	G,T	rs58042962		Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr17_KV766198v1_alt	89155	89156	G	A,T	rs1979277	SHMT1	Allele A is not associated with response to folic acid, hydroxychloroquine, methotrexate and sulfasalazine in people with Arthritis, Rheumatoid.	18322994
chr17_ML143374v1_fix	15747	15748	A	G,T	rs4562	ELP5	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr18	659828	659829	A	G,T	rs2853539	TYMS	Genotype AA is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.	19902562
chr18	661004	661005	A	C,G,T	rs2244500	TYMS	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.	29743634
chr18	661646	661647	G	A	rs2847153	TYMS	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.	29743634
chr18	673015	673016	C	A,T	rs699517	TYMS	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	29743634
chr18	673443	673452	TTAAAGTTA	TTA,TTAAAGTTAAAGTTA	rs11280056	TYMS	Allele del is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele TTAAAGTTA.	27217051
chr18	683606	683607	C	G,T	rs2612091	ENOSF1	Genotype CC is not associated with response to bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin or trastuzumab in people with Stomach Neoplasms as compared to genotypes CT + TT.	27995989
chr18	4970506	4970507	A	C	rs1466882		Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr18	6550117	6550118	C	G,T	rs4411591		Allele C is associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.	23233654
chr18	8275858	8275859	T	C	rs6506569	PTPRM	Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	29743634
chr18	8730054	8730055	G	A	rs2377898	MTCL1	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr18	9522607	9522608	G	A,C	rs329007	RALBP1	Genotype GG is associated with decreased response to bevacizumab, fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotypes AA + AG.	25069475
chr18	11980460	11980461	T	G	rs971363	IMPA2	Allele G is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	21047205
chr18	12877060	12877061	A	C,G,T	rs7234029	PTPN2	Allele G is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele A.	28107378
chr18	24464435	24464436	G	A,T	rs4483927	HRH4	Genotype TT is associated with decreased response to risperidone in people with Schizophrenia as compared to genotypes GG + GT.	23422377
chr18	28132642	28132643	G	A	rs8094439	CDH2	Genotype AA is associated with increased response to methadone as compared to genotypes AG + GG.	28358908
chr18	28136924	28136925	A	C	rs17446819	CDH2	Genotype CC is associated with increased response to methadone as compared to genotypes AA + AC.	28358908
chr18	36251225	36251226	C	A,T	rs594445	MOCOS	Genotypes AA + AC is associated with decreased dose of azathioprine in people with Kidney Transplantation as compared to genotype CC.	22495427
chr18	40449908	40449909	C	T	rs16973410		Genotype CC is associated with increased response to lithium in people with Bipolar Disorder as compared to genotypes CT + TT.	21961650
chr18	45334298	45334299	C	T	rs12456693	SLC14A2	Allele T is associated with increased response to clopidogrel in people with Coronary Artery Disease as compared to allele C.	30487649
chr18	47228279	47228280	G	A	rs9952628	SKOR2	Allele G is associated with response to perphenazine in people with Schizophrenia.	22920393
chr18	48927092	48927093	T	A,C	rs4939827	SMAD7	Allele C is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele T.	24727911
chr18	56651610	56651611	A	G,T	rs501415	WDR7	Allele G is not associated with response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele A.	25372392
chr18	58043775	58043776	A	G	rs75982813	NEDD4L	Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G.	23353631
chr18	58140840	58140841	G	A	rs520210	NEDD4L	Allele A is associated with increased response to citalopram in people with Depression as compared to allele G.	23809733
chr18	58149558	58149559	G	A	rs4149601	NEDD4L	Allele G is not associated with response to atenolol in people with Hypertension as compared to allele A.	23353631
chr18	58195614	58195615	G	A	rs1008899	NEDD4L	Genotypes AA + AG are associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype GG.	23353631
chr18	58227848	58227849	G	C	rs292449	NEDD4L	Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.	23353631
chr18	58792366	58792367	G	A	rs2874116		Allele G is associated with increased response to cyclosporine in people with Psoriasis as compared to allele A.	36229649
chr18	62337812	62337813	A	C,T	rs7239261	TNFRSF11A	Allele A is not associated with response to alendronate in women with Osteoporosis as compared to allele C.	26426211
chr18	62338909	62338910	G	A	rs12969154	TNFRSF11A	Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.	26426211
chr18	62348516	62348517	G	A,T	rs3826619	TNFRSF11A	Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.	26426211
chr18	62348701	62348702	G	A	rs11877530	TNFRSF11A	Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.	26426211
chr18	62360007	62360008	C	A,T	rs1805034	TNFRSF11A	Allele C is not associated with response to alendronate in women with Osteoporosis as compared to allele T.	26426211
chr18	62361421	62361422	A	C,G,T	rs8083511	TNFRSF11A	Allele A is not associated with response to alendronate in women with Osteoporosis as compared to allele C.	26426211
chr18	62361624	62361625	C	T	rs17069895	TNFRSF11A	Allele C is not associated with response to alendronate in women with Osteoporosis as compared to allele T.	26426211
chr18	62364255	62364256	G	A	rs7231887	TNFRSF11A	Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.	26426211
chr18	62412878	62412879	G	A	rs2980976	TNFRSF11A	Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele G.	23241943
chr19	1005230	1005231	C	T	rs2240158	GRIN3B	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32481444
chr19	1008683	1008684	G	A	rs2285906	GRIN3B	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	32481444
chr19	1008879	1008880	G	A,C,T	rs2285907	GRIN3B	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	32481444
chr19	1238899	1238900	T	A,C,G	rs2301759	CBARP	Genotype TT is associated with decreased clinical benefit to metformin in people with Diabetes Mellitus, Type 2 as compared to genotypes CC + CT.	39612420
chr19	1538138	1538139	T	A,C,G	rs12610827		Allele T is associated with increased clinical benefit to olanzapine in people with Schizophrenia as compared to allele G.	30886581
chr19	2194896	2194897	T	C,G	rs2269879	DOT1L	Genotypes CT + TT are associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype CC.	22440088
chr19	2232221	2232222	A	G,T	rs740406	DOT1L	Allele A is associated with decreased response to candesartan in people with Hypertension as compared to allele G.	31327267
chr19	6709692	6709693	C	T	rs2230205	C3	Genotype TT is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype CC.	22594510
chr19	6718375	6718376	G	A,C,T	rs2230199	C3	Genotypes CC + CG is not associated with response to eculizumab in people with paroxysmal nocturnal hemoglobinuria as compared to genotype GG.	24038027
chr19	6718522	6718523	T	C	rs2250656	C3	Genotype TT is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype CC.	22594510
chr19	7246649	7246650	A	C,G	rs2396185	INSR	Allele C is associated with increased response to topiramate as compared to genotype AA.	26524290
chr19	7690398	7690399	A	G,T	rs28364072	FCER2	Allele G is associated with increased dose of corticosteroids in children Asthma as compared to allele A.	21958076
chr19	10115375	10115376	G	A,C	rs2305795	EIF3G	Allele G is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele A.	38540428
chr19	10687086	10687087	C	A,G,T	rs76966440	ILF3	Allele T is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele C.	38540428
chr19	11116925	11116926	C	T	rs688	LDLR	Genotype CT is associated with response to atenolol in people with Hypertension.	15453913
chr19	11120204	11120205	T	C	rs5925	LDLR	Genotype CC is not associated with response to fluvastatin as compared to genotype TT.	16103896
chr19	11131367	11131368	G	A,C	rs14158	LDLR	Genotype GG is not associated with response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic and HIV Infections as compared to genotypes AA + AG.	21572301
chr19	11131981	11131982	T	A,C	rs1433099	LDLR	Genotype TT is associated with increased response to pravastatin in people with Vascular Diseases as compared to genotype CC.	18261733
chr19	11132088	11132089	A	G,T	rs2738466	LDLR	Genotype GG is associated with increased response to pravastatin in people with Vascular Diseases as compared to genotype AA.	18261733
chr19	11232026	11232027	A	C,G	rs12979813	DOCK6	Allele G is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele A.	38540428
chr19	11313026	11313027	C	A,G	rs322144	TSPAN16	Allele C is associated with decreased clinical benefit to apremilast in people with Psoriasis as compared to allele G.	38540428
chr19	11333454	11333455	C	G	rs896412	TMEM205	Allele G is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr19	11336274	11336275	T	C	rs172731	TMEM205	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr19	11354452	11354453	C	T	rs7251786	TMEM205	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr19	13207165	13207166	G	T	rs7254351	CACNA1A	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	26216687
chr19	13261816	13261817	A	C	rs2074880	CACNA1A	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	26216687
chr19	13277089	13277090	A	G	rs16030	CACNA1A	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.	26216687
chr19	13334393	13334394	C	G,T	rs2248069	CACNA1A	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	26216687
chr19	13410713	13410714	A	G,T	rs10416717	CACNA1A	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.	26216687
chr19	13479597	13479598	G	A	rs2112460	CACNA1A	Allele A is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele G.	27091189
chr19	15848389	15848390	G	A,C,T	rs2189784	CYP4F2	Allele A is not associated with dose of warfarin as compared to allele G.	20128861
chr19	15879620	15879621	C	G,T	rs2108622	CYP4F2	Genotype CC is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotypes CT + TT.	28429387
chr19	15886009	15886010	G	A	rs2074900	CYP4F2	Genotype AA is associated with decreased clearance of ticagrelor in healthy individuals as compared to genotypes AG + GG.	35280252
chr19	15889355	15889356	C	A,G,T	rs3093158	CYP4F2	Allele T is not associated with dose of warfarin in people with heart valve replacement as compared to allele C.	25126975
chr19	15890404	15890405	C	A	rs3093153	CYP4F2	Allele C is not associated with dose of warfarin as compared to allele A.	30821933
chr19	15897577	15897578	A	C	rs3093105	CYP4F2	Allele C is not associated with response to vitamin e in people with Fatty liver disease as compared to allele A.	24759732
chr19	15913727	15913728	A	G	rs1060467	CYP4F11	Allele G is associated with decreased dose of warfarin as compared to allele A.	28620303
chr19	15923903	15923904	A	G,T	rs8104361	CYP4F11	Allele A is not associated with dose of warfarin as compared to allele G.	30821933
chr19	17641879	17641880	A	C,T	rs12608932	UNC13A	Allele C is not associated with response to creatine in people with Amyotrophic Lateral Sclerosis as compared to allele A.	31624333
chr19	35851309	35851310	C	A,G,T	rs3814995	NPHS1	Allele T is associated with increased response to losartan in men with Hypertension as compared to allele C.	25622599
chr19	36183402	36183403	A	C,G,T	rs4805162	ZNF565	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr19	39241142	39241143	A	G	rs12980275	IFNL3	Genotype AA is not associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotypes AG + GG.	21390311
chr19	39241860	39241861	T	A,C	rs8105790	IFNL3	Allele C is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele T.	19749757
chr19	39243579	39243580	C	A,T	rs4803217	IFNL3	Genotypes AC + CC are associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to genotype AA.	26186989
chr19	39244282	39244283	A	G	rs11881222	IFNL3	Allele G is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele A.	19749757
chr19	39244465	39244466	T	C	rs8103142	IFNL3	Allele C is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele T.	19749757
chr19	39245003	39245004	C	G	rs28416813	IFNL3	Allele C is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele G.	19749757
chr19	39245278	39245279	C	T	rs4803219	IFNL3	Allele C is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele T.	19749757
chr19	39248146	39248147	C	G,T	rs12979860	IFNL3	Genotype CC is associated with decreased clearance of atorvastatin.	123467
chr19	39248513	39248515	TT	G,T	rs11322783	IFNL4	Genotype TT/TT is associated with increased response to ribavirin and sofosbuvir in people with Hepatitis C, Chronic as compared to genotypes G/TT + GG.	33127459
chr19	39252121	39252122	C	A	rs8109886		Genotype CC is not associated with response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AC.	27498543
chr19	39252462	39252463	A	T	rs8113007		Genotype AA is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C and HIV Infections as compared to genotypes AT + TT.	22328925
chr19	39252524	39252525	T	G	rs8099917	IFNL3	Genotype TT is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic and Hepatitis C, Chronic as compared to genotypes GG + GT.	26075078
chr19	39253180	39253181	G	A	rs7248668	IFNL3	Allele A is associated with increased response to peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to allele G.	19749757
chr19	39254505	39254506	C	A,G,T	rs10853728		Genotype GG is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes CC + CG.	21346780
chr19	40286681	40286682	G	A,C	rs34716810	AKT2	Genotype AA is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG.	22901187
chr19	40287018	40287019	C	G	rs62107593	AKT2	Genotype CC is not associated with response to carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CG + GG.	22901187
chr19	40718298	40718299	G	A,C	rs28493229	COQ8B	Genotypes CC + CG are associated with decreased response to Immunoglobulins in children with Mucocutaneous Lymph Node Syndrome as compared to genotype GG.	21987091
chr19	40796800	40796801	C	A,T	rs7937		Allele C is associated with increased concentrations of letrozole in women with Breast Neoplasms as compared to allele T.	34096894
chr19	40804665	40804666	A	C,G	rs3733829	EGLN2	Genotypes AA + AG are associated with decreased concentrations of 3-hydroxycotinine in people with Tobacco Use Disorder as compared to genotype GG.	31796940
chr19	40833990	40833991	T	C	rs12459249		Allele C is associated with decreased metabolism of nicotine as compared to allele T.	28921760
chr19	40835323	40835324	A	G,T	rs12461964		Allele A is associated with decreased clearance of nicotine as compared to allele G.	26407342
chr19	40845361	40845362	C	T	rs28399454	CYP2A6	Genotypes CT + TT are associated with decreased metabolism of nicotine as compared to genotype CC.	15592323
chr19	40847201	40847202	T	C	rs56113850	CYP2A6	Allele T is associated with increased concentrations of letrozole in women with Breast Neoplasms as compared to allele C.	34096894
chr19	40848590	40848591	C	A	rs8192726	CYP2A6	Allele A is not associated with metabolism of efavirenz in people with HIV Infections as compared to allele C.	23172109
chr19	40848806	40848807	A	G,T	rs8192725	CYP2A6	Genotypes AG + GG are associated with increased metabolism of tegafur as compared to genotype AA.	21521021
chr19	40850375	40850376	T	A,C	rs1137115	CYP2A6	Allele C is not associated with metabolism of nicotine as compared to allele T.	26132489
chr19	40850404	40850405	G	A,C	rs8192720	CYP2A6	Genotypes AA + AG are associated with increased metabolism of tegafur as compared to genotype GG.	21521021
chr19	40850473	40850474	A	C,G,T	rs28399433	CYP2A6	Allele C is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele A.	24729586
chr19	40852718	40852719	T	C	rs4105144		Allele T is not associated with concentrations of cotinine or nicotine in people with Tobacco Use Disorder as compared to allele C.	31796940
chr19	40855902	40855903	G	A	rs111645190		Allele A is not associated with metabolism of nicotine as compared to allele G.	28921760
chr19	40856387	40856388	C	T	rs113288603		Allele T is associated with decreased clearance of nicotine as compared to allele C.	26407342
chr19	40875741	40875742	A	C,G,T	rs12460590	CYP2A6	Allele A is not associated with increased dose of warfarin in people with an international normalized ratio (INR) of 2.0-3.0 as compared to allele C.	22248286
chr19	40986012	40986013	A	C,G,T	rs8109525	CYP2B6	Genotype GG is associated with increased response to bupropion in people with Tobacco Use Disorder as compared to genotypes AA + AG.	22048466
chr19	40988985	40988986	T	C,G	rs7254579	CYP2B6	Allele C is associated with metabolism of cyclophosphamide in people with Lupus erythematosus as compared to allele T.	26456622
chr19	40989527	40989528	A	G	rs3760657	CYP2B6	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32481444
chr19	40990555	40990556	T	A,C,G	rs4802101	CYP2B6	Allele C is associated with decreased metabolism of cyclophosphamide in people with Lupus erythematosus as compared to allele T.	26456622
chr19	40991368	40991369	C	T	rs8192709	CYP2B6	Genotype CC is not associated with clearance of efavirenz in people with HIV Infections as compared to genotypes CT + TT.	23254426
chr19	40994307	40994308	T	C	rs8100458	CYP2B6	Genotypes CT + TT are not associated with concentrations of efavirenz in people with HIV Infections as compared to genotype CC.	22471906
chr19	40998171	40998172	C	G,T	rs16974799	CYP2B6	Genotype CT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.	32481444
chr19	41004221	41004222	A	G,T	rs2279342	CYP2B6	Genotypes AT + TT is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype AA.	35280252
chr19	41006886	41006887	C	T	rs4803419	CYP2B6	Genotype CT is associated with decreased concentrations of levonorgestrel in women with HIV Infections as compared to genotype CC.	28187506
chr19	41006935	41006936	G	A,T	rs3745274	CYP2B6	Allele T (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele G (assigned as normal metabolizer phenotype) .	19659438
chr19	41009577	41009578	G	A	rs2279344	CYP2B6	Allele A is not associated with concentrations of methadone as compared to allele G.	28184434
chr19	41009796	41009797	T	A,C,G	rs2279345	CYP2B6	Allele T is not associated with exposure to olanzapine in healthy individuals as compared to allele C.	33378980
chr19	41012315	41012316	T	C	rs28399499	CYP2B6	Allele C (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele T (assigned as normal metabolizer phenotype) .	19659438
chr19	41012867	41012868	C	T	rs8192719	CYP2B6	Allele T is not associated with concentrations of (S)-EDDP as compared to allele C.	28184434
chr19	41013400	41013401	G	A,T	rs36118214	CYP2B6	Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype AA.	19659438
chr19	41016809	41016810	C	A,G,T	rs3211371	CYP2B6	Genotype TT is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype CC.	16433869
chr19	41017110	41017111	C	T	rs3181842	CYP2B6	Genotypes CC + CT are associated with increased metabolism of efavirenz in healthy individuals as compared to genotype TT.	28960269
chr19	41017397	41017398	T	A,C,G	rs7246465	CYP2B6	Genotypes CT + TT are associated with increased metabolism of efavirenz in healthy individuals as compared to genotype CC.	28960269
chr19	41018181	41018182	A	C,G	rs707265	CYP2B6	Genotypes AA + AG are associated with increased metabolism of efavirenz in healthy individuals as compared to genotype GG.	28960269
chr19	41018247	41018248	T	C	rs1042389	CYP2B6	Allele C is not associated with response to efavirenz or non-nucleoside reverse transcriptase inhibitors in women with HIV Infections as compared to genotype TT.	22951632
chr19	41025691	41025692	C	G,T	rs35930845	CYP2B6	Genotypes CG + GG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype CC.	35280252
chr19	41025919	41025920	A	C,G,T	rs3745276	CYP2B6	Genotypes AA + AG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype GG.	35280252
chr19	41026099	41026100	G	A	rs434606	CYP2B6	Genotypes AA + AG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype GG.	35280252
chr19	41052972	41052973	G	A	rs56156262	CYP2B6	Genotypes AA + AG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype GG.	35280252
chr19	41352970	41352971	C	G,T	rs1800471	TGFB1	Genotype CG is associated with decreased response to etanercept in people with Arthritis, Rheumatoid as compared to genotype GG.	12759288
chr19	41353015	41353016	G	A,C	rs1800470	TGFB1	Genotype AG is associated with increased response to rituximab in people with Arthritis, Rheumatoid as compared to genotype AA.	22129793
chr19	41354390	41354391	A	G	rs1800469	TGFB1	Allele A is associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.	22111603
chr19	43334600	43334601	G	A,T	rs7247267		Allele T is associated with decreased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.	23753411
chr19	43551573	43551574	T	C,G	rs25487	XRCC1	Allele C is not associated with response to radiotherapy in people with Nasopharyngeal Neoplasms as compared to allele T.	37266339
chr19	43553421	43553422	G	A	rs1799782	XRCC1	Genotypes AA + AG is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	22821704
chr19	44891078	44891079	T	C	rs71352238	APOE	Genotypes CC + CT are associated with decreased response to rosuvastatin as compared to genotype TT.	22331829
chr19	44892361	44892362	A	G	rs2075650	TOMM40	Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A.	27045730
chr19	44905578	44905579	T	G	rs405509	APOE	Genotype TT is associated with increased response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to genotypes GG + GT.	32795354
chr19	44908683	44908684	T	C	rs429358	APOC1	Genotype CC is not associated with increased response to acitretin in people with Psoriasis as compared to genotypes CT + TT.	16433808
chr19	44908821	44908822	C	T	rs7412	APOC1	Genotype CC is not associated with increased response to acitretin in people with Psoriasis as compared to genotypes CT + TT.	16433808
chr19	44912382	44912383	G	A,C	rs445925		Allele A is associated with increased response to hmg coa reductase inhibitors as compared to allele G.	25350695
chr19	44919688	44919689	A	G	rs4420638	APOC1	Allele G is associated with decreased response to hmg coa reductase inhibitors in people with Cardiovascular Diseases or Hypercholesterolemia as compared to allele A.	27648687
chr19	45351660	45351661	T	A,G	rs13181	ERCC2	Genotypes GG + GT is not associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.	39319218
chr19	45352265	45352266	G	A	rs1052555	ERCC2	Genotypes AA + AG is associated with decreased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	24446315
chr19	45359190	45359191	A	G,T	rs50872	ERCC2	Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr19	45364000	45364001	C	A,T	rs1799793	ERCC2	Genotypes CT + TT is associated with decreased clinical benefit to cisplatin, doxorubicin and methotrexate in people with Osteosarcoma as compared to genotype CC.	39771563
chr19	45365050	45365051	T	G	rs238406	ERCC2	Genotypes GT + TT is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	24446315
chr19	45370683	45370684	G	A,C,T	rs3810366	ERCC2	Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.	28796378
chr19	45408743	45408744	A	C,G	rs735482	ERCC1	Allele C is not associated with response to cisplatin in women with Ovarian Neoplasms as compared to allele A.	32173978
chr19	45409147	45409148	G	A,C	rs2336219	ERCC1	Genotypes AG + GG are associated with increased response to cisplatin in women with Ovarian Neoplasms as compared to genotype AA.	32173978
chr19	45409477	45409478	C	A,G,T	rs3212986	ERCC1	Genotypes AA + AC is not associated with increased clinical benefit to Platinum compounds in people with Neoplasms as compared to genotype CC.	37141338
chr19	45413182	45413183	T	G	rs3212980	ERCC1	Genotype GT is associated with increased response to cisplatin in women with Ovarian Neoplasms as compared to genotype TT.	32173978
chr19	45417537	45417538	C	G,T	rs3212964	ERCC1	Allele T is not associated with response to cisplatin in women with Ovarian Neoplasms as compared to allele C.	32173978
chr19	45420394	45420395	A	G	rs11615	ERCC1	Allele A is not associated with response to carboplatin and pemetrexed in people with Mesothelioma as compared to allele G.	21262916
chr19	45421103	45421104	G	A,C,T	rs3212948	ERCC1	Allele C is associated with increased response to fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to genotype GG.	20385995
chr19	45423657	45423658	C	A,G,T	rs2298881	ERCC1	Genotypes AA + AC is not associated with increased clinical benefit to Platinum compounds in people with Neoplasms as compared to genotype CC.	37141338
chr19	45526895	45526896	G	A,C	rs10995	VASP	Genotypes AG + GG are associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype AA.	28115488
chr19	45679045	45679046	T	A	rs10423928	GIPR	Allele A is not associated with response to sitagliptin or vildagliptin in people with Diabetes Mellitus, Type 2 as compared to allele T.	27160388
chr19	45872520	45872521	C	T	rs16980091	FOXA3	Allele T is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele C.	30100615
chr19	48234448	48234449	A	T	rs2043211	CARD8	Genotype TT is associated with decreased response to etanercept or infliximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AT.	37332933
chr19	52048767	52048768	C	T	rs3752120	ZNF432	Genotype TT is associated with decreased response to budesonide, corticosteroids, fluticasone propionate or fluticasone/salmeterol in people with Asthma.	24280104
chr19	52948037	52948038	T	A,C	rs9304742	ZNF816	Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotypes CT + TT.	27670765
chr19	54885500	54885501	G	A	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19	55368503	55368504	C	G,T	rs1126757	IL11	Genotypes CT + TT is associated with increased response to escitalopram in people with Depression as compared to genotype CC.	23142150
chr19	57620254	57620255	G	A,T	rs10413455	ZNF134	Allele A is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr19	57633192	57633193	A	C,G,T	rs10420097	ZNF211	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr19_GL949747v2_alt	530732	530733	A	G	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19_GL949752v1_alt	789865	789866	G	A	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19_KI270917v1_alt	164447	164448	G	A	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19_KI270920v1_alt	171520	171521	G	A	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19_KI270921v1_alt	255739	255740	G	A	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19_KI270922v1_alt	161450	161451	G	A	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19_KI270923v1_alt	162867	162868	G	A	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19_KI270929v1_alt	159718	159719	G	A	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19_KI270938v1_alt	868026	868027	G	A	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19_KV575250v1_alt	214573	214574	G	A	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr19_KV575258v1_alt	26484	26485	C	T	rs11666735	FCAR	Genotypes AA + AG are not associated with increased response to pravastatin in men with Hypercholesterolemia as compared to genotype GG.	17008591
chr1_KN196474v1_fix	3055	3056	G	A	rs7169	SLC16A1	Genotype GG is associated with increased clinical benefit to valproic acid in children with Epilepsy as compared to genotypes AA + AG.	39711059
chr1_KN538361v1_fix	152300	152301	T	G,A,C	rs2477134	PADI4	Allele G is associated with increased concentrations of uric acid in people with Hypertension as compared to allele T.	29580174
chr1_KN538361v1_fix	181366	181367	T	A,C,G	rs2240340	PADI4	Allele T is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.	25834819
chr2	2269047	2269048	T	A,C	rs79663562	MYT1L	Allele C is associated with decreased response to allopurinol as compared to allele T.	30924126
chr2	10122792	10122793	T	C,G	rs1130609	RRM2	Genotypes GT + TT is associated with decreased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotype GG.	24024897
chr2	10123746	10123747	C	G,T	rs5030743	RRM2	Genotypes CG + GG is associated with decreased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotype CC.	24024897
chr2	10538411	10538412	A	C,G,T	rs13002976		Allele G is not associated with response to bevacizumab and ranibizumab in people with as compared to allele A.	29852030
chr2	11750301	11750302	C	G	rs10192566	LPIN1	Allele G is associated with increased response to rosiglitazone in people with Diabetes Mellitus, Type 2 as compared to allele C.	18693052
chr2	14177681	14177682	T	A,C	rs10193126	TRIB2	Allele C is associated with increased response to allopurinol as compared to allele T.	30924126
chr2	15383917	15383918	A	G	rs1019358	NBAS	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	21047205
chr2	21005954	21005955	C	A,T	rs1801701	APOB	Genotype CC is associated with increased response to irbesartan in people with Hypertrophy, Left Ventricular as compared to genotypes CT + TT.	15614026
chr2	21008651	21008652	G	A,T	rs676210	APOB	Genotype AA is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotypes AG + GG.	20724655
chr2	21041027	21041028	G	A,C	rs1367117	APOB	Genotype AG is associated with response to irbesartan in people with Hypertension.	15453913
chr2	25235676	25235677	C	A,T	rs2304429	DNMT3A	Genotype TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CC + CT.	27740732
chr2	26691495	26691496	C	T	rs1275988	KCNK3	Allele C is associated with increased response to candesartan in people with Hypertension as compared to allele T.	31327267
chr2	27518369	27518370	T	C	rs780094	GCKR	Genotypes CT + TT are associated with increased response to fenofibrate in people with Hypertriglyceridemia.	19056598
chr2	31022783	31022784	A	G,T	rs12999804	GALNT14	Allele A is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.	21635146
chr2	31023382	31023383	T	A,C	rs10209881	GALNT14	Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.	21635146
chr2	31024618	31024619	T	C,G	rs6752303	GALNT14	Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.	21635146
chr2	31024647	31024648	G	T	rs9679162	GALNT14	Genotype TT is associated with increased response to cisplatin, fluorouracil and mitoxantrone in people with Liver Neoplasms as compared to genotypes GG + GT.	31611591
chr2	31026147	31026148	T	A,C,G	rs5009910	GALNT14	Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.	21635146
chr2	31026560	31026561	T	A,G	rs12613732	GALNT14	Allele G is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.	21635146
chr2	31027107	31027108	T	A,C,G	rs7608731	GALNT14	Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.	21635146
chr2	31348919	31348920	A	C,G,T	rs1884725	XDH	Allele G is associated with decreased dose of allopurinol or febuxostat in people with Gout as compared to allele A.	27798726
chr2	31580635	31580636	G	A,C,T	rs523349	SRD5A2	Genotype CC is associated with increased response to abiraterone in men with Prostatic Neoplasms as compared to genotypes CG + GG.	33649516
chr2	38071006	38071007	A	G,T	rs1056837	CYP1B1	Allele A is associated with decreased clinical benefit to codeine or tramadol in men with Pain as compared to allele G.	35102242
chr2	38071733	38071734	T	A,C,G	rs162561	CYP1B1	Genotype GG is associated with decreased response to docetaxel in people with Breast Neoplasms as compared to genotypes GT + TT.	30334909
chr2	38075033	38075034	C	A	rs1056827	CYP1B1	Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele C.	28696411
chr2	38075246	38075247	G	A,C	rs10012	CYP1B1	Allele C is associated with decreased response to risperidone in people with Schizophrenia as compared to allele G.	28696411
chr2	38080366	38080367	T	C,G	rs162555	CYP1B1	Genotypes CT + TT are not associated with concentrations of exemestane in women with Breast Neoplasms as compared to genotype CC.	27549341
chr2	43813261	43813262	G	C	rs6720173	ABCG5	Allele C is associated with increased clearance of 5'-deoxy-5-fluorouridine in people with Colorectal Neoplasms as compared to allele G.	32559325
chr2	43839107	43839108	G	A,C	rs11887534	ABCG8	Genotypes CC + CG is associated with decreased clinical benefit to atorvastatin or simvastatin in people with Dyslipidaemia as compared to genotype GG.	34173968
chr2	45797072	45797073	T	A,C	rs6720975	PRKCE	Allele T is associated with increased response to donepezil, galantamine and rivastigmine in people with Alzheimer Disease as compared to allele C.	23374588
chr2	46185282	46185283	C	G,T	rs2278773	PRKCE	Allele C is associated with response to perphenazine in people with Schizophrenia.	22920393
chr2	46325318	46325319	T	C	rs4953344	EPAS1	Allele C is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele T.	26100253
chr2	46329493	46329494	A	C,G,T	rs12712973	EPAS1	Allele A is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele C.	24070809
chr2	46330504	46330505	G	A,C	rs9679290	EPAS1	Allele C is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele G.	24070809
chr2	46334062	46334063	A	C,G,T	rs6726454	EPAS1	Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele A.	24070809
chr2	46355242	46355243	G	A,T	rs7589621	EPAS1	Allele A is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele G.	24070809
chr2	46363651	46363652	T	C	rs3768728	EPAS1	Allele C is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele T.	26100253
chr2	46369293	46369294	G	A,C	rs1374749	EPAS1	Allele A is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele G.	26100253
chr2	47402758	47402759	T	A,G	rs1863332	MSH2	Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele T.	28796378
chr2	48962781	48962782	C	T	rs6166	FSHR	Genotype CC is associated with increased dose of gonadotropin,chorionic in women as compared to genotype CT.	16758348
chr2	50438028	50438029	T	A,C	rs4971678	NRXN1	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr2	51015131	51015132	A	C,G,T	rs12467557	NRXN1	Genotype AA is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.	24633560
chr2	51020518	51020519	T	A,C	rs10490162	NRXN1	Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes CC + CT.	24633560
chr2	60487725	60487726	A	C,G,T	rs6545816	BCL11A	Allele A is not associated with increased response to hydroxyurea in people with beta-Thalassemia.	28639471
chr2	60490907	60490908	T	C,G	rs1427407	BCL11A	Allele T is associated with increased response to hydroxyurea in people with beta-Thalassemia as compared to allele G.	28639471
chr2	60492834	60492835	C	A,G,T	rs766432	BCL11A	Allele C is associated with increased clinical benefit to hydroxyurea in people with Beta-thalassemia and related diseases as compared to allele A.	22686296
chr2	60493815	60493816	A	C,G,T	rs4671393	BCL11A	Allele A is associated with increased response to hydroxyurea in people with beta-Thalassemia as compared to allele G.	28639471
chr2	60494904	60494905	C	G,T	rs6706648	BCL11A	Allele T is not associated with increased response to hydroxyurea in people with beta-Thalassemia as compared to allele C.	28639471
chr2	60892335	60892336	G	A	rs842647	REL	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	32606912
chr2	60908993	60908994	G	T	rs13031237	REL	Allele T is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	25834819
chr2	64980939	64980940	G	A	rs10211524	SLC1A4	Genotype AA is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.	25209194
chr2	68181904	68181905	G	A,C,T	rs1868402	PPP3R1	Allele A is associated with increased response to cyclosporine in people with Psoriasis as compared to allele G.	36229649
chr2	75049301	75049302	C	G	rs881	TACR1	Allele G is not associated with dose of opioids in people with Pain as compared to allele C.	21398039
chr2	75059978	75059979	G	A,T	rs4439987	TACR1	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr2	75074635	75074636	C	A,G,T	rs6546952	TACR1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr2	75107644	75107645	T	C,G	rs2160652	TACR1	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr2	75147138	75147139	T	A,G	rs12475818	TACR1	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr2	75153825	75153826	T	A,C,G	rs3771836	TACR1	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr2	75158065	75158066	G	A	rs10191107	TACR1	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr2	75177827	75177828	C	G,T	rs12713837	TACR1	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr2	75195904	75195905	A	G,T	rs6725334	TACR1	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr2	75198496	75198497	G	A	rs2024512	TACR1	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr2	75198601	75198602	A	G,T	rs6715729	TACR1	Genotype GG is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes AA + AG.	29177570
chr2	75200751	75200752	G	A	rs2111375	TACR1	Genotype AA is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes AG + GG.	29177570
chr2	79673968	79673969	A	C,G,T	rs11126740	CTNNA2	Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotypes AG + GG.	27670765
chr2	85550509	85550510	C	G	rs11676382	GGCX	Allele G is associated with decreased dose of warfarin as compared to allele C.	20694283
chr2	85553007	85553008	G	A	rs2592551	GGCX	Genotypes AA + AG is associated with increased dose of warfarin in people with Atrial Fibrillation as compared to genotype GG.	24148610
chr2	85553412	85553413	C	T	rs699664	GGCX	Genotypes CC + CT are not associated with dose of warfarin in people with heart valve replacement as compared to genotype TT.	28429387
chr2	85560217	85560218	C	A,T	rs12714145	GGCX	Allele T is not associated with dose of warfarin.	19794411
chr2	88124546	88124547	T	C	rs2241883	FABP1	Genotypes CC + CT are not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.	15249972
chr2	96941333	96941334	A	G	rs6728642	FAM178B	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr2	99438695	99438696	T	C	rs3087399	REV1	Genotypes CC + CT are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype TT.	25748439
chr2	99439043	99439044	A	G	rs3087386	REV1	Genotypes AA + AG are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype GG.	25748439
chr2	99442407	99442408	C	G,T	rs3087403	REV1	Genotypes CT + TT are associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype CC.	25748439
chr2	105653154	105653155	A	G	rs10193895		Genotypes AG + GG are not associated with response to clozapine in people with Schizophrenia as compared to genotype AA.	21332319
chr2	107989379	107989380	C	G,T	rs6542746	SLC5A7	Allele C is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr2	107995062	107995063	G	A	rs11685873	SLC5A7	Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele A.	25730470
chr2	108006865	108006866	T	A,C,G	rs6720783	SLC5A7	Allele G is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele T.	25730470
chr2	108258787	108258788	T	C,G	rs6722745	SULT1C3	Allele T is associated with decreased response to candesartan in people with Hypertension as compared to allele C.	31327267
chr2	108378351	108378352	C	G	rs1402467	SULT1C4	Allele G is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele C.	20038957
chr2	111150113	111150114	T	A,C	rs724710	BCL2L11	Allele T is associated with decreased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele C.	24223824
chr2	112771662	112771663	T	C	rs11677416	IL1A	Allele C is associated with increased response to olanzapine in people with Schizophrenia as compared to allele T.	21107309
chr2	112779645	112779646	C	A	rs17561	IL1A	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele C.	32606912
chr2	112785382	112785383	G	A,C,T	rs1800587	IL1A	Allele A is not associated with clinical benefit to almotriptan, eletriptan, frovatriptan, rizatriptan, sumatriptan or zolmitriptan in people with Migraine without Aura as compared to allele G.	36614097
chr2	112832812	112832813	G	A	rs1143634	IL1B	Genotype GG is not associated with response to omeprazole and rabeprazole in people with Helicobacter Infections as compared to genotypes AA + AG.	21054464
chr2	112836809	112836810	G	A	rs1143627	IL1B	Genotypes AG + GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors or ustekinumab in people with Psoriasis as compared to genotype AA.	28696418
chr2	112837289	112837290	A	G	rs16944	IL1B	Genotype AG is associated with increased response to lansoprazole, omeprazole or rabeprazole in people with Helicobacter Infections as compared to genotype GG.	16815316
chr2	112838251	112838252	C	A,G	rs1143623	IL1B	Genotype GG is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CG.	26401715
chr2	112840529	112840530	G	A,C	rs4848306	IL1B	Genotypes AA + AG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative and Inflammatory Bowel Diseases as compared to genotype GG.	24776844
chr2	113109276	113109277	G	T	rs7580634	IL1RN	Allele G is not associated with response to anakinra or canakinumab in children with Arthritis, Juvenile Rheumatoid as compared to allele T.	31599092
chr2	113109710	113109711	T	A,C	rs55709272	IL1RN	Allele T is not associated with response to anakinra or canakinumab in children with Arthritis, Juvenile Rheumatoid as compared to allele C.	31599092
chr2	113111988	113111989	C	T	rs62158853	IL1RN	Allele C is not associated with response to anakinra or canakinumab in children with Arthritis, Juvenile Rheumatoid as compared to allele T.	31599092
chr2	113113147	113113148	T	G	rs62158854	IL1RN	Allele T is not associated with response to anakinra or canakinumab in children with Arthritis, Juvenile Rheumatoid as compared to allele G.	31599092
chr2	113113581	113113596	AATAATAATAATAAT	AATAATAATAAT,AATAATAATAATAATAAT,AATAATAATAATAATAATAAT	rs55663133	IL1RN	Allele AATAATAATAATAATAAT is not associated with response to anakinra or canakinumab in children with Arthritis, Juvenile Rheumatoid as compared to allele AATAATAATAAT.	31599092
chr2	113116889	113116890	T	C	rs4251961	IL1RN	Genotypes CC + CT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype TT.	24776844
chr2	113129629	113129630	T	C	rs419598	IL1RN	Allele C is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele T.	32606912
chr2	127260486	127260487	A	C,G	rs3738948	ERCC3	Genotypes AG + GG is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype AA.	25069034
chr2	127418285	127418286	C	G,T	rs1799808	PROC	Genotype CC is associated with increased dose of phenprocoumon as compared to genotypes CT + TT.	21110013
chr2	127418298	127418299	G	A,C,T	rs1799809	PROC	Genotype AA is not associated with increased dose of phenprocoumon as compared to genotypes AG + GG.	21110013
chr2	127421976	127421977	G	A	rs2069919	PROC	Allele G is not associated with dose of warfarin.	19794411
chr2	134445590	134445591	T	C,G	rs661899	MGAT5	Genotype TT is associated with decreased clinical benefit to ursodeoxycholic acid in people with Cholangitis as compared to genotypes CC + CT.	37845416
chr2	138521351	138521352	G	A,C	rs10170310	SPOPL	Allele C is associated with decreased response to olanzapine in people with Schizophrenia as compared to allele A.	23241943
chr2	141731022	141731023	G	A,C,T	rs874295	LRP1B	Allele G is associated with response to risperidone in people with Schizophrenia.	22920393
chr2	151869422	151869423	C	A	rs3768652	CACNB4	Genotypes AA + AC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype CC.	30032160
chr2	157933912	157933913	A	G,T	rs35806662		Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr2	161151236	161151237	T	C	rs1267067	TANK	Genotype CC is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.	28639493
chr2	161308496	161308497	A	T	rs9713	PSMD14	Allele A is associated with response to risperidone in people with Schizophrenia.	22920393
chr2	162015287	162015288	C	A,T	rs2909451	DPP4	Genotype TT is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.	39792745
chr2	162029378	162029379	A	C,G,T	rs4664443	DPP4	Genotype GG is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.	39792745
chr2	162047873	162047874	A	C	rs17848916	DPP4	Genotype AC is not associated with response to peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotype AA.	26339796
chr2	162073468	162073469	A	G	rs17574	DPP4	Genotype AA is not associated with response to peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotype AG.	26339796
chr2	162074214	162074215	T	G	rs13015258	DPP4	Genotype GG is not associated with response to peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotypes GT + TT.	26339796
chr2	162404180	162404181	T	C	rs17716942	KCNH7	Genotype CC is not associated with response to etanercept in people with Psoriasis as compared to genotype TT.	27564082
chr2	164106975	164106976	T	A,C	rs1446468		Allele T is associated with increased response to metoprolol in people with Hypertension as compared to allele C.	31327267
chr2	165295878	165295879	G	A	rs17183814	SCN2A	Allele A is not associated with response to carbamazepine or valproic acid in people with Epilepsy as compared to allele G.	23859570
chr2	165311992	165311993	A	G	rs2304016	SCN2A	Genotype GG is not associated with resistance to carbamazepine or oxcarbazepine in people with Epilepsy as compared to genotype AA.	25155934
chr2	166036277	166036278	C	G,T	rs2298771	SCN1A	Allele C is not associated with increased dose of carbamazepine in people with Epilepsy as compared to allele T.	22188362
chr2	166053033	166053034	C	T	rs3812718	SCN1A	Allele T is associated with increased clinical benefit to valproic acid in children with Epilepsy as compared to allele C.	37451178
chr2	166059386	166059387	T	C	rs10188577	SCN1A	Genotype CT is associated with increased resistance to antiepileptics in people with Epilepsy.	24342961
chr2	166242647	166242648	A	C,G	rs6746030	SCN9A	Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.	31014225
chr2	166521467	166521468	A	C	rs13015447		Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr2	166596950	166596951	T	A,C	rs1596996		Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr2	166616232	166616233	A	G,T	rs2218603		Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr2	167134844	167134845	C	A,T	rs7606603	XIRP2	Allele C is associated with decreased response to atenolol in people with Hypertension as compared to allele T.	29650764
chr2	168343184	168343185	C	A,T	rs16855294		Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr2	168532580	168532581	G	A,C	rs13393173	CERS6	Allele A is associated with increased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	33124499
chr2	168973817	168973818	A	C,G,T	rs2287622	ABCB11	Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.	30100615
chr2	169014371	169014372	A	G	rs4148776	ABCB11	Allele G is associated with increased response to glibenclamide in people with as compared to allele A.	27403931
chr2	170815567	170815568	C	A,G	rs3762556	GAD1	Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele C.	31866536
chr2	170815680	170815681	G	T	rs3791878	GAD1	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	31866536
chr2	170815884	170815885	C	A,G,T	rs3762555	GAD1	Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele C.	31866536
chr2	170816964	170816965	G	A,C,T	rs3749034	GAD1	Allele G is associated with increased dose of methadone in people with Heroin Dependence as compared to allele A.	31866536
chr2	170822114	170822115	T	C,G	rs769404	GAD1	Genotype CT is not associated with dose of methadone in people with Heroin Dependence as compared to genotype CC.	31866536
chr2	170860292	170860293	G	A,C,T	rs769395	GAD1	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	31866536
chr2	175056028	175056029	T	C	rs1153702	ATF2	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.	30106255
chr2	175057653	175057654	A	C	rs7583431	ATF2	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.	30106255
chr2	175074875	175074876	G	A,C	rs2302663	ATF2	Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele A.	30106255
chr2	175078525	175078526	C	A,G,T	rs3845744	ATF2	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.	30106255
chr2	175168486	175168487	C	A,G,T	rs268214	ATF2	Allele C is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.	30106255
chr2	175183177	175183178	T	A,G	rs1982235	ATF2	Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.	30106255
chr2	181437034	181437035	C		rs5836788		Allele del is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	29743634
chr2	181691407	181691408	C	G	rs6719578		Genotype CG is associated with increased response to metformin as compared to genotype GG.	28453780
chr2	184885914	184885915	T	C,G	rs62200793	ZNF804A	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr2	184913700	184913701	A	C,T	rs1344706	ZNF804A	Genotype AA is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotypes AC + CC.	21892778
chr2	184943351	184943352	C	T	rs12693402	ZNF804A	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	21961650
chr2	186089404	186089405	A	G	rs77583603		Allele G is associated with decreased response to acamprosate in people with Alcoholism as compared to allele A.	34302059
chr2	187396193	187396194	T	C,G	rs6710852	CALCRL	Allele G is associated with increased clinical benefit to erenumab in people with Migraine with Aura or Migraine without Aura as compared to allele T.	36627267
chr2	191099906	191099907	T	A,G	rs7574865	STAT4	Allele T is associated with decreased response to etanercept in people with Arthritis, Rheumatoid as compared to allele G.	28107378
chr2	192057529	192057530	T	A,G	rs3738883	TMEFF2	Allele G is associated with response to risperidone in people with Schizophrenia.	22920393
chr2	200121621	200121622	A	G,T	rs7588746		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr2	200285316	200285317	C	T	rs295137	SPATS2L	Allele C is not associated with response to salbutamol in children with Asthma as compared to allele T.	23992748
chr2	200330878	200330879	C	T	rs295114	SPATS2L	Allele C is not associated with response to salbutamol in children with Asthma as compared to allele T.	23992748
chr2	200604660	200604661	T	C	rs75995567	AOX1	Allele T is associated with increased dose of allopurinol or febuxostat in people with Gout as compared to allele C.	27798726
chr2	200659012	200659013	A	C,G,T	rs10931910	AOX1	Allele G is not associated with decreased clearance of XK469 in people with Neoplasms as compared to allele A.	24300566
chr2	200661606	200661607	A	G	rs55754655	AOX1	Allele G is associated with decreased response to azathioprine in people with Inflammatory Bowel Diseases as compared to allele A.	19500084
chr2	200669665	200669666	A	G	rs3731722	AOX1	Allele G is associated with dose of allopurinol or febuxostat in people with Gout as compared to allele A.	27798726
chr2	200676897	200676898	C	T	rs11678615	AOX1	Allele T is associated with dose of allopurinol or febuxostat in people with Gout as compared to allele C.	27798726
chr2	200678772	200678773	C	A,T	rs6729738		Genotype CC is associated with increased response to cannabidiol in people with Epilepsy as compared to genotypes AA + AC.	34464454
chr2	203745672	203745673	C	A,T	rs1980422	CD28	Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.	23007924
chr2	203866281	203866282	A	G,T	rs4553808	CTLA4	Genotypes AG + GG is associated with increased exposure to tacrolimus in people with Kidney Transplantation as compared to genotype AA.	28112181
chr2	203866795	203866796	C	T	rs16840252	CTLA4	Allele T is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele C.	29318894
chr2	203867990	203867991	A	G,T	rs231775	CTLA4	Allele A is not associated with increased clinical benefit to avatrombopag, corticosteroids, eltrombopag or rituximab Thrombocytopenia as compared to allele G.	38485815
chr2	203874195	203874196	G	A,T	rs3087243	CTLA4	Allele G is not associated with increased clinical benefit to avatrombopag, corticosteroids, eltrombopag or rituximab Thrombocytopenia as compared to allele A.	38485815
chr2	207534204	207534205	A	G	rs889895	CREB1	Allele A is not associated with response to antidepressants in people with Mental Disorders as compared to allele G.	23537502
chr2	207564626	207564627	T	A,C	rs6740584	CREB1	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	23537502
chr2	207629509	207629510	T	A,C,G	rs2952768	METTL21A	Genotype CC is associated with increased dose of morphine in women with Pain, Postoperative as compared to genotypes CT + TT.	37456358
chr2	208188355	208188356	A	C,G	rs7579275	ABCB11	Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.	30100615
chr2	210016168	210016169	C	G,T	rs7570090	RPE	Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.	37098852
chr2	214780739	214780740	C	G,T	rs2229571	BARD1	Allele C is not associated with decreased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.	30071039
chr2	214780820	214780821	C	A,G,T	rs2070096	BARD1	Allele A is associated with decreased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.	30071039
chr2	215321101	215321102	C	T	rs10197559	ATIC	Genotypes CT + TT is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	25084201
chr2	215325296	215325297	C	G	rs2372536	ATIC	Allele C is not associated with response to folic acid, hydroxychloroquine, methotrexate and sulfasalazine in people with Arthritis, Rheumatoid as compared to allele G.	18322994
chr2	215325930	215325931	C	T	rs7563206	ATIC	Genotypes CT + TT is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	27676277
chr2	215333247	215333248	T	A,C	rs12995526	ATIC	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	29743634
chr2	215340443	215340444	G	A	rs16853826	ATIC	Genotype GG is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	25084201
chr2	215341329	215341330	A	G	rs4673990	ATIC	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.	29743634
chr2	215345512	215345513	C	T	rs16853834	ATIC	Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	29743634
chr2	215347615	215347616	T	A,C,G	rs4673993	ATIC	Genotype CC is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.	27992285
chr2	219218556	219218557	C	A,G,T	rs1109866	ABCB6	Allele T is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele C.	24192121
chr2	219218730	219218731	G	T	rs1109867	ABCB6	Allele T is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.	24192121
chr2	219219746	219219747	G	A	rs3731885	ABCB6	Allele A is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.	24192121
chr2	219220141	219220142	G	A	rs3755047	ABCB6	Allele A is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.	24192121
chr2	226155936	226155937	A	G	rs7578326	IRS1	Allele G is not associated with response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to allele A.	28696414
chr2	226229028	226229029	T	A,C	rs2943641	IRS1	Allele T is not associated with response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to allele C.	28696414
chr2	226795827	226795828	C	A,G,T	rs1801278	IRS1	Genotypes CT + TT is associated with decreased response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	28696414
chr2	232355543	232355544	C	A,G,T	rs28845026		Allele T is associated with increased concentrations of anastrozole in women with Breast Neoplasms as compared to allele C.	30648747
chr2	233250192	233250193	C	A,G,T	rs10210302	ATG16L1	Genotypes CT + TT is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype CC.	25712183
chr2	233274721	233274722	A	G	rs2241880	ATG16L1	Genotypes AG + GG is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.	39159789
chr2	233618224	233618225	C	A,G,T	rs1042597	UGT1A8	Genotype CC is associated with increased response to raloxifene in women with Menopause and Schizophrenia as compared to genotype CG.	27546373
chr2	233669781	233669782	C	T	rs17868320	UGT1A9	Genotype CC is not associated with metabolism of mycophenolic acid as compared to genotype TT.	22765258
chr2	233670046	233670047	T	A,G	rs6731242	UGT1A10	Genotype GG is not associated with increased dose of valproic acid in people with Epilepsy as compared to genotypes GG + GT.	21806385
chr2	233671493	233671494	C	A,T	rs2741045	UGT1A9	Allele C is not associated with metabolism of mycophenolic acid in people with Kidney Transplantation as compared to allele T.	25163792
chr2	233671602	233671603	T	A,C	rs2741046	UGT1A9	Allele C is not associated with metabolism of mycophenolic acid in people with Kidney Transplantation as compared to allele T.	25163792
chr2	233671658	233671659	T	A	rs6714486	UGT1A9	Genotypes AA + AT is associated with decreased dose-adjusted trough concentrations of mycophenolic acid in children with Kidney Transplantation as compared to genotype TT.	33967795
chr2	233671807	233671817	TTTTTTTTTT	TTTTTTTT,TTTTTTTTT,TTTTTTTTTTT	rs3832043	UGT1A9	Genotype del/del is not associated with response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes T/del + TT.	16636344
chr2	233673187	233673188	T	C	rs2741049	UGT1A9	Allele T is not associated with response to azathioprine or mycophenolic acid in people with lung transplantation as compared to allele C.	30992538
chr2	233682323	233682324	T	A,G	rs17868323	UGT1A7	Allele G is associated with concentrations of axitinib in people with Carcinoma, Renal Cell as compared to allele T.	29682213
chr2	233682327	233682328	C	A,G,T	rs17863778	UGT1A9	Allele A is not associated with metabolism of mycophenolic acid in people with Kidney Transplantation as compared to allele C.	25163792
chr2	233693022	233693023	T	A,G	rs6759892	UGT1A6	Genotype TT is associated with increased concentrations of valproic acid in people with Epilepsy as compared to genotypes GG + GT.	39564784
chr2	233693544	233693545	A	G	rs2070959	UGT1A6	Genotype AA is associated with increased response to deferiprone in people with beta-Thalassemia as compared to genotypes AG + GG.	24036429
chr2	233693555	233693556	A	C	rs1105879	UGT1A6	Allele A is not associated with response to deferiprone in people with beta-Thalassemia as compared to allele C.	24036429
chr2	233718889	233718890	C	A,T	rs6755571	UGT1A4	Allele A is not associated with concentrations of lamotrigine in people with Epilepsy as compared to allele C.	29791014
chr2	233718961	233718962	T	A,G	rs2011425	UGT1A4	Genotype GG is not associated with increased clearance of lamotrigine as compared to genotypes GT + TT.	23263737
chr2	233719290	233719291	T	C,G	rs2011404	UGT1A4	Allele C is associated with increased concentrations of clozapine in people with Schizophrenia or Psychotic Disorder as compared to allele T.	40048458
chr2	233728368	233728369	A	G	rs2008584	UGT1A3	Genotype AA is associated with decreased half-life time of mirabegron in healthy individuals as compared to genotype AG.	39204422
chr2	233728375	233728376	T	C	rs1983023	UGT1A3	Genotype TT is associated with increased response to deferasirox in people with beta-Thalassemia as compared to genotypes CC + CT.	30651574
chr2	233729060	233729061	T	C	rs3806596	UGT1A3	Genotype CC is associated with increased response to deferasirox in people with beta-Thalassemia as compared to genotypes CT + TT.	27043265
chr2	233729206	233729207	G	A,C	rs6706232	UGT1A3	Allele A is associated with increased response to risperidone in people with Schizophrenia as compared to allele G.	28696411
chr2	233749469	233749470	C	T	rs7604115	UGT1A3	Allele T is associated with decreased concentrations of montelukast in healthy individuals as compared to allele C.	28940478
chr2	233757012	233757013	T	A,C,G	rs4124874	UGT1A1	Genotypes GG + GT are not associated with response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.	16636344
chr2	233757135	233757136	G	A	rs10929302	UGT1A1	Genotype AA is associated with increased clearance of fesoterodine in healthy individuals as compared to genotype AG.	39338398
chr2	233757934	233757935	C	T	rs12052787	UGT1A9	Allele T is associated with increased response to simvastatin as compared to allele C.	25493567
chr2	233759290	233759291	G	A,C	rs2003569	UGT1A9	Allele A is associated with increased response to simvastatin as compared to allele G.	25493567
chr2	233759923	233759924	C	T	rs887829	UGT1A1	Allele T is associated with increased metabolism of atorvastatin as compared to allele C.	32128760
chr2	233760497	233760498	G	A	rs4148323	UGT1A1	Genotype AA is associated with decreased response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG.	16636344
chr2	233764075	233764076	T	A,G	rs4148324	UGT1A1	Genotypes GG + GT is associated with increased dose-adjusted trough concentrations of topiramate in children with Epilepsy as compared to genotype TT.	37858371
chr2	233764815	233764816	T	A,C	rs4148326	UGT1A1	Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.	29791011
chr2	233767182	233767183	C	T	rs34650714	UGT1A8	Genotype CC is associated with decreased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to genotype CT.	39752799
chr2	233767811	233767812	T	C	rs12471326	UGT1A9	Genotype CT is associated with increased concentrations of cotinine glucuronide as compared to genotype TT.	31959879
chr2	233769012	233769013	C	T	rs4148328	UGT1A1	Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr2	233772769	233772770	T	C,G	rs10929303	UGT1A8	Genotype CC is associated with decreased concentrations of n-desmethyltramadol in people with Death as compared to genotypes CT + TT.	39752799
chr2	233772998	233772999	G	A,C,T	rs8330	MROH2A	Genotype GG is associated with increased formation of acetaminophen glucuronide in healthy individuals as compared to genotypes CC + CG.	28932176
chr2	233774703	233774704	A	G	rs11563250	MROH2A	Allele G is not associated with increased dose of levothyroxine in people with Thyroid Neoplasms.	27527610
chr2	233911932	233911933	C	G	rs6724624		Allele G is not associated with response to Selective serotonin (5HT1) agonists in people with Migraine without Aura as compared to allele C.	30256423
chr2	233916447	233916448	T	A,C	rs10166942	TRPM8	Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.	31014225
chr2	236086400	236086401	G	A,C	rs1869295	AGAP1	Allele C is associated with response to risperidone in people with Schizophrenia.	22920393
chr2	237865061	237865062	A	G	rs12465864	RAMP1	Allele G is associated with decreased clinical benefit to erenumab in people with Migraine with Aura or Migraine without Aura as compared to allele A.	36627267
chr2	237880274	237880275	G	A	rs13386048	RAMP1	Allele A is associated with decreased clinical benefit to erenumab in people with Migraine with Aura or Migraine without Aura as compared to allele G.	36627267
chr2	237905304	237905305	A	G	rs6431564	RAMP1	Allele G is associated with increased clinical benefit to erenumab in people with Migraine with Aura or Migraine without Aura as compared to allele A.	36627267
chr2	237913556	237913557	G	A,C	rs7590387	RAMP1	Allele G is associated with decreased clinical benefit to erenumab in people with Migraine NOS as compared to allele C.	34965002
chr2	237927497	237927498	A	C,G	rs12615320		Allele G is associated with decreased response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele A.	38071464
chr2	238197073	238197074	T	C	rs113095083	ILKAP	Allele C is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele T.	25695618
chr2	238240328	238240329	C	A	rs56294817	HES6	Allele A is not associated with response to citalopram, fluoxetine or paroxetine in people with Depressive Disorder, Major as compared to allele C.	19481584
chr2	238241003	238241004	C	G	rs1374385	HES6	Allele C is not associated with response to citalopram, fluoxetine or paroxetine in people with Depressive Disorder, Major as compared to allele G.	19481584
chr2	238277947	238277948	G	C	rs2304672	PER2	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	21781277
chr2	240592061	240592062	A	G	rs3792269	CAPN10	Allele G is associated with decreased response to metformin in people with Diabetes Mellitus as compared to allele A.	25327507
chr2	241431685	241431686	C	A,T	rs757978	FARP2	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr20	388260	388261	A	G,T	rs2295490	TRIB3	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr20	1979579	1979580	A	C,G,T	rs910080	PDYN	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32481444
chr20	1989287	1989288	A	G	rs2235751	PDYN	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	32481444
chr20	1994211	1994212	T	A,C	rs1997794	PDYN	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr20	2520224	2520225	C	T	rs4815273		Allele T is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.	23753411
chr20	2522093	2522094	C	T	rs6083538		Allele T is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.	23753411
chr20	3081820	3081821	G	C,T	rs2740204	OXT	Allele T is associated with increased response to clozapine in people with Schizophrenia as compared to allele G.	20196918
chr20	3203487	3203488	C	T	rs2295553	DDRGK1	Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	29743634
chr20	3213195	3213196	C	A,G	rs1127354	ITPA	Genotype CC is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AC.	29683944
chr20	3213246	3213247	A	C	rs7270101	ITPA	Genotype AA is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AC + CC.	29683944
chr20	3668513	3668514	C	G	rs2787094	ADAM33	Genotype CC is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotypes CG + GG.	27977334
chr20	3670824	3670825	T	A	rs2853209	ADAM33	Genotype AA is associated with decreased clinical benefit to corticosteroids and selective beta-2-adrenoreceptor agonists in people with Asthma as compared to genotype TT.	36766510
chr20	3671117	3671118	C	T	rs3918396	ADAM33	Genotype TT is associated with decreased clinical benefit to corticosteroids and selective beta-2-adrenoreceptor agonists in people with Asthma as compared to genotypes CC + CT.	36766510
chr20	6802626	6802627	T	C	rs2650972		Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	29743634
chr20	8591577	8591578	G	A	rs6108160	PLCB1	Allele A is associated with increased response to Selective serotonin reuptake inhibitors in people with Depression as compared to allele G.	25649181
chr20	10256574	10256575	T	A,C,G	rs363020	SNAP25	Genotype AA is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to genotypes AT + TT.	23131881
chr20	10306435	10306436	G	A,C,T	rs3746544	SNAP25	Genotype TT is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to genotypes GG + GT.	23131881
chr20	10306439	10306440	T	C	rs1051312	SNAP25	Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.	17023870
chr20	10307093	10307094	T	A,C	rs8636	SNAP25	Genotype CT is associated with increased response to amisulpride in people with Schizophrenia as compared to genotypes CC + TT.	28947383
chr20	15144217	15144218	A	G	rs76026520	MACROD2	Allele G is associated with increased clinical benefit to hydrocodone or oxycodone in people with Pain as compared to allele A.	35102242
chr20	35177812	35177813	A	G	rs1415774	PROCR	Allele G is not associated with dose of warfarin in people with heart valve replacement as compared to allele A.	25126975
chr20	44351774	44351775	C	A,G,T	rs1884613	HNF4A	Genotype CC is associated with increased concentrations of efavirenz in people with HIV Infections as compared to genotypes CG + GG.	26774523
chr20	44401794	44401795	G	A,T	rs2071197	HNF4A	Genotype AA is associated with decreased concentrations of lamotrigine in people with Epilepsy as compared to genotypes AG + GG.	26213157
chr20	44406497	44406498	C	A,T	rs3212183	HNF4A	Allele C is not associated with response to lamotrigine in people with Epilepsy as compared to allele T.	27610747
chr20	44409343	44409344	T	C	rs3212185	HNF4A	Genotype CT is not associated with response to metformin as compared to genotype CC.	28453780
chr20	44409608	44409609	C	T	rs6031587	HNF4A	Allele T is not associated with metabolism of irinotecan in people with Colorectal Neoplasms as compared to allele C.	29706892
chr20	44415721	44415722	C	G,T	rs3212198	HNF4A	Allele T is associated with increased dose of warfarin in people with heart valve replacement as compared to allele C.	25356900
chr20	44430056	44430057	T	G	rs11086926	HNF4A	Genotype GG is not associated with response to metformin as compared to genotypes GT + TT.	28453780
chr20	44624273	44624274	T	C	rs244076	ADA	Allele C is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid.	19902562
chr20	44651585	44651586	C	A,G,T	rs73598374	ADA	Allele C is not associated with discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	27217051
chr20	45094985	45094986	T	C	rs734784	KCNS1	Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.	31014225
chr20	46007336	46007337	C	T	rs3918242	MMP9	Allele T is associated with increased response to ulinastatin in people with Pancreatitis as compared to allele C.	31192912
chr20	46011052	46011053	G	T	rs2274755	MMP9	Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.	28045923
chr20	46011935	46011936	A	G	rs2236416	MMP9	Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.	28045923
chr20	46014471	46014472	G	A,C	rs17577	MMP9	Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.	28045923
chr20	46118342	46118343	T	A,C,G	rs1883832	CD40	Genotype CC is associated with decreased clinical benefit to prednisolone in children with Thrombocytopenia as compared to genotypes CT + TT.	39350313
chr20	46119307	46119308	T	A,G	rs4810485	CD40	Allele T is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	23007924
chr20	46448269	46448270	A	C,G	rs446112		Genotype AA is associated with increased resistance to etoposide as compared to genotypes AG + GG.	17537913
chr20	49885068	49885069	A	C,G,T	rs645544	SLC9A8	Genotype GG is associated with decreased response to adalimumab or infliximab in people with Psoriasis as compared to genotypes AA + AG.	29192552
chr20	51536804	51536805	T	A,C,G	rs3787186	NFATC2	Genotypes CC + CT is associated with decreased response to adalimumab, etanercept or infliximab in people with Arthritis, Rheumatoid as compared to genotype TT.	34320607
chr20	54156201	54156202	T	A,C,G	rs927650	CYP24A1	Genotypes CT + TT is associated with decreased metabolism of deferasirox in people with beta-Thalassemia as compared to genotype CC.	29160302
chr20	54164711	54164712	G	C,T	rs2762939	CYP24A1	Allele G is not associated with response to calcitriol, cisplatin and docetaxel in people with Carcinoma, Non-Small-Cell Lung as compared to allele C.	23435876
chr20	54166140	54166141	G	A	rs3787554	CYP24A1	Allele G is not associated with response to calcitriol, cisplatin and docetaxel in people with Carcinoma, Non-Small-Cell Lung as compared to allele A.	23435876
chr20	54170357	54170358	C	T	rs2585428	CYP24A1	Allele C is associated with decreased trough concentration of telaprevir in people with Hepatitis C as compared to allele T.	26158282
chr20	54174978	54174979	C	T	rs2248359	CYP24A1	Genotypes CT + TT is associated with increased concentrations of daclatasvir in people with Hepatitis C as compared to genotype CC.	29790402
chr20	56864306	56864307	C	G,T	rs6025211		Genotypes CC + TT are not associated with response to cisplatin and fluorouracil in people with Liver Neoplasms as compared to genotype CT.	31611591
chr20	56905220	56905221	T	A,C	rs6064463		Allele C is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele T.	29743634
chr20	57063693	57063694	A	C	rs6127921		Allele C is associated with decreased response to citalopram in people with Depressive Disorder, Major as compared to allele A.	19846067
chr20	57545214	57545215	T	C,G	rs4810083	PCK1	Genotypes CT + TT is associated with increased clinical benefit to metformin in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	39928707
chr20	58903751	58903752	C	G,T	rs7121	GNAS	Genotype CC is associated with increased response to cisplatin and fluorouracil in people with Esophageal Neoplasms as compared to genotypes CT + TT.	19274060
chr20	58987046	58987047	C	G,T	rs2273359	NELFCD	Genotype CG is associated with increased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to genotype CC.	23753411
chr20	61816981	61816982	G	A,T	rs4925300	CDH4	Allele A is associated with response to ziprasidone in people with Schizophrenia.	22920393
chr20	62216347	62216348	C	G,T	rs3787429	HRH3	Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CT.	21652606
chr20	62216365	62216366	C	A,G,T	rs3787430	HRH3	Genotype TT is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CC + CT.	21652606
chr20	63346203	63346204	G	A,C	rs2236196	CHRNA4	Genotypes AA + AG is not associated with response to varenicline in people with Tobacco Use Disorder as compared to genotype GG.	25774163
chr20	63349638	63349639	T	C,G	rs3827020	CHRNA4	Allele C is not associated with exposure to nicotine in men as compared to allele T.	29666375
chr20	63349781	63349782	G	A,C	rs1044396	CHRNA4	Genotype GG is associated with decreased response to varenicline in people with Tobacco Use Disorder as compared to genotypes AA + AG.	25774163
chr20	63350201	63350202	C	A,T	rs2229959	CHRNA4	Allele C is associated with increased response to nicotine in people with daily smoking as compared to allele A.	20854418
chr20	63356469	63356470	C	T	rs2273502	CHRNA4	Allele T is not associated with response to nicotine in women as compared to allele C.	20231857
chr20	63359521	63359522	T	A,C	rs6090384	CHRNA4	Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.	17948872
chr20	64083429	64083430	C	A,G,T	rs6010717	OPRL1	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32481444
chr20	64096561	64096562	C	T	rs7271530	OPRL1	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32481444
chr20	64098077	64098078	C	T	rs2229205	OPRL1	Genotype CT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.	32481444
chr20_KI270870v1_alt	1507	1508	C	T	rs7271530	OPRL1	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32481444
chr20_KI270870v1_alt	3023	3024	C	T	rs2229205	OPRL1	Genotype CT is associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.	32481444
chr21	16329272	16329273	A	C,G,T	rs239022	LINC00478	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr21	18938574	18938575	T	C	rs79663003		Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	26806518
chr21	18940293	18940294	T	C	rs78015114		Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	26806518
chr21	18954017	18954018	G	A	rs74795342		Allele G is associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	26806518
chr21	18955108	18955109	T	G	rs75222709		Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.	26806518
chr21	20732376	20732377	C	G	rs2826494		Allele G is associated with response to lithium in people with Bipolar Disorder as compared to allele C.	21961650
chr21	24531790	24531791	A	G,T	rs4816969		Allele G is not associated with clearance of tenofovir in people with HIV Infections as compared to allele A.	37098852
chr21	24533659	24533660	C	A,G	rs9305223		Allele G is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.	37098852
chr21	24544202	24544203	T	A,C	rs2226443		Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.	37098852
chr21	24551596	24551597	C	G,T	rs2829163		Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.	37098852
chr21	24559611	24559612	T	A,G	rs7282679		Allele A is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.	37098852
chr21	28055778	28055779	G	A,C,T	rs2831440		Allele T is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele G.	27091189
chr21	28883960	28883961	A	C,G,T	rs2254638	N6AMT1	Allele G is associated with decreased response to clopidogrel in people with Coronary Artery Disease as compared to allele A.	30487649
chr21	29595187	29595188	C	A,G,T	rs2832407	GRIK1	Allele A is not associated with increased response to naltrexone null topiramate in people with Alcoholism as compared to allele C.	38706338
chr21	33341700	33341701	G	C,T	rs1012335	IFNAR1	Allele G is associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele C.	22111603
chr21	33403137	33403138	T	C,G	rs8126756	IFNGR2	Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease as compared to genotype TT.	28139755
chr21	34996361	34996362	G	A,C	rs11702779	RUNX1	Genotype AA is associated with increased response to methacholine chloride in children with Asthma as compared to genotypes AG + GG.	21803869
chr21	36070333	36070334	G	C,T	rs25678	CBR1	Genotype CC is associated with decreased exposure to daunorubicin in people with Leukemia, Myeloid, Acute as compared to genotypes CG + GG.	27738808
chr21	36072674	36072675	C	A,T	rs20572	CBR1	Allele T is associated with increased concentrations of doxorubicin in women with Breast Neoplasms as compared to allele C.	38491961
chr21	36073014	36073015	G	A,C	rs9024	CBR1	Genotype GG is associated with increased clearance of doxorubicin in people with Breast Neoplasms as compared to genotype AG.	19016765
chr21	37645859	37645860	T	C,G	rs2835859	KCNJ6	Genotype TT is associated with increased dose of fentanyl in people with Pain, Postoperative as compared to genotypes CC + CT.	25615449
chr21	37714661	37714662	T	A,C	rs2070995	KCNJ6	Genotype TT is associated with increased dose of methadone in people with Substance-Related Disorders as compared to genotypes CC + CT.	20220551
chr21	37917642	37917643	C	G,T	rs6517442	KCNJ6	Genotype CC is associated with increased dose of opioids in people with Low Back Pain as compared to genotypes CT + TT.	31269327
chr21	39371918	39371919	T	C	rs3761372		Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr21	42278704	42278705	A	C,G,T	rs182694	ABCG1	Allele A is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.	24192121
chr21	43061780	43061781	G	A	rs4920037	CBS	Genotypes AA + AG are associated with increased metabolism of Arsenic compounds as compared to genotype GG.	20670920
chr21	43066853	43066854	C	T	rs234709	CBS	Genotypes CT + TT are associated with increased metabolism of Arsenic compounds as compared to genotype CC.	20670920
chr21	43687680	43687681	T	A,C	rs9306160	RRP1B	Allele T is associated with increased response to atenolol in people with Hypertension as compared to allele C.	31327267
chr21	45512413	45512414	G	A	rs7499	SLC19A1	Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.	31099054
chr21	45512703	45512704	G	A,C,T	rs17004785	SLC19A1	Genotype CG is associated with increased clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.	35446233
chr21	45514946	45514947	A	C	rs1051296	SLC19A1	Genotypes AC + CC are associated with decreased concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.	24927955
chr21	45525109	45525110	A	C,G,T	rs2838956	SLC19A1	Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.	31099054
chr21	45528652	45528653	G	A,C	rs2838958	SLC19A1	Genotypes AG + GG are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.	28525903
chr21	45531641	45531642	A	C,G,T	rs12659	SLC19A1	Allele A is associated with decreased response to carboplatin, cisplatin and fluorouracil in people with Uterine Cervical Neoplasms as compared to allele G.	16875718
chr21	45536656	45536657	A	G	rs3788200	SLC19A1	Genotypes AG + GG are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.	28525903
chr21	45537879	45537880	T	C,G	rs1051266	SLC19A1	Genotype CT is associated with decreased response to methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype TT.	27409003
chr21	45538001	45538002	G	A,C,T	rs1131596	SLC19A1	Genotypes AG + GG are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.	28525903
chr22	17084144	17084145	G	A,C	rs4819554	IL17RA	Genotype AA is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotypes AG + GG.	27670766
chr22	17108318	17108319	C	A,T	rs879577	IL17RA	Allele T is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to allele C.	27670766
chr22	18994049	18994050	T	C	rs1210638	DGCR5	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.	25897834
chr22	19932835	19932836	C	A,G,T	rs9606186	COMT	Allele C is not associated with response to risperidone in people with Schizophrenia as compared to allele G.	28696411
chr22	19940568	19940569	G	A,C,T	rs2075507	COMT	Allele G is associated with decreased dose of morphine in people with Neoplasms as compared to allele A.	19094200
chr22	19941360	19941361	C	T	rs2020917	COMT	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr22	19941503	19941504	C	T	rs13306278	COMT	Genotype CT is not associated with exposure to olanzapine in healthy individuals as compared to genotype CC.	33378980
chr22	19942585	19942586	T	A,C	rs737866	COMT	Allele T is associated with decreased dose of morphine in people with Neoplasms as compared to allele C.	19094200
chr22	19942597	19942598	A	G,T	rs737865	COMT	Genotype AA is associated with decreased response to bupropion in smokers as compared to genotypes AG + GG.	16876132
chr22	19943883	19943884	T	A,C	rs933271	COMT	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr22	19944452	19944453	T	C,G	rs7287550	COMT	Allele C is associated with decreased dose of morphine in people with Neoplasms as compared to allele T.	19094200
chr22	19946527	19946528	T	C	rs174675	COMT	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr22	19950009	19950010	T	C,G	rs5993882	COMT	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr22	19950114	19950115	T	G	rs5993883	COMT	Allele T is associated with decreased response to quetiapine in people with Schizophrenia as compared to allele G.	26282453
chr22	19955473	19955474	A	G	rs5746849	COMT	Allele A is associated with decreased dose of morphine in people with Neoplasms as compared to allele G.	19094200
chr22	19957653	19957654	A	G	rs740603	COMT	Allele A is associated with decreased dose of morphine in people with Neoplasms as compared to allele G.	19094200
chr22	19960813	19960814	T	C	rs4646312	COMT	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr22	19961489	19961490	C	T	rs165722	COMT	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr22	19962428	19962429	A	G,T	rs6269	COMT	Genotype GG is associated with decreased response to butorphanol in healthy individuals as compared to genotypes AA + AG.	31806881
chr22	19962711	19962712	C	T	rs4633	COMT	Genotype CC is associated with decreased response to butorphanol in healthy individuals as compared to genotypes CT + TT.	31806881
chr22	19962904	19962905	A	G	rs2239393	COMT	Allele A is associated with decreased dose of morphine in people with Neoplasms as compared to allele G.	19094200
chr22	19963683	19963684	C	G,T	rs4818	COMT	Allele G is not associated with response to butorphanol in healthy individuals as compared to allele C.	31806881
chr22	19963747	19963748	G	A	rs4680	COMT	Genotype GG is associated with increased response to modafinil in people with methamphetamine dependence as compared to genotypes AA + AG.	22217949
chr22	19965037	19965038	G	A	rs165774	COMT	Allele G is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.	26902643
chr22	19966934	19966935	C	T	rs174699	ARVCF	Allele T is associated with decreased dose of morphine in people with Neoplasms as compared to allele C.	19094200
chr22	19969257	19969258	G	A,C	rs165599	COMT	Genotypes AA + AG are associated with increased response to bupropion in smokers as compared to genotype GG.	16876132
chr22	19969499	19969500	C	A,G,T	rs165728	ARVCF	Allele T is associated with decreased dose of morphine in people with Neoplasms as compared to allele C.	19094200
chr22	19971949	19971950	C	A,G,T	rs165815	COMT	Genotypes CT + TT are not associated with response to antipsychotics in people with Schizophrenia as compared to genotype CC.	27287786
chr22	20813498	20813499	G	A	rs165854	PI4KA	Genotypes AG + GG is associated with decreased response to antipsychotics in people with Schizophrenia.	25209194
chr22	21760714	21760715	C	A,G	rs6928	MAPK1	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele G.	23537502
chr22	21761596	21761597	C	T	rs13515	MAPK1	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	23537502
chr22	21807836	21807837	A	G	rs3729910	MAPK1	Allele G is associated with increased response to glibenclamide in people with as compared to allele A.	27403931
chr22	21850503	21850504	G	A	rs8136867	MAPK1	Allele A is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele G.	23537502
chr22	23075490	23075491	A	G	rs3788339	GNAZ	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr22	23285181	23285182	A	G,T	rs140504	BCR	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	21047205
chr22	24406595	24406596	G	A,C,T	rs5751862	ADORA2A	Allele A is not associated with response to regadenoson as compared to allele G.	28358597
chr22	24429542	24429543	C	A,G,T	rs2298383	ADORA2A	Allele T is not associated with response to regadenoson as compared to allele C.	28358597
chr22	24430703	24430704	T	A,C	rs3761422	ADORA2A	Allele T is not associated with response to regadenoson as compared to allele C.	28358597
chr22	24434626	24434627	T	C,G	rs2267076	ADORA2A	Allele T is not associated with response to regadenoson as compared to allele C.	28358597
chr22	24440055	24440056	T	C	rs2236624	ADORA2A	Allele T is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	32448869
chr22	24441332	24441333	T	C	rs5751876	ADORA2A	Allele T is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid.	19902562
chr22	24444707	24444708	C	A,T	rs17004921	ADORA2A-AS1	Genotypes CT + TT are associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	32448869
chr22	28800768	28800769	G	A,C,T	rs2269577	XBP1	Genotype CG is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	23510626
chr22	36700881	36700882	T	C,G	rs2284017	CACNG2	Allele C is associated with increased response to lithium in people with Bipolar Disorder as compared to allele T.	18408563
chr22	36701518	36701519	C	G,T	rs2284018	CACNG2	Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder as compared to genotypes CC + CT.	18408563
chr22	36860803	36860804	G	A,C,T	rs1883112	NCF4	Genotype AA is associated with increased response to idarubicin in people with Leukemia, Myeloid, Acute as compared to genotype GG.	28485375
chr22	37148769	37148770	G	A	rs3218253	IL2RB	Allele A is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	23007924
chr22	37236729	37236730	T	A,G	rs13058338	RAC2	Genotype AT is associated with increased response to idarubicin in people with Leukemia, Myeloid, Acute as compared to genotype TT.	28485375
chr22	39570850	39570851	C	T	rs3747178	CACNA1I	Allele T is associated with decreased clinical benefit to ethosuximide in children with Epilepsy as compared to allele C.	28165634
chr22	40831081	40831082	C	A,G	rs138335	ST13	Allele G is associated with decreased response to corticosteroids in children with Asthma as compared to allele C.	25616159
chr22	40835048	40835049	A	G	rs138337	ST13	Allele G is associated with decreased response to corticosteroids in children with Asthma as compared to allele A.	25616159
chr22	41682661	41682662	A	G	rs6519270	SNU13	Allele G is associated with increased concentrations of vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hodgkin Disease, Rhabdomyosarcoma, Medulloblastoma or Glioma as compared to allele A.	35884569
chr22	41880737	41880738	G	C	rs2228314	SREBF2	Genotype GG is not associated with response to simvastatin in people with Hypercholesterolemia as compared to genotypes CC + CG.	16158080
chr22	41992821	41992822	A	G	rs56234624	SEPTIN3	Allele G is associated with increased concentrations of metoprolol as compared to allele A.	37307170
chr22	42016706	42016707	G	A,T	rs5758550	WBP2NL	Allele A is associated with decreased clearance of risperidone as compared to allele G.	38963454
chr22	42108674	42108675	A	G	rs6002616		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr22	42126389	42126390	G	A,C	rs28371738	CYP2D6	Allele A is associated with increased concentrations of alpha-hydroxymetoprolol as compared to allele G.	37307170
chr22	42128944	42128945	C	T	rs3892097	CYP2D6	Genotype CC is associated with increased response to fluoxetine in men with Alcoholism and Depressive Disorder, Major as compared to genotype CT.	34529603
chr22	42129769	42129770	G	A,C,T	rs28371706	CYP2D6	Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV Infections as compared to genotype GG.	22111602
chr22	42129818	42129819	G	T	rs28371703	CYP2D6	Genotype GT is associated with increased half-life time of fluoxetine in healthy individuals as compared to genotype GG.	37763120
chr22	42130691	42130692	G	A,C	rs1065852	CYP2D6	Allele A is associated with decreased clearance of alpha-hydroxymetoprolol in healthy individuals as compared to allele G.	10223777
chr22	42131288	42131289	G	A,T	rs74966855	CYP2D6	Genotype TT is not associated with metabolism of dextromethorphan as compared to genotype GG.	25141893
chr22	42171083	42171084	T	C	rs9306356		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr22	42213141	42213142	T	C	rs5758651	TCF20	Allele C is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.	38637968
chr22	42516090	42516091	C	G,T	rs11553441	RRP7A	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr22	43001029	43001030	C	T	rs2413739	PACSIN2	Genotype CC is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes CT + TT.	29683944
chr22	43928846	43928847	C	A,G,T	rs738409	PNPLA3	Genotypes CG + GG is associated with increased clinical benefit to alogliptin in people with Diabetes Mellitus, Type 2, Fatty liver disease and Body Weight Changes as compared to genotype CC.	26147768
chr22	46202409	46202410	A	C,G	rs4823613	PPARA	Allele G is associated with decreased metabolism of tacrolimus in people with Kidney Transplantation as compared to allele A.	24658827
chr22	46214169	46214170	G	A	rs4253728	PPARA	Genotype AA is not associated with metabolism of cyclosporine in people with Kidney Transplantation as compared to allele G.	24658827
chr22	46214511	46214512	A	G	rs4253730	PPARA	Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.	29318894
chr22	46218376	46218377	C	G	rs1800206	PPARA	Allele C is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to allele G.	12042669
chr22	46219982	46219983	T	A,C	rs1800234	PPARA	Genotypes CC + CT is associated with decreased clinical benefit to chiglitazar in people with Diabetes Mellitus, Type 2 as compared to genotype TT.	39555806
chr22	46234736	46234737	G	C,T	rs4253778	PPARA	Genotype GG is associated with increased response to fenofibrate in people with Diabetes Mellitus as compared to genotypes CC + CG.	15608561
chr22	47888764	47888765	G	A	rs9627183		Allele G is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.	18821564
chr22	50525806	50525807	G	A,C,T	rs11479	TYMP	Genotypes AA + AG is associated with dose of capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype GG.	24167597
chr22	50528484	50528485	T	A,C,G	rs470119	IMPDH2	Allele T is not associated with response to fluorouracil in people with Colonic Neoplasms as compared to allele C.	20665215
chr22	50625987	50625988	T	C	rs2071421	ARSA	Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr22_GL383582v2_alt	31019	31020	A	G	rs6002616		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr22_GL383582v2_alt	81266	81267	T	C	rs9306356		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr22_GL383582v2_alt	123337	123338	T	C	rs5758651	TCF20	Allele C is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.	38637968
chr22_KB663609v1_alt	31019	31020	A	G	rs6002616		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr22_KB663609v1_alt	48716	48717	A	G,C	rs28371738	CYP2D6	Allele A is associated with increased concentrations of alpha-hydroxymetoprolol as compared to allele G.	37307170
chr22_KB663609v1_alt	51271	51272	T	C	rs3892097	CYP2D6	Genotype CC is associated with increased response to fluoxetine in men with Alcoholism and Depressive Disorder, Major as compared to genotype CT.	34529603
chr22_KB663609v1_alt	52096	52097	G	A,C,T	rs28371706	CYP2D6	Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV Infections as compared to genotype GG.	22111602
chr22_KB663609v1_alt	52145	52146	G	T	rs28371703	CYP2D6	Genotype GT is associated with increased half-life time of fluoxetine in healthy individuals as compared to genotype GG.	37763120
chr22_KB663609v1_alt	53018	53019	A	G,C	rs1065852	CYP2D6	Allele A is associated with decreased clearance of alpha-hydroxymetoprolol in healthy individuals as compared to allele G.	10223777
chr22_KB663609v1_alt	53615	53616	G	A,T	rs74966855	CYP2D6	Genotype TT is not associated with metabolism of dextromethorphan as compared to genotype GG.	25141893
chr22_KI270877v1_alt	81597	81598	G	A,C,T	rs1883112	NCF4	Genotype AA is associated with increased response to idarubicin in people with Leukemia, Myeloid, Acute as compared to genotype GG.	28485375
chr22_KI270928v1_alt	31019	31020	A	G	rs6002616		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr22_KI270928v1_alt	48730	48731	G	A,C	rs28371738	CYP2D6	Allele A is associated with increased concentrations of alpha-hydroxymetoprolol as compared to allele G.	37307170
chr22_KI270928v1_alt	51285	51286	C	T	rs3892097	CYP2D6	Genotype CC is associated with increased response to fluoxetine in men with Alcoholism and Depressive Disorder, Major as compared to genotype CT.	34529603
chr22_KI270928v1_alt	52110	52111	G	A,C,T	rs28371706	CYP2D6	Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV Infections as compared to genotype GG.	22111602
chr22_KI270928v1_alt	52159	52160	G	T	rs28371703	CYP2D6	Genotype GT is associated with increased half-life time of fluoxetine in healthy individuals as compared to genotype GG.	37763120
chr22_KI270928v1_alt	53032	53033	G	A,C	rs1065852	CYP2D6	Allele A is associated with decreased clearance of alpha-hydroxymetoprolol in healthy individuals as compared to allele G.	10223777
chr22_KI270928v1_alt	53629	53630	G	A,T	rs74966855	CYP2D6	Genotype TT is not associated with metabolism of dextromethorphan as compared to genotype GG.	25141893
chr22_KI270928v1_alt	93428	93429	T	C	rs9306356		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr22_KI270928v1_alt	135486	135487	T	C	rs5758651	TCF20	Allele C is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.	38637968
chr22_KN196485v1_alt	23636	23637	A	G	rs6002616		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr22_KN196485v1_alt	73887	73888	T	C	rs9306356		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr22_KN196485v1_alt	115945	115946	T	C	rs5758651	TCF20	Allele C is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.	38637968
chr22_KN196486v1_alt	11955	11956	A	G,C	rs28371738	CYP2D6	Allele A is associated with increased concentrations of alpha-hydroxymetoprolol as compared to allele G.	37307170
chr22_KN196486v1_alt	14510	14511	C	T	rs3892097	CYP2D6	Genotype CC is associated with increased response to fluoxetine in men with Alcoholism and Depressive Disorder, Major as compared to genotype CT.	34529603
chr22_KN196486v1_alt	15335	15336	G	A,C,T	rs28371706	CYP2D6	Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV Infections as compared to genotype GG.	22111602
chr22_KN196486v1_alt	15384	15385	G	T	rs28371703	CYP2D6	Genotype GT is associated with increased half-life time of fluoxetine in healthy individuals as compared to genotype GG.	37763120
chr22_KN196486v1_alt	16257	16258	A	G,C	rs1065852	CYP2D6	Allele A is associated with decreased clearance of alpha-hydroxymetoprolol in healthy individuals as compared to allele G.	10223777
chr22_KN196486v1_alt	16854	16855	G	A,T	rs74966855	CYP2D6	Genotype TT is not associated with metabolism of dextromethorphan as compared to genotype GG.	25141893
chr22_KN196486v1_alt	70352	70353	T	C	rs9306356		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr22_KN196486v1_alt	112410	112411	T	C	rs5758651	TCF20	Allele C is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.	38637968
chr22_KQ458387v1_alt	13393	13394	A	G	rs6002616		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr22_KQ458387v1_alt	73257	73258	T	C	rs9306356		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr22_KQ458387v1_alt	115313	115314	T	C	rs5758651	TCF20	Allele C is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.	38637968
chr22_KQ458388v1_alt	2281	2282	A	G	rs6002616		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr22_KQ458388v1_alt	19978	19979	A	G,C	rs28371738	CYP2D6	Allele A is associated with increased concentrations of alpha-hydroxymetoprolol as compared to allele G.	37307170
chr22_KQ458388v1_alt	22533	22534	C	T	rs3892097	CYP2D6	Genotype CC is associated with increased response to fluoxetine in men with Alcoholism and Depressive Disorder, Major as compared to genotype CT.	34529603
chr22_KQ458388v1_alt	23358	23359	G	A,C,T	rs28371706	CYP2D6	Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV Infections as compared to genotype GG.	22111602
chr22_KQ458388v1_alt	23407	23408	G	T	rs28371703	CYP2D6	Genotype GT is associated with increased half-life time of fluoxetine in healthy individuals as compared to genotype GG.	37763120
chr22_KQ458388v1_alt	24280	24281	A	G,C	rs1065852	CYP2D6	Allele A is associated with decreased clearance of alpha-hydroxymetoprolol in healthy individuals as compared to allele G.	10223777
chr22_KQ458388v1_alt	24877	24878	G	A,T	rs74966855	CYP2D6	Genotype TT is not associated with metabolism of dextromethorphan as compared to genotype GG.	25141893
chr22_KQ458388v1_alt	92074	92075	T	C	rs9306356		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr22_KQ458388v1_alt	134132	134133	T	C	rs5758651	TCF20	Allele C is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.	38637968
chr22_KQ759761v1_alt	4130	4131	A	G,C	rs28371738	CYP2D6	Allele A is associated with increased concentrations of alpha-hydroxymetoprolol as compared to allele G.	37307170
chr22_KQ759761v1_alt	6685	6686	T	C	rs3892097	CYP2D6	Genotype CC is associated with increased response to fluoxetine in men with Alcoholism and Depressive Disorder, Major as compared to genotype CT.	34529603
chr22_KQ759761v1_alt	7510	7511	G	A,C,T	rs28371706	CYP2D6	Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV Infections as compared to genotype GG.	22111602
chr22_KQ759761v1_alt	7559	7560	T	G	rs28371703	CYP2D6	Genotype GT is associated with increased half-life time of fluoxetine in healthy individuals as compared to genotype GG.	37763120
chr22_KQ759761v1_alt	8432	8433	A	G,C	rs1065852	CYP2D6	Allele A is associated with decreased clearance of alpha-hydroxymetoprolol in healthy individuals as compared to allele G.	10223777
chr22_KQ759761v1_alt	9029	9030	G	A,T	rs74966855	CYP2D6	Genotype TT is not associated with metabolism of dextromethorphan as compared to genotype GG.	25141893
chr22_KQ759761v1_alt	62488	62489	T	C	rs9306356		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr22_KQ759761v1_alt	104545	104546	T	C	rs5758651	TCF20	Allele C is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.	38637968
chr2_KN538363v1_fix	195530	195531	C	A,G,T	rs10210302	ATG16L1	Genotypes CT + TT is associated with increased response to adalimumab in people with Crohn Disease as compared to genotype CC.	25712183
chr2_KN538363v1_fix	220059	220060	A	G	rs2241880	ATG16L1	Genotypes AG + GG is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.	39159789
chr3	195075	195076	C	G,T	rs1516338	CHL1	Genotype TT is associated with increased response to antidepressants in people with Bipolar Disorder, Depressive Disorder or Depressive Disorder, Major as compared to genotype CC.	25943212
chr3	2423406	2423407	A	C,G,T	rs17194378	CNTN4	Allele A is associated with response to ziprasidone in people with Schizophrenia.	22920393
chr3	6992861	6992862	G	C,T	rs2069062	GRM7	Genotype CC is associated with increased response to risperidone in people with as compared to genotypes CG + GG.	26905411
chr3	7625096	7625097	C	T	rs3792452	GRM7	Allele T is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.	28871191
chr3	9757088	9757089	C	G,T	rs1052133	OGG1	Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele C.	28796378
chr3	9757428	9757429	A	G	rs293795	OGG1	Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.	28796378
chr3	9918385	9918386	C	T	rs708567	IL17RC	Genotype CC is associated with increased clinical benefit to tildrakizumab in people with Psoriasis as compared to genotypes CT + TT.	39081053
chr3	11055172	11055173	G	A,C,T	rs2933304		Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr3	11224227	11224228	G	A	rs13064530	HRH1	Allele G is not associated with response to clozapine in people with Schizophrenia as compared to allele A.	22722500
chr3	11249928	11249929	A	C,G,T	rs2606731	HRH1	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	11250995	11250996	C	G,T	rs346076	HRH1	Allele T is not associated with dose of opioids in people with Pain as compared to allele C.	21398039
chr3	11259020	11259021	T	C	rs901865	HRH1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	11262187	11262188	T	A,C	rs346070	HRH1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	12351625	12351626	C	G,T	rs1801282	PPARG	Genotype CG is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	23147557
chr3	14145948	14145949	G	C,T	rs2228001	XPC	Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele T.	28796378
chr3	14178522	14178523	G	C,T	rs1870134	XPC	Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr3	14801651	14801652	C	A,G,T	rs294610		Allele A is associated with increased response to atenolol or metoprolol in people with Hypertension as compared to allele C.	31033190
chr3	21753381	21753382	C	G,T	rs4261893	ZNF385D	Genotype TT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes CC + CT.	28696415
chr3	21753430	21753431	C	A,G,T	rs9873889	ZNF385D	Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr3	21754287	21754288	C	G,T	rs9879065	ZNF385D	Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr3	21756082	21756083	T	G	rs9310657	ZNF385D	Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr3	21756083	21756084	C	T	rs9310658	ZNF385D	Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr3	21756202	21756203	G	A,C,T	rs7616119	ZNF385D	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr3	21756948	21756949	A	C,G,T	rs7653345	ZNF385D	Allele A is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr3	21757050	21757051	G	A,C,T	rs9819548	ZNF385D	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr3	21757154	21757155	T	A,C,G	rs13093500	ZNF385D	Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr3	21757420	21757421	G	A,C	rs12630569	ZNF385D	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr3	21757834	21757835	G	A,C,T	rs9824595	ZNF385D	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr3	21757935	21757936	T	A,C,G	rs4334661	ZNF385D	Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr3	23132387	23132388	G	A	rs7625956		Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr3	23132841	23132842	G	A,C	rs4858478		Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr3	27715526	27715527	G	C,T	rs2371108	EOMES	Allele T is associated with increased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.	29095108
chr3	30420910	30420911	G	A,T	rs7640543		Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele G.	31014225
chr3	30845324	30845325	C	T	rs17026688	GADL1	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	24369049
chr3	32259859	32259860	T	C	rs4627790	CMTM8	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr3	39492989	39492990	A	G	rs616147	MOBP	Genotypes AA + AG are associated with increased response to creatine in people with Amyotrophic Lateral Sclerosis as compared to genotype GG.	31624333
chr3	41200846	41200847	C	A,T	rs4533622	CTNNB1	Genotype AA is associated with increased response to thalidomide in people with Multiple Myeloma as compared to genotypes AC + CC.	26521987
chr3	41237948	41237949	A	G	rs4135385	CTNNB1	Genotype AA is associated with increased response to cyclophosphamide, dexamethasone and thalidomide in people with Multiple Myeloma as compared to genotypes AG + GG.	26521987
chr3	46373452	46373487	ACAGTCAGTATCAATTCTGGAAGAATTTCCAGACA	ACA	rs333	CCR5	Allele del is associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele GTCAGTATCAATTCTGGAAGAATTTCCAGACA.	22111603
chr3	46941246	46941247	T	A,C	rs4682844	CCDC12	Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.	37098852
chr3	47418188	47418189	C	A,T	rs12487736	SCAP	Allele T is not associated with response to fluvastatin in people with Coronary Artery Disease as compared to allele C.	12436350
chr3	48695412	48695413	G	A	rs61740999	IP6K2	Genotype AG is associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to genotype GG.	38637968
chr3	49026676	49026677	A	G	rs11706052	IMPDH2	Genotype AA is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes AG + GG.	29683944
chr3	49357400	49357401	G	A	rs1050450	GPX1	Allele G is not associated with response to clozapine in people with Schizophrenia as compared to allele A.	19946932
chr3	49368661	49368662	G	A,T	rs11716445	RHOA	Allele A is associated with decreased response to pravastatin or simvastatin in people with Hypercholesterolemia as compared to allele G.	23166513
chr3	50332114	50332115	C	A	rs2073498	RASSF1	Genotypes AA + AC is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to genotype CC.	27698403
chr3	52224355	52224356	T	A,C,G	rs352139	TLR9	Genotype TT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease or Inflammatory Bowel Diseases as compared to genotypes CC + CT.	24776844
chr3	52799202	52799203	G	A,C	rs2535629	ITIH3	Genotype AA is associated with increased response to clozapine in people with Schizophrenia as compared to genotypes AG + GG.	27396837
chr3	53517874	53517875	A	C,G,T	rs312481	CACNA1D	Genotype GG is associated with increased clinical benefit to amlodipine in people with Hypertension as compared to genotypes AA + AG.	39492848
chr3	53842190	53842191	A	G	rs6801605	CHDH	Allele A is associated with increased clinical benefit to acamprosate in people with Alcoholism as compared to allele G.	38852760
chr3	54220101	54220102	G	A	rs4505744	CACNA2D3	Genotype AA is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype GG.	30032160
chr3	54365580	54365581	T	A,C	rs7427395	CACNA2D3	Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT.	30032160
chr3	54544777	54544778	G	A	rs11130424	CACNA2D3	Genotypes AG + GG is associated with increased resistance to radiotherapy in people with Nasopharyngeal Neoplasms as compared to genotype AA.	36624463
chr3	54940130	54940131	T	A,C,G	rs6806020		Allele C is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T.	19749758
chr3	59771848	59771849	T	A,C,G	rs49411	FHIT	Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	27091189
chr3	60113240	60113241	C	T	rs760316	FHIT	Allele C is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele T.	27001119
chr3	60424453	60424454	A	G	rs241692	FHIT	Allele G is not associated with response to bevacizumab and ranibizumab in people with as compared to allele A.	29852030
chr3	88809890	88809891	A	G	rs13093031		Genotype GG is associated with increased response to fentanyl in people with Pain, Postoperative as compared to genotypes AA + AG.	29502940
chr3	98140849	98140850	T	C	rs35123024		Allele C is associated with decreased response to atenolol and hydrochlorothiazide in people with Hypertension as compared to allele T.	29097388
chr3	111506077	111506078	C	A,T	rs9828223		Allele T is associated with decreased response to adalimumab in people with Crohn Disease as compared to allele C.	31043678
chr3	113327792	113327793	A	G	rs13064411	CFAP44	Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to genotype AA.	25602530
chr3	114127165	114127166	T	A,G	rs2399496	DRD3	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	114128260	114128261	T	A,C	rs9817063	DRD3	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	114128435	114128436	T	A,C	rs3732790	DRD3	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	114144039	114144040	G	A,C	rs963468	DRD3	Genotype GG is associated with decreased response to duloxetine in people with Anxiety Disorders as compared to genotypes AA + AG.	22249355
chr3	114150487	114150488	C	A,G,T	rs3773679	DRD3	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	114157427	114157428	G	A,C,T	rs167771	DRD3	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr3	114160714	114160715	G	A,C	rs167770	DRD3	Genotype AG is associated with decreased response to duloxetine in people with Anxiety Disorders as compared to genotypes AA + GG.	22249355
chr3	114166547	114166548	T	C	rs324023	DRD3	Genotype CT is associated with decreased response to duloxetine in people with Anxiety Disorders as compared to genotypes CC + TT.	22249355
chr3	114171967	114171968	C	T	rs6280	DRD3	Genotypes CC + CT is associated with increased response to risperidone in children with Autistic Disorder as compared to genotype TT.	19997080
chr3	114172194	114172195	C	T	rs324026	DRD3	Genotypes CC + CT are associated with decreased response to duloxetine in people with Anxiety Disorders as compared to genotype TT.	22249355
chr3	119778197	119778198	G	A,T	rs7643038	NR1I2	Allele G is associated with decreased metabolism of methotrexate in children with Osteosarcoma as compared to allele A.	27566582
chr3	119780659	119780660	T	A,C,G	rs1523130	NR1I2	Allele C is not associated with concentrations of atazanavir in people with HIV Infections as compared to allele T.	18831695
chr3	119781187	119781188	C	T	rs3814055	NR1I2	Genotype TT is associated with decreased metabolism of temsirolimus in people with Urinary Bladder Neoplasms as compared to genotypes CC + CT.	28676933
chr3	119782191	119782192	C	A	rs1523127	NR1I2	Genotypes AA + AC is associated with decreased response to efavirenz or nevirapine in people with HIV Infections as compared to genotype CC.	34504302
chr3	119782459	119782460	G	A	rs2276706	NR1I2	Genotype GG is associated with decreased metabolism of repaglinide in men as compared to genotype AA.	23807564
chr3	119782550	119782558	AGGAGAAG	AG,AGGAGAAGGAGAAG	rs3842689	NR1I2	Genotype del/del is associated with increased resistance to corticosteroids in children with as compared to genotype GAGAAG/GAGAAG.	27377607
chr3	119785533	119785534	G	A,C,T	rs10934498	NR1I2	Genotype AA is associated with decreased exposure to irinotecan in people with Colonic Neoplasms as compared to genotypes AG + GG.	27116457
chr3	119799569	119799570	C	G,T	rs2472677	NR1I2	Genotype TT is associated with decreased concentrations of atazanavir in people with HIV Infections as compared to genotypes CC + CT.	18831695
chr3	119802207	119802208	T	C,G	rs13059232	NR1I2	Allele C is not associated with metabolism of cyclophosphamide in people with as compared to allele T.	26456622
chr3	119805243	119805244	G	A,C,T	rs4688040	NR1I2	Allele T is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to allele G.	23252947
chr3	119805803	119805804	A	C,G	rs2461817	NR1I2	Genotype CC is associated with increased concentrations of midazolam in people with respiratory failure requiring assisted ventilation as compared to genotypes AA + AC.	40066084
chr3	119806649	119806650	A	G	rs7643645	NR1I2	Allele G is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to allele A.	23252947
chr3	119807524	119807525	G	A	rs1464602	NR1I2	Genotype GG is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype AA.	23173844
chr3	119810031	119810032	C	T	rs12721616	NR1I2	Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.	30100615
chr3	119812010	119812011	G	A	rs3732357	NR1I2	Genotypes AA + AG is associated with decreased exposure to rifampin in people with Tuberculosis as compared to genotype GG.	38543282
chr3	119813804	119813805	A	C,G,T	rs2472682	NR1I2	Allele C is not associated with dose of warfarin as compared to allele A.	29298995
chr3	119815305	119815306	C	G,T	rs2276707	NR1I2	Genotypes CT + TT is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to genotype CC.	25271728
chr3	119817581	119817582	G	A	rs3732359	NR1I2	Genotype GG is associated with increased concentrations of voriconazole as compared to genotype AA.	31932875
chr3	119817733	119817734	C	G,T	rs3732360	NR1I2	Genotype CC is not associated with concentrations of efavirenz in people with HIV Infections as compared to genotypes CT + TT.	26779253
chr3	119817870	119817871	C	T	rs1054190	NR1I2	Genotype CC is not associated with concentrations of efavirenz in people with HIV Infections as compared to genotypes CT + TT.	26779253
chr3	119818049	119818050	G	A,C	rs1054191	NR1I2	Genotype GG is not associated with concentrations of efavirenz in people with HIV Infections as compared to genotypes AA + AG.	26779253
chr3	119818406	119818407	A	C,T	rs3814057	NR1I2	Genotype CC is associated with increased concentrations of voriconazole as compared to genotypes AA + AC.	31932875
chr3	119818443	119818444	T	C	rs3814058	NR1I2	Genotype CC is associated with decreased metabolism of repaglinide in men as compared to genotype TT.	23807564
chr3	119823449	119823450	A	C,G	rs3732361	GSK3B	Allele A is associated with increased concentrations of methotrexate in children with Osteosarcoma as compared to allele G.	27566582
chr3	119912966	119912967	A	C,G,T	rs6438552	GSK3B	Genotype GG is associated with increased response to lithium in people with Bipolar Disorder.	21781277
chr3	120094434	120094435	A	C,G,T	rs334558	GSK3B	Genotype GG is associated with increased response to citalopram and fluoxetine in people with Depressive Disorder, Major as compared to allele A.	18195729
chr3	120096109	120096110	T	A	rs3755557	GSK3B	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	21047205
chr3	121928438	121928439	C	A,G,T	rs1143671	SLC15A2	Genotype TT is associated with decreased dose of warfarin as compared to genotype CC.	29234073
chr3	121929320	121929321	G	A	rs1143672	SLC15A2	Genotype AA is associated with decreased dose of warfarin as compared to genotype GG.	29234073
chr3	122715082	122715083	G	A,C	rs10433340	PARP14	Allele A is associated with increased concentrations of 6-hydroxy s-warfarin in people with Atrial Fibrillation, venous thromboembolism or Heart Valve Diseases as compared to allele G.	36210801
chr3	124737894	124737895	G	A,C	rs1801019	UMPS	Allele C is not associated with response to fluorouracil in people with Colonic Neoplasms as compared to allele G.	20665215
chr3	124740090	124740091	T	A	rs2291078	UMPS	Allele A is associated with decreased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele T.	25372392
chr3	124743976	124743977	A	G	rs3772809	UMPS	Allele G is associated with decreased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele A.	25372392
chr3	124744111	124744112	A	G	rs3772810	UMPS	Allele G is associated with decreased response to capecitabine and fluorouracil in people with Neoplasm Metastasis as compared to allele A.	25372392
chr3	126146922	126146923	C	A,G	rs2886059	ALDH1L1	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr3	126543248	126543249	G	A,C	rs1054097	CHST13	Allele C is associated with increased response to glibenclamide in people with as compared to allele G.	27403931
chr3	128806409	128806410	C	T	rs4548	RAB7A	Genotype CT is associated with increased exposure to vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hodgkin Disease, Rhabdomyosarcoma, Medulloblastoma or Glioma as compared to genotype CC.	35884569
chr3	129796284	129796285	G	C,T	rs2811332	TMCC1	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	21961650
chr3	133756877	133756878	C	A,T	rs1799852	TF	Allele T is associated with increased response to adalimumab in people with Crohn Disease as compared to allele C.	27115882
chr3	133822038	133822039	C	T	rs17376019	SRPRB	Genotype CT is associated with decreased concentrations of ethanol in healthy individuals as compared to genotype CC.	31002879
chr3	143592417	143592418	A	G	rs4839603	SLC9A9	Genotype GG is associated with decreased dose of fentanyl or remifentanil in people with Pain as compared to genotypes AA + AG.	29207912
chr3	148697099	148697100	T	A	rs275651	AGTR1	Genotypes AA + AT is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype TT.	27021566
chr3	148714581	148714582	A	C,G,T	rs2640543	AGTR1	Genotype GG is associated with response to benazepril in women with Hypertension as compared to genotype AA.	21449848
chr3	148741607	148741608	C	G,T	rs5182	AGTR1	Genotypes CC + CT is associated with decreased response to perindopril in people with Coronary Artery Disease as compared to genotype TT.	27021566
chr3	148742200	148742201	A	C	rs5186	AGTR1	Genotype AA is associated with decreased response to perindopril in people with Hypertension as compared to genotypes AC + CC.	8952600
chr3	149669893	149669894	G	A	rs3811715	WWTR1	Genotype GG is not associated with response to cetuximab in people with Colorectal Neoplasms as compared to genotypes AA + AG.	27698403
chr3	151337856	151337857	T	C	rs16846673	P2RY12	Genotype TT is not associated with decreased response to clopidogrel as compared to genotype CC.	26362473
chr3	151338809	151338810	A	C,G,T	rs6809699	P2RY12	Genotype AA is not associated with response to clopidogrel in people with Carotid Artery Diseases as compared to genotypes AC + CC.	26526111
chr3	151338827	151338828	G	A,T	rs6785930	P2RY12	Genotype GG is associated with decreased response to ticagrelor in healthy individuals as compared to genotype AG.	26083990
chr3	151339853	151339854	G	A,C	rs2046934	P2RY12	Allele G is not associated with response to clopidogrel in people with Acute coronary syndrome as compared to allele A.	17337040
chr3	151356834	151356835	T	G	rs7428575	P2RY12	Allele G is not associated with response to clopidogrel in people with Coronary Disease as compared to allele T.	27566695
chr3	151357136	151357137	A	G	rs3732759	P2RY12	Genotype GG is associated with decreased response to clopidogrel in people with Coronary Disease as compared to genotypes AA + AG.	27566695
chr3	151381952	151381953	A	C,G	rs6787801	P2RY12	Genotype AG is associated with decreased response to ticagrelor in healthy individuals as compared to genotype AA.	26083990
chr3	151827812	151827813	G	A,T	rs1803155	AADAC	Genotype GG is associated with decreased exposure to rifampin in people with Tuberculosis as compared to genotypes AA + AG.	38315168
chr3	152836567	152836568	A	G,T	rs701265	P2RY1	Allele G is not associated with response to clopidogrel as compared to allele A.	16581111
chr3	160712080	160712081	A	G	rs7624766		Allele G is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele A.	29743634
chr3	165773491	165773492	C	T	rs1803274	BCHE	Genotype CC is associated with increased response to rivastigmine in people with Alzheimer Disease as compared to genotypes CT + TT.	17047484
chr3	165788068	165788069	T	C	rs1355534	BCHE	Genotype TT is not associated with response to donepezil in people with Alzheimer Disease as compared to genotypes CC + CT.	18780301
chr3	171006939	171006940	C	G,T	rs1499821	SLC2A2	Genotype CC is associated with increased dose-adjusted trough concentrations of tacrolimus in people with lung transplantation as compared to genotypes CT + TT.	38327217
chr3	171007093	171007094	T	C	rs8192675	SLC2A2	Allele C is associated with increased response to metformin in people with Diabetes Mellitus as compared to allele T.	27500523
chr3	171253501	171253502	C	A,T	rs2088885	TNIK	Genotype AA is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes AC + CC.	35698907
chr3	171262185	171262186	T	C,G	rs7627954	TNIK	Genotype CC is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes CT + TT.	35698907
chr3	172524099	172524100	G	A	rs12488654	TNFSF10	Genotype GG is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes AA + AG.	27977511
chr3	176534889	176534890	C	T	rs57449396	TBL1XR1	Allele T is associated with decreased response to allopurinol as compared to allele C.	30924126
chr3	178741876	178741877	T	C	rs9839376	KCNMB2	Genotype CC is associated with decreased response to ritodrine as compared to genotypes CT + TT.	32371615
chr3	178743982	178743983	C	T	rs7624046	KCNMB2	Genotype TT is associated with decreased response to ritodrine as compared to genotypes CC + CT.	32371615
chr3	179156078	179156079	C	T	rs77576241	PIK3CA	Allele T is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele C.	36581799
chr3	179173632	179173633	A	G	rs67562832	PIK3CA	Allele G is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele A.	36581799
chr3	183917090	183917091	T	A,C	rs1533682	ABCC5	Genotype TT is associated with increased clearance of doxorubicin in women with Breast Neoplasms as compared to genotypes CC + CT.	26975227
chr3	183917979	183917980	C	T	rs1000002	ABCC5	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	21449672
chr3	183924514	183924515	G	A	rs8180093	ABCC5	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.	21449672
chr3	183936080	183936081	A	C,G,T	rs2139560	ABCC5	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.	21449672
chr3	183942796	183942797	G	A	rs3749442	ABCC5	Allele A is associated with increased response to glibenclamide in people with as compared to allele G.	27403931
chr3	183972200	183972201	G	A,C	rs3805111	ABCC5	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.	21449672
chr3	183978081	183978082	C	A	rs3792581	ABCC5	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	21449672
chr3	183982422	183982423	C	A,G,T	rs2293001	ABCC5	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	21449672
chr3	184002710	184002711	C	A,G	rs4148572	ABCC5	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	21449672
chr3	184015995	184015996	A	C,G,T	rs4148557	ABCC5	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.	21449672
chr3	184031942	184031943	T	C	rs939334	HTR3D	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	184036240	184036241	T	A,C	rs6792482	HTR3D	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	184036505	184036506	G	A,C,T	rs6443930	HTR3D	Genotype GG is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes CC + CG.	29177570
chr3	184040717	184040718	G	A,T	rs7621975	HTR3D	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr3	184055032	184055033	G	A,C,T	rs6808122	HTR3C	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr3	184056973	184056974	C	A,T	rs6766410	HTR3C	Genotype CC is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes AA + AC.	29177570
chr3	184060221	184060222	G	A,C,T	rs6807362	HTR3C	Genotype GG is not associated with response to granisetron or palonosetron in people with Nausea and Vomiting as compared to genotypes CC + CG.	29177570
chr3	184060509	184060510	G	A	rs6807670	HTR3C	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr3	184099938	184099939	A	G,T	rs6443950	HTR3E	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	184100627	184100628	G	A,C	rs7627615	HTR3E	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr3	184101366	184101367	T	C,G	rs7432211	HTR3E	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr3	184102177	184102178	G	C	rs4912522	HTR3E	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr3	185793898	185793899	G	C,T	rs4402960	IGF2BP2	Genotypes GT + TT are associated with increased response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to genotype GG.	20523342
chr3	185811291	185811292	A	C	rs1470579	IGF2BP2	Genotypes AC + CC are associated with decreased response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to genotype AA.	20523342
chr3	186841635	186841636	A	G	rs16861194	ADIPOQ	Genotype AG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	25405601
chr3	186841684	186841685	C	A,G,T	rs266729	ADIPOQ	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CG + GG.	25405601
chr3	186853102	186853103	T	A,C,G	rs2241766	ADIPOQ	Genotype GT is associated with increased response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	25405601
chr3	186853333	186853334	G	C,T	rs1501299	ADIPOQ	Genotypes GT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	25405601
chr3	186853406	186853407	A	G,T	rs2241767	ADIPOQ	Genotype AA are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes AG + GG.	25405601
chr3	186853696	186853697	T	C	rs3821799	ADIPOQ	Genotypes CT + TT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype CC.	25405601
chr3	186853769	186853770	A	G	rs3774261	ADIPOQ	Genotypes AG + GG are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype AA.	25405601
chr3	186856285	186856286	C	T	rs1063537	ADIPOQ	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	25405601
chr3	186856374	186856375	T	A,C,G	rs2082940	ADIPOQ	Genotype CC are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotypes CT + TT.	25405601
chr3	186856393	186856394	T	C	rs1063538	ADIPOQ	Genotypes CC + CT are not associated with response to pioglitazone in people with Diabetes Mellitus as compared to genotype TT.	25405601
chr3	188227135	188227136	A	C,G,T	rs1975991	LPP	Allele A is associated with decreased exposure to 2-hydroxyatorvastatin, 4-hydroxyatorvastatin, atorvastatin and atorvastatin lactone in healthy individuals as compared to allele G.	38493369
chr3	194361432	194361436	CCCC	CCC	rs11313667	LRRC15	Allele del is associated with increased response to atenolol, hydrochlorothiazide or metoprolol in people with Hypertension as compared to allele C.	26729753
chr4	2904979	2904980	G	A,T	rs4961	ADD1	Allele T is not associated with response to hydrochlorothiazide in people with Essential hypertension as compared to allele G.	14553962
chr4	2988771	2988772	G	A,T	rs2960306	GRK4	Genotype TT is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype GG.	19119263
chr4	3004315	3004316	C	A,G,T	rs1024323	GRK4	Genotype CC is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype TT.	19119263
chr4	3037422	3037423	T	C,G	rs1801058	GRK4	Genotype CT is not associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype CC.	19119263
chr4	3233252	3233253	G	A,T	rs362272	HTT	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr4	3240372	3240373	G	A	rs362306	HTT	Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele G.	28696411
chr4	3241490	3241491	C	G,T	rs362267	HTT	Allele T is associated with decreased response to risperidone in people with Schizophrenia as compared to allele C.	28696411
chr4	3767568	3767588	GGGGGCGGGGCCGGGGGCGG	GGGGGCGG	rs61767072	ADRA2C	Allele del is associated with increased response to Beta Blocking Agents in children with Cardiomyopathy, Dilated as compared to allele GGGGCGGGGCCG.	25406899
chr4	3768062	3768088	GGGGAGCTTTCCCAGAGACCCGGGGA	GGGGAGCTTTCCCAGAGACCCGGGGAGCTTTCCCAGAGACCCGGGGA,GGGGAGCTTTCCCAGAGACCCGGGGAGCTTTCCCAGAGACCCGGGGAGCTTTCCCAGAGACCCGGGGA	rs11269124	ADRA2C	Genotypes GGGGAGCTTTCCCAGAGACCC/del + del/del are associated with increased response to clonidine in people with Liver Cirrhosis as compared to genotype GGGGAGCTTTCCCAGAGACCC/GGGGAGCTTTCCCAGAGACCC.	20833658
chr4	6301626	6301627	G	A,C	rs734312	WFS1	Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.	31014225
chr4	7322868	7322869	C	A,T	rs73208473	SORCS2	Allele A is associated with decreased exposure to atazanavir in women with HIV Infections as compared to allele C.	31562781
chr4	9961140	9961141	T	C	rs11942223	SLC2A9	Allele T is not associated with dose of allopurinol in people with Gout as compared to allele C.	29341237
chr4	10665284	10665285	G	A,T	rs13144136	CLNK	Allele G is associated with increased response to Antihypertensives in people with Hypertension as compared to allele T.	28222112
chr4	14788853	14788854	G	A	rs12502866		Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr4	15400490	15400491	T	A,C	rs10032941	C1QTNF7	Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.	37098852
chr4	15736108	15736109	G	A	rs28404156	BST1	Allele A is associated with increased response to Beta blocking agents, selective in people with Hypertension as compared to allele G.	31423876
chr4	23864715	23864716	T	A,C	rs10213440	PPARGC1A	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	25327507
chr4	24800211	24800212	C	G	rs1799895	SOD3	Allele G is not associated with response to epirubicin, fluorouracil and oxaliplatin in people with Neoplasm Metastasis and Stomach Neoplasms.	25545243
chr4	39413372	39413373	A	G	rs11940694	KLB	Allele A is associated with decreased dose of ethanol as compared to allele G.	27911795
chr4	44919547	44919548	G	A	rs1390913		Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	21961650
chr4	46237986	46237987	A	C,G,T	rs511310		Genotype GG is not associated with decreased response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype AA.	24236484
chr4	46388847	46388848	C	G	rs11503014	GABRA2	Genotype CC is associated with decreased response to propofol as compared to genotypes CG + GG.	28611364
chr4	47227229	47227230	C	A,G	rs16860087	GABRB1	Allele A is associated with increased dose of antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to allele C.	26780210
chr4	47308249	47308250	A	T	rs4627835	GABRB1	Allele T is associated with increased dose of antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to allele A.	26780210
chr4	53933077	53933078	T	C,G	rs871606	CHIC2	Allele T is not associated with response to atenolol in people with Hypertension as compared to allele C.	23087401
chr4	54227863	54227864	C	A,G	rs1800810	PDGFRA	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	30713339
chr4	54228299	54228300	G	A	rs1800813	PDGFRA	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele A.	30713339
chr4	54228461	54228462	G	C,T	rs1800812	PDGFRA	Allele T is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele G.	30713339
chr4	54273603	54273604	T	A,C	rs35597368	PDGFRA	Allele T is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	30713339
chr4	54285872	54285873	C	A,T	rs2228230	PDGFRA	Allele T is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	30713339
chr4	55090668	55090669	G	A,C	rs7671745	KDR	Genotype GG is not associated with response to ranibizumab in people with Macular Degeneration as compared to genotype AA.	22840423
chr4	55106806	55106807	T	A	rs1870377	KDR	Genotypes AA + AT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype TT.	24090479
chr4	55113390	55113391	C	A,T	rs2305948	KDR	Genotypes CT + TT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype CC.	24090479
chr4	55125563	55125564	T	C,G	rs7667298	KDR	Genotypes CC + CT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype TT.	24090479
chr4	55126198	55126199	A	C,G	rs2071559	KDR	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23559864
chr4	55435201	55435202	A	G	rs1801260	CLOCK	Allele G is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele A.	21781277
chr4	55443824	55443825	A	C,G	rs3736544	CLOCK	Allele A is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.	21781277
chr4	55459197	55459198	G	C	rs34897046	CLOCK	Allele C is not associated with increased response to lithium in people with Bipolar Disorder as compared to allele G.	21781277
chr4	61828998	61828999	T	A,C,G	rs1868790	ADGRL3	Genotype AA is associated with decreased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotypes AT + TT.	28871191
chr4	61873822	61873823	G	A	rs6551665	ADGRL3	Genotypes AG + GG are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype AA.	25989180
chr4	61878521	61878522	C	A,G,T	rs1947274	ADGRL3	Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.	25229170
chr4	61878826	61878827	T	A,C	rs1947275	ADGRL3	Genotypes CT + TT are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype CC.	25989180
chr4	61888601	61888602	A	G	rs6858066	ADGRL3	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.	28871191
chr4	61899311	61899312	G	C,T	rs2345039	ADGRL3	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.	25229170
chr4	61903412	61903413	G	A,C,T	rs6813183	ADGRL3	Genotypes CC + CG are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype GG.	25989180
chr4	61914103	61914104	A	G,T	rs1355368	ADGRL3	Genotypes AG + GG are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype AA.	25989180
chr4	61935009	61935010	T	A,C	rs734644	ADGRL3	Genotypes CC + CT are associated with increased response to methylphenidate in children Attention Deficit Disorder with Hyperactivity as compared to genotype TT.	25989180
chr4	68647128	68647129	T	C,G	rs4148269	UGT2B15	Allele G is associated with increased response to glibenclamide in people with as compared to allele T.	27403931
chr4	68670365	68670366	A	C	rs1902023	UGT2B15	Allele A is associated with decreased clearance of acetaminophen in healthy individuals as compared to allele C.	28663312
chr4	68748340	68748341	T	A	rs416593	UGT2B@	Genotypes AA + AT is associated with decreased exposure to clozapine N+ glucuronide as compared to genotype AA.	35105285
chr4	68789836	68789837	A	G,T	rs1513559	UGT2B@	Genotypes AG + GG is associated with decreased exposure to clozapine N+ glucuronide as compared to genotype AA.	35105285
chr4	68812654	68812655	C	A,G	rs2331559		Allele C is not associated with clearance of nicotine as compared to allele G.	33675323
chr4	68816217	68816218	G	A,T	rs61750900	UGT2B10	Allele T is associated with decreased metabolism of nicotine as compared to allele G.	17909004
chr4	68817136	68817137	T	A,G	rs835309	UGT2B10	Allele G is not associated with clearance of nicotine as compared to allele T.	33675323
chr4	68825802	68825803	G	C	rs11726322	UGT2B10	Allele G is not associated with clearance of nicotine as compared to allele C.	33675323
chr4	68880928	68880929	A	G	rs77107237		Allele G is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele A.	26833182
chr4	69027985	69027986	A	C,G,T	rs4296738	UGT2B7	Allele A is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele G.	28256933
chr4	69028135	69028136	G	A	rs4235108	UGT2B7	Allele A is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele G.	28256933
chr4	69062828	69062829	T	C	rs11931604	UGT2B7	Allele C is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele T.	28256933
chr4	69081679	69081680	T	C,G	rs4587017	UGT2B7	Allele G is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele T.	28256933
chr4	69095214	69095215	A	C,G	rs4455491	UGT2B7	Allele A is not associated with metabolism of morphine in people with Pain, Postoperative as compared to allele G.	23686330
chr4	69095620	69095621	G	A,C	rs7438135	UGT2B7	Genotype AA is associated with increased clinical benefit to cannabinoids in people with Pain as compared to genotypes AG + GG.	36292717
chr4	69096193	69096194	A	C,G,T	rs7662029	UGT2B7	Genotype GG is associated with increased dose-adjusted trough concentrations of mycophenolic acid acyl glucuronide in people with Kidney Transplantation as compared to genotype AG.	39054222
chr4	69096359	69096360	T	A,C,G	rs7668258	UGT2B7	Genotype CC is associated with increased clearance of lamotrigine as compared to genotypes CT + TT.	23263737
chr4	69096382	69096383	G	A	rs73823859	UGT2B7	Allele G is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.	26902643
chr4	69096395	69096396	T	C	rs7668282	UGT2B7	Allele C is not associated with dose of morphine in people with Pain, Postoperative as compared to allele T.	26902643
chr4	69096730	69096731	G	A,C,T	rs12233719	UGT2B7	Genotype GG is associated with increased concentrations of valproic acid in people with Epilepsy as compared to genotype GT.	29243113
chr4	69096891	69096892	A	G,T	rs28365063	UGT2B7	Genotype AA is not associated with increased clearance of lamotrigine as compared to genotypes AG + GG.	23263737
chr4	69097705	69097706	G	A,C,T	rs62296959	UGT2B7	Allele A is not associated with metabolism of morphine in children as compared to allele G.	30920410
chr4	69098069	69098070	C	T	rs28375964	UGT2B7	Allele T is not associated with metabolism of morphine in children as compared to allele C.	30920410
chr4	69098225	69098226	A	G,T	rs62298861	UGT2B7	Allele G is not associated with concentrations of codeine or morphine as compared to allele A.	24747667
chr4	69098552	69098553	A	G,T	rs28365062	UGT2B7	Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotypes AA + AG.	24729586
chr4	69098618	69098619	A	T	rs7438284	UGT2B7	Allele A is associated with increased response to lorazepam and valproic acid in healthy individuals as compared to allele T.	17687269
chr4	69098619	69098620	T	C	rs7439366	UGT2B7	Allele C is not associated with decreased metabolism of labetalol in healthy individuals as compared to allele T.	23090703
chr4	69105218	69105219	A	C,T	rs10028494	UGT2B7	Allele A is not associated with dose of fentanyl in people with Pain, Postoperative as compared to allele C.	28256933
chr4	69112089	69112090	T	A,C	rs10006452	UGT2B7	Allele C is not associated with metabolism of morphine in children as compared to allele T.	30920410
chr4	69113031	69113032	T	A,C	rs6851533	UGT2B7	Allele C is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele T.	28256933
chr4	69123280	69123281	G	A	rs12645107	UGT2B7	Allele A is not associated with response to fentanyl in people with Pain, Postoperative as compared to allele G.	28256933
chr4	70993475	70993476	C	A,G,T	rs80143932	DCK	Allele G is associated with increased response to cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C.	15564883
chr4	70993634	70993635	C	A,G,T	rs2306744	DCK	Allele T is associated with increased response to cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C.	15564883
chr4	70996956	70996957	T	A,C,G	rs3775289	DCK	Genotype CC is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.	18538445
chr4	71008027	71008028	A	C,G	rs12648166	DCK	Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele G.	24361227
chr4	71028146	71028147	C	T	rs4694362	DCK	Allele T is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele C.	24361227
chr4	71029542	71029543	C	G,T	rs4643786	DCK	Genotypes CC + CT is associated with decreased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotype TT.	30088438
chr4	71752616	71752617	A	C,T	rs7041	GC	Genotype AA is associated with increased response to deferasirox in people with beta-Thalassemia as compared to genotypes AC + CC.	30651574
chr4	73740306	73740307	A	C,G,T	rs4073	CXCL8	Genotypes AA + AT are associated with decreased response to bevacizumab and cyclophosphamide in women with Ovarian Neoplasms as compared to genotype TT.	19010874
chr4	73998832	73998833	G	A,C,T	rs352046	CXCL5	Genotype CC is associated with increased response to hmg coa reductase inhibitors in people with Acute coronary syndrome as compared to genotypes CG + GG.	18769620
chr4	74384108	74384109	T	C	rs7687621	EREG	Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CT + TT.	23959273
chr4	74386632	74386633	C	T	rs1017733	EREG	Genotype TT is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CC + CT.	23959273
chr4	74459586	74459587	A	C,G,T	rs2132065	AREG	Genotype AA is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AT + TT.	23959273
chr4	74462390	74462391	G	A	rs11725706	AREG	Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.	23959273
chr4	74463404	74463405	G	A,C,T	rs1353295	AREG	Genotype GG is associated with increased response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.	23959273
chr4	74471141	74471142	A	C	rs3913032	AREG	Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AC.	23959273
chr4	74521196	74521197	G	C,T	rs6447003	AREG	Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CG + GG.	23959273
chr4	74529594	74529595	G	A,C,T	rs13104811	AREG	Genotype GG is associated with increased response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.	23959273
chr4	74554069	74554070	A	G,T	rs10034692	AREG	Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.	23959273
chr4	74556243	74556244	A	C,G,T	rs9996584	AREG	Genotype AA is associated with increased response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AG + GG.	23959273
chr4	74556360	74556361	C	A,G	rs11942466	AREG	Genotype AA is associated with decreased response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AC + CC.	23959273
chr4	76023631	76023632	C	T	rs56061981	CXCL10	Genotypes CT + TT are associated with increased response to peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to genotype CC.	26339796
chr4	78070035	78070036	G	A	rs4386623	FRAS1	Genotypes AA + AG is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype GG.	37626805
chr4	80243568	80243569	C	T	rs1458038	FGF5	Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele T.	23087401
chr4	88040418	88040419	C	T	rs2725215	PKD2	Allele T is associated with decreased response to allopurinol as compared to allele C.	30924126
chr4	88099781	88099782	G	A,C	rs4148157	ABCG2	Allele A is associated with decreased response to allopurinol as compared to allele G.	30924126
chr4	88104088	88104089	C	T	rs76979899	ABCG2	Allele T is associated with decreased response to allopurinol as compared to allele C.	30924126
chr4	88107325	88107326	T	A,C	rs2231148	ABCG2	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	21449672
chr4	88108099	88108100	A	C,G	rs2622628	ABCG2	Genotype AA is not associated with increased concentrations of lamotrigine in people with Epilepsy as compared to genotype CC.	26213157
chr4	88109688	88109689	T	C,G	rs12505410	ABCG2	Allele G is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele T.	24123600
chr4	88109767	88109768	C	A,G	rs2622621	ABCG2	Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr4	88112374	88112375	T	C,G	rs13120400	ABCG2	Genotypes CC + CT is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype TT.	24123600
chr4	88117929	88117930	A	G	rs1481012	ABCG2	Genotypes AG + GG are associated with increased response to rosuvastatin as compared to genotype AA.	22331829
chr4	88122481	88122482	G	A,C,T	rs45499402	ABCG2	Allele C is associated with decreased response to allopurinol.	30924126
chr4	88124178	88124179	A	G,T	rs2199936	ABCG2	Genotypes AA + AG are associated with increased response to rosuvastatin as compared to genotype GG.	22331829
chr4	88129845	88129846	A	C,G	rs2725256	ABCG2	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.	21449672
chr4	88131170	88131171	G	C,T	rs2231142	ABCG2	Genotypes GT + TT are associated with increased exposure to rosuvastatin in people with Diabetes Mellitus and Hypercholesterolemia as compared to genotype GG.	32361904
chr4	88133514	88133515	A	G	rs4148155	ABCG2	Allele G is associated with decreased response to allopurinol as compared to allele A.	30924126
chr4	88134226	88134227	G	A	rs17731538	ABCG2	Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.	29791011
chr4	88139961	88139962	C	T	rs2231137	ABCG2	Allele C is not associated with clearance of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele T.	24404132
chr4	88140112	88140113	C	A,T	rs1564481	ABCG2	Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr4	88140757	88140758	C	A,T	rs2725252	ABCG2	Genotypes AC + CC is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype AA.	24123600
chr4	88141360	88141361	G	T	rs13137622	ABCG2	Genotypes GT + TT are associated with increased clearance of methotrexate in people with Osteosarcoma as compared to genotype GG.	29791011
chr4	88143428	88143429	A	C,G,T	rs3114018	ABCG2	Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.	29791011
chr4	88143449	88143450	C	A,G,T	rs3109823	ABCG2	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	21449672
chr4	88144922	88144923	C	T	rs6857600	ABCG2	Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr4	88147302	88147303	G	A,C,T	rs17731799	ABCG2	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	21449672
chr4	88157771	88157772	T	A,C	rs2622604	ABCG2	Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr4	88159564	88159571	GTGAGTG	GTGAGTGAGTG,GTGAGTGAGTGAGTG	rs3219191	ABCG2	Allele del is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele TGAG.	21449672
chr4	88162513	88162514	T	C,G	rs3114020	ABCG2	Genotypes CC + CT are associated with increased concentrations of lamotrigine in people with Epilepsy as compared to genotype TT.	26213157
chr4	88169724	88169725	T	C,G	rs10011796	ABCG2	Allele T is not associated with decreased response to allopurinol in people with Gout as compared to allele C.	29342288
chr4	89500201	89500202	T	C	rs1908557		Allele C is associated with decreased response to bupropion in people with Depression as compared to allele T.	27622933
chr4	93221347	93221348	G	A	rs1875705	GRID2	Genotype GG is associated with increased response to risperidone in people with as compared to genotypes AA + AG.	26905411
chr4	94435176	94435177	G	A	rs10008257		Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	21047205
chr4	94449653	94449654	G	A	rs2433320	PDLIM5	Allele A is not associated with response to lithium in people with Bipolar Disorder.	21047205
chr4	94458589	94458590	A	G,T	rs2433322	PDLIM5	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	21047205
chr4	96767815	96767816	G	A	rs61692318		Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr4	98680789	98680790	A	G	rs11947402	TSPAN5	Allele G is associated with decreased concentrations of serotonin in people with Depressive Disorder as compared to allele A.	26903268
chr4	99273819	99273820	G	A	rs6811453	ADH1A	Allele A is associated with increased resistance to cytarabine, fludarabine, gemtuzumab ozogamicin and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele G.	22584460
chr4	99280920	99280921	C	A,T	rs1229976	ADH1A	Genotype CT is not associated with concentrations of ethanol in healthy individuals as compared to genotype TT.	31002879
chr4	99282289	99282290	A	C	rs2276332	ADH1A	Allele C is associated with metabolism of ethanol.	19193628
chr4	99286420	99286421	G	A,C,T	rs1229967	ADH1A	Allele C is associated with metabolism of ethanol.	19193628
chr4	99289689	99289690	A	G	rs931635	ADH1A	Allele A is associated with metabolism of ethanol.	19193628
chr4	99296585	99296586	C	G,T	rs1826909	ADH1A	Allele T is associated with increased resistance to cytarabine, fludarabine, gemtuzumab ozogamicin and idarubicin in people with Leukemia, Myeloid, Acute as compared to allele C.	22584460
chr4	99307787	99307788	T	C	rs17033	ADH1B	Allele C is associated with metabolism of ethanol.	19193628
chr4	99307859	99307860	G	A	rs2066702	ADH1B	Allele A is associated with decreased response to naltrexone in men with Alcoholism as compared to allele G.	34680127
chr4	99311720	99311721	A	G	rs1229985	ADH1B	Allele G is associated with metabolism of ethanol.	19193628
chr4	99313982	99313983	C	A,T	rs2018417	ADH1B	Allele A is associated with metabolism of ethanol.	19193628
chr4	99318161	99318162	T	C,G	rs1229984	ADH1B	Genotypes CC + CT are not associated with concentrations of ethanol in healthy individuals as compared to genotype TT.	31002879
chr4	99338683	99338684	T	C	rs1662060	ADH1C	Allele C is associated with metabolism of ethanol.	19193628
chr4	99339631	99339632	T	A,C	rs698	ADH1C	Allele C is associated with increased response to naltrexone in men with Alcoholism as compared to allele T.	34680127
chr4	99344799	99344800	C	A,T	rs283411	ADH1C	Allele A is associated with metabolism of ethanol.	19193628
chr4	99350198	99350199	G	A	rs283416	ADH1C	Allele A is associated with metabolism of ethanol.	19193628
chr4	99421744	99421745	C	G,T	rs1154461	ADH7	Allele C is associated with metabolism of ethanol.	19193628
chr4	99574330	99574331	G	A,T	rs1800591	MTTP	Genotypes GT + TT are associated with response to pravastatin in men.	15136504
chr4	101195925	101195926	C	A,T	rs3730251	PPP3CA	Genotypes CT + TT are not associated with response to tacrolimus in people with Kidney Transplantation as compared to genotype CC.	28435308
chr4	102500997	102501005	ATTGATTG	ATTG	rs28362491	NFKB1	Allele (ATTG)1 is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele ATTGATTG.	32606912
chr4	102503035	102503036	A	C,G,T	rs3774932	NFKB1	Allele G is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele A.	32606912
chr4	102560403	102560404	T	C,G	rs230504	NFKB1	Genotypes CT + TT is associated with increased response to flupenthixol in people with Schizophrenia as compared to genotype CC.	27992301
chr4	102565058	102565059	A	G,T	rs230493	NFKB1	Genotype AT is associated with increased response to flupenthixol in people with Schizophrenia as compared to genotype TT.	27992301
chr4	102589956	102589957	G	A,C	rs3774959	NFKB1	Genotype AG is associated with increased response to flupenthixol in people with Schizophrenia as compared to genotype GG.	27992301
chr4	105192913	105192914	A	G,T	rs12505746	TET2	Allele A is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele G.	25695618
chr4	105376355	105376356	G	A,C,T	rs2636697	PPA2	Allele G is associated with decreased response to risperidone in people with Schizophrenia as compared to allele A.	23241943
chr4	105432211	105432212	A	C	rs2636719	PPA2	Allele A is associated with decreased response to risperidone in people with Schizophrenia as compared to allele C.	23241943
chr4	106752690	106752691	T	A,C,G	rs1364805		Allele T is associated with increased response to montelukast in people with Asthma as compared to allele G.	26083242
chr4	109737910	109737911	T	C	rs10033900	CFI	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.	23842101
chr4	109912953	109912954	A	C,G	rs4444903	EGF	Allele G is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to allele A.	27897268
chr4	109962187	109962188	C	G,T	rs929446	EGF	Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CT + TT.	23959273
chr4	109967850	109967851	A	C,T	rs11568972	EGF	Genotype AA is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AC + CC.	23959273
chr4	109976158	109976159	C	T	rs11568993	EGF	Genotype CC is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotype CT.	23959273
chr4	109988859	109988860	G	A	rs2074390	EGF	Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.	23959273
chr4	109989858	109989859	G	A,C	rs6850557	EGF	Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AG.	23959273
chr4	109993270	109993271	A	G,T	rs4698803	EGF	Genotype TT is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes AA + AT.	23959273
chr4	110006406	110006407	G	A,C	rs6533485	EGF	Genotype GG is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to genotypes CC + CG.	23959273
chr4	119320746	119320747	T	A,C,G	rs1799883	FABP2	Genotype TT is not associated with increased dose of valproic acid in people with Epilepsy as compared to genotypes CC + CT.	21806385
chr4	122456824	122456825	A	C	rs2069762	IL2	Genotype AA is associated with increased dose of opioids in people with Pain and Neoplasms as compared to genotypes AC + CC.	38126330
chr4	122588265	122588266	G	C,T	rs6822844	IL2	Allele G is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.	23007924
chr4	122825786	122825787	C	A,G	rs308395	FGF2	Genotypes CG + GG is associated with decreased response to lenalidomide or thalidomide in people with Multiple Myeloma as compared to genotype CC.	28373444
chr4	122826930	122826931	C	G,T	rs1449683	FGF2	Genotypes CC + CT are associated with decreased response to fluvoxamine in people with Depressive Disorder as compared to genotype TT.	25710119
chr4	122861412	122861413	C	A	rs1960669	FGF2	Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele C.	28045923
chr4	126294162	126294163	A	G	rs17010902		Allele A is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.	23753411
chr4	128287103	128287104	G	C,T	rs3733260	PGRMC2	Genotype TT is not associated with decreased concentrations of 2-hydroxyatorvastatin in healthy individuals as compared to genotypes GG + GT.	22510778
chr4	129244308	129244309	C	T	rs10007051		Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr4	129249426	129249427	A	G	rs11933890		Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr4	129253014	129253015	A	C,G	rs62319299		Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr4	129255323	129255324	G	T	rs56229625		Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr4	129255324	129255325	C	T	rs55881666		Allele C is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr4	140101162	140101163	G	A	rs11100483	MAML3	Allele A is associated with response to perphenazine in people with Schizophrenia.	22920393
chr4	147539884	147539885	T	C	rs5333	EDNRA	Genotypes CC + CT is associated with increased resistance to prednisone in children with Nephrotic Syndrome as compared to genotype TT.	30672385
chr4	148436322	148436323	C	A,T	rs5522	NR3C2	Genotype TT is associated with increased response to enalapril in people with Hypertension as compared to genotypes CC + CT.	24059494
chr4	148437219	148437220	G	C	rs2070950	NR3C2	Genotype CC is not associated with increased response to enalapril in people with Hypertension as compared to genotypes CG + GG.	24059494
chr4	153685973	153685974	T	A	rs4696480	TLR2	Genotype TT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotypes AA + AT.	24776844
chr4	153688370	153688371	T	A,C,G	rs1816702	TLR2	Genotypes CT + TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease as compared to genotype CC.	24776844
chr4	153700793	153700794	C	A,T	rs11938228	TLR2	Genotypes AA + AC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative or Inflammatory Bowel Diseases as compared to genotype CC.	24776844
chr4	153703503	153703504	T	C	rs3804099	TLR2	Genotypes CC + CT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammatory Bowel Diseases as compared to genotype TT.	24776844
chr4	153704256	153704257	T	A,C	rs3804100	TLR2	Genotypes CC + CT are associated with decreased dose of morphine in women with Pain, Postoperative as compared to genotype TT.	27649267
chr4	157133261	157133262	C	G,T	rs17035723	GLRB	Allele T is not associated with response to acamprosate in people with Alcoholism as compared to allele C.	25290263
chr4	158680523	158680524	C	T	rs11559290	ETFDH	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr4	161386159	161386160	C	A,T	rs3749598	FSTL5	Genotypes AA + AC is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	39159789
chr4	173328441	173328442	A	G,T	rs6832850	HMGB2	Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.	24684392
chr4	173336541	173336542	T	C	rs7686909	HMGB2	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.	24684392
chr4	176627446	176627447	C	A,G,T	rs1002976	VEGFC	Allele C is associated with increased concentrations of uric acid in people with Hypertension as compared to allele T.	29580174
chr4	176687552	176687553	C	T	rs7664413	VEGFA	Genotypes CT + TT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype CC.	24090479
chr4	180916587	180916588	C	G,T	rs6848893		Genotype CT is not associated with response to oxycodone as compared to genotype TT.	31493434
chr4	182892271	182892272	C	A,T	rs12507552	DCTD	Genotype CC is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.	22838950
chr4	182894534	182894535	A	C,G,T	rs4742	DCTD	Genotype AA is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AG + GG.	18538445
chr4	184649398	184649399	T	C,G	rs113420705	CASP3	Genotypes CT + TT are associated with decreased response to Immunoglobulins in children with Mucocutaneous Lymph Node Syndrome as compared to genotype CC.	21987091
chr4	186082919	186082920	C	G,T	rs3775291	TLR3	Genotype CT is associated with decreased response to Measles vaccines as compared to genotype CC.	18325643
chr4	186264956	186264957	A	G	rs3756009	F11	Allele G is not associated with dose of warfarin in people with heart valve replacement as compared to allele A.	25126975
chr4	186595500	186595501	T	A,C,G	rs2306987	FAT1	Allele A is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.	19893579
chr4	186597821	186597822	C	A,G,T	rs2306990	FAT1	Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.	19893579
chr4	186603865	186603866	A	C,T	rs2637777	FAT1	Allele A is not associated with response to aripiprazole in people with Schizophrenia as compared to allele C.	19893579
chr4	186604208	186604209	C	G	rs2304865	FAT1	Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele G.	19893579
chr4_GL000257v2_alt	223497	223498	T	C,G	rs4148269	UGT2B15	Allele G is associated with increased response to glibenclamide in people with as compared to allele T.	27403931
chr4_GL000257v2_alt	246720	246721	C	A	rs1902023	UGT2B15	Allele A is associated with decreased clearance of acetaminophen in healthy individuals as compared to allele C.	28663312
chr4_GL000257v2_alt	324359	324360	A	T	rs416593	UGT2B@	Genotypes AA + AT is associated with decreased exposure to clozapine N+ glucuronide as compared to genotype AA.	35105285
chr4_GL000257v2_alt	365862	365863	G	A,T	rs1513559	UGT2B@	Genotypes AG + GG is associated with decreased exposure to clozapine N+ glucuronide as compared to genotype AA.	35105285
chr4_GL000257v2_alt	388673	388674	C	A,G	rs2331559		Allele C is not associated with clearance of nicotine as compared to allele G.	33675323
chr4_GL000257v2_alt	392236	392237	G	A,T	rs61750900	UGT2B10	Allele T is associated with decreased metabolism of nicotine as compared to allele G.	17909004
chr4_GL000257v2_alt	393155	393156	T	A,G	rs835309	UGT2B10	Allele G is not associated with clearance of nicotine as compared to allele T.	33675323
chr4_GL000257v2_alt	401821	401822	G	C	rs11726322	UGT2B10	Allele G is not associated with clearance of nicotine as compared to allele C.	33675323
chr4_GL000257v2_alt	456947	456948	A	G	rs77107237		Allele G is associated with increased concentrations of cotinine in people with Tobacco Use Disorder as compared to allele A.	26833182
chr5	609977	609978	C	T	rs924607	CEP72	Genotype TT is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes CC + CT.	39159789
chr5	1392595	1392596	G	A,C	rs3863145	SLC6A3	Genotype GG is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to genotypes AA + AG.	25642918
chr5	1392605	1392606	T	G	rs10064525	SLC6A3	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32736537
chr5	1394406	1394407	C	A,T	rs27072	SLC6A3	Allele T is not associated with response to heroin as compared to allele C.	32736537
chr5	1394699	1394700	A	G	rs1042098	SLC6A3	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32736537
chr5	1411296	1411297	T	C	rs6347	SLC6A3	Genotype TT is not associated with decreased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CT.	22947179
chr5	1432709	1432710	G	A,C,T	rs460000	SLC6A3	Genotype GG is associated with increased response to amphetamine in healthy individuals as compared to genotypes GT + TT.	20091113
chr5	1445500	1445501	A	T	rs2975226	SLC6A3	Allele A is associated with increased response to clozapine in people with Schizophrenia as compared to allele T.	20580759
chr5	1446273	1446274	A	G	rs2652511	SLC6A3	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.	28871191
chr5	1447646	1447647	G	C,T	rs11564750		Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.	28871191
chr5	1447725	1447726	G	A	rs2550956	SLC6A3	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.	16082688
chr5	1447744	1447745	C	G,T	rs2652510		Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.	16082688
chr5	1450328	1450329	C	T	rs2550948	SLC6A3	Genotypes CC + CT are associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype TT.	28871191
chr5	1461273	1461274	C	A,T	rs2292023	SLC6A3	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25642918
chr5	6720953	6720954	A	G,T	rs274717	TENT4A	Genotypes AG + GG are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype AA.	22838950
chr5	6723446	6723447	T	C,G	rs274713	TENT4A	Genotype GG is associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes GT + TT.	22838950
chr5	6834053	6834054	T	C	rs11134178	MIR4278	Allele T is associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.	18821564
chr5	7634118	7634119	G	A,C,T	rs1544938	ADCY2	Allele C is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele G.	26788534
chr5	7802249	7802250	C	T	rs2290910	ADCY2	Genotypes CC + CT is associated with decreased response to lithium in people with Bipolar Disorder as compared to genotype TT.	32893730
chr5	7870859	7870860	A	G	rs1801394	MTRR	Allele A is associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G.	29743634
chr5	7878065	7878066	C	T	rs1532268	MTRR	Genotypes CT + TT is associated with increased exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	35434830
chr5	7887364	7887365	C	A,G,T	rs162040	MTRR	Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele C.	29743634
chr5	12968228	12968229	A	G	rs35661809		Allele G is associated with increased response to salbutamol in children with as compared to allele A.	29509491
chr5	12978453	12978454	G	A	rs17834628		Allele A is associated with increased response to salbutamol in children with as compared to allele G.	29509491
chr5	32278126	32278127	A	G	rs73069924	MTMR12	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr5	35874472	35874473	C	A,T	rs6897932	IL7R	Allele T is not associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele C.	22111603
chr5	36689260	36689261	A	G	rs1529461	SLC1A3	Genotypes AA + AG is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotype GG.	25209194
chr5	37818036	37818037	T	A,C	rs2973049	GDNF	Genotypes CT + TT is associated with decreased response to paroxetine in people with Depressive Disorder, Major as compared to genotype CC.	24577123
chr5	37828741	37828742	G	A,C,T	rs2216711	GDNF	Genotypes AA + AG is associated with decreased response to paroxetine in women with Depressive Disorder, Major as compared to genotype GG.	24577123
chr5	38870805	38870806	A	G	rs74378198	OSMR	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr5	39030604	39030605	G	A,C	rs6878291	RICTOR	Genotype GG is associated with decreased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype AA.	27676404
chr5	39045239	39045240	A	C,G,T	rs7703002	RICTOR	Genotype AA is associated with decreased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.	27676404
chr5	39048732	39048733	A	G	rs7719775	RICTOR	Genotype AA is associated with decreased response to platinum in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	27676404
chr5	40393502	40393503	A	C,G,T	rs10512734	PTGER4	Genotype GG is associated with increased response to adalimumab in people with Crohn Disease as compared to genotypes AA + AG.	25712183
chr5	40745643	40745644	C	A	rs11749180	PRKAA1	Allele A is associated with decreased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.	25991289
chr5	40782136	40782137	C	A,G,T	rs249429	PRKAA1	Allele T is not associated with response to metformin in people with Diabetes Mellitus as compared to allele C.	25327507
chr5	41142503	41142504	C	A,G,T	rs9200	C6	Genotypes CC + CT are associated with decreased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotype TT.	28685716
chr5	41158386	41158387	A	G	rs3805715	C6	Genotype AA is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AG + GG.	28685716
chr5	41158469	41158470	A	C,G,T	rs6865420	C6	Genotype AC is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AA + CC.	28685716
chr5	41161386	41161387	A	G,T	rs3805716	C6	Genotype AA is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AT + TT.	28685716
chr5	41165641	41165642	C	G,T	rs10052999	C6	Genotypes CC + TT are associated with decreased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotype CT.	28685716
chr5	41198965	41198966	A	C,G,T	rs7443562	C6	Genotype AA is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AG + GG.	28685716
chr5	42194756	42194757	T	C	rs16872401		Allele C is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele T.	29650764
chr5	43969951	43969952	A	G,T	rs62368105		Allele G is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.	34488071
chr5	56900776	56900777	G	A	rs96844	MAP3K1	Genotypes AG + GG are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype AA.	27670765
chr5	59591046	59591047	T	C	rs295943	PDE4D	Allele T is associated with decreased clinical benefit to apremilast in people with Psoriasis as compared to allele C.	38540428
chr5	59684119	59684120	C	T	rs17382202	PDE4D	Allele T is associated with increased response to quetiapine in people with Schizophrenia as compared to allele C.	23241943
chr5	59703215	59703216	A	G	rs17742120	PDE4D	Allele G is associated with increased response to quetiapine in people with Schizophrenia as compared to allele A.	23241943
chr5	59715680	59715681	G	A	rs2164660	PDE4D	Allele A is associated with increased response to quetiapine in people with Schizophrenia as compared to allele G.	23241943
chr5	59821462	59821468	CTGTCT	CT,CTGTCTGTCT	rs10556657	PDE4D	Genotype CT/CT is associated with decreased clinical benefit to tildrakizumab in people with Psoriasis as compared to genotypes CT/CTGTCT + CTGTCT/CTGTCT.	39081053
chr5	63955023	63955024	T	G	rs1364043	HTR1A	Genotype TT is associated with increased response to fluvoxamine, milnacipran and paroxetine in people with Depressive Disorder, Major as compared to genotypes GG + GT.	18484082
chr5	63955834	63955835	T	C	rs1423691	HTR1A	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr5	63960163	63960164	A	C,G	rs878567	HTR1A	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr5	63962737	63962738	C	A,G	rs6295	HTR1A	Genotype GG is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CC + CG.	23733030
chr5	63965501	63965502	C	T	rs10042486	HTR1A	Genotype TT is associated with increased concentrations of quetiapine in men with Schizophrenia as compared to genotype CT.	38312123
chr5	73621912	73621913	G	A	rs929740	ARHGEF28	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr5	75319195	75319196	C	A,T	rs17671591	HMGCR	Genotypes CT + TT is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotype CC.	26408409
chr5	75347029	75347030	A	T	rs17244841	HMGCR	Allele A is not associated with response to fluvastatin in people with renal transplantation as compared to allele T.	17563401
chr5	75355258	75355259	A	G,T	rs3846662	HMGCR	Genotype AA is associated with decreased response to hmg coa reductase inhibitors in women with familial hypercholesterolemia as compared to allele G.	26466344
chr5	75359672	75359673	T	G	rs17238540	HMGCR	Allele T is not associated with response to fluvastatin in people with renal transplantation as compared to allele G.	17563401
chr5	75998584	75998585	C	A,G,T	rs10214163	SV2C	Genotype TT is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes CC + CT.	23886675
chr5	76104641	76104642	C	G	rs2134227	SV2C	Genotype GG is not associated with response to quetiapine in people with Schizophrenia as compared to genotypes CC + CG.	23886675
chr5	76133777	76133778	A	G	rs2112865	SV2C	Genotype AA is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes AG + GG.	23886675
chr5	76135873	76135874	G	A	rs12522597	SV2C	Genotype GG is not associated with response to ziprasidone in people with Schizophrenia as compared to genotypes AA + AG.	23886675
chr5	76144529	76144530	A	C,G,T	rs4580760	SV2C	Genotype CC is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes AA + AC.	23886675
chr5	76181837	76181838	A	G	rs7732173	SV2C	Genotype AA is not associated with response to risperidone in people with Schizophrenia as compared to genotypes AG + GG.	23886675
chr5	76182390	76182391	T	A,C,G	rs10514062	SV2C	Genotype TT is not associated with response to risperidone in people with Schizophrenia as compared to genotypes AA + AT.	23886675
chr5	76183960	76183961	G	A	rs2358531	SV2C	Genotype GG is not associated with response to risperidone in people with Schizophrenia as compared to genotypes AA + AG.	23886675
chr5	76196876	76196877	C	T	rs12655684	SV2C	Genotype CC is not associated with response to ziprasidone in people with Schizophrenia as compared to genotypes CT + TT.	23886675
chr5	76216831	76216832	G	C	rs1995380	SV2C	Genotype GG is not associated with response to risperidone in people with Schizophrenia as compared to genotypes CC + CG.	23886675
chr5	76219160	76219161	C	T	rs11960832	SV2C	Genotype TT is associated with decreased response to olanzapine in people with Schizophrenia as compared to genotypes CC + CT.	23886675
chr5	76268004	76268005	A	C	rs6882321	SV2C	Genotype AA is not associated with response to risperidone in people with Schizophrenia as compared to genotypes AC + CC.	23886675
chr5	76274832	76274833	A	C,G,T	rs1995381	SV2C	Genotype AA is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes AG + GG.	23886675
chr5	76279029	76279030	A	G	rs6874435	SV2C	Genotype AA is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes AG + GG.	23886675
chr5	76295884	76295885	C	A,G,T	rs2270927	SV2C	Genotype CC is not associated with response to olanzapine in people with Schizophrenia as compared to genotypes CG + GG.	23886675
chr5	76298917	76298918	G	A	rs31244	SV2C	Genotype GG is not associated with response to quetiapine in people with Schizophrenia as compared to genotypes AA + AG.	23886675
chr5	80619200	80619201	G	A	rs1232027		Allele A is associated with increased response to methotrexate in people with Arthritis, Psoriatic as compared to allele G.	20472929
chr5	80628971	80628972	T	A	rs7387	DHFR	Allele A is associated with response to methotrexate in people with Arthritis, Rheumatoid.	19902562
chr5	80644323	80644324	T	C	rs1643650	DHFR	Genotypes CC + CT is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype TT.	25084201
chr5	80654961	80654962	A	C,G,T	rs1650697	DHFR	Allele G is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.	33501733
chr5	80655313	80655314	T	C	rs408626	DHFR	Allele C is associated with decreased clinical benefit to methotrexate in people with Crohn Disease as compared to allele T.	38369687
chr5	80746455	80746456	T	C,G	rs863221	MSH3	Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele T.	28796378
chr5	80873117	80873118	G	A	rs26279	MSH3	Allele G is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.	28796378
chr5	83076845	83076846	G	A,T	rs2075685	XRCC4	Allele T is associated with decreased response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr5	83081184	83081185	G	A	rs1478486	XRCC4	Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr5	83177825	83177826	A	G	rs10040363	XRCC4	Allele G is associated with decreased response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele A.	28796378
chr5	84941242	84941243	C	T	rs12518285		Allele T is not associated with trough concentration of vancomycin as compared to allele C.	26030142
chr5	84944558	84944559	A	G,T	rs10085144		Allele G is not associated with trough concentration of vancomycin as compared to allele A.	26030142
chr5	84945792	84945793	T	C	rs10070381		Allele C is not associated with trough concentration of vancomycin as compared to allele T.	26030142
chr5	84953147	84953148	C	G,T	rs9293392		Allele T is not associated with trough concentration of vancomycin as compared to allele C.	26030142
chr5	84953972	84953973	G	A,T	rs62360865		Allele A is not associated with trough concentration of vancomycin as compared to allele G.	26030142
chr5	87651773	87651774	C	A,T	rs3919583		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr5	88619763	88619764	A	G	rs324899		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr5	95466584	95466585	G	A,C	rs12657120	SKIC3	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr5	95481197	95481198	C	A,G	rs4639250	SKIC3	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr5	96766239	96766240	A	C,G,T	rs27524	ERAP1	Genotype AA is not associated with response to adalimumab in people with Psoriasis as compared to genotype GG.	27564082
chr5	108251081	108251082	A	C,G	rs7706429	FBXL17	Allele G is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele A.	25695618
chr5	108253256	108253257	A	C,T	rs4431329	FBXL17	Allele T is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele A.	25695618
chr5	112865396	112865397	A	C,G	rs495794	SRP19	Allele G is associated with increased response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele A.	22795047
chr5	112900599	112900600	A	G	rs153549	REEP5	Allele A is associated with increased response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.	22795047
chr5	112918679	112918680	G	A,C,T	rs153560	REEP5	Allele G is associated with increased response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele A.	22795047
chr5	125363545	125363546	G	A,C,T	rs6889896		Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr5	131110725	131110726	C	A,G,T	rs7728773	HINT1	Genotypes CT + TT is associated with increased clinical benefit to daclatasvir null sofosbuvir in people with Hepatitis C, Chronic as compared to genotype CC.	34843922
chr5	131160321	131160322	C	T	rs3852209	HINT1	Genotypes CT + TT are associated with increased response to nicotine in people with Tobacco Use Disorder as compared to genotype CC.	17978999
chr5	131161734	131161735	T	A,C	rs3864283	HINT1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr5	131165057	131165058	A	C,G,T	rs2278060	HINT1	Genotypes AC + CC are not associated with response to nicotine in people with Tobacco Use Disorder as compared to genotype AA.	17978999
chr5	131165148	131165149	A	G	rs4696	HINT1	Genotype AA is not associated with increased clinical benefit to daclatasvir null sofosbuvir in people with Hepatitis C, Chronic as compared to genotypes AG + GG.	34843922
chr5	132059421	132059422	G	A	rs181781	IL3	Genotype AA is associated with increased exposure to tacrolimus in people with Kidney Transplantation as compared to genotypes AG + GG.	28112181
chr5	132094424	132094425	G	A	rs657075	IL3	Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.	29318894
chr5	132327368	132327369	T	C,G	rs272893	SLC22A4	Allele T is not associated with response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.	27859023
chr5	132340626	132340627	C	T	rs1050152	SLC22A4	Genotype CC is not associated with clearance of busulfan in children with Transplantation as compared to genotype TT.	24192117
chr5	132367885	132367886	G	C,T	rs2631372	SLC22A5	Genotypes CG + GG are associated with increased response to imatinib in people with Gastrointestinal Stromal Tumors as compared to genotype CC.	23127916
chr5	132368083	132368084	T	A,C,G	rs2631370	SLC22A5	Allele C is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele T.	30713339
chr5	132369765	132369766	C	A,G,T	rs2631367	SLC22A5	Genotypes CG + GG are associated with increased response to imatinib in people with Gastrointestinal Stromal Tumors as compared to genotype CC.	23127916
chr5	132448700	132448701	G	T	rs12521868	C5orf56	Allele G is associated with decreased response to hydrochlorothiazide in people with Hypertension as compared to allele T.	31327267
chr5	132544223	132544224	A	G	rs2069812	IL5	Genotypes AA + AG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.	36361964
chr5	132567706	132567707	A	C,T	rs2299014	RAD50	Genotypes AA + AC is associated with increased resistance to cytarabine and daunorubicin in people with Leukemia, Myeloid, Acute as compared to genotype CC.	39738991
chr5	132660150	132660151	T	A,C	rs1295686	IL13	Allele T is associated with decreased response to Hepatitis vaccines as compared to allele C.	21111021
chr5	132660807	132660808	A	C,G	rs848	IL13	Genotypes AA + AC is associated with decreased response to ustekinumab in people with Psoriasis as compared to genotype CC.	27977334
chr5	135892475	135892476	G	A,C	rs2069885	IL9	Genotypes AA + AG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.	36361964
chr5	135964587	135964588	C	G	rs2107506	LECT2	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	21961650
chr5	140118019	140118020	T	A	rs2013169	PURA	Allele T is associated with decreased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr5	140633330	140633331	A	C,G,T	rs2569190	CD14	Genotypes AA + AG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype GG.	24776844
chr5	141152583	141152584	G	A,C	rs17844444	PCDHB6	Allele A is associated with decreased clinical benefit to verapamil in people with Migraine NOS as compared to allele G.	33829662
chr5	141178946	141178947	A	G	rs3733694	PCDHB8	Allele G is associated with decreased clinical benefit to verapamil in people with Migraine NOS as compared to allele A.	33829662
chr5	143277247	143277248	A	G	rs258747	NR3C1	Genotype AA is not associated with decreased concentrations of 2-hydroxyatorvastatin in healthy individuals as compared to genotypes AG + GG.	22510778
chr5	143278055	143278056	T	C	rs6198	NR3C1	Genotype CC is associated with increased time to response to dexamethasone in people with COVID-19 as compared to genotypes CT + TT.	39135792
chr5	143281924	143281925	A	G	rs6196	NR3C1	Allele G is associated with decreased resistance to prednisone in people with Nephrotic Syndrome as compared to allele A.	29207898
chr5	143282714	143282715	G	A,C,T	rs258751	NR3C1	Allele A is associated with decreased resistance to prednisone in people with Nephrotic Syndrome as compared to allele G.	29207898
chr5	143317729	143317730	A	C,G,T	rs33388	NR3C1	Genotype AA is associated with increased time to response to dexamethasone in people with COVID-19 as compared to genotypes AT + TT.	39135792
chr5	143320933	143320934	C	G,T	rs33389	NR3C1	Genotype TT is associated with increased time to response to dexamethasone in people with COVID-19 as compared to genotypes CC + CT.	39135792
chr5	143399009	143399010	G	C	rs41423247	NR3C1	Genotype GG is associated with decreased clinical benefit to antiepileptics in children with Epilepsy as compared to genotypes CC + CG.	39920787
chr5	143407135	143407136	G	A	rs10052957	NR3C1	Allele A is associated with decreased resistance to prednisone in people with Nephrotic Syndrome as compared to allele G.	29207898
chr5	148120327	148120328	G	A,C,T	rs2303070	SPINK5	Allele T is associated with increased response to glibenclamide in people with as compared to allele G.	27403931
chr5	148166888	148166889	T	A,G	rs9285669		Allele A is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele T.	25695618
chr5	148452492	148452493	C	A,G,T	rs1971431	HTR4	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr5	148494992	148494993	G	A,C	rs4264931	HTR4	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr5	148627449	148627450	G	A,C,T	rs2068190	HTR4	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr5	148650500	148650501	C	A,G,T	rs1862342	HTR4	Allele T is not associated with dose of opioids in people with Pain as compared to allele C.	21398039
chr5	148825808	148825809	A	C,G,T	rs2053044	ADRB2	Genotypes AA + AG is associated with increased response to ramipril in people with Hypertension as compared to genotype GG.	26111150
chr5	148826784	148826785	C	A,G,T	rs1042711	ADRB2	Allele T is not associated with response to atenolol in people with Essential hypertension.	20235788
chr5	148826876	148826877	G	A,C	rs1042713	ADRB2	Allele G is not associated with response to hydrochlorothiazide in people with Essential hypertension as compared to allele A.	14553962
chr5	148826909	148826910	G	A,C,T	rs1042714	ADRB2	Genotype CC is associated with increased response to atenolol or metoprolol in people with Tachycardia as compared to genotypes CG + GG.	31090079
chr5	148827353	148827354	C	A,T	rs1042718	ADRB2	Genotype AC is associated with increased response to fentanyl in healthy individuals as compared to genotype CC.	30281924
chr5	148827883	148827884	G	A,C	rs1042719	ADRB2	Genotype CC is not associated with dose of ephedrine or phenylephrine in people with Hypotension as compared to genotype GG.	26771271
chr5	148848932	148848933	G	A,C	rs11959113		Genotype AA is associated with increased dose of fentanyl in people with Pain, Postoperative as compared to genotypes AG + GG.	25615449
chr5	149280100	149280101	G	A	rs1438692	AFAP1L1	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr5	149723080	149723081	G	A,T	rs73277969		Allele T is associated with increased discontinuation of infliximab in people with Crohn Disease as compared to allele G.	37460671
chr5	153488876	153488877	T	C	rs548294	GRIA1	Allele C is not associated with response to almotriptan, eletriptan, frovatriptan, rizatriptan, sumatriptan or zolmitriptan in people with Migraine without Aura as compared to allele T.	24030684
chr5	153491448	153491449	G	A	rs2195450	GRIA1	Allele A is not associated with response to almotriptan, eletriptan, frovatriptan, rizatriptan, sumatriptan or zolmitriptan in people with Migraine without Aura as compared to allele G.	24030684
chr5	154063335	154063336	A	T	rs34767465		Allele T is not associated with response to adalimumab, certolizumab pegol or infliximab in people with Inflammatory Bowel Diseases as compared to allele A.	34380996
chr5	158411533	158411534	G	A	rs4551053	EBF1	Allele G is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele A.	23087401
chr5	159315941	159315942	T	A,G	rs3212227	IL12B	Allele G is not associated with response to methotrexate in people with Psoriasis as compared to allele T.	28444425
chr5	159323760	159323761	C	G,T	rs3213094	IL12B	Genotype CT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype CC.	27564082
chr5	159328121	159328122	C	G	rs3212217	IL12B	Genotype GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammatory Bowel Diseases as compared to genotype CC.	28139755
chr5	159332891	159332892	A	G	rs2546890	IL12B	Genotypes AG + GG are associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype AA.	27670765
chr5	159937990	159937991	G	A	rs10515807	ADRA1B	Allele G is associated with decreased dose of doxazosin or phenoxybenzamine in people with Pheochromocytoma or Paraganglioma as compared to allele A.	35453646
chr5	160452970	160452971	T	C	rs2431697	PTTG1	Genotypes CC + CT is associated with decreased response to etanercept in people with Psoriasis as compared to genotype TT.	28470127
chr5	161684167	161684168	G	A	rs1992647	GABRA6	Genotype AA is associated with decreased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotype GG.	23394390
chr5	161842776	161842777	T	A,C	rs6892782	GABRA1	Genotype CC is not associated with response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype TT.	24236484
chr5	161851331	161851332	C	T	rs6883877	GABRA1	Genotype CT is not associated with increased response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype CC.	24236484
chr5	161860840	161860841	G	A	rs10068980	GABRA1	Genotype AA is not associated with response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype GG.	24236484
chr5	161892307	161892308	T	A,C	rs1157122	GABRA1	Genotype CC is not associated with response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype TT.	24236484
chr5	161895882	161895883	G	A	rs2279020	GABRA1	Genotype GG is associated with increased response to propofol as compared to genotypes AA + AG.	28611364
chr5	161897891	161897892	A	G,T	rs2290732	GABRA1	Genotypes AA + AG are associated with increased response to carbamazepine in people with Epilepsy as compared to genotype GG.	22591328
chr5	163162851	163162852	T	C,G	rs4376293		Allele T is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.	23753411
chr5	166918082	166918083	C	T	rs13169373		Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.	34488071
chr5	168491920	168491921	T	A,C,G	rs244898	RARS1	Genotype TT is associated with increased response to cisplatin in people with Urinary Bladder Neoplasms as compared to genotypes CC + CT.	27150640
chr5	170382397	170382398	A	G,T	rs703505	KCNMB1	Genotypes AA + AG is associated with decreased clinical benefit to tocilizumab in people with Rheumatoid arthritis as compared to genotype GG.	39718059
chr5	170383791	170383792	C	T	rs11739136	KCNMB1	Genotypes CC + CT is associated with increased response to dexmedetomidine in people with surgery as compared to genotype TT.	37693312
chr5	170788633	170788634	T	C,G	rs10036156	GABRP	Genotypes CC + CT are associated with increased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotype TT.	23394390
chr5	172771551	172771552	G	A,C	rs881152	DUSP1	Allele G is not associated with increased response to salbutamol in people with Asthma as compared to allele A.	20673984
chr5	174642664	174642665	A	G	rs11749255		Allele A is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele G.	30237584
chr5	175336318	175336319	A	G	rs966775	DRD1	Genotypes AG + GG is associated with increased concentrations of fentanyl in people with Pain, Postoperative as compared to genotype AA.	37176129
chr5	175435416	175435417	G	T	rs265976	DRD1	Genotype GT is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes GG + TT.	17092969
chr5	175440895	175440896	T	A,C,G	rs4867798	DRD1	Genotypes CC + CT is associated with increased response to methylphenidate in children with Autism Spectrum Disorder as compared to genotype TT.	23856854
chr5	175441696	175441697	G	A,C,T	rs686	DRD1	Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G.	17092969
chr5	175443146	175443147	C	G,T	rs4532	DRD1	Genotype CC is not associated with dose of methadone in people with Substance-Related Disorders as compared to genotypes CT + TT.	18687376
chr5	175443192	175443193	C	T	rs5326	DRD1	Genotypes CC + TT are not associated with response to antipsychotics in people with Schizophrenia as compared to genotype CC.	27287786
chr5	175443898	175443899	A	C,G,T	rs265981	DRD1	Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G.	17092969
chr5	178981600	178981601	T	G	rs17078853	GRM6	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	32481444
chr5	178983149	178983150	C	G,T	rs2071247	GRM6	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr5	178983211	178983212	T	A,C	rs17078877	GRM6	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32481444
chr5	178986945	178986946	T	A,C,G	rs11746675	GRM6	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr5	178988935	178988936	A	G,T	rs2067011	GRM6	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32481444
chr5	180601716	180601717	T	A,C,G	rs307822	FLT4	Genotypes CT + TT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype CC.	24090479
chr5	180602470	180602471	C	G	rs6877011	FLT4	Allele G is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele C.	30713339
chr5	180650486	180650487	T	C,G	rs307805	FLT4	Genotypes CC + CT are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype TT.	24090479
chr5_KI270791v1_alt	48498	48499	G	T,A	rs2292023	SLC6A3	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25642918
chr5_KI270791v1_alt	59443	59444	G	A	rs2550948	SLC6A3	Genotypes CC + CT are associated with increased response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to genotype TT.	28871191
chr5_KI270791v1_alt	62027	62028	G	C,A	rs2652510		Allele C is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele T.	16082688
chr5_KI270791v1_alt	62046	62047	C	T	rs2550956	SLC6A3	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.	16082688
chr5_KI270791v1_alt	62125	62126	C	G,A	rs11564750		Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele C.	28871191
chr5_KI270791v1_alt	63498	63499	T	C	rs2652511	SLC6A3	Allele G is not associated with response to methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to allele A.	28871191
chr5_KI270791v1_alt	64271	64272	T	A	rs2975226	SLC6A3	Allele A is associated with increased response to clozapine in people with Schizophrenia as compared to allele T.	20580759
chr5_KI270791v1_alt	77062	77063	C	T,G,A	rs460000	SLC6A3	Genotype GG is associated with increased response to amphetamine in healthy individuals as compared to genotypes GT + TT.	20091113
chr5_KI270791v1_alt	102711	102712	A	G	rs6347	SLC6A3	Genotype TT is not associated with decreased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CC + CT.	22947179
chr5_KI270791v1_alt	119308	119309	T	C	rs1042098	SLC6A3	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32736537
chr5_KI270791v1_alt	119601	119602	G	T,A	rs27072	SLC6A3	Allele T is not associated with response to heroin as compared to allele C.	32736537
chr5_KI270791v1_alt	121402	121403	A	C	rs10064525	SLC6A3	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32736537
chr5_KI270791v1_alt	121412	121413	C	T,G	rs3863145	SLC6A3	Genotype GG is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to genotypes AA + AG.	25642918
chr5_KI270793v1_alt	16918	16919	G	A	rs924607	CEP72	Genotype TT is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes CC + CT.	39159789
chr5_KI270796v1_alt	84080	84081	G	A,C,T	rs6889896		Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr6	3010155	3010156	C	A,G,T	rs1143684	NQO2	Allele C is not associated with response to cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to allele T.	29938344
chr6	3887104	3887105	C	A	rs9328202		Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr6	6318561	6318562	C	A,T	rs5985	F13A1	Genotypes AA + AC are associated with decreased response to photodynamic therapy in people with Choroidal Neovascularization as compared to genotype CC.	26307969
chr6	12296021	12296022	G	T	rs5370	EDN1	Genotype GT is associated with increased response to atenolol and irbesartan in men with Essential hypertension as compared to genotype GG.	15188945
chr6	12903724	12903725	A	C,G,T	rs9349379	PHACTR1	Allele G is not associated with response to Selective serotonin (5HT1) agonists in people with Migraine without Aura as compared to allele A.	30256423
chr6	13070840	13070841	A	G	rs4615376	PHACTR1	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr6	15572842	15572843	C	T	rs742105	DTNBP1	Genotypes CT + TT are associated with increased response to clozapine in people with Schizophrenia as compared to genotype CC.	19369910
chr6	15627870	15627871	T	C	rs3213207	DTNBP1	Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.	20829635
chr6	15633200	15633201	T	A,C	rs1011313	DTNBP1	Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.	20829635
chr6	15650570	15650571	C	T	rs2005976	DTNBP1	Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele T.	20829635
chr6	15650900	15650901	G	A	rs760761	DTNBP1	Allele A is associated with increased response to citalopram in people with Depressive Disorder, Major as compared to allele G.	19065121
chr6	15653417	15653418	A	C,G	rs2619522	DTNBP1	Allele C is not associated with response to aripiprazole in people with Schizophrenia as compared to allele A.	20829635
chr6	15660639	15660640	T	C	rs909706	DTNBP1	Genotype CT is associated with increased response to haloperidol in people with Schizophrenia as compared to genotype CC.	19369910
chr6	16145093	16145094	A	C,G,T	rs9370867	MYLIP	Genotype AA is associated with increased response to atorvastatin in people with Hypercholesterolemia as compared to genotypes AG + GG.	25171759
chr6	17505712	17505713	A	C,G,T	rs910039	CAP2	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr6	18123270	18123271	C	G	rs12199316	TPMT	Allele G is associated with increased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	34412101
chr6	18130686	18130687	T	C,G	rs1142345	TPMT	Genotype TT is not associated with dose of mercaptopurine or methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotypes CC + CT.	29683944
chr6	18138996	18138997	C	T	rs1800460	TPMT	Genotype CT is associated with decreased dose of mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	35431360
chr6	20661018	20661019	G	A,C,T	rs7754840	CDKAL1	Genotype CG is associated with increased response to sitagliptin in people with Diabetes Mellitus, Type 2.	39792745
chr6	20679477	20679478	A	G,T	rs7756992	CDKAL1	Allele G is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele A.	27139004
chr6	20728499	20728500	T	A,C,G	rs6908425	CDKAL1	Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	27670765
chr6	23548121	23548122	G	A	rs2066911		Allele A is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele G.	19749758
chr6	24503361	24503362	C	T	rs2760118	ALDH5A1	Genotypes CT + TT is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to genotype CC.	24230997
chr6	25177279	25177280	A	G	rs6942227		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr6	25776720	25776721	G	A	rs11754288	SLC17A4	Allele A is associated with increased concentrations of losartan and losartan E-3174 in healthy individuals as compared to allele G.	38637968
chr6	25823215	25823216	A	C,G,T	rs1183201	SLC17A1	Allele T is not associated with dose of allopurinol in people with Gout as compared to allele A.	29341237
chr6	26090950	26090951	C	G,T	rs1799945	HFE	Allele G is associated with decreased dose of epoetin alfa in people with hemodialysis treatment as compared to allele C.	18025780
chr6	26091107	26091108	T	C	rs2071303	HFE	Genotypes CC + CT are associated with increased response to adalimumab in people with Crohn Disease as compared to genotype TT.	27115882
chr6	26092912	26092913	G	A	rs1800562	HFE	Allele A is associated with decreased dose of epoetin alfa in people with hemodialysis treatment as compared to allele G.	18025780
chr6	29783227	29783228	C	A,T	rs1611255		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6	29783975	29783976	C	A,T	rs1611259		Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6	29830804	29830804		ATTTGT,ATTTGTTCACGCCT,ATTTGTTCATGCCT	rs371194629	HLA-G	Genotype del/del is not associated with increased response to methotrexate in people with Arthritis, Rheumatoid.	19088262
chr6	29830832	29830833	C	A,T	rs1707	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CT + TT.	26633805
chr6	29830839	29830840	G	C	rs1710	HLA-G	Genotype GG is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CC + CG.	26633805
chr6	29830856	29830857	C	A	rs17179101	HLA-G	Genotype AC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6	29830864	29830865	C	T	rs17179108	HLA-G	Genotype CT is associated with increased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6	29830971	29830972	C	G,T	rs1063320	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CG + GG.	26633805
chr6	29831016	29831017	A	G	rs9380142	HLA-G	Genotype GG is associated with decreased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes AA + AG.	26633805
chr6	29831025	29831026	C	G	rs1610696	HLA-G	Genotypes CG + GG are not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6	30490286	30490287	G	A,T	rs1264457	HLA-E	Genotype AA is associated with increased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in women with Arthritis, Rheumatoid as compared to genotypes AG + GG.	26307125
chr6	31139583	31139584	C	A	rs2233945	PSORS1C1	Allele A is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	28107378
chr6	31261560	31261561	G	A	rs9366772	HLA-C	Allele A is associated with increased response to allopurinol as compared to allele G.	30924126
chr6	31285147	31285148	C	T	rs12191877	HLA-C	Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	27670765
chr6	31298312	31298313	G	A	rs4406273		Genotype AA is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.	27564082
chr6	31387341	31387342	C	T	rs13437088	HLA-B	Genotype TT is associated with decreased response to etanercept in people with Psoriasis as compared to genotypes CC + CT.	28470127
chr6	31411199	31411200	G	A	rs1051792	MICA	Genotype AA is associated with decreased clinical benefit to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylarthropathy as compared to genotypes AG + GG.	38372728
chr6	31498017	31498018	C	A,T	rs3828913	MICB	Genotype CC is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AC.	26075078
chr6	31572535	31572536	A	C,G,T	rs909253	LTA	Genotype AA is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	22129793
chr6	31573006	31573007	C	A	rs1041981	LTA	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.	15695296
chr6	31574530	31574531	T	C	rs1799964	TNF	Genotype TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CC + CT.	23057546
chr6	31574698	31574699	C	A,G	rs1800630	TNF	Genotype AA is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AC + CC.	22960943
chr6	31574704	31574705	C	T	rs1799724	TNF	Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CT + TT.	23057546
chr6	31574755	31574756	C	T	rs4248158	TNF	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.	22960943
chr6	31575185	31575186	G	A	rs1800750	TNF	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.	22960943
chr6	31575253	31575254	G	A	rs1800629	TNF	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	32606912
chr6	31575323	31575324	G	A	rs361525	TNF	Genotype AG is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.	23057546
chr6	31576049	31576050	G	A	rs1800610	TNF	Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	22129793
chr6	31588803	31588804	T	A,C	rs1052248	NCR3	Genotypes AT + TT is associated with increased clinical benefit to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype AA.	38714580
chr6	31936026	31936027	G	A,C	rs9332739	C2	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6	31946402	31946403	G	A,T	rs641153	CFB	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6	31962684	31962685	G	A	rs429608	SKIC2	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6	32622993	32622994	T	A,C	rs2097432		Genotypes CC + CT is associated with decreased response to infliximab in people with Crohn Disease as compared to genotype TT.	39055374
chr6	32956806	32956807	A	G	rs209474		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr6	32973037	32973038	C	G,T	rs17220479	BRD2	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr6	32982439	32982440	A	G	rs16871297		Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr6	33065244	33065245	A	G	rs3077	HLA-DPA1	Genotype GG is associated with increased response to peginterferon alfa-2b in people with Hepatitis B, Chronic as compared to genotypes AA + AG.	26387494
chr6	35385745	35385746	A	G	rs6922548	PPARD	Allele G is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele A.	20038957
chr6	35394747	35394748	G	A,C,T	rs7769719	PPARD	Allele G is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele A.	20038957
chr6	35402028	35402029	C	A,G,T	rs1883322	PPARD	Allele C is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele T.	20038957
chr6	35411000	35411001	C	A,T	rs2016520	PPARD	Allele C is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele T.	20038957
chr6	35427232	35427233	C	T	rs3734254	PPARD	Allele T is associated with increased response to docetaxel and thalidomide in people with Prostatic Neoplasms as compared to allele C.	20038957
chr6	35574698	35574699	C	A,G	rs3800373	FKBP5	Genotypes AC + CC are associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype AA.	23733030
chr6	35639793	35639794	T	A,C	rs1360780	FKBP5	Genotype CC is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.	23733030
chr6	35654143	35654144	T	C	rs17614642	FKBP5	Genotype TT is associated with decreased response to bupropion in people with Depressive Disorder, Major as compared to genotype CT.	22947179
chr6	35702205	35702206	A	C,G,T	rs4713916	FKBP5	Genotype AA is associated with increased response to antidepressants in people with Depressive Disorder as compared to genotypes AG + GG.	15565110
chr6	36039220	36039221	T	A,C,G	rs3804454	MAPK14	Allele G is not associated with response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to allele T.	24070809
chr6	37381256	37381257	G	A	rs2284922	RNF8	Allele A is associated with increased response to carboplatin, docetaxel and trastuzumab in women with Breast Neoplasms.	30071039
chr6	39048859	39048860	C	T	rs10305420	GLP1R	Allele T is not associated with decreased clinical benefit to albiglutide, dulaglutide or Glucagon-like peptide-1 (GLP-1) analogues in people with Diabetes Mellitus, Type 2 as compared to allele C.	36528349
chr6	39065818	39065819	G	A,C,T	rs3765467	GLP1R	Genotype AG is associated with increased response to sitagliptin in people with Diabetes Mellitus, Type 2.	39792745
chr6	39066295	39066296	G	A,C	rs6923761	GLP1R	Genotype AA is associated with decreased response to sitagliptin in people with Diabetes Mellitus, Type 2.	39792745
chr6	39079094	39079095	C	G,T	rs761386	GLP1R	Genotypes CT + TT is associated with increased response to exenatide in people with Diabetes Mellitus, Type 2 as compared to genotype CC.	25785276
chr6	39340965	39340966	A	G	rs9471077	KIF6	Genotypes AG + GG are associated with increased response to atorvastatin or pravastatin.	20886236
chr6	39348015	39348016	C	A,G,T	rs9462535	KIF6	Genotypes AA + AC are associated with increased response to atorvastatin or pravastatin.	20886236
chr6	39357301	39357302	A	G	rs20455	KIF6	Genotypes AG + GG are associated with increased response to pravastatin in people with Myocardial Infarction as compared to genotype AA.	20403483
chr6	41232815	41232816	A	C,G	rs9369266	TREML4	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr6	41237496	41237497	G	A,C	rs13204353	TREML4	Allele G is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr6	41661987	41661988	C	A	rs6458232		Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele A.	21635146
chr6	43764116	43764117	C	G,T	rs833058		Allele T is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele C.	26100253
chr6	43764931	43764932	A	G	rs699946	VEGFA	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6	43768651	43768652	A	C,T	rs699947	VEGFA	Genotypes AC + CC are associated with increased response to ranibizumab in people with Macular Degeneration as compared to genotype AA.	23570466
chr6	43768678	43768698	GGTCCCACTCTTCCCACAGG	GG,GGTCCCACTCTTCCCACAGGTCCCACTCTTCCCACAGG	rs144854329	VEGFA	Genotype del/del is associated with increased response to cetuximab in people with Colorectal Neoplasms as compared to genotypes GGTCCCACTCTTCCCACA/GGTCCCACTCTTCCCACA + GGTCCCACTCTTCCCACA/del.	26615857
chr6	43769748	43769749	C	G,T	rs833061	VEGFA	Allele C is not associated with response to bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to allele T.	25955730
chr6	43770092	43770093	A	G	rs1570360	VEGFA	Genotypes AA + AG are not associated with increased response to ranibizumab in people with Macular Degeneration as compared to genotype GG.	23570466
chr6	43770612	43770613	C	G,T	rs2010963	VEGFA	Allele G is not associated with response to bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to allele C.	25955730
chr6	43771239	43771240	C	G,T	rs25648	VEGFA	Allele T is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	28639493
chr6	43774789	43774790	G	A	rs833068	VEGFA	Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.	28045923
chr6	43774841	43774842	T	C,G	rs833069	VEGFA	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele T.	23559864
chr6	43777357	43777358	C	A	rs2146323	VEGFA	Genotype CC is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes AA + AC.	23584701
chr6	43778431	43778432	C	G,T	rs3025000	VEGFA	Genotypes CT + TT are associated with increased response to bevacizumab or ranibizumab in people with Macular Degeneration as compared to genotype CC.	23149126
chr6	43782849	43782850	G	C	rs3025030	VEGFA	Allele C is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele G.	26100253
chr6	43783337	43783338	A	G	rs3025033	VEGFA	Allele G is not associated with response to anthracyclines and related substances, bevacizumab, cyclophosphamide, docetaxel, epirubicin and taxanes in women with Breast Neoplasms as compared to allele A.	26100253
chr6	43784798	43784799	C	T	rs3025039	VEGFA	Genotype CC is not associated with decreased response to bevacizumab in people with Macular Degeneration as compared to genotype TT.	22594510
chr6	43785474	43785475	A	C,G,T	rs10434	VEGFA	Genotypes AA + AG are not associated with response to cisplatin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to genotype GG.	24090479
chr6	43794384	43794385	T	C	rs9369421	VEGFA	Genotypes CC + CT are associated with increased response to carboplatin and taxanes in women with as compared to genotype TT.	26194361
chr6	44221462	44221463	G	A	rs3778504	SLC29A1	Genotypes AA + AG are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype GG.	22838950
chr6	44226607	44226608	G	A,C	rs747199	SLC29A1	Genotype GG is not associated with metabolism of gemcitabine as compared to genotypes CC + CG.	24300978
chr6	44228254	44228255	C	T	rs9394992	SLC29A1	Genotype CC is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.	20665488
chr6	44228840	44228841	T	C	rs324148	SLC29A1	Genotype CC is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.	20665488
chr6	44233215	44233216	A	C,G	rs760370	SLC29A1	Genotype GG is associated with decreased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AA + AG.	20665488
chr6	44233996	44233997	C	A	rs3734703	SLC29A1	Allele A is associated with increased response to cytarabine in people with Leukemia, Myeloid, Acute as compared to allele C.	27422302
chr6	44386903	44386904	C	T	rs992160	CDC5L	Genotypes CT + TT are associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotype CC.	22838950
chr6	52148897	52148898	A		rs142410335	MIR133B	Genotype AA is not associated with dose of warfarin as compared to genotype A/del.	28429387
chr6	52185987	52185988	A	C,G,T	rs3819024	IL17A	Genotypes AG + GG is associated with decreased clinical benefit to budesonide, fluticasone/salmeterol, formoterol or omalizumab in children with Asthma as compared to genotype AA.	38232251
chr6	52186234	52186235	G	A,C	rs2275913	IL17A	Genotypes AA + AG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative and Inflammatory Bowel Diseases as compared to genotype GG.	24776844
chr6	52236940	52236941	T	C	rs763780	IL17F	Allele T is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele C.	24361227
chr6	52803871	52803872	T	A,C,G	rs3957356	GSTA1	Allele T is associated with decreased clearance of busulfan in children with hematopoietic stem cell transplantation as compared to allele C.	35214132
chr6	52803888	52803889	A	G,T	rs3957357	GSTA1	Genotype AA is associated with increased clearance of busulfan in children with Transplantation as compared to genotypes AG + GG.	24192117
chr6	52843998	52843999	G	A,C	rs4715354	GSTA5	Allele G is not associated with decreased clearance of busulfan in people with Neoplasms as compared to allele A.	24192531
chr6	52849338	52849339	C	A	rs7746993		Allele C is not associated with decreased clearance of busulfan in people with Neoplasms as compared to allele A.	24192531
chr6	55774229	55774230	G	A	rs41271330	BMP5	Allele A is associated with decreased response to escitalopram in people with Depressive Disorder, Major as compared to allele G.	23926243
chr6	77460344	77460345	T	C	rs9361233	HTR1B	Genotypes CC + TT is associated with increased response to fluoxetine in children with Depressive Disorder, Major as compared to genotype CT.	28025020
chr6	77461406	77461407	C	T	rs13212041	HTR1B	Genotype TT is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to genotypes CC + CT.	23131881
chr6	77462542	77462543	C	G	rs6296	HTR1B	Allele G is not associated with response to rizatriptan in people with Migraine without Aura as compared to allele C.	17563839
chr6	77463563	77463564	T	A,C,G	rs130058	HTR1B	Allele A is not associated with response to venlafaxine in people with Depressive Disorder, Major as compared to allele T.	28068779
chr6	77463664	77463665	A	C	rs11568817	HTR1B	Allele C is not associated with response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity as compared to allele A.	23131881
chr6	77464491	77464492	T	A,C	rs1778258	HTR1B	Allele T is associated with increased response to citalopram, clomipramine, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline in people with Obsessive-Compulsive Disorder as compared to allele C.	40054571
chr6	77466124	77466125	C	A,T	rs9361235	HTR1B	Genotypes CC + TT is associated with increased response to fluoxetine in children with Depressive Disorder, Major as compared to genotype CT.	28025020
chr6	83799352	83799353	G	A,C,T	rs1081848	TRAF1	Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	22129793
chr6	88140380	88140381	T	A,C	rs806368	CNR1	Genotypes CT + TT are associated with increased dose of methadone in people with Heroin Dependence as compared to genotype CC.	32481444
chr6	88141461	88141462	T	C	rs12720071	CNR1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr6	88143915	88143916	C	A,T	rs1049353	CNR1	Genotypes CT + TT is associated with increased clinical benefit to liraglutide in people with Diabetes Mellitus, Type 2 and Obesity as compared to genotype CC.	24322329
chr6	88154933	88154934	A	G	rs806380	CNR1	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32481444
chr6	98829990	98829991	C	T	rs1869641	POU2F2	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr6	98830551	98830552	T	A,C	rs2444933	POU2F2	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr6	98831572	98831573	A	C	rs1883306	POU2F2	Allele A is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr6	98833932	98833933	C	A,G	rs195862	POU2F2	Allele C is not associated with response to platinum in people with Lung Neoplasms as compared to allele A.	24643204
chr6	98836655	98836656	T	C	rs3823036	POU2F2	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele C.	24643204
chr6	98841598	98841599	T	A	rs195854	POU2F2	Allele T is not associated with response to platinum in people with Lung Neoplasms as compared to allele A.	24643204
chr6	106120158	106120159	C	A,G,T	rs548234	PRDM1	Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.	23007924
chr6	106207741	106207742	T	A,C	rs9373839	ATG5	Genotype CT is associated with decreased clinical benefit to tildrakizumab in people with Psoriasis as compared to genotypes CC + TT.	39081053
chr6	106326154	106326155	T	C	rs510432	ATG5	Genotypes CT + TT are associated with increased response to adalimumab in people with Inflammatory Bowel Diseases as compared to genotype CC.	27096233
chr6	110438804	110438805	A	G	rs12210538	SLC22A16	Allele G is not associated with response to cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to allele A.	29938344
chr6	110442671	110442672	A	G	rs723685	SLC22A16	Allele G is not associated with response to cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to allele A.	29938344
chr6	110456758	110456759	A	G	rs6907567	SLC22A16	Allele G is not associated with response to cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to allele A.	29938344
chr6	111299554	111299555	G	A	rs465646	REV3L	Genotypes AG + GG are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype AA.	25748439
chr6	111307422	111307423	C	T	rs3204953	REV3L	Genotypes CT + TT are not associated with increased response to cisplatin in people with Osteosarcoma as compared to genotype CC.	25748439
chr6	111352510	111352511	T	A,C	rs240993	REV3L	Genotype TT is not associated with response to adalimumab in people with Psoriasis as compared to genotype CC.	27564082
chr6	111374683	111374684	G	A	rs462779	REV3L	Genotypes AG + GG are associated with decreased response to cisplatin in people with Osteosarcoma as compared to genotype AA.	25748439
chr6	111592058	111592059	C	A,T	rs33980500	TRAF3IP2	Allele T is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	28107378
chr6	111674462	111674463	A	G	rs3730353	FYN	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	21047205
chr6	111720155	111720156	T	A,C	rs706895	FYN	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	21047205
chr6	112346990	112346991	C	T	rs9384825	RFPL4B	Allele T is associated with decreased metabolism of tramadol as compared to allele C.	30971809
chr6	116279646	116279647	G	A,T	rs3828743	TSPYL1	Genotypes AG + GG is associated with increased clearance of cyclosporine in men with Kidney Transplantation as compared to genotype AA.	38380703
chr6	117755820	117755821	G	A,C	rs7750468		Allele G is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele A.	19749758
chr6	131570679	131570680	A	G,T	rs2781659	ARG1	Allele A is associated with increased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele G.	18617639
chr6	132571366	132571367	T	C,G	rs7772821	TAAR6	Genotype GG is associated with increased response to corticosteroids in people with Asthma as compared to genotypes GT + TT.	25919112
chr6	132572625	132572626	G	A,T	rs4305746	TAAR6	Genotypes AA + AG are associated with increased response to aripiprazole in people with Schizophrenia as compared to genotype GG.	19345712
chr6	133291775	133291776	G	C	rs17301249	EYA4	Allele C is associated with decreased response to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	33124499
chr6	136781226	136781227	C	A,G,T	rs9376230	MAP3K5	Genotype CC is associated with increased clinical benefit to hydroxyurea in people with Beta-thalassemia and related diseases.	23556445
chr6	136784261	136784262	C	T	rs9483947	MAP3K5	Genotype CC is associated with increased clinical benefit to hydroxyurea in people with Beta-thalassemia and related diseases.	23556445
chr6	137219382	137219383	A	G	rs2234711	IFNGR1	Genotype AG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype AA.	28139755
chr6	137681037	137681038	C	A,G,T	rs6927172	TNFAIP3	Genotypes CG + GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative and Inflammatory Bowel Diseases as compared to genotype CC.	24776844
chr6	137681499	137681500	C	T	rs10499194		Allele T is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.	25834819
chr6	137685366	137685367	G	A	rs6920220	TNFAIP3	Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	22129793
chr6	137874928	137874929	T	C,G	rs2230926	TNFAIP3	Allele T is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele G.	28639493
chr6	137878279	137878280	G	A,C,T	rs610604	TNFAIP3	Genotype GG is associated with decreased clinical benefit to tildrakizumab in people with Psoriasis as compared to genotypes GT + TT.	39081053
chr6	138928987	138928988	C	G	rs17068112	REPS1	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr6	143957124	143957125	T	C	rs2247408	PLAGL1	Allele C is associated with response to olanzapine in people with Schizophrenia.	22920393
chr6	143959391	143959392	A	G	rs3819811	PLAGL1	Allele A is associated with response to olanzapine in people with Schizophrenia.	22920393
chr6	145701394	145701395	T	A,C,G	rs1415744	EPM2A	Allele C is associated with increased response to chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone or trifluoperazine in people with Schizophrenia as compared to allele T.	27092952
chr6	149400553	149400554	G	A,T	rs237025	SUMO4	Genotype AA is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AG + GG.	28941036
chr6	151807941	151807942	T	A,C	rs2077647	ESR1	Allele T is associated with increased response to glibenclamide in people with as compared to allele C.	27403931
chr6	151842148	151842149	A	G	rs4986936	ESR1	Allele G is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.	26902643
chr6	151842199	151842200	T	C,G	rs2234693	ESR1	Allele C is not associated with dose of morphine in people with Pain, Postoperative as compared to allele T.	26902643
chr6	151842245	151842246	A	G	rs9340799	ESR1	Allele A is not associated with response to raloxifene in women Menopause and Schizophrenia as compared to allele G.	27546373
chr6	151944386	151944387	G	A,C,T	rs1801132	ESR1	Allele C is not associated with response to raloxifene in women Menopause and Schizophrenia as compared to allele G.	27546373
chr6	152992696	152992697	G	A,T	rs766127	MTRF1L	Allele G is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele A.	27091189
chr6	152994559	152994560	C	T	rs3192723	OPRM1	Genotype CC is associated with decreased response to methadone in people with Heroin Dependence as compared to genotypes CT + TT.	30420869
chr6	153024049	153024050	A	G,T	rs672170	RGS17	Allele A is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele G.	27091189
chr6	153704003	153704004	T	C	rs73568641		Allele C is associated with decreased dose of methadone in women with Opioid-Related Disorders as compared to allele T.	34910759
chr6	154010048	154010049	T	A,C	rs1319339	OPRM1	Allele C is not associated with dose of morphine in people with Pain, Postoperative as compared to allele T.	26902643
chr6	154014537	154014538	A	G	rs1294092	OPRM1	Allele G is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele A.	31206155
chr6	154027469	154027470	A	C	rs7776341	OPRM1	Allele C is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.	26902643
chr6	154027673	154027674	A	C,G	rs1074287	OPRM1	Allele G is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele A.	23223006
chr6	154037797	154037798	G	A	rs12205732	OPRM1	Allele A is not associated with dose of heroin in people with Heroin Dependence as compared to allele G.	31940240
chr6	154038225	154038226	A	G	rs17174629	OPRM1	Allele G is not associated with dose of morphine in people with Pain as compared to allele A.	29259946
chr6	154039372	154039373	G	T	rs6912029	OPRM1	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele G.	31940240
chr6	154039560	154039561	C	A,G,T	rs1799972	OPRM1	Allele T is not associated with dose of morphine in people with Pain as compared to allele C.	29259946
chr6	154039661	154039662	A	G	rs1799971	OPRM1	Allele G is not associated with response to modafinil in people with methamphetamine dependence as compared to allele A.	22217949
chr6	154039912	154039913	C	T	rs12209447	OPRM1	Allele T is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele C.	23223006
chr6	154040883	154040884	C	T	rs510769	OPRM1	Allele T is not associated with dose of ethanol as compared to allele C.	26042510
chr6	154043003	154043004	C	T	rs3798676	OPRM1	Allele T is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele C.	23223006
chr6	154043681	154043682	C	T	rs553202	OPRM1	Allele T is associated with increased response to ethanol as compared to allele C.	18433502
chr6	154047411	154047412	C	G,T	rs511435	OPRM1	Allele T is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele C.	31206155
chr6	154051556	154051557	A	G	rs499796	OPRM1	Allele G is not associated with concentrations of cotinine in people with Heroin Dependence as compared to allele A.	23223006
chr6	154053956	154053957	C	A	rs524731	OPRM1	Allele A is associated with increased response to ethanol as compared to allele C.	18433502
chr6	154058016	154058017	G	A	rs3823010	OPRM1	Allele A is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele G.	31206155
chr6	154059014	154059015	T	G	rs7748401	OPRM1	Allele G is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele T.	23223006
chr6	154059876	154059877	G	T	rs3778148	OPRM1	Allele T is associated with increased response to ethanol as compared to allele G.	18433502
chr6	154061406	154061407	A	G	rs495491	OPRM1	Allele G is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele A.	31206155
chr6	154062522	154062523	T	C	rs3778150	OPRM1	Genotypes CC + CT are associated with decreased response to ethanol as compared to genotype TT.	28273335
chr6	154069937	154069938	A	G,T	rs10457090	OPRM1	Allele G is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele A.	23223006
chr6	154070233	154070234	G	A	rs1461773	OPRM1	Allele A is associated with increased response to ethanol as compared to allele G.	18433502
chr6	154072002	154072003	C	T	rs589046	OPRM1	Allele T is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele C.	23223006
chr6	154072122	154072123	C	A,G,T	rs1381376	OPRM1	Allele A is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele C.	31206155
chr6	154072695	154072696	A	G	rs3778152	OPRM1	Allele G is associated with increased concentrations of cotinine in people with Heroin Dependence as compared to allele A.	23223006
chr6	154074791	154074792	A	C	rs506247	OPRM1	Allele C is not associated with response to ethanol as compared to allele A.	18433502
chr6	154086831	154086832	C	T	rs563649	OPRM1	Allele T is not associated with response to ethanol as compared to allele C.	18433502
chr6	154090208	154090209	G	A	rs9479757	OPRM1	Genotype AG is associated with increased dose of heroin in people with Heroin Dependence as compared to genotype GG.	11933204
chr6	154090868	154090869	G	C,T	rs2075572	OPRM1	Allele G is associated with increased response to ethanol as compared to allele C.	18433502
chr6	154092119	154092120	A	G	rs10485057	OPRM1	Allele G is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele A.	31206155
chr6	154093310	154093311	A	C,G,T	rs540825	OPRM1	Allele T is not associated with dose of morphine in people with Pain, Postoperative as compared to allele A.	26902643
chr6	154093427	154093428	A	C,G	rs675026	OPRM1	Allele G is not associated with response to methadone in people with Heroin Dependence as compared to allele A.	30420869
chr6	154093437	154093438	C	A,G,T	rs562859	OPRM1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr6	154097011	154097012	T	A,C,G	rs548646	OPRM1	Allele T is associated with increased response to ethanol as compared to allele C.	18433502
chr6	154099921	154099922	G	A,T	rs9384179	OPRM1	Genotype AA is associated with increased dose of fentanyl in people with Pain, Postoperative as compared to genotypes AG + GG.	25615449
chr6	154100708	154100709	G	C,T	rs1323042	OPRM1	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr6	154101475	154101476	A	C,G	rs648007	OPRM1	Allele A is associated with increased response to ethanol as compared to allele G.	18433502
chr6	154103185	154103186	A	C,G,T	rs9322447	OPRM1	Allele G is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele A.	31206155
chr6	154103534	154103535	A	C,G,T	rs618207	OPRM1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr6	154106605	154106606	T	A,C	rs681243	OPRM1	Allele T is associated with increased response to ethanol as compared to allele C.	18433502
chr6	154107530	154107531	C	A,G,T	rs677830	OPRM1	Allele T is not associated with dose of morphine in people with Pain, Postoperative as compared to allele C.	26902643
chr6	154109879	154109880	G	A,T	rs609148	OPRM1	Allele A is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele G.	31206155
chr6	154115578	154115579	C	A,G	rs639855	OPRM1	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	21398039
chr6	154117493	154117494	A	G	rs648893	OPRM1	Allele G is not associated with response to ethanol as compared to allele A.	18433502
chr6	154119606	154119607	A	C,G,T	rs671531	OPRM1	Genotype GG is associated with decreased response to highly active antiretroviral therapy (haart) in people with HIV Infections as compared to genotypes AA + AG.	22457278
chr6	154120829	154120830	A	G	rs558025	OPRM1	Genotypes AG + GG are associated with decreased dose of methadone in people with Heroin Dependence as compared to genotype AA.	23651024
chr6	154121376	154121377	G	A,T	rs497976	OPRM1	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr6	154121540	154121541	G	A,T	rs642489	OPRM1	Allele T is not associated with response to ethanol as compared to allele G.	18433502
chr6	154124079	154124080	A	G	rs10485058	OPRM1	Allele G is not associated with dose of methadone in people with Opioid-Related Disorders as compared to allele A.	34910759
chr6	154157304	154157305	C	A,T	rs2236256	OPRM1	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele A.	30420869
chr6	154157431	154157432	G	C	rs2236257	OPRM1	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele G.	30420869
chr6	154157568	154157569	C	G,T	rs2236258	OPRM1	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	30420869
chr6	154157757	154157758	T	A,C,G	rs2236259	OPRM1	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	30420869
chr6	154157867	154157868	T	C	rs6902403	OPRM1	Allele C is not associated with response to methadone in people with Heroin Dependence as compared to allele T.	30420869
chr6	154247040	154247041	G	C	rs9322453	OPRM1	Allele C is not associated with dose of heroin in people with Heroin Dependence as compared to allele G.	31940240
chr6	154400422	154400423	C	G,T	rs6917661	CNKSR3	Allele C is not associated with response to lithium in people with Bipolar Disorder.	21047205
chr6	154962859	154962860	T	C	rs2273897	ABCC2	Genotype TT is associated with increased concentrations of emtricitabine in people with HIV Infections and Pregnancy as compared to genotypes CC + CT.	30767719
chr6	157939658	157939659	G	A,T	rs2364349	SNX9	Allele A is associated with decreased response to atenolol or metoprolol in people with Hypertension as compared to allele G.	29478026
chr6	159061488	159061489	C	G,T	rs394581	TAGAP	Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.	23007924
chr6	159692839	159692840	A	G	rs4880	SOD2	Allele G is not associated with response to clozapine in people with Schizophrenia as compared to allele A.	19946932
chr6	160120140	160120141	G	A,C,T	rs6935207	SLC22A1	Allele A is not associated with clearance of metformin in healthy individuals as compared to allele G.	30544975
chr6	160122090	160122091	T	A,C	rs1867351	SLC22A1	Allele C is not associated with exposure to metformin as compared to allele T.	29352482
chr6	160122115	160122116	C	T	rs12208357	SLC22A1	Allele T is associated with decreased response to Antiemetics And Antinauseants as compared to allele C.	20921968
chr6	160129896	160129897	T	A,C,G	rs9457841	SLC22A1	Allele C is associated with increased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to allele T.	39752799
chr6	160130171	160130172	G	A,C,T	rs683369	SLC22A1	Genotype CC is associated with decreased dose-adjusted trough concentrations of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes CG + GG.	37212851
chr6	160132273	160132274	C	T	rs34134157	SLC22A1	Genotype CC is associated with decreased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to genotype CT.	39752799
chr6	160134721	160134722	G	A	rs594709	SLC22A1	Genotypes AA + AG are associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to genotype GG.	26977146
chr6	160136610	160136611	C	G,T	rs2282143	SLC22A1	Genotype CC is associated with increased clearance of metformin in healthy individuals as compared to genotypes CT + TT.	23417334
chr6	160136671	160136672	C	T	rs35235578	SLC22A1	Genotype CT is associated with increased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to genotype CC.	39752799
chr6	160139812	160139813	A	C,G	rs628031	SLC22A1	Allele A is not associated with increased resistance to efavirenz, lamivudine, lopinavir, nevirapine, ritonavir and zidovudine in people with HIV Infections as compared to allele G.	23996099
chr6	160139848	160139853	ATGAT	AT	rs72552763	SLC22A1	Allele del is not associated with dose of morphine in people with Pain, Postoperative as compared to allele GAT.	34599645
chr6	160151833	160151834	C	A,G	rs622342	SLC22A1	Genotype AA is not associated with response to metformin in people with genetic variation at rs2289669.	19898263
chr6	160155978	160155979	G	A	rs41267797	SLC22A1	Genotype AG is associated with increased concentrations of n-desmethyltramadol and o-desmethyltramadol in people with Death as compared to genotype GG.	39752799
chr6	160231825	160231826	T	C	rs315978	SLC22A2	Allele T is not associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.	38852696
chr6	160249249	160249250	A	C	rs316019	SLC22A2	Genotype CC is associated with increased clearance of metformin in healthy individuals as compared to genotype AC.	23417334
chr6	160254731	160254732	T	A,C,G	rs316009	SLC22A2	Genotype TT is associated with increased response to metformin in people with Diabetes Mellitus as compared to genotypes CC + CT.	27415606
chr6	160275886	160275887	C	T	rs662301	SLC22A2	Allele T is not associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.	38852696
chr6	160451753	160451754	C	G	rs2076828	SLC22A3	Allele G is associated with decreased response to metformin in healthy individuals as compared to allele C.	25920679
chr6	160471208	160471209	C	G,T	rs3127602	SLC22A3	Allele T is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.	25991289
chr6	160589085	160589086	A	G	rs10455872	LPA	Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A.	27045730
chr6	166165781	166165782	C	T	rs2305089	TBXT	Genotype TT is associated with increased response to flunisolide in people with Asthma as compared to genotypes CC + CT.	22538805
chr6_GL000250v2_alt	1049061	1049062	A	C,T	rs1611255		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000250v2_alt	1049809	1049810	T	C,A	rs1611259		Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000250v2_alt	1096458	1096459	T	C,A	rs1707	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CT + TT.	26633805
chr6_GL000250v2_alt	1096465	1096466	C	G	rs1710	HLA-G	Genotype GG is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CC + CG.	26633805
chr6_GL000250v2_alt	1096482	1096483	C	A	rs17179101	HLA-G	Genotype AC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000250v2_alt	1096490	1096491	C	T	rs17179108	HLA-G	Genotype CT is associated with increased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000250v2_alt	1096597	1096598	G	C,T	rs1063320	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CG + GG.	26633805
chr6_GL000250v2_alt	1096642	1096643	A	G	rs9380142	HLA-G	Genotype GG is associated with decreased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes AA + AG.	26633805
chr6_GL000250v2_alt	1096651	1096652	G	C	rs1610696	HLA-G	Genotypes CG + GG are not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000250v2_alt	2830585	2830586	C	A,T	rs3828913	MICB	Genotype CC is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AC.	26075078
chr6_GL000250v2_alt	2908628	2908629	G	A	rs1800610	TNF	Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	22129793
chr6_GL000250v2_alt	2921382	2921383	T	A,C	rs1052248	NCR3	Genotypes AT + TT is associated with increased clinical benefit to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype AA.	38714580
chr6_GL000250v2_alt	4261656	4261657	A	G	rs209474		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr6_GL000250v2_alt	4369924	4369925	A	G	rs3077	HLA-DPA1	Genotype GG is associated with increased response to peginterferon alfa-2b in people with Hepatitis B, Chronic as compared to genotypes AA + AG.	26387494
chr6_GL000251v2_alt	1267011	1267012	A	C,T	rs1611255		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000251v2_alt	1267759	1267760	T	C,A	rs1611259		Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000251v2_alt	1314408	1314409	T	C,A	rs1707	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CT + TT.	26633805
chr6_GL000251v2_alt	1314415	1314416	C	G	rs1710	HLA-G	Genotype GG is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CC + CG.	26633805
chr6_GL000251v2_alt	1314432	1314433	C	A	rs17179101	HLA-G	Genotype AC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000251v2_alt	1314440	1314441	C	T	rs17179108	HLA-G	Genotype CT is associated with increased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000251v2_alt	1314547	1314548	G	C,T	rs1063320	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CG + GG.	26633805
chr6_GL000251v2_alt	1314592	1314593	A	G	rs9380142	HLA-G	Genotype GG is associated with decreased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes AA + AG.	26633805
chr6_GL000251v2_alt	1314601	1314602	G	C	rs1610696	HLA-G	Genotypes CG + GG are not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000251v2_alt	1970021	1970022	A	G,T	rs1264457	HLA-E	Genotype AA is associated with increased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in women with Arthritis, Rheumatoid as compared to genotypes AG + GG.	26307125
chr6_GL000251v2_alt	2621976	2621977	C	A	rs2233945	PSORS1C1	Allele A is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	28107378
chr6_GL000251v2_alt	2742469	2742470	G	A	rs9366772	HLA-C	Allele A is associated with increased response to allopurinol as compared to allele G.	30924126
chr6_GL000251v2_alt	2766058	2766059	C	T	rs12191877	HLA-C	Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	27670765
chr6_GL000251v2_alt	2779219	2779220	G	A	rs4406273		Genotype AA is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.	27564082
chr6_GL000251v2_alt	2867690	2867691	C	T	rs13437088	HLA-B	Genotype TT is associated with decreased response to etanercept in people with Psoriasis as compared to genotypes CC + CT.	28470127
chr6_GL000251v2_alt	2891570	2891571	G	A	rs1051792	MICA	Genotype AA is associated with decreased clinical benefit to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylarthropathy as compared to genotypes AG + GG.	38372728
chr6_GL000251v2_alt	2975359	2975360	C	A,T	rs3828913	MICB	Genotype CC is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AC.	26075078
chr6_GL000251v2_alt	3049822	3049823	G	A,C,T	rs909253	LTA	Genotype AA is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	22129793
chr6_GL000251v2_alt	3050293	3050294	A	C	rs1041981	LTA	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.	15695296
chr6_GL000251v2_alt	3051817	3051818	T	C	rs1799964	TNF	Genotype TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CC + CT.	23057546
chr6_GL000251v2_alt	3051985	3051986	C	A,G	rs1800630	TNF	Genotype AA is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AC + CC.	22960943
chr6_GL000251v2_alt	3051991	3051992	C	T	rs1799724	TNF	Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CT + TT.	23057546
chr6_GL000251v2_alt	3052042	3052043	C	T	rs4248158	TNF	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.	22960943
chr6_GL000251v2_alt	3052472	3052473	G	A	rs1800750	TNF	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.	22960943
chr6_GL000251v2_alt	3052540	3052541	A	G	rs1800629	TNF	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	32606912
chr6_GL000251v2_alt	3052610	3052611	G	A	rs361525	TNF	Genotype AG is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.	23057546
chr6_GL000251v2_alt	3053336	3053337	G	A	rs1800610	TNF	Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	22129793
chr6_GL000251v2_alt	3066086	3066087	T	A,C	rs1052248	NCR3	Genotypes AT + TT is associated with increased clinical benefit to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype AA.	38714580
chr6_GL000251v2_alt	3413453	3413454	G	A,C	rs9332739	C2	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000251v2_alt	3423829	3423830	G	A,T	rs641153	CFB	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000251v2_alt	3440111	3440112	G	A	rs429608	SKIC2	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000251v2_alt	4041400	4041401	C	T,A	rs2097432		Genotypes CC + CT is associated with decreased response to infliximab in people with Crohn Disease as compared to genotype TT.	39055374
chr6_GL000251v2_alt	4369007	4369008	A	G	rs209474		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr6_GL000251v2_alt	4385246	4385247	C	G,T	rs17220479	BRD2	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr6_GL000251v2_alt	4394652	4394653	A	G	rs16871297		Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr6_GL000251v2_alt	4477095	4477096	A	G	rs3077	HLA-DPA1	Genotype GG is associated with increased response to peginterferon alfa-2b in people with Hepatitis B, Chronic as compared to genotypes AA + AG.	26387494
chr6_GL000252v2_alt	1046212	1046213	C	A,T	rs1611255		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000252v2_alt	1046960	1046961	C	A,T	rs1611259		Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000252v2_alt	1093617	1093617		ATTTGT,ATTTGTTCACGCCT,ATTTGTTCATGCCT	rs371194629	HLA-G	Genotype del/del is not associated with increased response to methotrexate in people with Arthritis, Rheumatoid.	19088262
chr6_GL000252v2_alt	1093645	1093646	T	C,A	rs1707	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CT + TT.	26633805
chr6_GL000252v2_alt	1093652	1093653	G	C	rs1710	HLA-G	Genotype GG is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CC + CG.	26633805
chr6_GL000252v2_alt	1093669	1093670	C	A	rs17179101	HLA-G	Genotype AC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000252v2_alt	1093677	1093678	C	T	rs17179108	HLA-G	Genotype CT is associated with increased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000252v2_alt	1093784	1093785	C	G,T	rs1063320	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CG + GG.	26633805
chr6_GL000252v2_alt	1093829	1093830	G	A	rs9380142	HLA-G	Genotype GG is associated with decreased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes AA + AG.	26633805
chr6_GL000252v2_alt	1093838	1093839	C	G	rs1610696	HLA-G	Genotypes CG + GG are not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000252v2_alt	1746118	1746119	A	G,T	rs1264457	HLA-E	Genotype AA is associated with increased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in women with Arthritis, Rheumatoid as compared to genotypes AG + GG.	26307125
chr6_GL000252v2_alt	2398913	2398914	C	A	rs2233945	PSORS1C1	Allele A is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	28107378
chr6_GL000252v2_alt	2519343	2519344	G	A	rs9366772	HLA-C	Allele A is associated with increased response to allopurinol as compared to allele G.	30924126
chr6_GL000252v2_alt	2542887	2542888	T	C	rs12191877	HLA-C	Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	27670765
chr6_GL000252v2_alt	2556054	2556055	A	G	rs4406273		Genotype AA is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.	27564082
chr6_GL000252v2_alt	2745625	2745626	C	A,T	rs3828913	MICB	Genotype CC is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AC.	26075078
chr6_GL000252v2_alt	2820266	2820267	A	C,G,T	rs909253	LTA	Genotype AA is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	22129793
chr6_GL000252v2_alt	2820739	2820740	C	A	rs1041981	LTA	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.	15695296
chr6_GL000252v2_alt	2822263	2822264	C	T	rs1799964	TNF	Genotype TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CC + CT.	23057546
chr6_GL000252v2_alt	2822431	2822432	C	A,G	rs1800630	TNF	Genotype AA is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AC + CC.	22960943
chr6_GL000252v2_alt	2822437	2822438	C	T	rs1799724	TNF	Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CT + TT.	23057546
chr6_GL000252v2_alt	2822488	2822489	C	T	rs4248158	TNF	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.	22960943
chr6_GL000252v2_alt	2822918	2822919	G	A	rs1800750	TNF	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.	22960943
chr6_GL000252v2_alt	2822986	2822987	G	A	rs1800629	TNF	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	32606912
chr6_GL000252v2_alt	2823056	2823057	A	G	rs361525	TNF	Genotype AG is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.	23057546
chr6_GL000252v2_alt	2823782	2823783	G	A	rs1800610	TNF	Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	22129793
chr6_GL000252v2_alt	2836540	2836541	A	T,C	rs1052248	NCR3	Genotypes AT + TT is associated with increased clinical benefit to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype AA.	38714580
chr6_GL000252v2_alt	3183805	3183806	G	A,C	rs9332739	C2	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000252v2_alt	3194182	3194183	G	A,T	rs641153	CFB	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000252v2_alt	3210459	3210460	G	A	rs429608	SKIC2	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000252v2_alt	3867048	3867049	T	A,C	rs2097432		Genotypes CC + CT is associated with decreased response to infliximab in people with Crohn Disease as compared to genotype TT.	39055374
chr6_GL000252v2_alt	4200339	4200340	A	G	rs209474		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr6_GL000252v2_alt	4225973	4225974	A	G	rs16871297		Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr6_GL000252v2_alt	4308775	4308776	A	G	rs3077	HLA-DPA1	Genotype GG is associated with increased response to peginterferon alfa-2b in people with Hepatitis B, Chronic as compared to genotypes AA + AG.	26387494
chr6_GL000253v2_alt	1045803	1045804	C	A,T	rs1611255		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000253v2_alt	1046551	1046552	C	A,T	rs1611259		Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000253v2_alt	1093290	1093290		ATTTGT,ATTTGTTCACGCCT,ATTTGTTCATGCCT	rs371194629	HLA-G	Genotype del/del is not associated with increased response to methotrexate in people with Arthritis, Rheumatoid.	19088262
chr6_GL000253v2_alt	1093318	1093319	T	C,A	rs1707	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CT + TT.	26633805
chr6_GL000253v2_alt	1093325	1093326	G	C	rs1710	HLA-G	Genotype GG is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CC + CG.	26633805
chr6_GL000253v2_alt	1093342	1093343	C	A	rs17179101	HLA-G	Genotype AC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000253v2_alt	1093350	1093351	C	T	rs17179108	HLA-G	Genotype CT is associated with increased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000253v2_alt	1093457	1093458	C	G,T	rs1063320	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CG + GG.	26633805
chr6_GL000253v2_alt	1093502	1093503	A	G	rs9380142	HLA-G	Genotype GG is associated with decreased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes AA + AG.	26633805
chr6_GL000253v2_alt	1093511	1093512	C	G	rs1610696	HLA-G	Genotypes CG + GG are not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000253v2_alt	1800521	1800522	G	A,T	rs1264457	HLA-E	Genotype AA is associated with increased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in women with Arthritis, Rheumatoid as compared to genotypes AG + GG.	26307125
chr6_GL000253v2_alt	2450108	2450109	C	A	rs2233945	PSORS1C1	Allele A is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	28107378
chr6_GL000253v2_alt	2570596	2570597	G	A	rs9366772	HLA-C	Allele A is associated with increased response to allopurinol as compared to allele G.	30924126
chr6_GL000253v2_alt	2594146	2594147	C	T	rs12191877	HLA-C	Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	27670765
chr6_GL000253v2_alt	2607300	2607301	G	A	rs4406273		Genotype AA is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.	27564082
chr6_GL000253v2_alt	2695948	2695949	C	T	rs13437088	HLA-B	Genotype TT is associated with decreased response to etanercept in people with Psoriasis as compared to genotypes CC + CT.	28470127
chr6_GL000253v2_alt	2719784	2719785	G	A	rs1051792	MICA	Genotype AA is associated with decreased clinical benefit to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylarthropathy as compared to genotypes AG + GG.	38372728
chr6_GL000253v2_alt	2877576	2877577	A	C,G,T	rs909253	LTA	Genotype AA is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	22129793
chr6_GL000253v2_alt	2878047	2878048	C	A	rs1041981	LTA	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.	15695296
chr6_GL000253v2_alt	2879571	2879572	T	C	rs1799964	TNF	Genotype TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CC + CT.	23057546
chr6_GL000253v2_alt	2879739	2879740	C	A,G	rs1800630	TNF	Genotype AA is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AC + CC.	22960943
chr6_GL000253v2_alt	2879745	2879746	C	T	rs1799724	TNF	Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CT + TT.	23057546
chr6_GL000253v2_alt	2879796	2879797	C	T	rs4248158	TNF	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.	22960943
chr6_GL000253v2_alt	2880226	2880227	G	A	rs1800750	TNF	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.	22960943
chr6_GL000253v2_alt	2880294	2880295	G	A	rs1800629	TNF	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	32606912
chr6_GL000253v2_alt	2880364	2880365	G	A	rs361525	TNF	Genotype AG is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.	23057546
chr6_GL000253v2_alt	2881090	2881091	G	A	rs1800610	TNF	Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	22129793
chr6_GL000253v2_alt	2893844	2893845	T	A,C	rs1052248	NCR3	Genotypes AT + TT is associated with increased clinical benefit to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype AA.	38714580
chr6_GL000253v2_alt	3240989	3240990	G	A,C	rs9332739	C2	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000253v2_alt	3251379	3251380	A	G,T	rs641153	CFB	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000253v2_alt	4041446	4041447	T	A,C	rs2097432		Genotypes CC + CT is associated with decreased response to infliximab in people with Crohn Disease as compared to genotype TT.	39055374
chr6_GL000253v2_alt	4376174	4376175	G	A	rs209474		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr6_GL000253v2_alt	4392421	4392422	C	G,T	rs17220479	BRD2	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr6_GL000253v2_alt	4401817	4401818	A	G	rs16871297		Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr6_GL000253v2_alt	4484941	4484942	A	G	rs3077	HLA-DPA1	Genotype GG is associated with increased response to peginterferon alfa-2b in people with Hepatitis B, Chronic as compared to genotypes AA + AG.	26387494
chr6_GL000254v2_alt	1045878	1045879	C	A,T	rs1611255		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000254v2_alt	1046626	1046627	C	A,T	rs1611259		Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000254v2_alt	1093275	1093275		ATTTGT,ATTTGTTCACGCCT,ATTTGTTCATGCCT	rs371194629	HLA-G	Genotype del/del is not associated with increased response to methotrexate in people with Arthritis, Rheumatoid.	19088262
chr6_GL000254v2_alt	1093303	1093304	T	C,A	rs1707	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CT + TT.	26633805
chr6_GL000254v2_alt	1093310	1093311	G	C	rs1710	HLA-G	Genotype GG is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CC + CG.	26633805
chr6_GL000254v2_alt	1093327	1093328	C	A	rs17179101	HLA-G	Genotype AC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000254v2_alt	1093335	1093336	C	T	rs17179108	HLA-G	Genotype CT is associated with increased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000254v2_alt	1093442	1093443	C	G,T	rs1063320	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CG + GG.	26633805
chr6_GL000254v2_alt	1093487	1093488	G	A	rs9380142	HLA-G	Genotype GG is associated with decreased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes AA + AG.	26633805
chr6_GL000254v2_alt	1093496	1093497	C	G	rs1610696	HLA-G	Genotypes CG + GG are not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000254v2_alt	1834342	1834343	G	A,T	rs1264457	HLA-E	Genotype AA is associated with increased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in women with Arthritis, Rheumatoid as compared to genotypes AG + GG.	26307125
chr6_GL000254v2_alt	2483720	2483721	C	A	rs2233945	PSORS1C1	Allele A is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	28107378
chr6_GL000254v2_alt	2604277	2604278	G	A	rs9366772	HLA-C	Allele A is associated with increased response to allopurinol as compared to allele G.	30924126
chr6_GL000254v2_alt	2627832	2627833	C	T	rs12191877	HLA-C	Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	27670765
chr6_GL000254v2_alt	2641009	2641010	G	A	rs4406273		Genotype AA is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.	27564082
chr6_GL000254v2_alt	2839973	2839974	C	A,T	rs3828913	MICB	Genotype CC is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AC.	26075078
chr6_GL000254v2_alt	2914431	2914432	A	C,G,T	rs909253	LTA	Genotype AA is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	22129793
chr6_GL000254v2_alt	2914904	2914905	C	A	rs1041981	LTA	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.	15695296
chr6_GL000254v2_alt	2916428	2916429	C	T	rs1799964	TNF	Genotype TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CC + CT.	23057546
chr6_GL000254v2_alt	2916596	2916597	A	C,G	rs1800630	TNF	Genotype AA is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AC + CC.	22960943
chr6_GL000254v2_alt	2916602	2916603	C	T	rs1799724	TNF	Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CT + TT.	23057546
chr6_GL000254v2_alt	2916653	2916654	C	T	rs4248158	TNF	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.	22960943
chr6_GL000254v2_alt	2917083	2917084	G	A	rs1800750	TNF	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.	22960943
chr6_GL000254v2_alt	2917151	2917152	G	A	rs1800629	TNF	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	32606912
chr6_GL000254v2_alt	2917221	2917222	G	A	rs361525	TNF	Genotype AG is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.	23057546
chr6_GL000254v2_alt	2917947	2917948	G	A	rs1800610	TNF	Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	22129793
chr6_GL000254v2_alt	2930696	2930697	A	T,C	rs1052248	NCR3	Genotypes AT + TT is associated with increased clinical benefit to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype AA.	38714580
chr6_GL000254v2_alt	3278062	3278063	G	A,C	rs9332739	C2	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000254v2_alt	3288438	3288439	G	A,T	rs641153	CFB	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000254v2_alt	3304720	3304721	G	A	rs429608	SKIC2	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000254v2_alt	4255855	4255856	A	G	rs209474		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr6_GL000254v2_alt	4272094	4272095	C	G,T	rs17220479	BRD2	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr6_GL000254v2_alt	4364309	4364310	A	G	rs3077	HLA-DPA1	Genotype GG is associated with increased response to peginterferon alfa-2b in people with Hepatitis B, Chronic as compared to genotypes AA + AG.	26387494
chr6_GL000255v2_alt	1046213	1046214	A	C,T	rs1611255		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000255v2_alt	1046961	1046962	T	C,A	rs1611259		Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000255v2_alt	1093612	1093613	T	C,A	rs1707	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CT + TT.	26633805
chr6_GL000255v2_alt	1093619	1093620	C	G	rs1710	HLA-G	Genotype GG is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CC + CG.	26633805
chr6_GL000255v2_alt	1093636	1093637	C	A	rs17179101	HLA-G	Genotype AC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000255v2_alt	1093644	1093645	C	T	rs17179108	HLA-G	Genotype CT is associated with increased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000255v2_alt	1093751	1093752	G	C,T	rs1063320	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CG + GG.	26633805
chr6_GL000255v2_alt	1093796	1093797	A	G	rs9380142	HLA-G	Genotype GG is associated with decreased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes AA + AG.	26633805
chr6_GL000255v2_alt	1093805	1093806	G	C	rs1610696	HLA-G	Genotypes CG + GG are not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000255v2_alt	1745382	1745383	A	G,T	rs1264457	HLA-E	Genotype AA is associated with increased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in women with Arthritis, Rheumatoid as compared to genotypes AG + GG.	26307125
chr6_GL000255v2_alt	2397609	2397610	A	C	rs2233945	PSORS1C1	Allele A is not associated with response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	28107378
chr6_GL000255v2_alt	2516986	2516987	G	A	rs9366772	HLA-C	Allele A is associated with increased response to allopurinol as compared to allele G.	30924126
chr6_GL000255v2_alt	2540818	2540819	C	T	rs12191877	HLA-C	Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	27670765
chr6_GL000255v2_alt	2553959	2553960	G	A	rs4406273		Genotype AA is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.	27564082
chr6_GL000255v2_alt	2643023	2643024	C	T	rs13437088	HLA-B	Genotype TT is associated with decreased response to etanercept in people with Psoriasis as compared to genotypes CC + CT.	28470127
chr6_GL000255v2_alt	2666927	2666928	A	G	rs1051792	MICA	Genotype AA is associated with decreased clinical benefit to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylarthropathy as compared to genotypes AG + GG.	38372728
chr6_GL000255v2_alt	2753917	2753918	C	A,T	rs3828913	MICB	Genotype CC is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AC.	26075078
chr6_GL000255v2_alt	2828352	2828353	A	C,G,T	rs909253	LTA	Genotype AA is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	22129793
chr6_GL000255v2_alt	2828825	2828826	C	A	rs1041981	LTA	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.	15695296
chr6_GL000255v2_alt	2830349	2830350	C	T	rs1799964	TNF	Genotype TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CC + CT.	23057546
chr6_GL000255v2_alt	2830517	2830518	C	A,G	rs1800630	TNF	Genotype AA is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AC + CC.	22960943
chr6_GL000255v2_alt	2830523	2830524	C	T	rs1799724	TNF	Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CT + TT.	23057546
chr6_GL000255v2_alt	2830574	2830575	C	T	rs4248158	TNF	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.	22960943
chr6_GL000255v2_alt	2831004	2831005	A	G	rs1800750	TNF	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.	22960943
chr6_GL000255v2_alt	2831072	2831073	G	A	rs1800629	TNF	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	32606912
chr6_GL000255v2_alt	2831142	2831143	A	G	rs361525	TNF	Genotype AG is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.	23057546
chr6_GL000255v2_alt	2831868	2831869	G	A	rs1800610	TNF	Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	22129793
chr6_GL000255v2_alt	2844626	2844627	T	A,C	rs1052248	NCR3	Genotypes AT + TT is associated with increased clinical benefit to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype AA.	38714580
chr6_GL000255v2_alt	3192000	3192001	G	A,C	rs9332739	C2	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000255v2_alt	3202377	3202378	G	A,T	rs641153	CFB	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000255v2_alt	3218654	3218655	G	A	rs429608	SKIC2	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000255v2_alt	3822370	3822371	C	T,A	rs2097432		Genotypes CC + CT is associated with decreased response to infliximab in people with Crohn Disease as compared to genotype TT.	39055374
chr6_GL000255v2_alt	4151116	4151117	A	G	rs209474		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr6_GL000255v2_alt	4167362	4167363	C	G,T	rs17220479	BRD2	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr6_GL000255v2_alt	4176757	4176758	A	G	rs16871297		Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr6_GL000255v2_alt	4259876	4259877	A	G	rs3077	HLA-DPA1	Genotype GG is associated with increased response to peginterferon alfa-2b in people with Hepatitis B, Chronic as compared to genotypes AA + AG.	26387494
chr6_GL000256v2_alt	1089377	1089378	C	A,T	rs1611255		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000256v2_alt	1090125	1090126	C	A,T	rs1611259		Allele T is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr6_GL000256v2_alt	1136877	1136878	T	C,A	rs1707	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CT + TT.	26633805
chr6_GL000256v2_alt	1136884	1136885	C	G	rs1710	HLA-G	Genotype GG is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CC + CG.	26633805
chr6_GL000256v2_alt	1136901	1136902	C	A	rs17179101	HLA-G	Genotype AC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000256v2_alt	1136909	1136910	C	T	rs17179108	HLA-G	Genotype CT is associated with increased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000256v2_alt	1137016	1137017	G	C,T	rs1063320	HLA-G	Genotype CC is not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes CG + GG.	26633805
chr6_GL000256v2_alt	1137061	1137062	A	G	rs9380142	HLA-G	Genotype GG is associated with decreased response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotypes AA + AG.	26633805
chr6_GL000256v2_alt	1137070	1137071	G	C	rs1610696	HLA-G	Genotypes CG + GG are not associated with response to capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype CC.	26633805
chr6_GL000256v2_alt	1791055	1791056	A	G,T	rs1264457	HLA-E	Genotype AA is associated with increased response to adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab or methotrexate in women with Arthritis, Rheumatoid as compared to genotypes AG + GG.	26307125
chr6_GL000256v2_alt	2563512	2563513	G	A	rs9366772	HLA-C	Allele A is associated with increased response to allopurinol as compared to allele G.	30924126
chr6_GL000256v2_alt	2587344	2587345	C	T	rs12191877	HLA-C	Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	27670765
chr6_GL000256v2_alt	2600485	2600486	G	A	rs4406273		Genotype AA is not associated with response to ustekinumab in people with Psoriasis as compared to genotype GG.	27564082
chr6_GL000256v2_alt	2689605	2689606	C	T	rs13437088	HLA-B	Genotype TT is associated with decreased response to etanercept in people with Psoriasis as compared to genotypes CC + CT.	28470127
chr6_GL000256v2_alt	2713476	2713477	G	A	rs1051792	MICA	Genotype AA is associated with decreased clinical benefit to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylarthropathy as compared to genotypes AG + GG.	38372728
chr6_GL000256v2_alt	2797312	2797313	C	A,T	rs3828913	MICB	Genotype CC is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes AA + AC.	26075078
chr6_GL000256v2_alt	2871815	2871816	A	C,G,T	rs909253	LTA	Genotype AA is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.	22129793
chr6_GL000256v2_alt	2872286	2872287	C	A	rs1041981	LTA	Allele C is not associated with response to etanercept in people with Arthritis, Rheumatoid as compared to allele A.	15695296
chr6_GL000256v2_alt	2873810	2873811	T	C	rs1799964	TNF	Genotype TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CC + CT.	23057546
chr6_GL000256v2_alt	2873978	2873979	C	A,G	rs1800630	TNF	Genotype AA is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AC + CC.	22960943
chr6_GL000256v2_alt	2873984	2873985	C	T	rs1799724	TNF	Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotypes CT + TT.	23057546
chr6_GL000256v2_alt	2874035	2874036	C	T	rs4248158	TNF	Genotype CC is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes CT + TT.	22960943
chr6_GL000256v2_alt	2874465	2874466	G	A	rs1800750	TNF	Genotype GG is not associated with decreased response to infliximab in people with Colonic Diseases, Functional as compared to genotypes AA + AG.	22960943
chr6_GL000256v2_alt	2874533	2874534	G	A	rs1800629	TNF	Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G.	32606912
chr6_GL000256v2_alt	2874603	2874604	G	A	rs361525	TNF	Genotype AG is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylitis, Ankylosing as compared to genotype GG.	23057546
chr6_GL000256v2_alt	2875329	2875330	G	A	rs1800610	TNF	Genotype GG is not associated with response to rituximab in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.	22129793
chr6_GL000256v2_alt	2888084	2888085	T	A,C	rs1052248	NCR3	Genotypes AT + TT is associated with increased clinical benefit to adalimumab, certolizumab pegol, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype AA.	38714580
chr6_GL000256v2_alt	3237215	3237216	G	A,C	rs9332739	C2	Allele C is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000256v2_alt	3247591	3247592	G	A,T	rs641153	CFB	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000256v2_alt	3263873	3263874	G	A	rs429608	SKIC2	Allele A is not associated with response to ranibizumab in people with Macular Degeneration as compared to allele G.	23842101
chr6_GL000256v2_alt	4025065	4025066	T	A,C	rs2097432		Genotypes CC + CT is associated with decreased response to infliximab in people with Crohn Disease as compared to genotype TT.	39055374
chr6_GL000256v2_alt	4356045	4356046	A	G	rs209474		Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr6_GL000256v2_alt	4422288	4422289	C	G,T	rs17220479	BRD2	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	25897834
chr6_GL000256v2_alt	4431696	4431697	A	G	rs16871297		Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr6_GL000256v2_alt	4514227	4514228	A	G	rs3077	HLA-DPA1	Genotype GG is associated with increased response to peginterferon alfa-2b in people with Hepatitis B, Chronic as compared to genotypes AA + AG.	26387494
chr7	96803	96804	C	T	rs6973474		Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.	34488071
chr7	5335910	5335911	C	A,T	rs10234709	SLC29A4	Allele A is associated with decreased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.	25991289
chr7	7967877	7967878	T	A,C,G	rs37972	GLCCI1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr7	7968244	7968245	G	A,C,T	rs37973	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	7975325	7975326	C	T	rs37976	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	7978849	7978850	A	G	rs7792118	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	7980302	7980303	A	G	rs715377	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	7981938	7981939	A	G	rs12537880	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	7985679	7985680	T	C	rs7800750	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	7987542	7987543	A	C,G,T	rs37990	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr7	8002757	8002758	C	T	rs38010	GLCCI1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr7	8004852	8004853	G	T	rs2041362	GLCCI1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr7	8016033	8016034	C	T	rs17141876	GLCCI1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr7	8020425	8020426	C	T	rs1476823	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	8022099	8022100	T	A	rs10229643	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	8022862	8022863	C	T	rs13239966	GLCCI1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr7	8022959	8022960	G	A	rs10243846	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr7	8034977	8034978	C	T	rs13245462	GLCCI1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr7	8037728	8037729	G	A,T	rs10435183	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr7	8040850	8040851	A	C,G,T	rs7801924	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr7	8047008	8047009	A	G,T	rs4725061	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	8048763	8048764	G	A	rs10226865	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	8057257	8057258	A	C,T	rs13222222	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	8057990	8057991	T	C	rs6969971	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	8058509	8058510	G	A	rs9648623	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr7	8059187	8059188	C	T	rs13242904	GLCCI1	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr7	8061468	8061469	G	A,T	rs11978165	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	8062134	8062135	C	G,T	rs6463755	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	8070766	8070767	A	C,G	rs16872488	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	8072383	8072384	C	G,T	rs2191318	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	8073681	8073682	A	C,G	rs11976862	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	8074120	8074121	T	C	rs4236406	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	8075645	8075646	A	G,T	rs17142716	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	8076163	8076164	A	C,G	rs17142727	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	8076348	8076349	G	A,T	rs10253260	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.	27523435
chr7	8077301	8077302	C	A,G	rs10952084	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr7	8077317	8077318	G	A,T	rs6964558	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr7	8077867	8077868	T	G	rs6956039	GLCCI1	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	8082682	8082683	A	C	rs1468594	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr7	8083796	8083797	C	A,T	rs10257285	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	8085638	8085639	C	A	rs12668352	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.	27523435
chr7	8086333	8086334	C	G,T	rs929509	GLCCI1	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.	27523435
chr7	8088079	8088080	G	A	rs4725068	GLCCI1	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr7	8090097	8090098	G	A	rs6967565		Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.	27523435
chr7	9648478	9648479	A	G,T	rs4236420		Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr7	13597905	13597906	T	A	rs1568885		Allele A is associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid.	23233654
chr7	17565445	17565446	A	G,T	rs1448673		Allele G is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele A.	27001119
chr7	20643260	20643261	C	A,T	rs17143212	ABCB5	Allele T is not associated with clearance of talinolol in healthy individuals as compared to allele C.	27825374
chr7	22105465	22105466	T	C	rs16873129	RAPGEF5	Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	27091189
chr7	22693219	22693220	G	A	rs2097677		Allele A is associated with increased response to alogliptin, linagliptin, sitagliptin, teneligliptin or vildagliptin in people with Diabetes Mellitus, Type 2 as compared to allele G.	25802725
chr7	22720868	22720869	T	C	rs10499563	IL6	Genotypes CC + CT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative and Inflammatory Bowel Diseases as compared to genotype TT.	24776844
chr7	22726601	22726602	A	C,G,T	rs1800797	IL6	Allele G is associated with decreased response to peginterferon alfa-2a in people with Hepatitis C, Chronic as compared to allele A.	19387461
chr7	22726626	22726627	G	A,C	rs1800796	IL6	Allele G is associated with increased response to alogliptin, linagliptin, sitagliptin, teneligliptin or vildagliptin in people with Diabetes Mellitus, Type 2 as compared to allele C.	25802725
chr7	22727025	22727026	C	G,T	rs1800795	IL6	Allele G is associated with decreased response to peginterferon alfa-2a in people with Hepatitis C, Chronic as compared to allele C.	19387461
chr7	22728599	22728600	C	G,T	rs1524107	IL6	Allele C is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation.	29318894
chr7	22728629	22728630	G	A,C,T	rs2066992	IL6	Genotype GT is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotype GG.	26556688
chr7	22728952	22728953	C	G	rs2069840	IL6	Genotype CC is associated with decreased clinical benefit to tocilizumab in people with Rheumatoid arthritis as compared to genotype CG.	39718059
chr7	22734611	22734612	G	A,C,T	rs10242595	IL6	Genotype AA is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotypes AG + GG.	26556688
chr7	27200862	27200863	C	A,G	rs3807598	HOTTIP	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.	26729200
chr7	27202259	27202263	CTCT	CT	rs5883064	HOTTIP	Allele CT is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele del.	26729200
chr7	27202739	27202740	A	C,G,T	rs1859168	HOTTIP	Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele C.	26729200
chr7	30660355	30660356	G	C	rs2270007	CRHR2	Genotypes CC + CG are associated with decreased response to citalopram in people with Depressive Disorder, Major as compared to genotype GG.	17467808
chr7	30661979	30661980	T	C	rs73294475	CRHR2	Genotype CT is associated with increased response to salbutamol in children with Asthma as compared to genotype TT.	23992748
chr7	30676470	30676471	G	A,C	rs2267715	CRHR2	Allele G is associated with decreased response to salbutamol in people with Asthma as compared to allele A.	18408560
chr7	30678486	30678487	G	A	rs2284220	CRHR2	Allele G is not associated with decreased response to salbutamol in people with Asthma as compared to allele A.	18408560
chr7	30687160	30687161	A	C,T	rs7793837	CRHR2	Allele T is associated with decreased response to salbutamol and selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele A.	18408560
chr7	30689291	30689292	A	G,T	rs255100	CRHR2	Allele A is not associated with decreased response to salbutamol in people with Asthma as compared to allele T.	18408560
chr7	30922174	30922175	G	A	rs28362731	AQP1	Genotype AG is not associated with response to cisplatin in people with Mesothelioma as compared to genotype GG.	30840592
chr7	30924206	30924207	G	A,C	rs1049305	AQP1	Genotypes CC + CG are not associated with response to cisplatin in people with Mesothelioma as compared to genotype GG.	30840592
chr7	31032853	31032854	C	T	rs34548976		Allele T is associated with decreased response to adrenergics, inhalants in children with Asthma as compared to allele C.	25918834
chr7	33021333	33021334	A	C,G,T	rs3750117	NT5C3A	Genotype AA is associated with increased clearance of gemcitabine in people with Neoplasms as compared to genotype GG.	22838949
chr7	33043494	33043495	T	C	rs6946062	NT5C3A	Genotype TT is not associated with metabolism of gemcitabine as compared to genotypes CC + CT.	24300978
chr7	33120301	33120302	A	G	rs2392165		Genotypes AG + GG are associated with increased response to budesonide in children with Asthma as compared to genotype AA.	31557306
chr7	40301029	40301030	A	C	rs17171676	SUGCT	Allele C is associated with response to hmg coa reductase inhibitors as compared to allele A.	27045730
chr7	41691454	41691455	A	C	rs2237435	INHBA	Allele A is not associated with response to bevacizumab and ranibizumab in people with as compared to allele C.	29852030
chr7	44539580	44539581	G	A,C,T	rs2072183	NPC1L1	Allele G is associated with decreased response to hmg coa reductase inhibitors in people with Cardiovascular Diseases and Hypercholesterolemia as compared to allele C.	27648687
chr7	45607252	45607253	A	C,G,T	rs1521470	ADCY1	Allele A is associated with decreased response to lithium in people with Bipolar Disorder as compared to allele G.	29121268
chr7	50458520	50458521	G	A	rs11575553	DDC	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	32736537
chr7	50567278	50567279	T	A,C,G	rs12666409	DDC	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32736537
chr7	54239885	54239886	G	C,T	rs4351379	TRIB1	Genotypes CC + CG is associated with decreased response to VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors in people with Macular Degeneration as compared to genotype GG.	38999967
chr7	55019061	55019062	G	C,T	rs712829	EGFR	Allele T is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to allele G.	27897268
chr7	55161561	55161562	G	A,C,T	rs2227983	EGFR	Allele A is not associated with response to cetuximab or panitumumab in people with Colorectal Neoplasms as compared to allele G.	27897268
chr7	55201222	55201223	C	T	rs2293347	EGFR	Genotype CC is associated with decreased response to fluorouracil in people with Stomach Neoplasms as compared to genotypes CT + TT.	23816762
chr7	65908863	65908864	A	C,G	rs4072879	VKORC1L1	Genotype AA is associated with decreased dose of warfarin as compared to genotypes AG + GG.	29054760
chr7	65911468	65911469	C	T	rs10950022	VKORC1L1	Genotypes CC + CT is associated with decreased dose of warfarin as compared to genotype TT.	29054760
chr7	66125933	66125934	G	A	rs1976200	CRCP	Allele A is not associated with response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele G.	38071464
chr7	71273742	71273743	G	A,C	rs7794356	GALNT17	Allele A is associated with increased response to montelukast in people with Asthma as compared to allele G.	26083242
chr7	75960584	75960585	A	G,T	rs2868177	POR	Allele A is not associated with dose of acenocoumarol in people with Atrial Fibrillation, heart valve replacement and Thromboembolism as compared to allele G.	28592191
chr7	75979667	75979668	C	T	rs10239977	POR	Genotypes CT + TT is not associated with dose of warfarin as compared to genotype CC.	27488389
chr7	75981830	75981831	G	A	rs10954732	POR	Genotype GG is associated with increased concentrations of voriconazole as compared to genotype AA.	31932875
chr7	75982437	75982438	C	G,T	rs3815455	POR	Genotypes CT + TT is not associated with dose of warfarin as compared to genotype CC.	27488389
chr7	75983484	75983485	C	A,T	rs41301394	POR	Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.	27488389
chr7	75985687	75985688	C	T	rs1057868	POR	Allele T is associated with increased metabolism of tacrolimus in people with Kidney Transplantation as compared to allele C.	24658827
chr7	81508391	81508392	A	G	rs73151902		Allele A is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.	37098852
chr7	86679789	86679790	C	A,G,T	rs2299214	GRM3	Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes CT + TT.	25209194
chr7	86696057	86696058	A	C,G,T	rs724226	GRM3	Allele G is associated with increased response to risperidone in people with Schizophrenia.	19451915
chr7	86774158	86774159	A	G	rs6465084	GRM3	Genotype AA is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.	25096017
chr7	86804134	86804135	A	T	rs1468412	GRM3	Genotypes AA + AT is associated with decreased response to antipsychotics in people with Schizophrenia.	25209194
chr7	87499548	87499549	T	A,C	rs6946119		Allele T is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele C.	24192121
chr7	87504049	87504050	T	C	rs3842	ABCB1	Allele C is associated with metabolism of efavirenz in people with HIV Infections as compared to allele T.	24497997
chr7	87509194	87509195	G	A,C	rs2235048	ABCB1	Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.	29318894
chr7	87509328	87509329	A	C,G,T	rs1045642	ABCB1	Allele G is not associated with concentrations of atazanavir in people with HIV Infections as compared to allele A.	1655344
chr7	87509999	87510000	A	G	rs4437575	ABCB1	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr7	87511491	87511492	A	C,G	rs10808071	ABCB1	Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.	29791011
chr7	87512497	87512498	T	A,C,G	rs6949448	ABCB1	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	18424454
chr7	87519011	87519012	C	T	rs28401781	ABCB1	Allele T is associated with increased response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele C.	24192121
chr7	87520605	87520606	C	T	rs2235067	ABCB1	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	18424454
chr7	87522786	87522787	A	G	rs4148740	ABCB1	Genotype AG is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to genotype AA.	23252947
chr7	87524268	87524269	A	C,G	rs10280101	ABCB1	Allele C is not associated with exposure to olanzapine in healthy individuals as compared to allele A.	33378980
chr7	87527734	87527735	G	A	rs7787082	ABCB1	Allele A is not associated with exposure to olanzapine in healthy individuals as compared to allele G.	33378980
chr7	87528266	87528267	A	C,G	rs2373586	ABCB1	Genotypes AC + CC are not associated with exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.	27845419
chr7	87531244	87531245	A	G	rs2032583	ABCB1	Genotype AG is not associated with concentrations of desmethylcitalopram or escitalopram in people with Depressive Disorder, Major as compared to genotypes AA + GG.	36681895
chr7	87531301	87531302	A	C,T	rs2032582	ABCB1	Genotype AT is not associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele C.	21047202
chr7	87531732	87531733	T	C	rs4148739	ABCB1	Genotype TT is associated with decreased metabolism of carbamazepine in people with Epilepsy as compared to genotype CT.	23252947
chr7	87532203	87532204	T	C	rs11983225	ABCB1	Allele C is not associated with exposure to olanzapine in healthy individuals as compared to allele T.	33378980
chr7	87533732	87533733	C	A,T	rs4148738	ABCB1	Genotype CC is not associated with trough concentration of apixaban, dabigatran, edoxaban or rivaroxaban in people with Thromboembolism as compared to genotypes CT + TT.	36309848
chr7	87535032	87535033	A	C,G	rs117937072	ABCB1	Allele G is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele A.	29318894
chr7	87535575	87535576	T	A,C,G	rs10234411	ABCB1	Allele A is not associated with concentrations of carbamazepine in people with Epilepsy as compared to allele T.	26421491
chr7	87535669	87535670	A	G,T	rs10248420	ABCB1	Allele G is not associated with exposure to olanzapine in healthy individuals as compared to allele A.	33378980
chr7	87536433	87536434	C	A,G,T	rs2235040	ABCB1	Genotypes CC + CT are not associated with concentrations of desmethylcitalopram or escitalopram in people with Depressive Disorder, Major as compared to genotype TT.	36681895
chr7	87540039	87540040	C	T	rs12720067	ABCB1	Allele T is not associated with exposure to olanzapine in healthy individuals as compared to allele C.	33378980
chr7	87540385	87540386	A	C	rs12720066	ABCB1	Genotypes AC + CC are associated with decreased exposure to SN-38 in people with Colorectal Neoplasms as compared to genotype AA.	27845419
chr7	87541835	87541836	T	A,C	rs4148737	ABCB1	Allele C is not associated with exposure to olanzapine in healthy individuals as compared to allele T.	33378980
chr7	87542819	87542820	T	C	rs6961419	ABCB1	Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.	29791011
chr7	87544350	87544351	A	C,T	rs1922242	ABCB1	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	18424454
chr7	87549309	87549310	C	A,T	rs2235013	ABCB1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr7	87549769	87549770	G	A	rs2235035	ABCB1	Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele G.	29791011
chr7	87549826	87549827	A	G,T	rs2235033	ABCB1	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr7	87550284	87550285	A	G	rs1128503	ABCB1	Genotypes AG + GG are not associated with concentrations of desmethylcitalopram or escitalopram in people with Depressive Disorder, Major as compared to genotype AA.	36681895
chr7	87550492	87550493	C	A,T	rs2229109	ABCB1	Genotype CT is associated with increased resistance to doxorubicin, methotrexate, prednisolone and vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype CC.	25582575
chr7	87550881	87550882	C	A,T	rs10276036	ABCB1	Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.	29791011
chr7	87552101	87552102	C	A,T	rs6961665	ABCB1	Allele A is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr7	87560613	87560614	T	A,C,G	rs868755	ABCB1	Allele T is not associated with dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to allele G.	30713339
chr7	87565789	87565790	C	G,T	rs1202170	ABCB1	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	21398039
chr7	87570247	87570248	C	A,T	rs2235015	ABCB1	Genotype AA is not associated with concentrations of desmethylcitalopram or escitalopram in people with Depressive Disorder, Major as compared to genotype CC.	36681895
chr7	87571769	87571770	C	A,G,T	rs2520464	ABCB1	Genotype TT is not associated with dose of methadone in people with Heroin Dependence as compared to genotypes CC + CT.	18424454
chr7	87573298	87573299	C	A,G,T	rs10264990	ABCB1	Allele C is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele T.	29791011
chr7	87581728	87581729	T	A,C	rs1202171	ABCB1	Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr7	87589030	87589031	A	C,G,T	rs7802773	ABCB1	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr7	87590164	87590165	G	A,C	rs13229143	ABCB1	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	21398039
chr7	87591017	87591018	T	A,C	rs12535512	ABCB1	Genotypes CC + CT are not associated with response to risperidone in people with Schizophrenia as compared to genotype TT.	27456824
chr7	87591569	87591570	A	G,T	rs3789243	ABCB1	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	18424454
chr7	87600123	87600124	T	A,C,G	rs9282564	ABCB1	Allele C is associated with decreased concentrations of methadone in people with Opioid-Related Disorders as compared to allele T.	17178267
chr7	87600876	87600877	A	G	rs3213619	ABCB1	Allele A is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.	29318894
chr7	87604285	87604286	G	A	rs4728709	ABCB1	Allele G is not associated with exposure to olanzapine in healthy individuals as compared to allele A.	33378980
chr7	87615643	87615644	C	T	rs13233308	ABCB1	Allele T is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele C.	29791011
chr7	87649443	87649444	G	A,C,T	rs10267099	ABCB1	Allele G is not associated with clearance of methotrexate in people with Osteosarcoma as compared to allele A.	29791011
chr7	87713269	87713270	A	C,G	rs3747802	ABCB1	Allele A is not associated with response to citalopram, fluoxetine, paroxetine or sertraline in people with Depressive Disorder, Major as compared to allele G.	24192121
chr7	87714705	87714706	T	A,C	rs28656907	ABCB1	Genotype TT is associated with increased dose of imatinib in people with Gastrointestinal Stromal Tumors as compared to genotypes CC + CT.	30713339
chr7	92113413	92113414	C	G	rs7793861	CYP51A1	Allele G is associated with increased response to glibenclamide in people with as compared to allele C.	27403931
chr7	93375668	93375669	T	C	rs12672399	CALCR	Allele C is not associated with response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele T.	38071464
chr7	93394908	93394909	A	G	rs4470942	CALCR	Allele G is not associated with response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele A.	38071464
chr7	93502079	93502080	C	G,T	rs75252614	CALCR	Allele G is not associated with response to erenumab, fremanezumab or galcanezumab in people with Migraine without Aura or Migraine with Aura as compared to allele C.	38071464
chr7	95294543	95294544	G	A,C,T	rs854547	PON1	Allele A is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	18615156
chr7	95308133	95308134	T	A,C,G	rs662	PON1	Genotype CC is not associated with response to clopidogrel in people with Coronary Artery Disease as compared to genotype TT.	22462746
chr7	95316771	95316772	A	C,G,N,T	rs854560	PON1	Allele A is not associated with response to clopidogrel as compared to allele T.	28135763
chr7	95432608	95432609	A	G,T	rs2299267	PON2	Allele G is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele A.	27091189
chr7	98850870	98850871	C	A,T	rs1203844	CYP3A4	Allele C is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele T.	38540428
chr7	99647389	99647390	T	A,G	rs4646458		Allele G is associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele T.	21047202
chr7	99647456	99647457	A	C,T	rs4646457		Allele C is associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele A.	21047202
chr7	99648290	99648291	A	G	rs15524	CYP3A5	Genotypes AG + GG is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype AA.	35280252
chr7	99652770	99652771	A	AA	rs41303343	CYP3A5	Allele A is associated with increased concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele del.	28673292
chr7	99662738	99662739	C	A	rs4646453	CYP3A5	Genotypes AA + AC is not associated with decreased concentrations of AR-C124910XX or ticagrelor in healthy individuals as compared to genotype CC.	35280252
chr7	99665211	99665212	C	T	rs10264272	CYP3A5	Allele T is associated with increased concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele C.	28673292
chr7	99668694	99668695	G	A	rs4646450	CYP3A5	Genotype GG is associated with increased dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to genotypes AA + AG.	29454235
chr7	99668819	99668820	C	T	rs4646449	CYP3A5	Genotype CC is associated with increased concentrations of tacrolimus in people with Kidney Transplantation as compared to genotypes CT + TT.	39539273
chr7	99669164	99669165	A	G	rs3800959	CYP3A5	Allele A is not associated with dose-adjusted trough concentrations of tacrolimus in people with liver transplantation as compared to allele G.	29454235
chr7	99735324	99735325	T	G	rs45446698	CYP3A7	Allele G is associated with increased metabolism of atorvastatin as compared to allele T.	32128760
chr7	99756490	99756491	T	A,C,G	rs12333983	CYP3A4	Allele A is associated with dose of tacrolimus in people with Kidney Transplantation as compared to allele T.	21047202
chr7	99758351	99758352	T	C,G	rs3735451	CYP3A4	Genotype CC is associated with decreased concentrations of hydroxychloroquine in people with Arthritis, Rheumatoid or Lupus Erythematosus, Systemic as compared to genotypes CT + TT.	35135554
chr7	99763246	99763247	G	A,T	rs4646440	CYP3A4	Allele A is not associated with concentrations of carbamazepine in people with Epilepsy as compared to allele G.	26421491
chr7	99763842	99763843	C	T	rs2242480	CYP3A4	Allele T is not associated with metabolism of methadone in men with Heroin Dependence as compared to allele C.	33410778
chr7	99767459	99767460	G	A	rs4646437	CYP3A4	Genotypes AA + AG is not associated with increased dose-adjusted trough concentrations of voriconazole in children as compared to genotype GG.	35081606
chr7	99768095	99768096	A	G	rs2246709	CYP3A4	Genotypes AG + GG are associated with increased response to amlodipine in people with Hypertension as compared to genotype AA.	19907160
chr7	99768319	99768320	C	A,G,T	rs2687116	CYP3A4	Allele C is associated with increased response to carbamazepine, lamotrigine, phenytoin, primidone or valproic acid in children with Epilepsy as compared to allele A.	28343093
chr7	99768692	99768693	G	A	rs35599367	CYP3A4	Genotype GG is associated with increased metabolism of tacrolimus in people with Kidney Transplantation as compared to genotypes AA + AG.	21903774
chr7	99784472	99784473	C	A,G,T	rs2740574	CYP3A4	Allele C is associated with decreased concentrations of cyclosporine or tacrolimus in people with Kidney Transplantation as compared to allele T.	29043387
chr7	99823461	99823462	G	A	rs62471956	CYP3A43	Allele G is associated with decreased concentrations of ticagrelor in people with Acute coronary syndrome as compared to allele A.	25935875
chr7	99832219	99832220	A	G,T	rs651430	CYP3A43	Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr7	99857480	99857481	G	A	rs12535293	CYP3A43	Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr7	99859981	99859982	C	A,G	rs680055	CYP3A43	Genotype CG is associated with increased response to antipsychotics, aripiprazole, clozapine, haloperidol, olanzapine, quetiapine or risperidone in people with schizoaffective disorder or Schizophrenia as compared to genotype CC.	25150845
chr7	99862483	99862484	G	A	rs472660	CYP3A43	Genotype AA is associated with increased clearance of olanzapine in people with Schizophrenia as compared to genotypes AG + GG.	21519338
chr7	99862821	99862822	G	A	rs17161981	CYP3A43	Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr7	99866194	99866195	A	G	rs17161983	CYP3A43	Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr7	99876803	99876804	A	G	rs2572023		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr7	99879802	99879803	G	A	rs2527927		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr7	99941217	99941218	A	G	rs2527894		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr7	99953330	99953331	T	A,C	rs2527887		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr7	99980575	99980576	A	C,G,T	rs2525557		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr7	99985595	99985596	C	A,G,T	rs6960542		Allele C is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele T.	21519338
chr7	99986026	99986027	G	A,C,T	rs4729562		Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G.	21519338
chr7	100719674	100719675	C	A,G,T	rs1617640	EPO	Genotype AA is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes AC + CC.	23584701
chr7	100892017	100892018	C	A,G,T	rs2571598	ACHE	Genotype TT is associated with increased response to rivastigmine in people with Alzheimer Disease as compared to genotypes CC + CT.	18780301
chr7	101126256	101126257	A	G	rs2227631	SERPINE1	Allele G is associated with decreased response to citalopram and fluoxetine in people with Depressive Disorder, Major as compared to allele A.	18794724
chr7	101252198	101252199	G	A,C	rs6942609	ACHE	Allele A is not associated with response to donepezil, galantamine or rivastigmine in people with Alzheimer Disease as compared to allele G.	25730470
chr7	103513014	103513015	A	C,T	rs3808035	RELN	Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele A.	32082176
chr7	103545429	103545430	C	A	rs362719	RELN	Allele A is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele C.	32082176
chr7	103552084	103552085	C	G,T	rs2535764	RELN	Allele T is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele C.	32082176
chr7	103566786	103566787	T	C	rs362726	RELN	Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	32082176
chr7	103568580	103568581	T	C,G	rs362731	RELN	Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	32082176
chr7	103574672	103574673	T	A,C	rs362814	RELN	Allele A is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	32082176
chr7	103576771	103576772	A	C,G,T	rs362626	RELN	Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele A.	32082176
chr7	103581858	103581859	T	C	rs2237628	RELN	Allele C is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	32082176
chr7	103756634	103756635	T	A,C,G	rs3819479	RELN	Allele A is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	32082176
chr7	103764367	103764368	G	A	rs7341475	RELN	Allele A is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele G.	32082176
chr7	103819487	103819488	T	A,C,G	rs39339	RELN	Allele G is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	32082176
chr7	103936440	103936441	T	A,C,G	rs12705169	RELN	Allele G is not associated with response to aripiprazole, olanzapine, perphenazine, quetiapine or risperidone in people with Schizophrenia as compared to allele T.	32082176
chr7	105107451	105107452	G	T	rs117986340	KMT2E	Genotype GG is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to genotype GT.	28696415
chr7	106283803	106283804	T	C	rs3801266	NAMPT	Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.	27168100
chr7	106285306	106285307	C	A,G,T	rs1319501	NAMPT	Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.	27168100
chr7	110448994	110448995	T	C	rs11543791	ESR1	Genotype CC is associated with decreased response to raloxifene in women Menopause and Schizophrenia as compared to genotypes CT + TT.	27546373
chr7	121985054	121985055	A	G	rs12154537		Allele G is associated with increased response to escitalopram in people with Depressive Disorder, Major as compared to allele A.	34081644
chr7	127524903	127524904	A	C,G,T	rs6467136	PAX4	Genotypes AA + AG are not associated with response to repaglinide in people with Diabetes Mellitus, Type 2 as compared to genotype GG.	24752311
chr7	127606848	127606849	G	A,T	rs10229583	PAX4	Genotypes AA + AG are not associated with response to repaglinide or rosiglitazone in people with Diabetes Mellitus, Type 2 as compared to genotype GG.	24752311
chr7	128238729	128238730	G	A,C	rs7799039	LEP	Allele A is not associated with exposure to olanzapine in healthy individuals as compared to allele G.	33378980
chr7	128401284	128401285	A	C,G,T	rs4731448	IMPDH1	Genotype GG is associated with increased concentrations of methotrexate polyglutamate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AG.	39159789
chr7	128748593	128748594	G	A,T	rs2290228	CALU	Genotype AA is associated with decreased dose of warfarin as compared to genotype GG.	37273173
chr7	128754551	128754552	C	G,T	rs2307040	CALU	Genotype CT is not associated with increased dose of warfarin as compared to genotype CC.	37273173
chr7	128759169	128759170	A	G	rs339097	CALU	Allele G is associated with increased dose of warfarin.	20200517
chr7	128769170	128769171	A	G	rs1043550	CALU	Genotype AA is not associated with increased dose of phenprocoumon as compared to genotypes AG + GG.	21110013
chr7	128769525	128769526	T	A,C	rs11653	CALU	Allele T is not associated with dose of warfarin.	19794411
chr7	130496265	130496266	G	A,C	rs3807348	MIR335	Genotypes AA + AG is associated with increased response to cisplatin in people with Mesothelioma as compared to genotype GG.	38203360
chr7	137016560	137016561	T	A	rs8191992	CHRM2	Allele A is associated with response to fluticasone/salmeterol in people with Asthma as compared to allele T.	22370858
chr7	137017187	137017188	T	A,G	rs6962027	CHRM2	Allele A is associated with response to fluticasone/salmeterol in people with Asthma as compared to allele T.	22370858
chr7	139014843	139014844	T	C	rs7802493		Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.	25897834
chr7	147247996	147247997	G	A	rs11763492	CNTNAP2	Allele A is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.	23753411
chr7	147252272	147252273	C	T	rs13223171	CNTNAP2	Allele T is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.	23753411
chr7	150634288	150634289	G	A,T	rs34940374	GIMAP6	Allele A is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.	37098852
chr7	150861277	150861278	C	T	rs12539	AOC1	Genotypes CT + TT are associated with increased response to cannabidiol in people with Epilepsy as compared to genotype CC.	34464454
chr7	150951109	150951110	A	C,G,T	rs1137617	KCNH2	Genotype GG is not associated with response to candesartan, imidapril or irbesartan in people with Essential hypertension as compared to genotypes AA + AG.	23613831
chr7	150992990	150992991	C	G,T	rs2070744	NOS3	Genotype TT is not associated with response to salbutamol in healthy individuals as compared to genotypes CC + CT.	23543259
chr7	150999022	150999023	T	A,G	rs1799983	NOS3	Genotype GG is not associated with response to salbutamol in healthy individuals as compared to genotypes GT + TT.	23543259
chr7	151717954	151717955	A	G	rs10224002	PRKAG2	Allele A is associated with increased response to hydrochlorothiazide in people with Hypertension as compared to allele G.	31327267
chr7	151803292	151803293	C	T	rs4725434	PRKAG2	Allele T is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.	25991289
chr7	151807372	151807373	G	A	rs13224758	PRKAG2	Allele G is associated with increased response to rivaroxaban in people with Atrial Fibrillation as compared to allele A.	37203300
chr7	151807411	151807412	C	T	rs12703159	PRKAG2	Allele C is associated with increased response to rivaroxaban in people with Atrial Fibrillation as compared to allele T.	37203300
chr7	154385758	154385759	C	T	rs887929	UGT1A1	Genotype TT is not associated with concentrations of deferasirox in people with beta-Thalassemia as compared to genotypes CT + TT.	27193993
chr7	156182006	156182007	A	G,T	rs6961071		Genotype GG is associated with increased response to fentanyl in people with Pain, Postoperative as compared to genotypes AA + AG.	29502940
chr7	157087703	157087704	A	G	rs6966038		Allele G is associated with increased response to citalopram in people with Depressive Disorder, Major as compared to allele A.	19846067
chr7	157539477	157539478	T	A,C,G	rs221253	PTPRN2	Allele C is associated with response to olanzapine in people with Schizophrenia.	22920393
chr7	158532810	158532811	C	A,T	rs4909237	MIR595	Genotype TT are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma.	27649261
chr7	158733763	158733764	G	A,C,T	rs1061735	ESYT2	Allele G is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr7_KI270804v1_alt	52902	52903	C	T	rs6973474		Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.	34488071
chr7_KI270899v1_alt	89124	89125	C	T	rs6973474		Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.	34488071
chr7_ML143352v1_fix	72491	72492	C	T	rs6973474		Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.	34488071
chr8	2952058	2952059	T	A	rs11993031	CSMD1	Allele T is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele A.	25695618
chr8	3045497	3045498	A	G,T	rs7387065	CSMD1	Allele A is associated with decreased response to hydrochlorothiazide in people with Essential hypertension as compared to allele G.	25695618
chr8	3217515	3217516	C	A,T	rs6981827	CSMD1	Allele T is associated with decreased response to anastrozole in women with Breast Neoplasms as compared to allele C.	32701512
chr8	3269990	3269991	A	C,G,T	rs6990851	CSMD1	Allele G is associated with increased response to anastrozole in women with Breast Neoplasms as compared to allele A.	32701512
chr8	3912167	3912168	C	G,T	rs2954625	CSMD1	Genotypes CT + TT are associated with decreased response to metformin in people with Diabetes Mellitus as compared to genotype CC.	27415606
chr8	4606686	4606687	A	C,G	rs2617102	CSMD1	Genotypes AC + CC is associated with decreased response to metformin in people with Diabetes Mellitus as compared to genotype AA.	27415606
chr8	4610005	4610006	A	G,T	rs17070785	CSMD1	Allele A is associated with response to olanzapine in people with Schizophrenia.	22920393
chr8	6507400	6507401	T	C,G	rs2515409	ANGPT2	Allele C is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele T.	28045923
chr8	6516543	6516544	A	G	rs10102851	ANGPT2	Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.	28045923
chr8	6526077	6526078	A	C,G,T	rs2515462	ANGPT2	Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.	28045923
chr8	6538387	6538388	G	A,C,T	rs11989215	ANGPT2	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr8	6539241	6539242	G	A,T	rs13269021	ANGPT2	Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.	28045923
chr8	6539348	6539349	G	A,C	rs1375668	ANGPT2	Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.	28045923
chr8	6644837	6644838	T	A,C	rs17570753	MCPH1	Allele A is associated with response to perphenazine in people with Schizophrenia.	22920393
chr8	6646794	6646795	C	T	rs11774231		Allele C is associated with response to perphenazine in people with Schizophrenia.	22920393
chr8	11486463	11486464	C	A,G,T	rs2736340	BLK	Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.	23007924
chr8	11742060	11742061	A	C,G	rs10090884	GATA4	Genotype AA is not associated with dose of warfarin as compared to genotypes AC + CC.	26257249
chr8	11749886	11749887	G	A	rs3735814	GATA4	Genotypes AG + GG are not associated with decreased dose of phenprocoumon as compared to genotype AA.	23215884
chr8	11751906	11751907	T	G	rs2645400	GATA4	Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.	25026456
chr8	11754871	11754872	T	A,C	rs13273672	GATA4	Genotype CC is associated with decreased clinical benefit to Drugs used in alcohol dependence in people with Alcoholism as compared to genotypes CT + TT.	20585342
chr8	11756715	11756716	G	T	rs4841588	GATA4	Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.	25026456
chr8	18214397	18214398	A	C,G,T	rs13253389	NAT1	Genotypes AG + GG is associated with increased concentrations of cotinine in children as compared to genotype AA.	25156213
chr8	18390207	18390208	T	A	rs4646244	NAT2	Genotype AT is associated with decreased clearance of isoniazid in people with Tuberculosis as compared to genotype TT.	19891553
chr8	18400592	18400593	G	A,C	rs1799930	NAT2	Genotype AA is associated with decreased clearance of isoniazid in people with Tuberculosis as compared to genotype GG.	19891553
chr8	18415370	18415371	G	A	rs1495741	NAT2	Genotypes AG + GG is associated with decreased clinical benefit to iguratimod in people with Arthritis, Rheumatoid as compared to genotype AA.	29517409
chr8	19948196	19948197	G	A,C,T	rs1801177	LPL	Allele A is not associated with response to fenofibrate in people with Hypertriglyceridemia as compared to allele G.	12042669
chr8	19961565	19961566	T	A,G	rs320	LPL	Genotype GG is associated with decreased response to fenofibrate in people with Hypertriglyceridemia as compared to genotypes GT + TT.	19207029
chr8	19962212	19962213	C	A,G	rs328	LPL	Genotype GG is associated with increased response to pravastatin as compared to genotypes CC + CG.	16103896
chr8	21693287	21693288	A	G,T	rs1128397	GFRA2	Allele A is associated with decreased response to clozapine in people with Schizophrenia as compared to allele T.	20116071
chr8	21718896	21718897	C	A,G	rs13250096	GFRA2	Allele C is associated with decreased response to clozapine in people with Schizophrenia as compared to allele G.	20116071
chr8	21722497	21722498	G	A	rs4567028	GFRA2	Allele G is associated with decreased response to clozapine in people with Schizophrenia as compared to allele A.	20116071
chr8	22371314	22371315	C	T	rs17060812	SLC39A14	Allele C is associated with increased response to nortriptyline in people with Depression as compared to allele T.	20970119
chr8	22927887	22927888	C	G,T	rs17685420	PEBP4	Allele T is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr8	23191778	23191779	C	G,T	rs2230229	TNFRSF10A	Genotype TT is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes CC + CT.	27977511
chr8	23200706	23200707	T	G	rs20576	TNFRSF10A	Genotype TT is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes GG + GT.	27977511
chr8	23201810	23201811	C	A,G	rs20575	TNFRSF10A	Genotype GG is not associated with response to rituximab in people with Lymphoma, Follicular as compared to genotypes CC + CG.	27977511
chr8	23512504	23512505	C	T	rs11782370		Allele T is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.	34488071
chr8	23760949	23760950	A	G	rs310279	NKX2-6	Genotypes AG + GG is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype AA.	37626805
chr8	26770510	26770511	A	C,G,T	rs1048101	ADRA1A	Genotypes AA + AG are associated with increased response to nifedipine in people with Hypertension as compared to genotype GG.	19444285
chr8	27470993	27470994	G	A,C,T	rs2472553	CHRNA2	Allele A is not associated with response to bupropion, nicotine or varenicline in people with Tobacco Use Disorder as compared to allele G.	29621993
chr8	27567178	27567179	C	T	rs59724122	EPHX2	Allele T is associated with increased response to lithium in people with Bipolar Disorder as compared to allele C.	29121268
chr8	31034996	31034997	G	A	rs2725335	WRN	Allele A is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele G.	28796378
chr8	31167137	31167138	T	A,C	rs1346044	WRN	Allele C is not associated with response to fluorouracil, Platinum compounds and radiotherapy in people with Stomach Neoplasms as compared to allele T.	28796378
chr8	31622106	31622107	A	G	rs10954808		Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chr8	32460400	32460401	C	A	rs17716295	NRG1	Allele A is associated with decreased response to antipsychotics in people with Schizophrenia as compared to allele C.	26788534
chr8	32535291	32535292	A	G	rs13250975	NRG1	Allele G is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele A.	26788534
chr8	40544854	40544855	C	A,G,T	rs1367094	ZMAT4	Allele T is associated with increased response to atenolol or metoprolol in people with Hypertension as compared to allele C.	26729753
chr8	42695354	42695355	C	G,T	rs6474412		Allele C is not associated with concentrations of 3-hydroxycotinine, cotinine or nicotine in people with Tobacco Use Disorder as compared to allele T.	31796940
chr8	42695920	42695921	C	T	rs6474413	CHRNB3	Allele T is not associated with response to bupropion, nicotine or varenicline in people with Tobacco Use Disorder as compared to allele C.	29621993
chr8	42697489	42697490	G	A,C,T	rs4950	CHRNB3	Allele G is associated with increased response to nicotine in smokers as compared to allele A.	18055561
chr8	42704442	42704443	G	A	rs13280604	CHRNB3	Allele G is associated with increased response to nicotine in smokers as compared to allele A.	18055561
chr8	42751042	42751043	G	A,T	rs9298629	CHRNB3	Allele T is not associated with response to nicotine in women as compared to allele G.	20231857
chr8	42753055	42753056	G	C	rs2304297	CHRNB3	Allele C is not associated with response to nicotine in women as compared to allele G.	20231857
chr8	42763302	42763303	A	G,T	rs2217732	CHRNA6	Allele G is not associated with response to nicotine in women as compared to allele A.	20231857
chr8	42764857	42764858	C	G	rs1072003	CHRNA6	Allele G is not associated with response to nicotine in women as compared to allele C.	20231857
chr8	53226263	53226264	C	A,T	rs16918842	OPRK1	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.	31940240
chr8	53228387	53228388	C	T	rs3802279	OPRK1	Genotype CC is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes CT + TT.	31940240
chr8	53228602	53228603	T	C	rs3802281	OPRK1	Genotype TT is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes CC + CT.	31940240
chr8	53229263	53229264	C	T	rs963549	OPRK1	Allele T is not associated with dose of heroin in people with Heroin Dependence as compared to allele C.	31940240
chr8	53229593	53229594	G	A	rs16918875	OPRK1	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele G.	31806881
chr8	53229596	53229597	T	C,G	rs702764	OPRK1	Genotype CC is associated with increased response to butorphanol in healthy individuals as compared to genotypes CT + TT.	31806881
chr8	53237473	53237474	A	G	rs16918909	OPRK1	Allele G is not associated with response to heroin as compared to allele A.	28692418
chr8	53239817	53239818	T	C	rs997917	OPRK1	Allele C is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele T.	31206155
chr8	53240421	53240422	T	C	rs6473797	OPRK1	Allele C is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele T.	31206155
chr8	53240562	53240563	A	G	rs6473799	OPRK1	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32481444
chr8	53244113	53244114	T	C	rs7813478	OPRK1	Allele C is not associated with response to heroin as compared to allele T.	28692418
chr8	53248141	53248142	A	G	rs16918941	OPRK1	Allele A is not associated with response to naltrexone in people with Tobacco Use Disorder as compared to allele G.	31206155
chr8	53248555	53248556	T	A,C	rs6985606	OPRK1	Allele T is not associated with response to heroin as compared to allele C.	28692418
chr8	53251001	53251002	C	A,G,T	rs1051660	OPRK1	Allele A is not associated with response to butorphanol in healthy individuals as compared to allele C.	31806881
chr8	53252241	53252242	C	G,T	rs3808627	OPRK1	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	31940240
chr8	54638366	54638367	G	T	rs374527		Allele G is not associated with response to efavirenz in people with HIV Infections as compared to allele T.	25461247
chr8	55911998	55911999	G	A	rs1546519	LYN	Allele G is associated with response to ziprasidone in people with Schizophrenia.	22920393
chr8	58500364	58500365	G	A,C,T	rs3808607	CYP7A1	Genotype GG is not associated with response to atorvastatin as compared to genotype TT.	16103896
chr8	63015186	63015187	T	A,C	rs17279558	GGH	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr8	63026204	63026205	G	A	rs11545078	GGH	Genotypes AA + AG is associated with increased discontinuation of methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.	34575187
chr8	63029782	63029783	C	T	rs12681874	GGH	Allele T is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	33501733
chr8	63038677	63038678	C	A,T	rs11545077	GGH	Genotypes CC + CT are associated with increased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype TT.	32295690
chr8	63038752	63038753	A	G	rs1800909	GGH	Allele G is not associated with response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A.	32295690
chr8	63038891	63038892	A	C	rs11545076	GGH	Genotypes AC + CC are associated with increased response to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA.	32295690
chr8	63039121	63039122	C	A,T	rs719235	GGH	Allele A is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	33501733
chr8	63039168	63039169	G	A	rs3758149	GGH	Genotypes AA + AG are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype GG.	19827168
chr8	63040621	63040622	C	T	rs10464903	GGH	Allele T is not associated with exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C.	33501733
chr8	63999463	63999464	C	A,G	rs3850736		Allele G is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.	37098852
chr8	64044324	64044325	T	A,C,G	rs2356369		Allele C is not associated with clearance of tenofovir in people with HIV Infections as compared to allele T.	37098852
chr8	64069101	64069102	G	A	rs7841320		Allele A is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G.	37098852
chr8	66280143	66280144	T	C	rs4737771	CRH	Allele C is associated with decreased response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	27091189
chr8	67747911	67747912	T	A,C,G	rs2162145	CPA6	Allele T is associated with increased response to metformin in people with Diabetes Mellitus, Type 2 as compared to allele C.	29650774
chr8	68961216	68961217	T	C	rs16935279		Genotypes CC + CT are associated with decreased metabolism of antiepileptics in people with Bipolar Disorder and Psychotic Disorders as compared to genotype TT.	25944848
chr8	73989726	73989727	C	G	rs11465996	LY96	Genotypes CG + GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	28696418
chr8	74560987	74560988	A	G,T	rs2891356		Allele G is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele A.	27758888
chr8	74562293	74562294	C	A,T	rs746460		Allele T is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele C.	27758888
chr8	74566176	74566177	T	A,C,G	rs4476990		Allele G is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele C.	27758888
chr8	74567388	74567389	C	G,T	rs13260300		Allele T is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele C.	27758888
chr8	74602318	74602319	G	A	rs4735715		Allele A is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele G.	27758888
chr8	74603963	74603964	G	C,T	rs3802201		Allele C is not associated with increased response to anastrozole and exemestane in women with Breast Neoplasms as compared to allele G.	27758888
chr8	78800762	78800763	G	A	rs16906115	IL7	Genotype AA is associated with decreased clinical benefit to atezolizumab and bevacizumab in people with Carcinoma, Hepatocellular as compared to genotypes AG + GG.	38990762
chr8	79644264	79644265	G	A	rs113889867	STMN2	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	25897834
chr8	88535702	88535703	C	T	rs10504861	MMP16	Allele C is associated with increased response to Angiotensin II Antagonists in people with Migraine with Aura or Migraine without Aura as compared to allele T.	26502740
chr8	97154684	97154685	T	C	rs1835740		Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.	31014225
chr8	102187807	102187808	A	G	rs1265138	RRM2B	Genotype AA is associated with increased response to cladribine and cytarabine in children with Leukemia, Myeloid, Acute as compared to genotypes AG + GG.	24024897
chr8	102226602	102226603	G	A,C,T	rs2607658	RRM2B	Genotypes GG + GT is associated with increased concentrations of telbivudine in people with Hepatitis B, Chronic as compared to genotype TT.	38502357
chr8	107371096	107371097	G	A,C	rs2445365	ANGPT1	Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.	28045923
chr8	112812828	112812829	A	G	rs2432742	CSMD3	Allele A is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.	23753411
chr8	117172543	117172544	C	A,T	rs13266634	SLC30A8	Allele C is not associated with response to metformin in people with high risk of developing diabetes as compared to allele T.	21779873
chr8	119580574	119580575	G	A	rs7832704	ENPP2	Genotype AA is associated with increased dose of opioids in people with Pain, Postoperative as compared to genotypes AG + GG.	37108150
chr8	119593411	119593412	G	A	rs2249015	ENPP2	Genotype AA is associated with increased dose of opioids in people with Pain, Postoperative as compared to genotypes AG + GG.	37108150
chr8	121927682	121927683	C	A,T	rs11995962		Allele T is not associated with clearance of tenofovir in people with HIV Infections as compared to allele C.	37098852
chr8	122883054	122883055	T	C	rs17289471	ZHX2	Allele C is associated with increased response to peginterferon alfa-2a in people with Hepatitis B virus infection as compared to allele T.	39492517
chr8	127401059	127401060	G	T	rs6983267		Allele T is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele G.	24727911
chr8	127402646	127402647	T	C,G	rs7013278		Allele T is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele C.	24727911
chr8	127412546	127412547	A	C,G	rs7014346		Allele A is not associated with response to fluorouracil, irinotecan and oxaliplatin in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to allele G.	24727911
chr8	127735224	127735225	C	T	rs4645943	MYC	Genotypes CT + TT is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype CC.	26249541
chr8	127739079	127739080	T	C	rs4645962	MYC	Genotype CT is associated with decreased dose of warfarin in people with heart valve replacement as compared to genotype TT.	26249541
chr8	127742442	127742443	C	G,T	rs4645974	MYC	Genotype CC is associated with increased dose of warfarin in people with heart valve replacement as compared to genotypes CT + TT.	26249541
chr8	128008932	128008933	G	A,C	rs2114358	PVT1	Allele A is associated with increased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele G.	29095108
chr8	135413335	135413336	G	A,T	rs72732317		Allele T is associated with decreased metabolism of tramadol as compared to allele G.	30971809
chr8	142918183	142918184	A	G,T	rs1799998	CYP11B2	Genotypes AA + AG are associated with increased response to benazepril or imidapril in people with Essential hypertension as compared to genotype GG.	16765146
chr8_KZ208915v1_fix	40107	40108	T	A,C	rs17570753	MCPH1	Allele A is associated with response to perphenazine in people with Schizophrenia.	22920393
chr8_KZ208915v1_fix	42064	42065	C	T	rs11774231		Allele C is associated with response to perphenazine in people with Schizophrenia.	22920393
chr8_KZ208915v1_fix	1591366	1591367	C	A	rs4841588	GATA4	Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.	25026456
chr8_KZ208915v1_fix	1593210	1593211	A	T,G	rs13273672	GATA4	Genotype CC is associated with decreased clinical benefit to Drugs used in alcohol dependence in people with Alcoholism as compared to genotypes CT + TT.	20585342
chr8_KZ208915v1_fix	1596175	1596176	A	C	rs2645400	GATA4	Genotype TT is associated with increased dose of warfarin as compared to genotypes GG + GT.	25026456
chr8_KZ208915v1_fix	1598196	1598197	C	T	rs3735814	GATA4	Genotypes AG + GG are not associated with decreased dose of phenprocoumon as compared to genotype AA.	23215884
chr8_KZ208915v1_fix	1606019	1606020	T	G,C	rs10090884	GATA4	Genotype AA is not associated with dose of warfarin as compared to genotypes AC + CC.	26257249
chr8_KZ208915v1_fix	1861609	1861610	G	T,C,A	rs2736340	BLK	Allele C is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.	23007924
chr9	5074188	5074189	T	C	rs12343867	JAK2	Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Colitis, Ulcerative as compared to genotype TT.	28139755
chr9	6556838	6556839	C	G,T	rs10975641	GLDC	Allele G is associated with increased response to citalopram and escitalopram in people with Depressive Disorder, Major as compared to allele C.	21107318
chr9	8176225	8176226	T	G	rs10739150		Genotypes GG + GT are associated with increased response to atenolol in people with Hypertension as compared to genotype TT.	26425837
chr9	8879117	8879118	C	A,G,T	rs17584499	PTPRD	Genotype CC is associated with increased response to pioglitazone in people with Diabetes Mellitus, Type 2 as compared to genotypes CT + TT.	23147557
chr9	9059544	9059545	G	A,C	rs324498	PTPRD	Allele G is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele A.	30237584
chr9	9687486	9687487	C	G,T	rs4742610	PTPRD	Allele T is associated with resistance to trandolapril and verapamil in people with Hypertension as compared to allele C.	26425837
chr9	11018076	11018077	C	A,G,T	rs12346562		Genotypes AA + AC is associated with increased response to atenolol in people with Hypertension as compared to genotype CC.	26425837
chr9	11028274	11028275	A	G	rs1104514		Genotypes AA + AG are associated with increased response to atenolol in people with Hypertension as compared to genotype GG.	26425837
chr9	14087769	14087770	C	T	rs7858	NFIB	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr9	14163907	14163908	T	C	rs28379954	NFIB	Allele C is not associated with increased concentrations of dextromethorphan and dextrorphan in healthy individuals as compared to allele T.	38637968
chr9	20405631	20405632	C	A,T	rs10964552	MLLT3	Genotypes AA + AC are associated with decreased response to cisplatin in people with Urinary Bladder Neoplasms as compared to genotype CC.	27150640
chr9	20497143	20497144	G	A,C,T	rs6475448	MLLT3	Genotype AA is associated with increased response to montelukast in people with Asthma as compared to genotype GG.	26083242
chr9	21077716	21077717	G	A,C,T	rs1051922	IFNB1	Allele G is not associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele A.	22111603
chr9	22003367	22003368	G	A,T	rs1063192	CDKN2B	Allele G is associated with increased clinical benefit to apremilast in people with Psoriasis as compared to allele A.	38540428
chr9	22056499	22056500	G	A,C	rs10120688	CDKN2B-AS1	Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.	26729200
chr9	22125503	22125504	G	A,C	rs1333049		Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.	26729200
chr9	27561050	27561051	T	C	rs774359	C9orf72	Genotypes CC + CT is associated with increased response to ustekinumab in people with Psoriasis as compared to genotype TT.	27977334
chr9	34710262	34710263	G	A,C	rs2812378	CCL21	Allele A is not associated with response to adalimumab, etanercept, infliximab or Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	23007924
chr9	35704152	35704153	C	G,T	rs10814270	TLN1	Allele T is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele C.	36581799
chr9	35712005	35712006	G	A,C	rs2295795	TLN1	Allele A is not associated with increased resistance to clopidogrel in people with Coronary Disease as compared to allele G.	36581799
chr9	38643998	38643999	A	G	rs1890109	FAM201A	Genotypes AG + GG is associated with increased dose of warfarin in people with heart valve replacement as compared to genotype AA.	37626805
chr9	71336038	71336039	T	A,C,G	rs2043144		Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.	25897834
chr9	72930965	72930966	G	A	rs13959	ALDH1A1	Genotypes AG + GG is associated with increased clinical benefit to cyclophosphamide, doxorubicin, FEC100 or fluorouracil in people with Breast Neoplasms.	39012380
chr9	72953467	72953471	CTGG	CTGGTCAGGAGAGAACCCTGG,CTGGTGAGGAGAGAAACCTGG,CTGGTGAGGAGAGAACACTGG,CTGGTGAGGAGAGAACCCCTGG,CTGGTGAGGAGAGAACCCTGG,CTGGTGAGGAGAGAATCCTGG	rs6151031	ALDH1A1	Genotype CTGGTGAGGAGAGAACC/del is associated with decreased response to cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to genotype CTGGTGAGGAGAGAACC/CTGGTGAGGAGAGAACC.	29938344
chr9	76389296	76389297	C	T	rs11144870	RFK	Allele T is associated with decreased response to citalopram or escitalopram in people with Depressive Disorder, Major as compared to allele C.	22907730
chr9	80329286	80329287	A	G	rs17180299		Genotypes AG + GG are associated with increased concentrations of methadone in people with Opioid-Related Disorders as compared to genotype AA.	27010727
chr9	84284968	84284969	C	A,G	rs4877831	SLC28A3	Genotype GG is not associated with metabolism of gemcitabine as compared to genotypes CC + CG.	24300978
chr9	84286010	84286011	G	A	rs7853758	SLC28A3	Genotype GG is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes AA + AG.	20665488
chr9	84302385	84302386	T	C	rs10868138	SLC28A3	Genotype TT is not associated with increased response to gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CC + CT.	18538445
chr9	84305320	84305321	T	A,C,G	rs7867504	SLC28A3	Genotype CC is not associated with increased response to gemcitabine in people with Pancreatic Neoplasms as compared to genotypes CT + TT.	20665488
chr9	84331157	84331158	G	A	rs17343066	SLC28A3	Genotype AA is associated with increased concentrations of ara-CTP in children with Leukemia, Myeloid, Acute as compared to genotypes AG + GG.	30088438
chr9	84670999	84671000	C	G,T	rs1187326	NTRK2	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	21047205
chr9	84673277	84673278	G	A,T	rs1439050	NTRK2	Allele G is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	28244805
chr9	84673624	84673625	T	A,C	rs1187327	NTRK2	Allele C is not associated with response to lithium in people with Bipolar Disorder as compared to allele T.	21047205
chr9	84678541	84678542	T	A,C	rs1187352	NTRK2	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	28244805
chr9	84707624	84707625	T	C	rs1778929	NTRK2	Genotype TT is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes CC + CT.	25751398
chr9	84709495	84709496	C	A,G,T	rs1778933	NTRK2	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	28244805
chr9	84777666	84777667	C	A,G,T	rs10465180	NTRK2	Genotype CC is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes CT + TT.	25751398
chr9	84841435	84841436	G	A	rs2120266	NTRK2	Genotype AA is associated with increased dose of methadone in people with Heroin Dependence as compared to genotypes AG + GG.	23651024
chr9	84948454	84948455	T	C	rs2289658	NTRK2	Genotypes CC + CT are associated with increased dose of methadone in people with Heroin Dependence as compared to genotype TT.	23651024
chr9	84948544	84948545	C	A,T	rs2289657	NTRK2	Allele A is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele C.	28244805
chr9	84948646	84948647	G	A	rs2289656	NTRK2	Allele A is not associated with response to lithium in people with Bipolar Disorder as compared to allele G.	21047205
chr9	84955088	84955089	C	T	rs3824519	NTRK2	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	28244805
chr9	84986053	84986054	T	G	rs4358872	NTRK2	Genotype GG is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes GT + TT.	23651024
chr9	85001341	85001342	G	A,T	rs1948308	NTRK2	Genotype GG is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes AA + AG.	23651024
chr9	85002155	85002156	G	A	rs1565445	NTRK2	Genotype AA is not associated with response to lithium or valproic acid in people with Bipolar Disorder as compared to genotypes AG + GG.	23315174
chr9	85004507	85004508	A	C,T	rs2378676	NTRK2	Genotype AA is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes AC + CC.	23651024
chr9	85017402	85017403	C	A,G,T	rs4877900	NTRK2	Genotype CC is associated with decreased dose of methadone in people with Heroin Dependence as compared to genotypes CT + TT.	23651024
chr9	85025720	85025721	A	G	rs1387923	NTRK2	Genotype AA is associated with increased response to lithium in people with Bipolar Disorder.	21047205
chr9	85297755	85297756	C	T	rs2769605		Genotype CC is associated with decreased response to lithium or valproic acid in people with Bipolar Disorder as compared to genotypes CT + TT.	23315174
chr9	86348092	86348093	C	T	rs17461620	TUT7	Allele C is associated with decreased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to allele T.	19749758
chr9	87620878	87620879	A	C	rs11141915	DAPK1	Allele A is not associated with response to gemcitabine and paclitaxel in women with Breast Neoplasms as compared to allele C.	24361227
chr9	95956390	95956391	T	C,G	rs689979	ERCC6L2	Allele T is not associated with response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele C.	23753411
chr9	96023993	96023994	A	C,G,T	rs238		Allele A is associated with decreased response to diuretics, hydrochlorothiazide or Thiazides, plain in people with Hypertension as compared to allele G.	23753411
chr9	97697295	97697296	T	A,C,G	rs1800975	XPA	Genotype CC is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.	25069034
chr9	100301362	100301363	G	A,C,T	rs10123866	INVS	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr9	100302247	100302248	G	A,C,T	rs7472	TEX10	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr9	100302982	100302983	G	A,C,T	rs10124893	TEX10	Allele G is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr9	100309101	100309102	A	C,G,T	rs7035619	TEX10	Allele A is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele T.	29407288
chr9	100311308	100311309	C	A,G,T	rs6479008	TEX10	Allele C is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele A.	29407288
chr9	100349682	100349683	C	A,T	rs10989064	TEX10	Allele T is associated with increased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr9	101570212	101570213	A	C	rs7030238	GRIN3A	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32481444
chr9	101570760	101570761	T	C	rs1983812	GRIN3A	Allele C is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr9	101670590	101670591	T	C,G	rs942142	GRIN3A	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele T.	32481444
chr9	101670751	101670752	A	G	rs10512285	GRIN3A	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32481444
chr9	101733128	101733129	C	T	rs3983721	GRIN3A	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32481444
chr9	104800522	104800523	T	A,C	rs2230808	ABCA1	Genotype CC is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT.	20346718
chr9	104858585	104858586	C	G,T	rs2230806	ABCA1	Allele T is associated with decreased response to atorvastatin, rosuvastatin or simvastatin as compared to allele C.	31806882
chr9	104883195	104883196	G	C,T	rs12003906	ABCA1	Allele C is associated with decreased response to atorvastatin, pravastatin or simvastatin in people with Hyperlipidemias as compared to allele G.	20031551
chr9	104941652	104941653	G	A,C	rs2487032		Allele A is associated with decreased response to clopidogrel in people with Coronary Artery Disease as compared to allele G.	30487649
chr9	107487223	107487224	C	T	rs2236599	KLF4	Allele C is associated with increased response to hydroxyurea in people with Anemia, Sickle Cell and beta-Thalassemia as compared to allele T.	31393228
chr9	108212717	108212718	T	C	rs10512361		Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.	25897834
chr9	114341692	114341693	A	C,G,T	rs2250242	ORM2	Genotype AA is associated with increased clearance of docetaxel in men with Prostatic Neoplasms as compared to genotypes AG + GG.	24619498
chr9	116490349	116490350	A	G,T	rs6478241	ASTN2	Allele A is not associated with response to Selective serotonin (5HT1) agonists in people with Migraine without Aura as compared to allele G.	30256423
chr9	117194008	117194009	T	C	rs7858836	ASTN2	Genotypes CT + TT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype CC.	33476460
chr9	117196573	117196574	T	C	rs958804	ASTN2	Genotypes CC + CT are associated with decreased dose of fentanyl in people with Pain, Postoperative as compared to genotype TT.	33476460
chr9	117700860	117700861	A	G,T	rs2770150	TLR4	Genotype GG is associated with decreased response to Pertussis vaccines in children as compared to genotype AG.	17699831
chr9	117710485	117710486	C	T	rs1927907	TLR4	Allele T is not associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele C.	29318894
chr9	117712003	117712004	G	A,T	rs5030728	TLR4	Genotypes AA + AG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammatory Bowel Diseases as compared to genotype GG.	24776844
chr9	117713023	117713024	A	G,T	rs4986790	TLR4	Genotype AA is associated with increased response to Pertussis vaccines in children as compared to genotypes AG + GG.	22383676
chr9	117713323	117713324	C	T	rs4986791	TLR4	Allele T is associated with decreased clinical benefit to prednisolone in children with Thrombocytopenia as compared to allele C.	37638833
chr9	117718533	117718534	T	C	rs1554973	CNPY4	Genotypes CC + CT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammatory Bowel Diseases as compared to genotype TT.	24776844
chr9	120927960	120927961	G	A,C	rs3761847	TRAF1	Allele G is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A.	25834819
chr9	122370242	122370243	A	G	rs10306114	PTGS1	Genotype AG is associated with decreased response to latanoprost in people with Glaucoma, Open-Angle as compared to genotype AA.	25339146
chr9	122371227	122371228	C	T	rs3842787	PTGS1	Allele T is not associated with response to aspirin as compared to allele C.	19350112
chr9	122375415	122375416	A	T	rs10306135	PTGS1	Genotype AA is not associated with response to ketoprofen in people with Pain, Postoperative as compared to genotypes AT + TT.	35705023
chr9	122399590	122399591	C	T	rs12353214	PTGS1	Genotype CC is not associated with response to ketoprofen in people with Pain, Postoperative as compared to genotype CT.	35705023
chr9	123104492	123104493	C	G,T	rs9032	STRBP	Allele C is associated with increased response to methylphenidate in people with Attention Deficit Disorder with Hyperactivity.	29382897
chr9	125238839	125238840	C	T	rs430397	HSPA5	Genotype TT is associated with increased resistance to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.	21940774
chr9	125274965	125274966	C	T	rs10819043	GAPVD1	Allele T is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele C.	27001119
chr9	125366502	125366503	A	G	rs2291858	GAPVD1	Allele G is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele A.	27001119
chr9	125370927	125370928	T	C	rs10760397	GAPVD1	Allele C is associated with increased response to interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to allele T.	27001119
chr9	127800445	127800446	C	T	rs1544105	FPGS	Genotypes CT + TT are associated with decreased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype CC.	19902562
chr9	127804259	127804260	A	G	rs7856096	FPGS	Allele G is associated with decreased dose of warfarin as compared to allele A.	25079360
chr9	127824341	127824342	C	G,T	rs1800956	ENG	Allele G is associated with decreased clearance of methotrexate in children with Acute lymphoblastic leukemia as compared to allele C.	39611166
chr9	130483268	130483269	G	A,C,T	rs10901080	ASS1	Allele T is associated with increased response to hydroxyurea in people with Anemia, Sickle Cell and beta-Thalassemia as compared to allele G.	26895070
chr9	130502522	130502523	C	T	rs10793902	ASS1	Allele T is associated with increased response to hydroxyurea in people with Anemia, Sickle Cell and beta-Thalassemia as compared to allele C.	26895070
chr9	133533735	133533736	C	A,T	rs756770	ADAMTSL2	Allele A is associated with increased response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.	34488071
chr9	133635080	133635081	C	T	rs1611114	DBH	Allele T is not associated with dose of methadone in people with Heroin Dependence as compared to allele C.	32736537
chr9	133635392	133635393	T	A,C,G	rs1611115	DBH	Genotypes CT + TT are associated with increased response to levodopa in people with Cocaine-Related Disorders as compared to genotype CC.	24809448
chr9	133640521	133640522	T	A,C	rs2873804	DBH	Genotype CC is associated with increased response to bupropion in people with Depressive Disorder, Major as compared to genotypes CT + TT.	22947179
chr9	133642350	133642351	G	A	rs5320	DBH	Allele A is not associated with dose of methadone in people with Heroin Dependence as compared to allele G.	32736537
chr9	133652974	133652975	A	C,G,T	rs77905	DBH	Genotype GG is associated with decreased dose of nicotine in people with Tobacco Use Disorder as compared to genotypes AA + AG.	10975602
chr9	133658546	133658547	C	T	rs129882	DBH	Allele T is not associated with response to heroin as compared to allele C.	32736537
chr9	133659795	133659796	A	G	rs129915	DBH	Allele G is not associated with dose of methadone in people with Heroin Dependence as compared to allele A.	32736537
chr9	134041882	134041883	G	A,T	rs467387	BRD3	Genotype AA is associated with increased response to rivaroxaban in healthy individuals as compared to genotypes AG + GG.	38553322
chr9	134436439	134436440	G	A,C	rs1805343	RXRA	Allele A is associated with increased exposure to rosuvastatin in healthy individuals.	30100615
chr9	134441071	134441072	G	A,T	rs3132291	RXRA	Allele A is associated with increased metabolism of docetaxel in people with Nasopharyngeal Neoplasms as compared to allele G.	24193570
chr9	134441601	134441602	A	C,G,T	rs4842198		Allele G is associated with increased metabolism of docetaxel in people with Nasopharyngeal Neoplasms.	24193570
chr9	134448666	134448667	G	A	rs9409929		Allele A is associated with increased metabolism of vitamin d and analogues in people with Adenoma as compared to allele G.	20307661
chr9	134882698	134882699	T	C	rs3124955	FCN2	Allele T is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele C.	29407288
chr9	134883292	134883293	A	G,T	rs3128624	FCN2	Allele A is associated with decreased response to duloxetine in people with Depressive Disorder, Major as compared to allele G.	29407288
chr9	135703101	135703102	G	A,C,T	rs546120	KCNT1	Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.	24279416
chr9	135705127	135705128	G	A	rs496503	KCNT1	Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.	24279416
chr9	135711893	135711894	C	G,T	rs487750	KCNT1	Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.	24279416
chr9	135714077	135714078	C	G,T	rs1165016	KCNT1	Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.	24279416
chr9	135715704	135715705	A	G,T	rs498974	KCNT1	Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.	24279416
chr9	135724119	135724120	A	G,T	rs498618	KCNT1	Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.	24279416
chr9	135725456	135725457	T	C	rs1537416	KCNT1	Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.	24279416
chr9	135725654	135725655	G	C,T	rs7855716	KCNT1	Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.	24279416
chr9	135739807	135739808	C	T	rs755722	KCNT1	Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.	24279416
chr9	135752356	135752357	T	C	rs10735239	KCNT1	Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.	24279416
chr9	135756317	135756318	T	C	rs11103167	KCNT1	Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.	24279416
chr9	135761805	135761806	A	G	rs10118746	KCNT1	Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.	24279416
chr9	135771949	135771950	G	A,T	rs11103182	KCNT1	Allele G is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.	24279416
chr9	135776226	135776227	A	G,T	rs1318383	KCNT1	Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.	24279416
chr9	135778129	135778130	C	A	rs10776845	KCNT1	Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele C.	24279416
chr9	135785691	135785692	T	A	rs10776850	KCNT1	Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.	24279416
chr9	135789054	135789055	T	A,C	rs10858173	KCNT1	Allele C is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele T.	24279416
chr9	137011906	137011907	G	A,C,T	rs2271862	ABCA2	Allele G is associated with increased clearance of fluorouracil in people with Colorectal Neoplasms as compared to allele A.	32559325
chr9	137138631	137138632	G	C	rs11146020	GRIN1	Genotypes CC + CG are not associated with increased response to clozapine in people with Schizophrenia as compared to genotype GG.	21332319
chr9	138116188	138116189	A	G	rs2739258	CACNA1B	Genotypes AG + GG is associated with increased clinical benefit to nicardipine or nimodipine in people with Bipolar Disorder as compared to genotype AA.	37270865
chr9	138117611	138117612	A	G	rs2739260	CACNA1B	Genotypes AG + GG is associated with increased clinical benefit to nicardipine or nimodipine in people with Bipolar Disorder as compared to genotype AA.	37270865
chr9	138122078	138122079	C	T	rs2229949	CACNA1B	Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT.	30032160
chr9_KQ090018v1_alt	80689	80690	G	A,C	rs324498	PTPRD	Allele G is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele A.	30237584
chrX	9373807	9373808	C	A,G,T	rs715171		Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.	21635146
chrX	9967803	9967804	C	T	rs5934731		Allele C is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.	21635146
chrX	12885539	12885540	A	C,T	rs179008	TLR7	Allele A is not associated with response to interferon alfa-2a, recombinant in people with Hepatitis C, Chronic as compared to allele T.	20872712
chrX	15599937	15599938	A	C,G,T	rs2106809	ACE2	Genotype GG is associated with increased response to captopril in women with Hypertension as compared to genotypes AA + AG.	17473847
chrX	23356859	23356860	A	T	rs7051085	PTCHD1	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	25897834
chrX	43742115	43742116	A	G,T	rs979605	MAOA	Genotype AA is associated with decreased clinical benefit to antidepressants in people with Depressive Disorder, Major as compared to allele A.	36613935
chrX	43744143	43744144	T	C	rs1137070	MAOA	Allele C is not associated with response to rizatriptan in people with Migraine without Aura as compared to allele T.	17563839
chrX	43768751	43768752	T	A,C	rs1799836	MAOB	Allele T is associated with increased concentrations of 5-hydroxyindole-3-acetic acid and serotonin in men with Depressive Disorder, Major as compared to allele C.	36613935
chrX	45781103	45781104	T	C,G	rs5906072		Allele T is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele C.	21635146
chrX	114583808	114583809	G	A	rs3813928	HTR2C	Allele A is associated with decreased response to risperidone in children with Autistic Disorder as compared to genotype GG.	19997080
chrX	114584046	114584047	C	G,T	rs3813929	HTR2C	Allele T is not associated with exposure to olanzapine in healthy individuals as compared to allele C.	33378980
chrX	114903580	114903581	C	G	rs1414334	HTR2C	Allele G is not associated with exposure to olanzapine in healthy individuals as compared to allele C.	33378980
chrX	123182583	123182584	T	A,C	rs3761555	GRIA3	Genotype TT is associated with decreased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotypes CC + CT.	23394390
chrX	123183390	123183391	T	C	rs3761554	GRIA3	Genotype TT is associated with decreased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotypes CC + CT.	23394390
chrX	123403425	123403426	T	C	rs502434	GRIA3	Genotype CC is associated with decreased response to Selective serotonin reuptake inhibitors or venlafaxine in people with Depressive Disorder, Major as compared to genotypes CT + TT.	23394390
chrX	136648395	136648396	T	C,G	rs1126535	CD40LG	Allele T is associated with increased response to adalimumab in people with Arthritis, Rheumatoid as compared to allele C.	28639493
chrX	151969706	151969707	A	C,G,T	rs1139916	GABRE	Allele A is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele C.	31014225
chrX	152247401	152247402	T	C	rs6627221	GABRA3	Allele C is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele T.	31014225
chrX	152321842	152321843	A	G	rs2201169	GABRA3	Allele G is not associated with response to botulinum toxin type a in women with Migraine NOS as compared to allele A.	31014225
chrX	152413523	152413524	T	C	rs4828696	GABRA3	Genotype TT is not associated with increased response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype CC.	24236484
chrX	152437531	152437532	G	A,C,T	rs1112122	GABRA3	Genotype GG is not associated with response to carbamazepine, gabapentin, lamotrigine, oxcarbazepine, phenytoin, topiramate or valproic acid in people with Epilepsy as compared to genotype TT.	24236484
chrX	154046528	154046529	T	A,C	rs17435	MECP2	Allele A is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.	21635146
chrX	154059994	154059995	A	C,G	rs1734787	MECP2	Allele A is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele C.	21635146
chrX	154065468	154065469	A	C,G,T	rs1734791	MECP2	Allele A is associated with response to cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to allele T.	21635146
chrX	154536001	154536002	C	T	rs1050828	G6PD	Allele T is not associated with response to artemisinin and derivatives in people with Malaria, Falciparum as compared to allele C.	22940027
